thiocarbonyl group - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	thiocarbonyl group	go back to main search page
Accession:	CHEBI:30256	browse the term
Synonyms:	related_synonym:	>C=S; carbonothioyl; thiocarbonyl
	chemrof_smiles:	C()=S
	chemrof_formula:	CS

show annotations for term's descendants Sort by:
Rat (8170 ) Mouse (7913 ) Human (7915 ) Chinchilla (0 ) Bonobo (0 ) Dog (1 ) Squirrel (0 ) Pig (9 ) Green Monkey (0) Naked Mole-rat (0 ) All
Genes (8170)

3,7-dihydropurine-6-thione

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP binding cassette subfamily C member 8

decreases expression

EXP

Mercaptopurine results in decreased expression of ABCC8 mRNA

NCBI chr 1:105,734,992...105,816,272
Ensembl chr 1:105,734,992...105,815,982

G

alkaline ceramidase 2

increases expression

EXP

Mercaptopurine results in increased expression of ACER2 mRNA

NCBI chr 5:106,437,773...106,488,572
Ensembl chr 5:106,437,796...106,488,583

G

aconitate decarboxylase 1

increases expression

EXP

Mercaptopurine results in increased expression of ACOD1 mRNA

NCBI chr15:86,286,531...86,295,803
Ensembl chr15:86,286,579...86,295,687

G

actin gamma 2, smooth muscle

decreases expression

EXP

Mercaptopurine results in decreased expression of ACTG2 mRNA

NCBI chr 4:117,579,513...117,604,379
Ensembl chr 4:117,579,514...117,604,295

G

actin-related protein T3

increases expression

EXP

Mercaptopurine results in increased expression of ACTRT3 mRNA

NCBI chr 2:114,727,534...114,729,561
Ensembl chr 2:114,727,534...114,729,563

G

adrenomedullin

increases expression

EXP

Mercaptopurine results in increased expression of ADM mRNA

NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371

G

angiotensinogen

decreases expression

EXP

Mercaptopurine results in decreased expression of AGT mRNA

NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944

G

alanine--glyoxylate aminotransferase

increases expression

EXP

Mercaptopurine results in increased expression of AGXT mRNA

NCBI chr 9:101,122,793...101,132,746
Ensembl chr 9:101,122,793...101,132,745

G

A-kinase anchoring protein 12

decreases expression

EXP

Mercaptopurine results in decreased expression of AKAP12 mRNA

NCBI chr 1:43,135,515...43,225,245
Ensembl chr 1:43,199,008...43,225,557

G

A-kinase anchoring protein 3

increases expression

EXP

Mercaptopurine results in increased expression of AKAP3 mRNA

NCBI chr 4:161,374,198...161,400,062
Ensembl chr 4:161,374,407...161,400,230

G

aldehyde dehydrogenase 1 family, member B1

decreases expression

EXP

Mercaptopurine results in decreased expression of ALDH1B1 mRNA

NCBI chr 5:64,859,000...64,864,008
Ensembl chr 5:64,858,934...64,864,365

G

arachidonate 12-lipoxygenase, epidermal

decreases expression

EXP

Mercaptopurine results in decreased expression of ALOX12E mRNA

NCBI chr10:55,533,044...55,540,509
Ensembl chr10:55,533,044...55,540,509

G

arachidonate 15-lipoxygenase

decreases expression

EXP

Mercaptopurine results in decreased expression of ALOX15 mRNA

NCBI chr10:55,559,060...55,567,535
Ensembl chr10:55,559,061...55,567,723

G

alkaline phosphatase, intestinal

decreases expression

EXP

Mercaptopurine results in decreased expression of ALPI mRNA

NCBI chr 9:95,221,314...95,224,780
Ensembl chr 9:95,221,314...95,224,780

G

adenosine monophosphate deaminase 3

increases expression

EXP

Mercaptopurine results in increased expression of AMPD3 mRNA

NCBI chr 1:174,319,526...174,364,605
Ensembl chr 1:174,294,867...174,364,608

G

angiopoietin 2

increases expression

EXP

Mercaptopurine results in increased expression of ANGPT2 mRNA

NCBI chr16:77,790,760...77,841,241
Ensembl chr16:77,790,563...77,841,239

G

annexin A9

decreases expression

EXP

Mercaptopurine results in decreased expression of ANXA9 mRNA

NCBI chr 2:185,562,174...185,572,560
Ensembl chr 2:185,562,174...185,572,560

G

apolipoprotein C3

decreases expression

EXP

Mercaptopurine results in decreased expression of APOC3 mRNA

NCBI chr 8:55,428,172...55,430,352
Ensembl chr 8:55,428,024...55,458,679

G

ADP-ribosyltransferase 3

increases expression

EXP

Mercaptopurine results in increased expression of ART3 mRNA

NCBI chr14:15,921,540...16,003,764
Ensembl chr14:15,921,395...15,949,806

G

ankyrin repeat and SOCS box-containing 14

increases expression

EXP

Mercaptopurine results in increased expression of ASB14 mRNA

NCBI chr16:2,102,303...2,131,379
Ensembl chr16:2,102,363...2,130,590

G

aspartic peptidase, retroviral-like 1

increases expression

EXP

Mercaptopurine results in increased expression of ASPRV1 mRNA

NCBI chr 4:120,634,793...120,636,265
Ensembl chr 4:120,634,793...120,636,260

G

ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3

decreases expression

EXP

Mercaptopurine results in decreased expression of ATP2A3 mRNA

NCBI chr10:58,079,710...58,111,279
Ensembl chr10:58,079,852...58,111,278

G

BRCA1 associated RING domain 1

decreases expression

EXP

Mercaptopurine results in decreased expression of BARD1 mRNA

NCBI chr 9:80,069,960...80,144,167
Ensembl chr 9:80,069,960...80,176,873

G

basic leucine zipper ATF-like transcription factor 3

decreases expression

EXP

Mercaptopurine results in decreased expression of BATF3 mRNA

NCBI chr13:105,220,782...105,232,365
Ensembl chr13:105,220,390...105,232,369

G

BCL2 associated X, apoptosis regulator

increases expression

ISO

Mercaptopurine results in increased expression of BAX protein

NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429

G

BCL2, apoptosis regulator

decreases expression
multiple interactions

ISO

Mercaptopurine results in decreased expression of BCL2 protein
[Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein

PMID:9058596 PMID:21182165

NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900

G

Bcl2-like 1

decreases expression

ISO

Mercaptopurine results in decreased expression of BCL2L1 protein

NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907
Ensembl chr 1:161,745,540...161,764,907

G

BCL6 co-repressor-like 1

decreases expression

EXP

Mercaptopurine results in decreased expression of BCORL1 mRNA

NCBI chr X:132,394,703...132,462,414
Ensembl chr X:132,397,069...132,461,976

G

B-box and SPRY domain containing

decreases expression

EXP

Mercaptopurine results in decreased expression of BSPRY mRNA

NCBI chr 5:80,942,974...80,965,157
Ensembl chr 5:80,942,979...80,988,154

G

BTB domain containing 16

increases expression

EXP

Mercaptopurine results in increased expression of BTBD16 mRNA

NCBI chr 1:194,765,241...194,819,786
Ensembl chr 1:194,765,903...194,819,785

G

complement C1q A chain

increases expression

EXP

Mercaptopurine results in increased expression of C1QA mRNA

NCBI chr 5:154,417,086...154,419,933
Ensembl chr 5:154,417,087...154,427,732

G

carbonic anhydrase 4

decreases expression

EXP

Mercaptopurine results in decreased expression of CAR4 mRNA

NCBI chr10:70,325,102...70,333,916
Ensembl chr10:70,325,358...70,333,916

G

cyclase associated actin cytoskeleton regulatory protein 2

increases expression

EXP

Mercaptopurine results in increased expression of CAP2 mRNA

NCBI chr17:18,260,462...18,409,681
Ensembl chr17:18,261,646...18,409,563

G

carbonic anhydrase 7

decreases expression

EXP

Mercaptopurine results in decreased expression of CAR7 mRNA

NCBI chr19:435,520...444,927
Ensembl chr19:435,522...452,384

G

caspase 3

increases expression

EXP

Mercaptopurine results in increased expression of CASP3 protein

NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732

G

C-C motif chemokine ligand 5

decreases expression

EXP

Mercaptopurine results in decreased expression of CCL5 mRNA

NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884

G

cyclin E1

decreases expression

EXP

Mercaptopurine results in decreased expression of CCNE1 mRNA

NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822

G

C-C motif chemokine receptor 6

decreases expression

EXP

Mercaptopurine results in decreased expression of CCR6 mRNA

NCBI chr 1:55,022,037...55,055,857
Ensembl chr 1:55,021,833...55,046,059

G

CD19 molecule

decreases expression

EXP

Mercaptopurine results in decreased expression of CD19 mRNA

NCBI chr 1:190,417,853...190,424,494
Ensembl chr 1:190,417,853...190,424,355

G

Cd28 molecule

multiple interactions

ISO

Mercaptopurine inhibits the reaction [CD28 protein results in increased activity of [NFKB1 protein binds to RELA protein]]

NCBI chr 9:69,660,316...69,689,192
Ensembl chr 9:69,545,326...69,689,192

G

Cd68 molecule

increases expression

EXP

Mercaptopurine results in increased expression of CD68 mRNA

NCBI chr10:54,880,562...54,882,441
Ensembl chr10:54,880,563...54,882,540

G

CD79b molecule

decreases expression

EXP

Mercaptopurine results in decreased expression of CD79B mRNA

NCBI chr10:91,739,134...91,742,312
Ensembl chr10:91,739,137...91,742,405

G

cell division cycle 25B

decreases expression

EXP

Mercaptopurine results in decreased expression of CDC25B mRNA

NCBI chr 3:138,860,148...138,870,287
Ensembl chr 3:138,860,130...138,870,492

G

cell division cycle associated 3

decreases expression

EXP

Mercaptopurine results in decreased expression of CDCA3 mRNA

NCBI chr 4:159,321,203...159,325,072
Ensembl chr 4:159,321,014...159,325,068

G

cell division cycle associated 7 like

decreases expression

EXP

Mercaptopurine results in decreased expression of CDCA7L mRNA

NCBI chr 6:144,936,885...144,982,844
Ensembl chr 6:144,908,171...144,982,843

G

chymotrypsin like elastase 1

increases expression

EXP

Mercaptopurine results in increased expression of CELA1 mRNA

NCBI chr 7:133,651,939...133,665,136
Ensembl chr 7:133,651,941...133,665,061

G

centromere protein W

decreases expression

EXP

Mercaptopurine results in decreased expression of CENPW mRNA

NCBI chr 1:29,353,939...29,359,109
Ensembl chr 1:29,353,970...29,359,109

G

carboxylesterase 3a

increases expression

EXP

Mercaptopurine results in increased expression of CES3 mRNA

NCBI chr19:49,902,312...49,910,484

G

carboxylesterase 4A

increases expression

EXP

Mercaptopurine results in increased expression of CES4A mRNA

NCBI chr19:49,921,643...49,942,838
Ensembl chr19:49,921,608...49,939,461

G

chordin

increases expression

EXP

Mercaptopurine results in increased expression of CHRD mRNA

NCBI chr11:93,676,400...93,685,584
Ensembl chr11:93,676,400...93,685,278

G

chordin-like 1

decreases expression

EXP

Mercaptopurine results in decreased expression of CHRDL1 mRNA

NCBI chr X:111,685,864...111,789,684
Ensembl chr X:111,685,866...111,789,661

G

cholinergic receptor nicotinic alpha 2 subunit

decreases expression

EXP

Mercaptopurine results in decreased expression of CHRNA2 mRNA

NCBI chr15:44,517,862...44,534,144
Ensembl chr15:44,517,862...44,534,144

G

C-type lectin domain containing 14A

decreases expression

EXP

Mercaptopurine results in decreased expression of CLEC14A mRNA

NCBI chr 6:81,616,414...81,619,556
Ensembl chr 6:81,612,953...81,619,614

G

C-type lectin domain family 4, member D

increases expression

EXP

Mercaptopurine results in increased expression of CLEC4D mRNA

NCBI chr 4:158,275,287...158,286,978
Ensembl chr 4:158,275,341...158,287,055

G

calmegin

decreases expression

EXP

Mercaptopurine results in decreased expression of CLGN mRNA

NCBI chr19:41,601,568...41,633,207
Ensembl chr19:41,601,568...41,633,325

G

chloride intracellular channel 2

increases expression

EXP

Mercaptopurine results in increased expression of CLIC2 mRNA

NCBI chr20:154,630...169,655
Ensembl chr20:154,255...169,648

G

chondromodulin

decreases expression

EXP

Mercaptopurine results in decreased expression of CNMD mRNA

NCBI chr15:61,450,617...61,475,382
Ensembl chr15:61,450,450...61,475,350

G

collagen type XI alpha 1 chain

decreases expression

EXP

Mercaptopurine results in decreased expression of COL11A1 mRNA

NCBI chr 2:204,509,136...204,702,264
Ensembl chr 2:204,509,136...204,702,264

G

collagen type I alpha 1 chain

decreases expression

EXP

Mercaptopurine results in decreased expression of COL1A1 mRNA

NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460

G

collagen type II alpha 1 chain

decreases expression

EXP

Mercaptopurine results in decreased expression of COL2A1 mRNA

NCBI chr 7:130,977,561...131,006,627
Ensembl chr 7:130,977,561...131,006,627

G

corin, serine peptidase

increases expression

EXP

Mercaptopurine results in increased expression of CORIN mRNA

NCBI chr14:36,034,613...36,264,671
Ensembl chr14:36,034,993...36,264,649

G

coronin 6

increases expression

EXP

Mercaptopurine results in increased expression of CORO6 mRNA

NCBI chr10:62,808,172...62,817,788
Ensembl chr10:62,809,689...62,817,787

G

carboxypeptidase E

increases expression

EXP

Mercaptopurine results in increased expression of CPE mRNA

NCBI chr16:29,796,707...29,908,647
Ensembl chr16:29,796,689...29,909,524

G

cathepsin K

increases expression

EXP

Mercaptopurine results in increased expression of CTSK mRNA

NCBI chr 2:185,747,548...185,758,512
Ensembl chr 2:185,747,165...185,765,582

G

cathepsin Q-like 2

increases expression

EXP

Mercaptopurine results in increased expression of CTSQL2 mRNA

NCBI chr17:3,704,585...3,710,404

G

cortexin 3

increases expression

EXP

Mercaptopurine results in increased expression of CTXN3 mRNA

NCBI chr18:53,129,505...53,138,694
Ensembl chr18:53,129,489...53,138,693

G

cubilin

decreases expression

EXP

Mercaptopurine results in decreased expression of CUBN mRNA

NCBI chr17:81,293,619...81,501,694
Ensembl chr17:81,293,619...81,501,694

G

C-X-C motif chemokine ligand 2

increases expression

EXP

Mercaptopurine results in increased expression of CXCL2 mRNA

NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255

G

cytochrome P450, family 26, subfamily a, polypeptide 1

increases expression

EXP

Mercaptopurine results in increased expression of CYP26A1 mRNA

NCBI chr 1:244,883,822...244,887,657
Ensembl chr 1:244,883,752...244,887,657

G

cytochrome P450, family 2, subfamily j, polypeptide 4

increases expression

EXP

Mercaptopurine results in increased expression of CYP2J4 mRNA

NCBI chr 5:116,295,691...116,323,219
Ensembl chr 5:116,295,694...116,323,042

G

cytochrome P450, family 4, subfamily a, polypeptide 3

increases expression

EXP

Mercaptopurine results in increased expression of CYP4A3 mRNA

NCBI chr 5:134,334,396...134,352,268
Ensembl chr 5:134,334,701...134,352,236

G

DDB1 and CUL4 associated factor 12-like 1

decreases expression

EXP

Mercaptopurine results in decreased expression of DCAF12L1 mRNA

NCBI chr X:128,572,969...128,576,588
Ensembl chr X:128,572,811...128,577,222

G

DEF6 guanine nucleotide exchange factor

increases expression

EXP

Mercaptopurine results in increased expression of DEF6 mRNA

NCBI chr20:6,270,323...6,291,724
Ensembl chr20:6,269,357...6,291,771

G

dehydrogenase/reductase 9

increases expression

EXP

Mercaptopurine results in increased expression of DHRS9 mRNA

NCBI chr 3:74,553,357...74,579,535
Ensembl chr 3:74,555,606...74,581,376

G

iodothyronine deiodinase 2

increases expression

EXP

Mercaptopurine results in increased expression of DIO2 mRNA

NCBI chr 6:115,396,308...115,410,594
Ensembl chr 6:115,396,308...115,410,594

G

dickkopf like acrosomal protein 1

decreases expression

EXP

Mercaptopurine results in decreased expression of DKKL1 mRNA

NCBI chr 1:104,830,462...104,835,711
Ensembl chr 1:104,829,478...104,835,711

G

delta like non-canonical Notch ligand 2

increases expression

EXP

Mercaptopurine results in increased expression of DLK2 mRNA

NCBI chr 9:22,174,667...22,179,149
Ensembl chr 9:22,173,158...22,179,149

G

delta like canonical Notch ligand 3

decreases expression

EXP

Mercaptopurine results in decreased expression of DLL3 mRNA

NCBI chr 1:92,689,577...92,698,125
Ensembl chr 1:92,689,577...92,697,406

G

dopamine receptor D4

increases expression

EXP

Mercaptopurine results in increased expression of DRD4 mRNA

NCBI chr 1:205,825,937...205,829,124
Ensembl chr 1:205,826,049...205,830,458

G

dual oxidase 2

increases expression

EXP

Mercaptopurine results in increased expression of DUOX2 mRNA

NCBI chr 3:129,680,543...129,698,886
Ensembl chr 3:129,680,546...129,699,203

G

EGF containing fibulin extracellular matrix protein 1

increases expression

EXP

Mercaptopurine results in increased expression of EFEMP1 mRNA

NCBI chr14:106,811,769...106,890,961
Ensembl chr14:106,802,304...106,892,808

G

ephrin A1

multiple interactions

EXP

Mercaptopurine promotes the reaction [GW 1929 results in increased expression of EFNA1 mRNA]

NCBI chr 2:176,979,434...176,988,675
Ensembl chr 2:176,979,434...176,988,726

G

EH-domain containing 3

increases expression

EXP

Mercaptopurine results in increased expression of EHD3 mRNA

NCBI chr 6:27,392,709...27,417,445
Ensembl chr 6:27,392,709...27,417,445

G

E74 like ETS transcription factor 5

decreases expression

EXP

Mercaptopurine results in decreased expression of ELF5 mRNA

NCBI chr 3:110,264,460...110,291,926
Ensembl chr 3:110,252,797...110,291,926

G

endomucin

decreases expression

EXP

Mercaptopurine results in decreased expression of EMCN mRNA

NCBI chr 2:228,564,445...228,644,370
Ensembl chr 2:228,564,430...228,645,155

G

ectonucleotide pyrophosphatase/phosphodiesterase 2

decreases expression

EXP

Mercaptopurine results in decreased expression of ENPP2 mRNA

NCBI chr 7:88,092,140...88,214,758
Ensembl chr 7:88,092,140...88,214,957

G

erythrocyte membrane protein band 4.1-like 3

decreases expression

EXP

Mercaptopurine results in decreased expression of EPB41L3 mRNA

NCBI chr 9:116,502,864...116,707,274
Ensembl chr 9:116,462,807...116,707,274

G

erb-b2 receptor tyrosine kinase 2

decreases expression

EXP

Mercaptopurine results in decreased expression of ERBB2 mRNA

NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,907,460...83,931,481

G

ERH, mRNA splicing and mitosis factor like 1

decreases expression

EXP

Mercaptopurine results in decreased expression of ERHL1 mRNA

NCBI chr 2:134,631,796...134,635,102
Ensembl chr 2:134,629,172...134,645,681

G

endogenous retrovirus group FRD member 1, envelope

decreases expression

EXP

Mercaptopurine results in decreased expression of ERVFRD-1 mRNA

NCBI chr12:27,787,680...27,794,732
Ensembl chr12:27,787,680...27,794,732

G

estrogen receptor 1

increases expression

EXP

Mercaptopurine results in increased expression of ESR1 mRNA

NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354

G

coagulation factor XIII A1 chain

increases expression

EXP

Mercaptopurine results in increased expression of F13A1 mRNA

NCBI chr17:28,021,197...28,197,960
Ensembl chr17:28,020,845...28,197,948

G

family with sequence similarity 25, member A

increases expression

EXP

Mercaptopurine results in increased expression of FAM25A mRNA

NCBI chr16:9,686,922...9,690,728
Ensembl chr16:9,686,922...9,690,728

G

Fc gamma receptor 3A

increases expression

EXP

Mercaptopurine results in increased expression of FCGR3A mRNA

NCBI chr13:85,782,636...85,792,656
Ensembl chr13:85,782,490...85,792,651

G

ficolin B

increases expression

EXP

Mercaptopurine results in increased expression of FCN1 mRNA

NCBI chr 3:31,791,750...31,800,188
Ensembl chr 3:31,791,750...31,800,188

G

ferritin light chain 1

increases expression

EXP

Mercaptopurine results in increased expression of FTL mRNA

NCBI chr 1:105,072,858...105,074,705
Ensembl chr X:45,399,355...45,399,915
Ensembl chr 2:45,399,355...45,399,915
Ensembl chr 1:45,399,355...45,399,915

G

G0/G1switch 2

increases expression

EXP

Mercaptopurine results in increased expression of G0S2 mRNA

NCBI chr13:107,335,036...107,335,948
Ensembl chr13:107,335,036...107,336,293

G

glyceraldehyde-3-phosphate dehydrogenase

affects localization

ISO

Mercaptopurine affects the localization of GAPDH protein

NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:159,648,592...159,653,377

G

glycine amidinotransferase

increases expression

EXP

Mercaptopurine results in increased expression of GATM mRNA

NCBI chr 3:130,112,508...130,137,664
Ensembl chr 3:130,112,509...130,129,355

G

glutamate cysteine ligase, modifier subunit

increases expression

ISO

Mercaptopurine results in increased expression of GCLM mRNA

NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003

G

glial cells missing transcription factor 1

decreases expression

EXP

Mercaptopurine results in decreased expression of GCM1 mRNA

NCBI chr 8:87,805,993...87,819,229
Ensembl chr 8:87,805,993...87,819,229

G

growth differentiation factor 9

increases expression

EXP

Mercaptopurine results in increased expression of GDF9 mRNA

NCBI chr10:38,090,021...38,100,801
Ensembl chr10:38,089,878...38,100,797

G

ghrelin and obestatin prepropeptide

decreases expression

EXP

Mercaptopurine results in decreased expression of GHRL mRNA

NCBI chr 4:148,421,315...148,431,128
Ensembl chr 4:148,421,315...148,425,969

G

gap junction protein, beta 4

increases expression

EXP

Mercaptopurine results in increased expression of GJB4 mRNA

NCBI chr 5:144,948,231...144,964,014
Ensembl chr 5:144,951,184...144,964,097

G

G protein subunit gamma 8

increases expression

EXP

Mercaptopurine results in increased expression of GNG8 mRNA

NCBI chr 1:86,692,609...86,696,463
Ensembl chr 1:86,692,642...86,696,408

G

glutathione peroxidase 2

increases expression

ISO

Mercaptopurine results in increased expression of GPX2 mRNA

NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:101,226,745...101,230,862

G

glutathione peroxidase 3

increases expression

ISO

Mercaptopurine results in increased expression of GPX3 mRNA

NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,529,448...39,537,405

G

gremlin 1, DAN family BMP antagonist

increases expression

EXP

Mercaptopurine results in increased expression of GREM1 mRNA

NCBI chr 3:120,966,639...120,978,319
Ensembl chr 3:120,966,623...120,979,089

G

gastrin releasing peptide

increases expression

EXP

Mercaptopurine results in increased expression of GRP mRNA

NCBI chr18:61,658,655...61,672,037
Ensembl chr18:61,658,250...61,672,037

G

glutaredoxin and cysteine rich domain containing 2

increases expression

EXP

Mercaptopurine results in increased expression of GRXCR2 mRNA

NCBI chr18:34,235,734...34,249,139
Ensembl chr18:34,235,734...34,371,894

G

glutathione synthetase

increases expression

ISO

Mercaptopurine results in increased expression of GSS mRNA

NCBI chr 3:164,508,005...164,538,343
Ensembl chr 3:164,508,005...164,538,306

G

glutathione S-transferase mu 1

affects response to substance

ISO

GSTM1 gene polymorphism affects the susceptibility to Mercaptopurine

NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569

G

guanylate cyclase activator 2A

increases expression

EXP

Mercaptopurine results in increased expression of GUCA2A mRNA

NCBI chr 5:138,522,446...138,524,288
Ensembl chr 5:138,522,446...138,524,287

G

granzyme B

increases expression

EXP

Mercaptopurine results in increased expression of GZMB mRNA

NCBI chr15:34,459,007...34,462,469
Ensembl chr15:34,459,007...34,462,469

G

Granzyme B-like 1

increases expression

EXP

Mercaptopurine results in increased expression of GZMBL1 mRNA

NCBI chr15:34,056,878...34,060,691
Ensembl chr15:34,057,366...34,060,273

G

granzyme C

increases expression

EXP

Mercaptopurine results in increased expression of GZMC mRNA

NCBI chr15:34,437,312...34,440,006
Ensembl chr15:34,437,317...34,440,048

G

hepcidin antimicrobial peptide

increases expression

EXP

Mercaptopurine results in increased expression of HAMP mRNA

NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:95,298,307...95,300,297

G

heart and neural crest derivatives expressed 2

increases expression

EXP

Mercaptopurine results in increased expression of HAND2 mRNA

NCBI chr16:37,928,145...37,931,488
Ensembl chr16:37,928,145...37,931,488

G

hemoglobin subunit beta

decreases expression

EXP

Mercaptopurine results in decreased expression of HBB mRNA; Mercaptopurine results in decreased expression of HBB-B1 mRNA

NCBI chr 1:167,662,310...167,663,721
Ensembl chr 1:167,630,245...167,663,873

G

hemoglobin, epsilon 2

decreases expression

EXP

Mercaptopurine results in decreased expression of HBE2 mRNA

NCBI chr 1:167,691,174...167,692,802
Ensembl chr 1:167,683,760...167,706,139

G

heparin-binding EGF-like growth factor

decreases expression

EXP

Mercaptopurine results in decreased expression of HBEGF mRNA

NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,380,337...28,390,220

G

hephaestin

decreases expression

EXP

Mercaptopurine results in decreased expression of HEPH mRNA

NCBI chr X:65,160,628...65,412,457
Ensembl chr X:65,305,773...65,412,453

G

homeo box A13

decreases expression

EXP

Mercaptopurine results in decreased expression of HOXA13 mRNA

NCBI chr 4:82,689,566...82,691,701
Ensembl chr 4:82,689,566...82,691,701

G

hematopoietic prostaglandin D synthase

increases expression

EXP

Mercaptopurine results in increased expression of HPGDS mRNA

NCBI chr 4:95,698,265...95,727,733
Ensembl chr 4:95,702,392...95,938,501

G

hemopexin

increases expression

EXP

Mercaptopurine results in increased expression of HPX mRNA

NCBI chr 1:169,344,647...169,352,155
Ensembl chr 1:169,344,583...169,352,156

G

hydroxysteroid 11-beta dehydrogenase 1

increases expression

EXP

Mercaptopurine results in increased expression of HSD11B1 mRNA

NCBI chr13:107,277,526...107,327,462
Ensembl chr13:107,257,239...107,327,432

G

5-hydroxytryptamine receptor 2B

increases expression

EXP

Mercaptopurine results in increased expression of HTR2B mRNA

NCBI chr 9:94,184,442...94,206,851
Ensembl chr 9:94,190,109...94,204,087

G

HtrA serine peptidase 3

increases expression

EXP

Mercaptopurine results in increased expression of HTRA3 mRNA

NCBI chr14:79,293,535...79,321,936
Ensembl chr14:79,293,541...79,321,936

G

HtrA serine peptidase 4

increases expression

EXP

Mercaptopurine results in increased expression of HTRA4 mRNA

NCBI chr16:73,704,255...73,717,722
Ensembl chr16:73,704,184...73,717,722

G

immunoglobulin superfamily, member 11

increases expression

EXP

Mercaptopurine results in increased expression of IGSF11 mRNA

NCBI chr11:75,238,706...75,389,748
Ensembl chr11:75,236,545...75,390,425

G

interleukin 1 receptor antagonist

increases expression

EXP

Mercaptopurine results in increased expression of IL1RN mRNA

NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732

G

interleukin 23 receptor

increases expression

EXP

Mercaptopurine results in increased expression of IL23R mRNA

NCBI chr 4:97,910,230...98,003,759
Ensembl chr 4:97,909,972...98,004,110

G

inosine monophosphate dehydrogenase 2

increases expression

ISO

Mercaptopurine results in increased expression of IMPDH2 mRNA

NCBI chr 8:118,135,204...118,139,892
Ensembl chr 8:118,135,262...118,139,873

G

insulin 2

decreases expression

EXP

Mercaptopurine results in decreased expression of INS2 mRNA

NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805

G

iroquois homeobox 4

decreases expression

EXP

Mercaptopurine results in decreased expression of IRX4 mRNA

NCBI chr 1:31,859,101...31,868,089
Ensembl chr 1:31,859,101...31,868,089

G

junctional adhesion molecule 2

increases expression

EXP

Mercaptopurine results in increased expression of JAM2 mRNA

NCBI chr11:37,316,287...37,366,517
Ensembl chr11:37,317,511...37,367,510

G

potassium calcium-activated channel subfamily M regulatory beta subunit 4

increases expression

EXP

Mercaptopurine results in increased expression of KCNMB4 mRNA

NCBI chr 7:53,952,150...54,005,101
Ensembl chr 7:53,949,881...54,005,281

G

potassium voltage-gated channel subfamily Q member 2

decreases expression

EXP

Mercaptopurine results in decreased expression of KCNQ2 mRNA

NCBI chr 3:188,572,345...188,631,391
Ensembl chr 3:188,572,926...188,631,302

G

potassium sodium-activated channel subfamily T member 1

increases expression

EXP

Mercaptopurine results in increased expression of KCNT1 mRNA

NCBI chr 3:29,081,071...29,136,902
Ensembl chr 3:29,081,321...29,134,768

G

kinesin family member 20A

decreases expression

EXP

Mercaptopurine results in decreased expression of KIF20A mRNA

NCBI chr18:26,504,422...26,512,908
Ensembl chr18:26,504,072...26,512,909

G

kinesin family member 23

decreases expression

EXP

Mercaptopurine results in decreased expression of KIF23 mRNA

NCBI chr 8:71,293,439...71,321,911
Ensembl chr 8:71,293,482...71,320,856

G

kelch-like family member 40

increases expression

EXP

Mercaptopurine results in increased expression of KLHL40 mRNA

NCBI chr 8:130,318,793...130,324,309
Ensembl chr 8:130,318,794...130,326,299

G

kinetochore scaffold 1

decreases expression

EXP

Mercaptopurine results in decreased expression of KNL1 mRNA

NCBI chr 3:126,483,498...126,545,774
Ensembl chr 3:126,483,544...126,545,774

G

keratin 23

increases expression

EXP

Mercaptopurine results in increased expression of KRT23 mRNA

NCBI chr10:84,930,603...84,946,929
Ensembl chr10:84,930,603...84,946,929

G

LINE-1 type transposase domain containing 1

decreases expression

EXP

Mercaptopurine results in decreased expression of L1TD1 mRNA

NCBI chr 5:118,488,688...118,501,591
Ensembl chr 5:118,488,688...118,501,591

G

La ribonucleoprotein 6, translational regulator

increases expression

EXP

Mercaptopurine results in increased expression of LARP6 mRNA

NCBI chr 8:70,079,753...70,101,175
Ensembl chr 8:70,079,647...70,101,198

G

lipase, family member M

increases expression

EXP

Mercaptopurine results in increased expression of LIPM mRNA

NCBI chr 1:241,031,382...241,050,796
Ensembl chr 1:241,031,483...241,050,792

G

lumican

decreases expression

EXP

Mercaptopurine results in decreased expression of LUM mRNA

NCBI chr 7:34,245,323...34,252,510
Ensembl chr 7:34,245,360...34,252,508

G

mitogen activated protein kinase kinase 1

decreases phosphorylation

ISO

Mercaptopurine results in decreased phosphorylation of MAP2K1 protein

NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:73,578,752...73,650,184

G

mast cell protease 1

increases expression

EXP

Mercaptopurine results in increased expression of MCPT1 mRNA; Mercaptopurine results in increased expression of MCPT2 mRNA

NCBI chr15:33,841,606...33,844,174
Ensembl chr15:33,841,606...33,844,174

G

mast cell protease 10

increases expression

EXP

Mercaptopurine results in increased expression of MCPT10 mRNA

NCBI chr15:33,885,728...33,888,787
Ensembl chr15:33,885,731...33,888,756

G

mast cell protease 8

increases expression

EXP

Mercaptopurine results in increased expression of MCPT8 mRNA

NCBI chr15:33,769,575...33,772,633

G

mast cell protease 8-like 2

increases expression

EXP

Mercaptopurine results in increased expression of MCPT1L2 mRNA; Mercaptopurine results in increased expression of MCPT8L2 mRNA

NCBI chr15:33,718,389...33,731,960

G

mast cell protease 8-like 3

increases expression

EXP

Mercaptopurine results in increased expression of MCPT8L3 mRNA

NCBI chr15:33,673,264...33,676,288
Ensembl chr15:33,673,314...33,676,299

G

mast cell protease 9

increases expression

EXP

Mercaptopurine results in increased expression of MCPT9 mRNA

NCBI chr15:33,827,348...33,830,396
Ensembl chr15:33,827,378...33,830,396

G

mesenchyme homeobox 2

decreases expression

EXP

Mercaptopurine results in decreased expression of MEOX2 mRNA

NCBI chr 6:59,584,025...59,644,722
Ensembl chr 6:59,583,785...59,644,700

G

mesoderm specific transcript

decreases expression

EXP

Mercaptopurine results in decreased expression of MEST mRNA

NCBI chr 4:60,321,814...60,332,288
Ensembl chr 4:60,316,102...60,333,509

G

microfibril associated protein 3 like

increases expression

EXP

Mercaptopurine results in increased expression of MFAP3L mRNA

NCBI chr16:34,422,490...34,465,544
Ensembl chr16:34,426,696...34,441,709

G

microRNA 10b

increases expression

EXP

Mercaptopurine results in increased expression of MIR10B mRNA

NCBI chr 3:80,035,859...80,035,967
Ensembl chr 3:80,035,859...80,035,967

G

microRNA 142

decreases expression

EXP

Mercaptopurine results in decreased expression of MIR142 mRNA

NCBI chr10:73,055,104...73,055,190
Ensembl chr10:73,055,097...73,055,207

G

microRNA 144

decreases expression

EXP

Mercaptopurine results in decreased expression of MIR144 mRNA

NCBI chr10:63,459,397...63,459,479
Ensembl chr10:63,459,397...63,459,479

G

microRNA 146b

increases expression

EXP

Mercaptopurine results in increased expression of MIR146B mRNA

NCBI chr 1:255,144,860...255,144,947
Ensembl chr 1:255,144,860...255,144,947

G

microRNA 195

increases expression

EXP

Mercaptopurine results in increased expression of MIR195 mRNA

NCBI chr10:55,450,495...55,450,581
Ensembl chr10:55,450,495...55,450,581

G

microRNA 196b

increases expression

EXP

Mercaptopurine results in increased expression of MIR196B mRNA

NCBI chr 4:82,661,101...82,661,185

G

microRNA 21

increases expression

EXP

Mercaptopurine results in increased expression of MIR21 mRNA

NCBI chr10:71,902,600...71,902,691

G

microRNA 23a

increases expression

EXP

Mercaptopurine results in increased expression of MIR23A mRNA

NCBI chr19:40,859,769...40,859,843

G

microRNA 291a

decreases expression

EXP

Mercaptopurine results in decreased expression of MIR291A mRNA

NCBI chr 1:74,879,757...74,879,838

G

microRNA 292

decreases expression

EXP

Mercaptopurine results in decreased expression of MIR292 mRNA

NCBI chr 1:74,879,469...74,879,550

G

microRNA 29a

increases expression

EXP

Mercaptopurine results in increased expression of MIR29A mRNA

NCBI chr 4:60,617,955...60,618,042

G

microRNA 29c

increases expression

EXP

Mercaptopurine results in increased expression of MIR29C mRNA

NCBI chr13:109,099,359...109,099,446

G

microRNA 31

increases expression

EXP

Mercaptopurine results in increased expression of MIR31 mRNA

NCBI chr 5:108,714,849...108,714,954

G

microRNA 345

increases expression

EXP

Mercaptopurine results in increased expression of MIR345 mRNA

NCBI chr 6:133,518,403...133,518,498
Ensembl chr 6:133,518,403...133,518,498

G

microRNA 34a

increases expression

EXP

Mercaptopurine results in increased expression of MIR34A mRNA

NCBI chr 5:165,815,952...165,816,053
Ensembl chr 5:165,815,952...165,816,053

G

microRNA 451a

decreases expression

EXP

Mercaptopurine results in decreased expression of MIR451A mRNA

NCBI chr10:63,459,569...63,459,640
Ensembl chr10:63,459,569...63,459,640

G

microRNA 497

increases expression

EXP

Mercaptopurine results in increased expression of MIR497 mRNA

NCBI chr10:55,450,171...55,450,239
Ensembl chr10:55,450,162...55,450,241

G

microRNA let-7b

increases expression

EXP

Mercaptopurine results in increased expression of MIRLET7B mRNA

NCBI chr 7:118,684,038...118,684,122
Ensembl chr 7:118,684,038...118,684,122

G

matrix metallopeptidase 10

increases expression

EXP

Mercaptopurine results in increased expression of MMP10 mRNA

NCBI chr 8:12,974,707...12,982,613
Ensembl chr 8:12,974,707...12,982,613

G

matrix metallopeptidase 7

increases expression

EXP

Mercaptopurine results in increased expression of MMP7 mRNA

NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:13,133,043...13,140,755

G

molybdenum cofactor sulfurase

decreases oxidation
multiple interactions

ISO

MOCOS gene SNP results in decreased oxidation of Mercaptopurine
[MOCOS gene SNP results in decreased oxidation of Mercaptopurine] which results in decreased chemical synthesis of 6-thiouric acid; [MOCOS gene SNP results in decreased oxidation of Mercaptopurine] which results in decreased chemical synthesis of 6-thioxanthine; [MOCOS gene SNP results in decreased oxidation of Mercaptopurine] which results in increased chemical synthesis of Thioguanine

NCBI chr18:16,206,402...16,251,928
Ensembl chr18:16,206,402...16,251,928

G

msh homeobox 2

decreases expression

EXP

Mercaptopurine results in decreased expression of MSX2 mRNA

NCBI chr17:11,102,284...11,107,949
Ensembl chr17:11,102,247...11,107,945

G

metallothionein 2

increases expression

EXP

Mercaptopurine results in increased expression of MT2A mRNA

NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709

G

metallothionein 3

increases expression

EXP

Mercaptopurine results in increased expression of MT3 mRNA

NCBI chr19:10,854,676...10,856,080
Ensembl chr19:10,854,677...10,856,080

G

major vault protein

decreases response to substance

ISO

MVP results in decreased susceptibility to Mercaptopurine

NCBI chr 1:191,025,259...191,052,866
Ensembl chr 1:191,025,268...191,052,873

G

myosin heavy chain 6

decreases expression

EXP

Mercaptopurine results in decreased expression of MYH6 mRNA

NCBI chr15:32,388,102...32,413,663
Ensembl chr15:32,387,487...32,411,333

G

myosin light chain 7

increases expression

EXP

Mercaptopurine results in increased expression of MYL7 mRNA

NCBI chr14:84,994,644...84,997,173
Ensembl chr14:84,993,736...84,997,372

G

myosin XVI

increases expression

EXP

Mercaptopurine results in increased expression of MYO16 mRNA

NCBI chr16:85,586,428...86,066,537
Ensembl chr16:85,586,429...85,973,879

G

nuclear autoantigenic sperm protein

decreases expression

EXP

Mercaptopurine results in decreased expression of NASP mRNA

NCBI chr 5:135,294,599...135,319,992
Ensembl chr 5:135,294,032...135,319,591

G

nuclear factor kappa B subunit 1

multiple interactions

ISO

Mercaptopurine inhibits the reaction [CD28 protein results in increased activity of [NFKB1 protein binds to RELA protein]]

NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088

G

NPHS1 adhesion molecule, nephrin

increases expression

EXP

Mercaptopurine results in increased expression of NPHS1 mRNA

NCBI chr 1:94,848,261...94,876,522
Ensembl chr 1:94,848,261...94,876,521

G

nuclear receptor subfamily 4, group A, member 2

increases expression
multiple interactions

EXP

Mercaptopurine results in increased expression of NR4A2 mRNA
[GW 1929 co-treated with Mercaptopurine] results in increased expression of NR4A2 mRNA; [GW 1929 co-treated with Mercaptopurine] results in increased expression of NR4A2 protein; Mercaptopurine results in increased expression of and affects the localization of NR4A2 protein

NCBI chr 3:62,098,739...62,115,926
Ensembl chr 3:62,098,743...62,106,769

G

neurotrophin 3

increases expression

EXP

Mercaptopurine results in increased expression of NTF3 mRNA

NCBI chr 4:160,601,161...160,670,623
Ensembl chr 4:160,600,770...160,676,349

G

nudix hydrolase 15

increases response to substance

ISO

NUDT15 gene SNP results in increased susceptibility to Mercaptopurine

NCBI chr15:55,117,312...55,123,983

G

osteoglycin

decreases expression

EXP

Mercaptopurine results in decreased expression of OGN mRNA

NCBI chr17:15,238,500...15,259,167
Ensembl chr17:15,238,500...15,259,252

G

oleoyl-ACP hydrolase

increases expression

EXP

Mercaptopurine results in increased expression of OLAH mRNA

NCBI chr17:79,786,441...79,811,692
Ensembl chr17:79,786,832...79,811,688

G

orosomucoid 1

increases expression

EXP

Mercaptopurine results in increased expression of ORM1 mRNA

NCBI chr 5:81,788,509...81,791,661
Ensembl chr 5:81,788,395...81,791,667

G

protein kinase C and casein kinase substrate in neurons 1

decreases expression

EXP

Mercaptopurine results in decreased expression of PACSIN1 mRNA

NCBI chr20:5,719,929...5,769,492
Ensembl chr20:5,721,311...5,767,109

G

protocadherin 19

decreases expression

EXP

Mercaptopurine results in decreased expression of PCDH19 mRNA

NCBI chr X:101,061,002...101,166,777
Ensembl chr X:101,065,263...101,165,269

G

pellino E3 ubiquitin protein ligase family member 2

increases expression

EXP

Mercaptopurine results in increased expression of PELI2 mRNA

NCBI chr15:23,872,984...24,017,448
Ensembl chr15:23,872,984...24,014,817

G

proenkephalin

decreases expression

EXP

Mercaptopurine results in decreased expression of PENK mRNA

NCBI chr 5:21,981,381...21,987,074
Ensembl chr 5:21,981,382...21,986,705

G

pore forming protein-like

increases expression

EXP

Mercaptopurine results in increased expression of PFPL mRNA

NCBI chr 1:218,836,737...218,840,017
Ensembl chr 1:218,836,737...218,840,005

G

progesterone receptor

increases expression

EXP

Mercaptopurine results in increased expression of PGR mRNA

NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271

G

phosphatase and actin regulator 3

increases expression

EXP

Mercaptopurine results in increased expression of PHACTR3 mRNA

NCBI chr 3:185,582,134...185,801,404
Ensembl chr 3:185,582,796...185,801,822

G

pleckstrin homology-like domain, family A, member 2

decreases expression

EXP

Mercaptopurine results in decreased expression of PHLDA2 mRNA

NCBI chr 1:208,126,302...208,127,241
Ensembl chr 1:208,126,302...208,127,920

G

peptidase inhibitor 16

increases expression

EXP

Mercaptopurine results in increased expression of PI16 mRNA

NCBI chr20:7,377,739...7,387,003
Ensembl chr20:7,377,729...7,387,691

G

PICALM interacting mitotic regulator

decreases expression

EXP

Mercaptopurine results in decreased expression of PIMREG mRNA

NCBI chr10:57,168,136...57,173,713
Ensembl chr10:57,167,797...57,173,063

G

phospholipase A2 inhibitor and Ly6/Plaur domain containing

increases expression

EXP

Mercaptopurine results in increased expression of PINLYP mRNA

NCBI chr 1:89,262,559...89,268,402
Ensembl chr 1:89,262,560...89,267,913

G

phospholipase A2, group X

decreases expression

EXP

Mercaptopurine results in decreased expression of PLA2G10 mRNA

NCBI chr10:2,104,927...2,117,998
Ensembl chr10:2,104,927...2,116,172

G

pleckstrin homology and coiled-coil domain containing D1

decreases expression

EXP

Mercaptopurine results in decreased expression of PLEKHD1 mRNA

NCBI chr 6:106,071,966...106,103,250
Ensembl chr 6:106,071,901...106,117,826

G

perforin 1

increases expression

EXP

Mercaptopurine results in increased expression of PRF1 mRNA

NCBI chr20:29,789,040...29,794,550
Ensembl chr20:29,788,972...29,795,124

G

prolactin family 5, subfamily A, member 2

increases expression

EXP

Mercaptopurine results in increased expression of PRL5A2 mRNA

NCBI chr17:36,661,123...36,667,465
Ensembl chr17:36,661,129...36,667,465

G

prolactin receptor

decreases expression

EXP

Mercaptopurine results in decreased expression of PRLR mRNA

NCBI chr 2:60,861,391...61,051,883
Ensembl chr 2:60,861,658...61,051,882

G

PTTG1 regulator of sister chromatid separation, securin

decreases expression

EXP

Mercaptopurine results in decreased expression of PTTG1 mRNA

NCBI chr10:28,394,940...28,406,410
Ensembl chr10:28,394,814...28,406,309

G

REC8 meiotic recombination protein

decreases expression

EXP

Mercaptopurine results in decreased expression of REC8 mRNA

NCBI chr15:33,079,818...33,087,283
Ensembl chr15:33,079,801...33,087,282

G

RELA proto-oncogene, NF-kB subunit

affects localization
multiple interactions

ISO

Mercaptopurine affects the localization of RELA protein
Mercaptopurine inhibits the reaction [CD28 protein results in increased activity of [NFKB1 protein binds to RELA protein]]

NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817

G

resistin

increases expression

EXP

Mercaptopurine results in increased expression of RETN mRNA

NCBI chr12:6,508,653...6,511,115
Ensembl chr12:6,508,801...6,511,116

G

resistin-like gamma

increases expression

EXP

Mercaptopurine results in increased expression of RETNLG mRNA

NCBI chr11:65,393,907...65,395,639
Ensembl chr11:65,393,907...65,395,419

G

refilin B

decreases expression

EXP

Mercaptopurine results in decreased expression of RFLNB mRNA

NCBI chr10:61,391,947...61,398,224
Ensembl chr10:61,390,659...61,398,224

G

regulator of G-protein signaling 1

increases expression

EXP

Mercaptopurine results in increased expression of RGS1 mRNA

NCBI chr13:58,568,844...58,573,187
Ensembl chr13:58,568,844...58,573,187

G

rhodopsin

increases expression

EXP

Mercaptopurine results in increased expression of RHO mRNA

NCBI chr 4:150,653,205...150,658,367
Ensembl chr 4:150,653,205...150,658,367

G

RRAD, Ras related glycolysis inhibitor and calcium channel regulator

decreases expression

EXP

Mercaptopurine results in decreased expression of RRAD mRNA

NCBI chr19:360,581...363,874
Ensembl chr19:360,973...363,871

G

RT1 class II, locus Ba

affects response to substance

ISO

HLA-DQA1 gene polymorphism affects the susceptibility to Mercaptopurine

NCBI chr20:4,577,057...4,581,650
Ensembl chr20:4,576,843...4,581,653

G

RT1 class II, locus Db1

affects response to substance
decreases expression

ISO
EXP

HLA-DRB1 gene polymorphism affects the susceptibility to Mercaptopurine
Mercaptopurine results in decreased expression of RT1-DB1 mRNA

PMID:23358152 PMID:25217962

NCBI chr20:4,550,594...4,560,182
Ensembl chr20:4,550,596...4,560,165

G

retrotransposon-like 1

decreases expression

EXP

Mercaptopurine results in decreased expression of RTL1 mRNA

NCBI chr 6:134,325,231...134,335,780
Ensembl chr 6:134,325,271...134,363,493

G

reticulon 4 receptor-like 1

increases expression

EXP

Mercaptopurine results in increased expression of RTN4RL1 mRNA

NCBI chr10:60,541,584...60,615,302
Ensembl chr10:60,520,760...60,615,727

G

S100 calcium binding protein A16

decreases expression

EXP

Mercaptopurine results in decreased expression of S100A16 mRNA

NCBI chr 2:178,313,986...178,319,696
Ensembl chr 2:178,313,910...178,319,821

G

S100 calcium binding protein B

increases expression

EXP

Mercaptopurine results in increased expression of S100B mRNA

NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,348...12,381,081

G

S100 calcium binding protein Z

decreases expression

EXP

Mercaptopurine results in decreased expression of S100Z mRNA

NCBI chr 2:28,472,527...28,476,750
Ensembl chr 2:28,472,527...28,476,750

G

SATB homeobox 1

decreases expression

EXP

Mercaptopurine results in decreased expression of SATB1 mRNA

NCBI chr 9:4,916,958...5,010,359
Ensembl chr 9:4,917,215...4,989,925

G

somatomedin B and thrombospondin, type 1 domain containing

decreases expression

EXP

Mercaptopurine results in decreased expression of SBSPON mRNA

NCBI chr 5:8,186,004...8,216,576
Ensembl chr 5:8,185,985...8,218,898

G

secretory carrier membrane protein 5

decreases expression

EXP

Mercaptopurine results in decreased expression of SCAMP5 mRNA

NCBI chr 8:66,739,794...66,778,538
Ensembl chr 8:66,741,940...66,751,099

G

stearoyl-CoA desaturase

decreases expression

EXP

Mercaptopurine results in decreased expression of SCD1 mRNA

NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785

G

secretogranin V

increases expression

EXP

Mercaptopurine results in increased expression of SCG5 mRNA

NCBI chr 3:120,998,420...121,042,881
Ensembl chr 3:120,998,420...121,042,795

G

signal peptide, CUB domain and EGF like domain containing 3

increases expression

EXP

Mercaptopurine results in increased expression of SCUBE3 mRNA

NCBI chr20:6,200,891...6,232,848
Ensembl chr20:6,200,178...6,233,051

G

surfactant protein C

increases expression

EXP

Mercaptopurine results in increased expression of SFTPC mRNA

NCBI chr15:52,006,274...52,009,324
Ensembl chr15:52,006,283...52,009,475

G

SHC binding and spindle associated 1 like

increases expression

EXP

Mercaptopurine results in increased expression of SHCBP1L mRNA

NCBI chr13:68,118,861...68,149,646
Ensembl chr13:68,119,328...68,149,645

G

shisa family member 3

increases expression

EXP

Mercaptopurine results in increased expression of SHISA3 mRNA

NCBI chr14:40,917,563...40,922,135
Ensembl chr14:40,917,564...40,922,135

G

shisa family member 8

decreases expression

EXP

Mercaptopurine results in decreased expression of SHISA8 mRNA

NCBI chr 7:115,602,503...115,607,953
Ensembl chr 7:115,602,503...115,608,188

G

solute carrier family 22 member 3

decreases expression

EXP

Mercaptopurine results in decreased expression of SLC22A3 mRNA

NCBI chr 1:50,783,218...50,872,358
Ensembl chr 1:50,783,218...50,872,353

G

solute carrier family 22 member 8

increases transport

ISO

SLC22A8 protein results in increased transport of Mercaptopurine

NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:214,925,508...214,946,588

G

solute carrier family 2 member 2

decreases expression

EXP

Mercaptopurine results in decreased expression of SLC2A2 mRNA

NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:113,537,972...113,568,467

G

solute carrier family 2 member 3

decreases expression

EXP

Mercaptopurine results in decreased expression of SLC2A3 mRNA

NCBI chr 4:157,632,887...157,698,034
Ensembl chr 4:157,632,887...157,646,186

G

solute carrier family 35, member G1

decreases expression

EXP

Mercaptopurine results in decreased expression of SLC35G1 mRNA

NCBI chr 1:245,576,011...245,584,533
Ensembl chr 1:245,575,996...245,584,529

G

solute carrier family 38, member 5

decreases expression

EXP

Mercaptopurine results in decreased expression of SLC38A5 mRNA

NCBI chr X:16,885,701...16,894,470
Ensembl chr X:16,885,701...16,894,470

G

solute carrier family 5 member 5

decreases expression

EXP

Mercaptopurine results in decreased expression of SLC5A5 mRNA

NCBI chr16:18,580,705...18,590,692
Ensembl chr16:18,580,705...18,590,691

G

solute carrier family 7, member 14

decreases expression

EXP

Mercaptopurine results in decreased expression of SLC7A14 mRNA

NCBI chr 2:113,993,781...114,099,810
Ensembl chr 2:113,993,785...114,099,804

G

solute carrier family 9 member A2

decreases expression

EXP

Mercaptopurine results in decreased expression of SLC9A2 mRNA

NCBI chr 9:50,427,612...50,510,043
Ensembl chr 9:50,426,798...50,510,040

G

SPARC related modular calcium binding 2

decreases expression

EXP

Mercaptopurine results in decreased expression of SMOC2 mRNA

NCBI chr 1:63,935,627...64,064,952
Ensembl chr 1:63,935,647...64,064,955

G

synuclein, gamma

decreases expression

EXP

Mercaptopurine results in decreased expression of SNCG mRNA

NCBI chr16:9,706,765...9,712,072
Ensembl chr16:9,706,753...9,712,076

G

superoxide dismutase 2

increases expression

ISO

Mercaptopurine results in increased expression of SOD2 mRNA

NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168

G

sortilin-related VPS10 domain containing receptor 2

increases expression

EXP

Mercaptopurine results in increased expression of SORCS2 mRNA

NCBI chr14:78,592,290...78,960,582
Ensembl chr14:78,596,087...78,960,582

G

sclerostin domain containing 1

decreases expression

EXP

Mercaptopurine results in decreased expression of SOSTDC1 mRNA

NCBI chr 6:58,778,623...58,782,797
Ensembl chr 6:58,778,623...58,782,866

G

serine peptidase inhibitor, Kazal type 5

increases expression

EXP

Mercaptopurine results in increased expression of SPINK5 mRNA

NCBI chr18:36,515,347...36,584,038
Ensembl chr18:36,515,347...36,583,799

G

stefin A2-like 2

increases expression

EXP

Mercaptopurine results in increased expression of STFA2L2 mRNA

NCBI chr11:78,003,490...78,005,912
Ensembl chr11:78,003,545...78,005,913

G

seminal vesicle secretory protein 4

increases expression

EXP

Mercaptopurine results in increased expression of SVS4 mRNA

NCBI chr 3:173,367,643...173,369,878
Ensembl chr 3:173,367,643...173,369,878

G

synemin

increases expression

EXP

Mercaptopurine results in increased expression of SYNM mRNA

NCBI chr 1:130,743,891...130,774,254
Ensembl chr 1:130,743,897...130,773,824

G

tachykinin precursor 3

decreases expression

EXP

Mercaptopurine results in decreased expression of TAC2 mRNA

NCBI chr 7:65,447,817...65,454,427
Ensembl chr 7:65,447,817...65,454,427

G

transmembrane epididymal family member 3

increases expression

EXP

Mercaptopurine results in increased expression of TEDDM3 mRNA

NCBI chr11:93,493,233...93,494,572
Ensembl chr11:93,493,500...93,494,384

G

testin gene

increases expression

EXP

Mercaptopurine results in increased expression of TESTIN mRNA

NCBI chr17:3,829,012...3,864,995
Ensembl chr17:3,852,404...3,864,993

G

testis expressed 10

decreases expression

EXP

Mercaptopurine results in decreased expression of TEX10 mRNA

NCBI chr 5:67,557,770...67,603,904
Ensembl chr 5:67,557,770...67,603,904

G

transcription factor CP2-like 1

decreases expression

EXP

Mercaptopurine results in decreased expression of TFCP2L1 mRNA

NCBI chr13:32,286,643...32,346,671
Ensembl chr13:32,286,643...32,346,671

G

transferrin receptor

decreases expression

EXP

Mercaptopurine results in decreased expression of TFRC mRNA

NCBI chr11:81,668,478...81,690,318
Ensembl chr11:81,668,478...81,690,318

G

tyrosine hydroxylase

multiple interactions

EXP

[GW 1929 co-treated with Mercaptopurine] inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of TH protein]; Mercaptopurine inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of TH protein]

NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:207,500,962...207,557,227

G

thrombospondin 4

increases expression

EXP

Mercaptopurine results in increased expression of THBS4 mRNA

NCBI chr 2:25,718,219...25,760,345
Ensembl chr 2:25,718,219...25,761,369

G

thioesterase superfamily member 5

increases expression

EXP

Mercaptopurine results in increased expression of THEM5 mRNA

NCBI chr 2:184,665,335...184,675,041
Ensembl chr 2:184,669,822...184,675,744

G

transmembrane 4 L six family member 20

decreases expression

EXP

Mercaptopurine results in decreased expression of TM4SF20 mRNA

NCBI chr 9:91,486,847...91,500,745
Ensembl chr 9:91,486,847...91,500,745

G

transmembrane and coiled-coil domain family 2

decreases expression

EXP

Mercaptopurine results in decreased expression of TMCC2 mRNA

NCBI chr13:46,346,177...46,383,862
Ensembl chr13:46,346,177...46,383,862

G

transmembrane protein 100

decreases expression

EXP

Mercaptopurine results in decreased expression of TMEM100 mRNA

NCBI chr10:75,351,891...75,357,748
Ensembl chr10:75,351,271...75,360,364

G

transmembrane serine protease 7

increases expression

EXP

Mercaptopurine results in increased expression of TMPRSS7 mRNA

NCBI chr11:68,583,710...68,629,200
Ensembl chr11:68,586,092...68,629,145

G

tumor protein p53

affects activity

ISO

Mercaptopurine affects the activity of TP53 protein

NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299

G

thiopurine S-methyltransferase

affects metabolic processing
affects response to substance

ISO

TPMT protein affects the metabolism of Mercaptopurine
TPMT gene polymorphism affects the susceptibility to Mercaptopurine

PMID:12509611 PMID:14505127

NCBI chr17:17,850,308...17,868,976
Ensembl chr17:17,850,279...17,868,976

G

thyrotropin releasing hormone

increases expression

EXP

Mercaptopurine results in increased expression of TRH mRNA

NCBI chr 4:126,299,236...126,301,762
Ensembl chr 4:126,299,236...126,301,762

G

tribbles pseudokinase 1

increases expression

EXP

Mercaptopurine results in increased expression of IFIT1 mRNA

NCBI chr 7:93,096,001...93,102,547
Ensembl chr 7:93,095,973...93,117,480

G

transient receptor potential cation channel, subfamily V, member 6

increases expression

EXP

Mercaptopurine results in increased expression of TRPV6 mRNA

NCBI chr 4:71,474,006...71,489,667
Ensembl chr 4:71,474,007...71,489,671

G

tetraspanin 11

decreases expression

EXP

Mercaptopurine results in decreased expression of TSPAN11 mRNA

NCBI chr 4:162,424,327...162,491,653
Ensembl chr 4:162,424,549...162,492,932

G

thymidylate synthetase

affects response to substance

ISO

TYMS gene polymorphism affects the susceptibility to Mercaptopurine

NCBI chr 9:120,760,057...120,776,149
Ensembl chr 9:120,763,386...120,776,097

G

ubiquitin-activating enzyme, Chr Y

increases expression

EXP

Mercaptopurine results in increased expression of UBA1Y mRNA

NCBI chr Y:481,352...504,038
Ensembl chr Y:483,578...504,038

G

ubiquitin D

increases expression

EXP

Mercaptopurine results in increased expression of UBD mRNA

NCBI chr20:1,390,734...1,392,685
Ensembl chr20:1,390,600...1,413,965

G

urate (5-hydroxyiso-) hydrolase

decreases expression

EXP

Mercaptopurine results in decreased expression of URAH mRNA

NCBI chr 1:205,335,399...205,338,795
Ensembl chr 1:205,335,399...205,338,795

G

vav guanine nucleotide exchange factor 1

increases expression

ISO

Mercaptopurine results in increased expression of VAV1 protein

NCBI chr 9:2,248,856...2,295,905
Ensembl chr 9:2,248,914...2,296,922

G

vitamin D receptor

affects response to substance

ISO

VDR gene polymorphism affects the susceptibility to Mercaptopurine

NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:130,866,745...130,916,757

G

VGF nerve growth factor inducible

increases expression

EXP

Mercaptopurine results in increased expression of VGF mRNA

NCBI chr12:25,274,004...25,281,803
Ensembl chr12:25,273,333...25,282,703

G

vasoactive intestinal peptide receptor 2

decreases expression

EXP

Mercaptopurine results in decreased expression of VIPR2 mRNA

NCBI chr 6:143,139,672...143,213,609
Ensembl chr 6:143,144,523...143,213,609

G

vomeronasal 2 receptor, 12

decreases expression

EXP

Mercaptopurine results in decreased expression of VOM2R12 mRNA

NCBI chr 1:70,695,506...70,718,213
Ensembl chr 1:70,695,506...70,718,213

G

WAP four-disulfide core domain 1

increases expression

EXP

Mercaptopurine results in increased expression of WFDC1 mRNA

NCBI chr19:64,628,689...64,647,739
Ensembl chr19:64,607,794...64,648,028

G

WAP four-disulfide core domain 2

decreases expression

EXP

Mercaptopurine results in decreased expression of WFDC2 mRNA

NCBI chr 3:173,706,091...173,735,055
Ensembl chr 3:173,706,460...173,712,161

G

Wnt family member 10B

decreases expression

EXP

Mercaptopurine results in decreased expression of WNT10B mRNA

NCBI chr 7:131,801,046...131,806,850
Ensembl chr 7:131,801,046...131,806,850

G

Wnt family member 2B

decreases expression

EXP

Mercaptopurine results in decreased expression of WNT2B mRNA

NCBI chr 2:195,142,573...195,156,945
Ensembl chr 2:195,135,176...195,157,144

G

WT1 transcription factor

increases expression

EXP

Mercaptopurine results in increased expression of WT1 mRNA

NCBI chr 3:112,019,721...112,068,454
Ensembl chr 3:112,021,641...112,068,444

G

xanthine dehydrogenase

affects expression
increases expression

EXP

Mercaptopurine affects the expression of XDH mRNA
Mercaptopurine results in increased expression of XDH mRNA

PMID:22688000 PMID:23358152

NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350

G

XK related, X-linked

decreases expression

EXP

Mercaptopurine results in decreased expression of XKRX mRNA

NCBI chr X:101,634,438...101,733,814
Ensembl chr X:101,635,283...101,646,461

G

zinc finger and BTB domain containing 16

increases expression

EXP

Mercaptopurine results in increased expression of ZBTB16 mRNA

NCBI chr 8:57,885,886...58,073,507
Ensembl chr 8:57,891,081...58,073,507

G

zinc finger E-box binding homeobox 2

increases expression

EXP

Mercaptopurine results in increased expression of ZEB2 mRNA

NCBI chr 3:49,624,028...49,754,323
Ensembl chr 3:49,624,028...49,754,323

G

Zic family member 3

decreases expression

EXP

Mercaptopurine results in decreased expression of ZIC3 mRNA

NCBI chr X:141,159,623...141,165,587
Ensembl chr X:141,149,594...141,170,464

6-propyl-2-thiouracil

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

RIKEN cDNA 1700009N14 gene like

increases expression

EXP

Propylthiouracil results in increased expression of 1700009N14RIKL mRNA

NCBI chr 5:59,252,092...59,253,468
Ensembl chr 5:59,251,970...59,265,163

G

RIKEN cDNA 4933416E14 gene like

increases expression

EXP

Propylthiouracil results in increased expression of 4933416E14RIKL mRNA

NCBI chr X:15,013,608...15,043,710
Ensembl chr X:15,013,609...15,043,710

G

RIKEN cDNA 6430548M08 gene like

decreases expression

EXP

Propylthiouracil results in decreased expression of 6430548M08RIKL mRNA

NCBI chr19:65,076,626...65,125,185
Ensembl chr19:65,077,790...65,125,177

G

alpha-2-macroglobulin

increases expression

EXP

Propylthiouracil results in increased expression of A2M mRNA

NCBI chr 4:156,570,163...156,619,870
Ensembl chr 4:156,569,860...156,619,868

G

alpha-2-macroglobulin-like 1

increases expression

EXP

Propylthiouracil results in increased expression of A2ML1 mRNA

NCBI chr 4:163,501,210...163,543,419
Ensembl chr 4:163,501,585...163,543,506

G

aladin WD repeat nucleoporin

increases expression

EXP

Propylthiouracil results in increased expression of AAAS mRNA

NCBI chr 7:135,342,901...135,362,545
Ensembl chr 7:135,342,901...135,362,545

G

acetoacetyl-CoA synthetase

decreases expression

EXP

Propylthiouracil results in decreased expression of AACS mRNA

NCBI chr12:36,774,471...36,817,835
Ensembl chr12:36,774,471...36,822,543

G

aminoadipate aminotransferase

multiple interactions
decreases activity

EXP

Thyroxine inhibits the reaction [Propylthiouracil results in decreased activity of AADAT protein]

NCBI chr16:34,520,236...34,566,388
Ensembl chr16:34,520,238...34,566,540

G

AP2 associated kinase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of AAK1 mRNA

NCBI chr 4:120,845,012...121,009,170
Ensembl chr 4:120,858,557...121,004,236

G

adipogenesis associated, Mth938 domain containing

decreases expression

EXP

Propylthiouracil results in decreased expression of AAMDC mRNA

NCBI chr 1:161,273,205...161,303,253
Ensembl chr 1:161,262,347...161,299,340

G

AAR2 splicing factor

increases expression

EXP

Propylthiouracil results in increased expression of AAR2 mRNA

NCBI chr 3:165,517,467...165,540,260
Ensembl chr 3:165,517,556...165,548,519

G

alanine and arginine rich domain containing protein

increases expression

EXP

Propylthiouracil results in increased expression of AARD mRNA

NCBI chr 7:85,254,322...85,259,163
Ensembl chr 7:85,253,992...85,259,163

G

aminoadipate-semialdehyde dehydrogenase

decreases expression

EXP

Propylthiouracil results in decreased expression of AASDH mRNA

NCBI chr14:31,609,488...31,636,066
Ensembl chr14:31,609,528...31,636,500

G

aminoadipate-semialdehyde synthase

decreases expression

EXP

Propylthiouracil results in decreased expression of AASS mRNA

NCBI chr 4:52,572,146...52,628,811
Ensembl chr 4:52,572,147...52,657,600

G

apoptosis-associated tyrosine kinase

decreases expression

EXP

Propylthiouracil results in decreased expression of AATK mRNA

PMID:25825206 PMID:30047161

NCBI chr10:105,789,171...105,825,634
Ensembl chr10:105,785,469...105,825,618

G

4-aminobutyrate aminotransferase

decreases expression

EXP

Propylthiouracil results in decreased expression of ABAT mRNA

NCBI chr10:7,503,351...7,599,474
Ensembl chr10:7,492,022...7,599,474

G

ATP binding cassette subfamily A member 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ABCA1 mRNA

NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473

G

ATP binding cassette subfamily A member 4

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of ABCA4 mRNA

NCBI chr 2:212,849,470...212,986,730
Ensembl chr 2:212,755,803...212,986,729

G

ATP binding cassette subfamily A member 7

decreases expression

EXP

Propylthiouracil results in decreased expression of ABCA7 mRNA

NCBI chr 7:10,342,092...10,362,094
Ensembl chr 7:10,342,092...10,361,989

G

ATP binding cassette subfamily A member 8

decreases expression

EXP

Propylthiouracil results in decreased expression of ABCA8 mRNA

NCBI chr10:95,416,984...95,490,647
Ensembl chr10:95,416,205...95,490,452

G

ATP-binding cassette, subfamily A (ABC1), member 8a

increases expression

EXP

Propylthiouracil results in increased expression of ABCA8A mRNA

NCBI chr10:95,501,798...95,571,770
Ensembl chr10:95,501,798...95,571,873

G

ATP binding cassette subfamily B member 1A

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of ABCB1A mRNA
Propylthiouracil results in decreased expression of ABCB1A mRNA

PMID:19483382 PMID:24780913 PMID:25060363

NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135

G

ATP-binding cassette, sub-family B member 1B

increases expression

EXP

Propylthiouracil results in increased expression of ABCB1B mRNA

NCBI chr 4:26,197,706...26,280,156
Ensembl chr 4:26,106,903...26,279,567

G

ATP binding cassette subfamily B member 9

decreases expression

EXP

Propylthiouracil results in decreased expression of ABCB9 mRNA

NCBI chr12:38,146,659...38,192,862
Ensembl chr12:38,159,904...38,192,860

G

ATP binding cassette subfamily C member 2

increases expression

EXP

Propylthiouracil results in increased expression of ABCC2 mRNA

NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471

G

ATP binding cassette subfamily C member 3

increases expression

EXP

Propylthiouracil results in increased expression of ABCC3 mRNA

PMID:22504374 PMID:24780913

NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494

G

ATP binding cassette subfamily C member 4

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of ABCC4 mRNA
Propylthiouracil results in increased expression of ABCC4 mRNA

PMID:24780913 PMID:30047161

NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375

G

ATP binding cassette subfamily C member 6

affects expression
multiple interactions
increases expression

EXP
ISO

Propylthiouracil affects the expression of ABCC6 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of ABCC6 mRNA
Propylthiouracil results in increased expression of ABCC6 mRNA

PMID:19483382 PMID:24780913 PMID:36706583

NCBI chr 1:105,583,681...105,637,895
Ensembl chr 1:105,583,682...105,637,895

G

ATP binding cassette subfamily C member 8

decreases expression

EXP

Propylthiouracil results in decreased expression of ABCC8 mRNA

NCBI chr 1:105,734,992...105,816,272
Ensembl chr 1:105,734,992...105,815,982

G

ATP binding cassette subfamily D member 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ABCD2 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 7:124,142,597...124,191,202
Ensembl chr 7:124,142,595...124,191,202

G

ATP binding cassette subfamily E member 1

increases expression

EXP

Propylthiouracil results in increased expression of ABCE1 mRNA

NCBI chr19:45,109,880...45,134,819
Ensembl chr19:45,109,906...45,134,819

G

ATP binding cassette subfamily F member 2

increases expression

EXP

Propylthiouracil results in increased expression of ABCF2 mRNA

NCBI chr 4:11,485,865...11,500,067
Ensembl chr 4:11,487,395...11,500,053

G

ATP-binding cassette, subfamily G (WHITE), member 3

decreases expression

EXP

Propylthiouracil results in decreased expression of ABCG3 mRNA

NCBI chr14:5,068,275...5,143,762
Ensembl chr14:5,086,356...5,143,945

G

ATP-binding cassette, subfamily G (WHITE), member 3-like 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ABCG3L1 mRNA

PMID:24780913 PMID:30047161

NCBI chr14:5,429,242...5,481,948
Ensembl chr14:5,429,243...5,481,876

G

ATP-binding cassette, subfamily G (WHITE), member 3-like 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ABCG3L2 mRNA

NCBI chr14:4,798,053...4,847,424
Ensembl chr14:4,798,053...4,838,117

G

ATP binding cassette subfamily G member 4

decreases expression

EXP

Propylthiouracil results in decreased expression of ABCG4 mRNA

NCBI chr 8:53,508,005...53,525,314
Ensembl chr 8:53,508,005...53,523,571

G

ATP binding cassette subfamily G member 5

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of ABCG5 mRNA
Propylthiouracil results in decreased expression of ABCG5 mRNA

PMID:19483382 PMID:30047161

NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:15,717,936...15,743,376

G

abhydrolase domain containing 1

affects expression

EXP

Propylthiouracil affects the expression of ABHD1 mRNA

NCBI chr 6:31,142,476...31,147,464
Ensembl chr 6:31,142,476...31,147,464

G

abhydrolase domain containing 10, depalmitoylase

increases expression

EXP

Propylthiouracil results in increased expression of ABHD10 mRNA

NCBI chr11:68,543,860...68,556,059
Ensembl chr11:68,543,606...68,557,640

G

abhydrolase domain containing 14b

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of ABHD14B mRNA
Propylthiouracil results in decreased expression of ABHD14B mRNA

PMID:19483382 PMID:24780913

NCBI chr 8:115,966,792...115,970,829
Ensembl chr 8:115,965,932...115,970,833

G

abhydrolase domain containing 17A, depalmitoylase

affects expression

EXP

Propylthiouracil affects the expression of ABHD17A mRNA

NCBI chr 7:9,775,016...9,781,447

G

abhydrolase domain containing 17C, depalmitoylase

increases expression

EXP

Propylthiouracil results in increased expression of ABHD17C mRNA

NCBI chr 1:147,493,755...147,534,715
Ensembl chr 1:147,493,753...147,534,715

G

abhydrolase domain containing 2, acylglycerol lipase

decreases expression

EXP

Propylthiouracil results in decreased expression of ABHD2 mRNA

NCBI chr 1:142,626,748...142,707,892
Ensembl chr 1:142,626,732...142,712,674

G

abhydrolase domain containing 5, lysophosphatidic acid acyltransferase

decreases expression

EXP

Propylthiouracil results in decreased expression of ABHD5 mRNA

NCBI chr 8:130,877,834...130,903,947
Ensembl chr 8:130,877,703...130,903,947

G

ABI family, member 3

increases expression

EXP

Propylthiouracil results in increased expression of ABI3 mRNA

NCBI chr10:81,266,571...81,277,561
Ensembl chr10:81,266,571...81,277,561

G

ABI family member 3 binding protein

decreases expression

EXP

Propylthiouracil results in decreased expression of ABI3BP mRNA

NCBI chr11:57,381,282...57,597,989
Ensembl chr11:57,381,422...57,598,120

G

actin binding LIM protein family, member 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ABLIM2 mRNA

PMID:24780913 PMID:30047161

NCBI chr14:79,090,046...79,214,986
Ensembl chr14:79,090,923...79,214,972

G

actin binding LIM protein family, member 3

decreases expression

EXP

Propylthiouracil results in decreased expression of ABLIM3 mRNA

NCBI chr18:57,527,917...57,646,936
Ensembl chr18:57,527,917...57,646,710

G

ABR activator of RhoGEF and GTPase

increases expression

EXP

Propylthiouracil results in increased expression of ABR mRNA

NCBI chr10:61,760,743...61,959,526
Ensembl chr10:61,760,743...61,959,467

G

ankyrin repeat and BTB domain containing 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ABTB1 mRNA

NCBI chr 4:122,856,558...122,862,895
Ensembl chr 4:122,856,564...122,862,789

G

ankyrin repeat and BTB domain containing 2

increases expression

EXP

Propylthiouracil results in increased expression of ABTB2 mRNA

NCBI chr 3:110,409,672...110,563,488
Ensembl chr 3:110,409,627...110,563,487

G

acetyl-CoA carboxylase alpha

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of ACACA mRNA
Propylthiouracil results in decreased expression of ACACA mRNA

PMID:19483382 PMID:30047161

NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,511,857...69,773,888

G

acyl-CoA dehydrogenase family, member 10

decreases expression

EXP

Propylthiouracil results in decreased expression of ACAD10 mRNA

PMID:24780913 PMID:36843608

NCBI chr12:40,561,900...40,604,378
Ensembl chr12:40,566,701...40,604,378

G

acyl-CoA dehydrogenase family, member 11

decreases expression

EXP

Propylthiouracil results in decreased expression of ACAD11 mRNA

NCBI chr 8:113,560,142...113,625,346
Ensembl chr 8:113,560,196...113,625,352

G

acyl-CoA dehydrogenase family, member 8

increases expression

EXP

Propylthiouracil results in increased expression of ACAD8 mRNA

NCBI chr 8:33,641,420...33,665,542
Ensembl chr 8:33,641,420...33,665,542

G

acyl-CoA dehydrogenase family, member 9

increases expression

EXP

Propylthiouracil results in increased expression of ACAD9 mRNA

NCBI chr 2:120,871,329...120,894,306
Ensembl chr 2:120,871,227...120,894,709

G

acyl-CoA dehydrogenase, long chain

affects expression
increases expression

EXP

Propylthiouracil affects the expression of ACADL mRNA
Propylthiouracil results in increased expression of ACADL mRNA

PMID:19483382 PMID:30047161

NCBI chr 9:75,783,689...75,822,077
Ensembl chr 9:75,783,689...75,822,164

G

acyl-CoA dehydrogenase short chain

increases expression

EXP

Propylthiouracil results in increased expression of ACADS mRNA

NCBI chr12:47,154,259...47,163,580
Ensembl chr12:47,154,276...47,164,103

G

acyl-CoA dehydrogenase, very long chain

decreases expression

EXP

Propylthiouracil results in decreased expression of ACADVL mRNA

NCBI chr10:55,231,558...55,236,786
Ensembl chr10:55,231,440...55,236,750

G

aggrecan

decreases expression

EXP

Propylthiouracil results in decreased expression of ACAN mRNA

PMID:24780913 PMID:25825206

NCBI chr 1:142,390,951...142,453,779
Ensembl chr 1:142,390,951...142,453,779

G

ArfGAP with coiled-coil, ankyrin repeat and PH domains 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ACAP1 mRNA

NCBI chr10:55,104,040...55,119,280
Ensembl chr10:55,104,040...55,118,185

G

ArfGAP with coiled-coil, ankyrin repeat and PH domains 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ACAP2 mRNA

NCBI chr11:83,043,442...83,159,105
Ensembl chr11:83,043,511...83,159,107

G

acetyl-CoA acetyltransferase 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ACAT3 mRNA

NCBI chr 1:50,100,840...50,118,886
Ensembl chr 1:50,100,817...50,135,095

G

acyl-CoA binding domain containing 3

increases expression

EXP

Propylthiouracil results in increased expression of ACBD3 mRNA

NCBI chr13:94,987,643...95,016,356
Ensembl chr13:94,987,541...95,016,355

G

acyl-CoA binding domain containing 4

decreases expression

EXP

Propylthiouracil results in decreased expression of ACBD4 mRNA

NCBI chr10:88,548,146...88,558,588
Ensembl chr10:88,548,158...88,558,587

G

acyl-CoA binding domain containing 5

decreases expression

EXP

Propylthiouracil results in decreased expression of ACBD5 mRNA

NCBI chr17:90,114,250...90,156,286
Ensembl chr17:90,114,375...90,156,286

G

acyl-CoA binding domain containing 7

increases expression

EXP

Propylthiouracil results in increased expression of ACBD7 mRNA

NCBI chr17:79,813,106...79,821,254
Ensembl chr17:79,813,106...79,818,448

G

angiotensin I converting enzyme

decreases expression

EXP

Propylthiouracil results in decreased expression of ACE mRNA

PMID:24780913 PMID:25825206

NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942

G

angiotensin converting enzyme 2

decreases expression

ISO

Propylthiouracil results in decreased expression of ACE2 mRNA

NCBI chr X:33,925,458...33,972,851
Ensembl chr X:33,925,458...33,971,596

G

alkaline ceramidase 2

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of ACER2 mRNA
Propylthiouracil results in increased expression of ACER2 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 5:106,437,773...106,488,572
Ensembl chr 5:106,437,796...106,488,583

G

alkaline ceramidase 3

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of ACER3 mRNA
Propylthiouracil results in increased expression of ACER3 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 1:161,915,397...162,017,802
Ensembl chr 1:161,915,397...162,017,912

G

acetylcholinesterase

decreases expression

EXP

Propylthiouracil results in decreased expression of ACHE mRNA

NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410

G

atypical chemokine receptor 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ACKR2 mRNA

NCBI chr 8:130,438,703...130,451,106
Ensembl chr 8:130,384,559...130,464,393

G

atypical chemokine receptor 3

decreases expression

EXP

Propylthiouracil results in decreased expression of CXCR7 mRNA

NCBI chr 9:98,247,300...98,258,877
Ensembl chr 9:98,246,605...98,260,214

G

atypical chemokine receptor 4

decreases expression

EXP

Propylthiouracil results in decreased expression of ACKR4 mRNA

NCBI chr 8:113,595,325...113,599,762
Ensembl chr 8:113,595,293...113,602,372

G

ATP citrate lyase

increases expression

EXP

Propylthiouracil results in increased expression of ACLY mRNA

NCBI chr10:85,912,402...85,964,605
Ensembl chr10:85,912,402...85,963,631

G

aconitase 1

affects expression
increases expression

EXP

Propylthiouracil affects the expression of ACO1 mRNA
Propylthiouracil results in increased expression of ACO1 mRNA

PMID:19483382 PMID:30047161

NCBI chr 5:60,055,895...60,111,920
Ensembl chr 5:60,055,866...60,112,600

G

aconitase 2

affects expression

EXP

Propylthiouracil affects the expression of ACO2 mRNA

NCBI chr 7:115,265,816...115,308,931
Ensembl chr 7:115,265,791...115,308,892

G

acyl-CoA thioesterase 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of ACOT1 mRNA
Propylthiouracil results in decreased expression of ACOT1 mRNA

PMID:24780913 PMID:36843608

NCBI chr 6:109,367,274...109,375,268
Ensembl chr 6:109,367,268...109,380,749

G

acyl-CoA thioesterase 12

affects expression

EXP

Propylthiouracil affects the expression of ACOT12 mRNA

NCBI chr 2:24,721,648...24,763,686
Ensembl chr 2:24,721,910...24,765,298

G

acyl-CoA thioesterase 2

increases expression

EXP

Propylthiouracil results in increased expression of ACOT2 mRNA

NCBI chr 6:109,341,426...109,352,818
Ensembl chr 6:109,342,646...109,350,502

G

acyl-CoA thioesterase 4

affects expression
increases expression

EXP

Propylthiouracil affects the expression of ACOT4 mRNA
Propylthiouracil results in increased expression of ACOT4 mRNA

PMID:19483382 PMID:24780913

NCBI chr 6:109,399,032...109,405,138
Ensembl chr 6:109,399,578...109,405,138

G

acyl-CoA thioesterase 5

increases expression

EXP

Propylthiouracil results in increased expression of ACOT5 mRNA

NCBI chr 6:109,433,062...109,439,846
Ensembl chr 6:109,453,391...109,461,035
Ensembl chr 6:109,453,391...109,461,035

G

acyl-CoA oxidase 2

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of ACOX2 mRNA

NCBI chr15:19,090,820...19,122,392
Ensembl chr15:19,090,926...19,122,392

G

acyl-CoA oxidase-like

decreases expression

EXP

Propylthiouracil results in decreased expression of ACOXL mRNA

PMID:24780913 PMID:30047161

NCBI chr 3:135,514,340...135,820,291
Ensembl chr 3:135,514,275...135,820,291

G

acid phosphatase 2, lysosomal

increases expression

EXP

Propylthiouracil results in increased expression of ACP2 mRNA

NCBI chr 3:97,630,654...97,642,601
Ensembl chr 3:97,631,326...97,642,565

G

acid phosphatase 5, tartrate resistant

increases expression

EXP

Propylthiouracil results in increased expression of ACP5 mRNA

NCBI chr 8:28,939,984...28,946,639
Ensembl chr 8:28,939,985...28,943,929

G

acrosin

decreases expression

EXP

Propylthiouracil results in decreased expression of ACR mRNA

NCBI chr 7:122,517,910...122,524,110
Ensembl chr 7:122,517,934...122,524,087

G

acyl-CoA synthetase long-chain family member 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ACSL1 mRNA

NCBI chr16:52,487,870...52,554,110
Ensembl chr16:52,487,870...52,554,023

G

acyl-CoA synthetase long-chain family member 4

increases methylation
decreases expression

EXP

Propylthiouracil results in increased methylation of ACSL4 promoter
Propylthiouracil results in decreased expression of ACSL4 mRNA

NCBI chr X:110,739,633...110,803,416
Ensembl chr X:110,739,648...110,803,261

G

acyl-CoA synthetase long-chain family member 6

decreases expression

EXP

Propylthiouracil results in decreased expression of ACSL6 mRNA

NCBI chr10:38,940,668...38,999,515
Ensembl chr10:38,940,747...39,002,873

G

acyl-CoA synthetase medium-chain family member 1

increases expression

EXP

Propylthiouracil results in increased expression of ACSM1 mRNA

NCBI chr 1:183,417,052...183,451,897
Ensembl chr 1:183,416,009...183,454,217

G

acyl-CoA synthetase medium-chain family member 3

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of ACSM3 mRNA
Propylthiouracil results in decreased expression of ACSM3 mRNA

PMID:22504374 PMID:24780913 PMID:30047161

NCBI chr 1:183,564,652...183,591,328
Ensembl chr 1:183,564,635...183,591,437

G

acyl-CoA synthetase short-chain family member 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ACSS1 mRNA

NCBI chr 3:159,910,809...159,960,748
Ensembl chr 3:159,910,809...159,960,748

G

acyl-CoA synthetase short-chain family member 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ACSS2 mRNA

NCBI chr 3:164,464,124...164,507,607
Ensembl chr 3:164,464,055...164,519,830

G

acyl-CoA synthetase short-chain family member 3

decreases expression

EXP

Propylthiouracil results in decreased expression of ACSS3 mRNA

NCBI chr 7:44,127,725...44,336,707
Ensembl chr 7:44,127,122...44,336,684

G

actin, alpha 1, skeletal muscle

increases expression

EXP

Propylthiouracil results in increased expression of ACTA1 mRNA

NCBI chr19:68,781,168...68,784,194
Ensembl chr19:68,781,168...68,786,178

G

actin alpha 2, smooth muscle

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of ACTA2 mRNA

NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503

G

actin, beta

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of ACTB mRNA
Propylthiouracil results in decreased expression of RASA4 mRNA

NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242

G

actin, alpha, cardiac muscle 1

increases expression

EXP

Propylthiouracil results in increased expression of ACTC1 mRNA

NCBI chr 3:121,266,291...121,271,827
Ensembl chr 3:121,266,291...121,271,827

G

actin, gamma 1

increases expression

EXP

Propylthiouracil results in increased expression of ACTG1 mRNA

PMID:24780913 PMID:30047161 PMID:36843608

NCBI chr10:106,118,106...106,120,951
Ensembl chr10:106,118,108...106,120,951

G

actin gamma 2, smooth muscle

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of ACTG2 mRNA
Propylthiouracil results in increased expression of ACTG2 mRNA

PMID:24780913 PMID:30047161

NCBI chr 4:117,579,513...117,604,379
Ensembl chr 4:117,579,514...117,604,295

G

actin-like 6A

increases expression

EXP

Propylthiouracil results in increased expression of ACTL6A mRNA

NCBI chr 2:117,413,206...117,436,758
Ensembl chr 2:117,418,601...117,436,754

G

actinin, alpha 1

increases expression

EXP

Propylthiouracil results in increased expression of ACTN1 mRNA

NCBI chr 6:104,731,485...104,826,312
Ensembl chr 6:104,731,485...104,826,172

G

actinin alpha 3

decreases expression

EXP

Propylthiouracil results in decreased expression of ACTN3 mRNA

NCBI chr 1:211,588,473...211,604,401
Ensembl chr 1:211,588,474...211,604,401

G

actin related protein 1B

increases expression

EXP

Propylthiouracil results in increased expression of ACTR1B mRNA

NCBI chr 9:46,424,677...46,434,341
Ensembl chr 9:46,424,678...46,434,341

G

actin related protein 2

increases expression

EXP

Propylthiouracil results in increased expression of ACTR2 mRNA

NCBI chr14:98,500,119...98,535,092
Ensembl chr14:98,500,138...98,541,998

G

actin related protein 3B

decreases expression

EXP

Propylthiouracil results in decreased expression of ACTR3B mRNA

NCBI chr 4:9,995,553...10,089,422
Ensembl chr 4:9,996,155...10,089,553

G

actin-related protein T2

decreases expression

EXP

Propylthiouracil results in decreased expression of ACTRT2 mRNA

PMID:24780913 PMID:30047161

NCBI chr 5:170,518,470...170,519,870
Ensembl chr 5:170,518,165...170,521,164

G

activin A receptor type 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ACVR1 mRNA

NCBI chr 3:63,387,378...63,506,980
Ensembl chr 3:63,387,381...63,477,884

G

activin A receptor type 1C

decreases expression

EXP

Propylthiouracil results in decreased expression of ACVR1C mRNA

PMID:24780913 PMID:30047161

NCBI chr 3:63,224,322...63,301,252
Ensembl chr 3:63,227,559...63,301,205

G

activin A receptor type 2A

increases expression

EXP

Propylthiouracil results in increased expression of ACVR2A mRNA

NCBI chr 3:53,614,143...53,701,933
Ensembl chr 3:53,614,171...53,701,941

G

activin A receptor type 2B

increases expression

EXP

Propylthiouracil results in increased expression of ACVR2B mRNA

NCBI chr 8:128,016,589...128,056,193
Ensembl chr 8:128,016,526...128,048,171

G

aminoacylase 1

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of ACY1 mRNA
Propylthiouracil results in increased expression of ACY1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 8:115,951,068...115,956,471
Ensembl chr 8:115,951,068...115,956,405

G

acylphosphatase 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ACYP2 mRNA

NCBI chr14:108,402,837...108,572,367
Ensembl chr14:108,402,544...108,633,318

G

adenosine deaminase

increases expression

EXP

Propylthiouracil results in increased expression of ADA mRNA

PMID:24780913 PMID:30047161

NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:172,818,176...172,842,293

G

adenosine deaminase domain containing 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ADAD2 mRNA

NCBI chr19:64,573,915...64,578,194
Ensembl chr19:64,573,883...64,578,192

G

ADAM metallopeptidase domain 10

decreases expression

EXP

Propylthiouracil results in decreased expression of ADAM10 mRNA

NCBI chr 8:80,226,862...80,358,728
Ensembl chr 8:80,226,674...80,361,600

G

ADAM metallopeptidase domain 11

decreases expression

EXP

Propylthiouracil results in decreased expression of ADAM11 mRNA

NCBI chr10:88,224,185...88,242,865
Ensembl chr10:88,224,347...88,242,864

G

ADAM metallopeptidase domain 15

affects expression

EXP

Propylthiouracil affects the expression of ADAM15 mRNA

NCBI chr 2:177,052,363...177,062,879
Ensembl chr 2:177,052,363...177,062,849

G

ADAM metallopeptidase domain 19

decreases expression

EXP

Propylthiouracil results in decreased expression of ADAM19 mRNA

NCBI chr10:30,992,713...31,084,455
Ensembl chr10:30,992,754...31,084,455

G

ADAM metallopeptidase domain 1a

decreases expression

EXP

Propylthiouracil results in decreased expression of ADAM1A mRNA

NCBI chr12:40,674,460...40,680,988
Ensembl chr12:40,676,918...40,684,619

G

ADAM metallopeptidase domain 2

increases expression

EXP

Propylthiouracil results in increased expression of ADAM2 mRNA

NCBI chr15:44,418,191...44,459,570
Ensembl chr15:44,418,199...44,459,516

G

ADAM metallopeptidase domain 22

decreases expression

EXP

Propylthiouracil results in decreased expression of ADAM22 mRNA

NCBI chr 4:26,670,984...26,925,843
Ensembl chr 4:26,671,112...26,925,843

G

a disintegrin and metalloprotease domain 34-like

decreases expression

EXP

Propylthiouracil results in decreased expression of ADAM34L mRNA

NCBI chr16:55,269,522...55,274,688
Ensembl chr16:55,269,525...55,274,512

G

a disintegrin and metalloprotease domain 4

decreases expression

EXP

Propylthiouracil results in decreased expression of ADAM4 mRNA

PMID:24780913 PMID:30047161

NCBI chr 6:106,854,533...106,856,979

G

ADAM metallopeptidase domain 7

decreases expression

EXP

Propylthiouracil results in decreased expression of ADAM7 mRNA

NCBI chr15:47,009,176...47,057,581
Ensembl chr15:47,009,176...47,057,581

G

ADAM metallopeptidase domain 9

increases expression

EXP

Propylthiouracil results in increased expression of ADAM9 mRNA

NCBI chr16:73,725,186...73,804,284
Ensembl chr16:73,725,114...73,804,646

G

ADAM-like, decysin 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ADAMDEC1 mRNA

NCBI chr15:47,076,011...47,097,065
Ensembl chr15:47,076,019...47,097,065

G

ADAM metallopeptidase with thrombospondin type 1 motif, 1

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of ADAMTS1 mRNA
Propylthiouracil results in increased expression of ADAMTS1 mRNA

PMID:25825206 PMID:30047161

NCBI chr11:38,418,565...38,427,384
Ensembl chr11:38,418,101...38,427,390

G

ADAM metallopeptidase with thrombospondin type 1 motif, 10

increases expression

EXP

Propylthiouracil results in increased expression of ADAMTS10 mRNA

NCBI chr 7:15,033,859...15,063,800
Ensembl chr 7:15,033,934...15,063,800

G

ADAM metallopeptidase with thrombospondin type 1 motif, 12

increases expression

EXP

Propylthiouracil results in increased expression of ADAMTS12 mRNA

NCBI chr 2:61,759,975...62,054,716
Ensembl chr 2:61,759,987...62,054,716

G

ADAM metallopeptidase with thrombospondin type 1 motif, 15

decreases expression

EXP

Propylthiouracil results in decreased expression of ADAMTS15 mRNA

NCBI chr 8:37,566,064...37,589,446
Ensembl chr 8:37,566,065...37,589,446

G

ADAM metallopeptidase with thrombospondin type 1 motif, 17

decreases expression

EXP

Propylthiouracil results in decreased expression of ADAMTS17 mRNA

NCBI chr 1:129,856,062...130,178,430
Ensembl chr 1:129,856,074...130,176,844

G

ADAM metallopeptidase with thrombospondin type 1 motif, 18

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of ADAMTS18 mRNA
Propylthiouracil results in decreased expression of ADAMTS18 mRNA

PMID:24780913 PMID:30047161

NCBI chr19:58,596,095...58,749,239
Ensembl chr19:58,597,761...58,749,138

G

ADAM metallopeptidase with thrombospondin type 1 motif, 19

increases expression
multiple interactions

EXP
ISO

Propylthiouracil results in increased expression of ADAMTS19 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of ADAMTS19 mRNA

PMID:24780913 PMID:25825206 PMID:36706583

NCBI chr18:54,545,357...54,729,184
Ensembl chr18:54,545,357...54,729,181

G

ADAM metallopeptidase with thrombospondin type 1 motif, 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ADAMTS2 mRNA

PMID:24780913 PMID:30047161

NCBI chr10:35,422,030...35,627,483
Ensembl chr10:35,422,030...35,627,483

G

ADAM metallopeptidase with thrombospondin type 1, motif 3

increases expression

EXP

Propylthiouracil results in increased expression of ADAMTS3 mRNA

NCBI chr14:18,515,249...18,721,887
Ensembl chr14:18,515,249...18,721,887

G

ADAM metallopeptidase with thrombospondin type 1 motif, 4

decreases expression

EXP

Propylthiouracil results in decreased expression of ADAMTS4 mRNA

PMID:24780913 PMID:25825206

NCBI chr13:86,203,011...86,212,500
Ensembl chr13:86,202,642...86,212,514

G

ADAM metallopeptidase with thrombospondin type 1 motif, 5

increases expression

EXP

Propylthiouracil results in increased expression of ADAMTS5 mRNA

NCBI chr11:38,486,945...38,533,516
Ensembl chr11:38,486,955...38,533,516

G

ADAM metallopeptidase with thrombospondin type 1 motif, 7

increases expression

EXP

Propylthiouracil results in increased expression of ADAMTS7 mRNA

PMID:24780913 PMID:30047161

NCBI chr 8:99,584,529...99,624,132
Ensembl chr 8:99,584,529...99,624,132

G

ADAM metallopeptidase with thrombospondin type 1 motif, 9

increases expression
affects expression

EXP

Propylthiouracil results in increased expression of ADAMTS9 mRNA
Propylthiouracil affects the expression of ADAMTS9 mRNA

PMID:24780913 PMID:25825206

NCBI chr 4:126,847,726...127,019,924
Ensembl chr 4:126,847,729...127,019,876

G

ADAMTS-like 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of ADAMTSL1 mRNA
Propylthiouracil results in decreased expression of ADAMTSL1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 5:105,010,471...105,965,792
Ensembl chr 5:105,010,464...105,964,394

G

ADAMTS-like 2

increases expression

EXP

Propylthiouracil results in increased expression of ADAMTSL2 mRNA

NCBI chr 3:30,795,882...30,832,635
Ensembl chr 3:30,802,700...30,832,635

G

ADAMTS-like 3

increases expression

EXP

Propylthiouracil results in increased expression of ADAMTSL3 mRNA

NCBI chr 1:145,698,004...146,006,195
Ensembl chr 1:145,698,004...146,006,195

G

ADAMTS-like 4

decreases expression

EXP

Propylthiouracil results in decreased expression of ADAMTSL4 mRNA

NCBI chr 2:185,924,582...185,936,039
Ensembl chr 2:185,924,594...185,935,796

G

ADAMTS-like 5

decreases expression

EXP

Propylthiouracil results in decreased expression of ADAMTSL5 mRNA

NCBI chr 7:10,013,306...10,021,924
Ensembl chr 7:10,013,929...10,021,924

G

ArfGAP with dual PH domains 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ADAP2 mRNA

NCBI chr10:65,635,891...65,665,019
Ensembl chr10:65,622,434...65,664,022

G

adenosine deaminase, RNA-specific

decreases expression

EXP

Propylthiouracil results in decreased expression of ADAR mRNA

NCBI chr 2:177,436,076...177,475,969
Ensembl chr 2:177,436,094...177,475,971

G

adenosine deaminase, RNA-specific, B1

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of ADARB1 mRNA
Propylthiouracil results in increased expression of ADARB1 mRNA

PMID:24780913 PMID:30047161

NCBI chr20:11,222,171...11,350,416
Ensembl chr20:11,222,164...11,350,415

G

adenosine deaminase RNA specific B2

increases expression

EXP

Propylthiouracil results in increased expression of ADARB2 mRNA

NCBI chr17:66,660,586...67,211,104
Ensembl chr17:66,665,506...67,210,749

G

adenosine deaminase, tRNA-specific 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ADAT2 mRNA

NCBI chr 1:9,774,680...9,795,376
Ensembl chr 1:9,774,680...9,795,376

G

aarF domain containing kinase 5

decreases expression

EXP

Propylthiouracil results in decreased expression of ADCK5 mRNA

NCBI chr 7:110,182,275...110,200,088
Ensembl chr 7:110,181,981...110,200,088

G

adenylate cyclase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ADCY1 mRNA

NCBI chr14:86,125,119...86,234,459
Ensembl chr14:86,124,850...86,261,075

G

adenylate cyclase 10

decreases expression

EXP

Propylthiouracil results in decreased expression of ADCY10 mRNA

NCBI chr13:80,280,595...80,366,939
Ensembl chr13:80,284,295...80,366,926

G

adenylate cyclase 4

increases expression

EXP

Propylthiouracil results in increased expression of ADCY4 mRNA

NCBI chr15:33,236,201...33,252,070
Ensembl chr15:33,236,208...33,252,026

G

adenylate cyclase 5

decreases expression

EXP

Propylthiouracil results in decreased expression of ADCY5 mRNA

NCBI chr11:78,976,861...79,123,343
Ensembl chr11:78,976,861...79,123,343

G

adenylate cyclase 7

decreases expression

EXP

Propylthiouracil results in decreased expression of ADCY7 mRNA

NCBI chr19:34,913,154...34,972,366
Ensembl chr19:34,914,322...34,936,743

G

adenylate cyclase 8

increases expression

EXP

Propylthiouracil results in increased expression of ADCY8 mRNA

NCBI chr 7:98,306,434...98,555,687
Ensembl chr 7:98,306,464...98,555,038

G

adenylate cyclase 9

decreases expression

EXP

Propylthiouracil results in decreased expression of ADCY9 mRNA

NCBI chr10:11,645,373...11,768,462
Ensembl chr10:11,645,282...11,765,792

G

adducin 1

affects expression

EXP

Propylthiouracil affects the expression of ADD1 mRNA

NCBI chr14:80,333,242...80,401,641
Ensembl chr14:80,333,244...80,391,732

G

adducin 2

increases expression

EXP

Propylthiouracil results in increased expression of ADD2 mRNA

PMID:24780913 PMID:36843608

NCBI chr 4:120,001,977...120,101,090
Ensembl chr 4:120,002,054...120,101,091

G

adducin 3

decreases expression

EXP

Propylthiouracil results in decreased expression of ADD3 mRNA

NCBI chr 1:262,152,722...262,260,504
Ensembl chr 1:262,154,996...262,260,504

G

adhesion G protein-coupled receptor A1

increases expression

EXP

Propylthiouracil results in increased expression of ADGRA1 mRNA

NCBI chr 1:204,059,218...204,102,869
Ensembl chr 1:204,059,367...204,102,869

G

adhesion G protein-coupled receptor B1

decreases expression

EXP

Propylthiouracil results in decreased expression of ADGRB1 mRNA

NCBI chr 7:108,293,681...108,365,892
Ensembl chr 7:108,293,818...108,365,870

G

adhesion G protein-coupled receptor B3

increases expression

EXP

Propylthiouracil results in increased expression of ADGRB3 mRNA

NCBI chr 9:34,917,474...35,645,350
Ensembl chr 9:34,917,474...35,644,811

G

adhesion G protein-coupled receptor F4

increases expression

EXP

Propylthiouracil results in increased expression of ADGRF4 mRNA

NCBI chr 9:25,769,265...25,800,438
Ensembl chr 9:25,769,265...25,800,438

G

adhesion G protein-coupled receptor G1

increases expression

EXP

Propylthiouracil results in increased expression of ADGRG1 mRNA

NCBI chr19:10,009,983...10,047,138
Ensembl chr19:10,010,031...10,047,124

G

adhesion G protein-coupled receptor G2

increases expression

EXP

Propylthiouracil results in increased expression of ADGRG2 mRNA

NCBI chr X:38,106,067...38,231,286
Ensembl chr X:38,106,067...38,231,331

G

adhesion G protein-coupled receptor G6

decreases expression

EXP

Propylthiouracil results in decreased expression of ADGRG6 mRNA

PMID:24780913 PMID:25825206

NCBI chr 1:10,633,004...10,774,685
Ensembl chr 1:10,631,829...10,774,023

G

adhesion G protein-coupled receptor L2

increases expression

EXP

Propylthiouracil results in increased expression of ADGRL2 mRNA; Propylthiouracil results in increased expression of LPHN2 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 2:240,356,176...240,987,246
Ensembl chr 2:240,356,177...240,855,933

G

adhesion G protein-coupled receptor L3

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of ADGRL3 mRNA
Propylthiouracil results in decreased expression of LPHN3 mRNA

PMID:24780913 PMID:30047161

NCBI chr14:26,690,891...27,458,132
Ensembl chr14:26,722,194...27,280,418

G

alcohol dehydrogenase 1C (class I), gamma polypeptide

decreases expression

EXP

Propylthiouracil results in decreased expression of ADH1 mRNA

NCBI chr 2:229,470,703...229,482,291
Ensembl chr 2:229,470,703...229,482,291

G

alcohol dehydrogenase 4 (class II), pi polypeptide

affects expression

EXP

Propylthiouracil affects the expression of ADH4 mRNA

NCBI chr 2:229,622,092...229,640,120
Ensembl chr 2:229,622,095...229,641,879

G

alcohol dehydrogenase 6A (class V)

decreases expression

EXP

Propylthiouracil results in decreased expression of ADH6A mRNA

NCBI chr 2:229,497,121...229,519,403
Ensembl chr 2:229,497,173...229,519,401

G

alcohol dehydrogenase, iron containing, 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ADHFE1 mRNA

NCBI chr 5:14,488,784...14,515,405
Ensembl chr 5:14,488,788...14,515,835

G

adipose secreted signaling protein

increases expression

EXP

Propylthiouracil results in increased expression of ADISSP mRNA

NCBI chr 3:138,817,752...138,832,208
Ensembl chr 3:138,813,179...138,831,847

G

adrenomedullin

increases expression

EXP

Propylthiouracil results in increased expression of ADM mRNA

NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371

G

activity-dependent neuroprotector homeobox

decreases expression

EXP

Propylthiouracil results in decreased expression of ADNP mRNA

NCBI chr 3:177,310,258...177,340,379
Ensembl chr 3:177,310,258...177,336,188

G

2-aminoethanethiol dioxygenase

increases expression

EXP

Propylthiouracil results in increased expression of ADO mRNA

NCBI chr20:21,043,694...21,044,862
Ensembl chr20:21,043,317...21,048,483

G

adenosine A1 receptor

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of ADORA1 mRNA
Propylthiouracil results in increased expression of ADORA1 mRNA

PMID:24780913 PMID:30047161

NCBI chr13:48,210,922...48,247,826
Ensembl chr13:48,213,273...48,247,190

G

adenosine A2a receptor

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of ADORA2A mRNA
Propylthiouracil results in increased expression of ADORA2A mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr20:13,315,270...13,332,802
Ensembl chr20:13,315,270...13,332,802

G

adenosine A2B receptor

increases expression

EXP

Propylthiouracil results in increased expression of ADORA2B mRNA

NCBI chr10:47,439,712...47,456,092
Ensembl chr10:47,439,701...47,456,091

G

ADP-dependent glucokinase

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of ADPGK mRNA
Propylthiouracil results in increased expression of ADPGK mRNA

PMID:24780913 PMID:30047161

NCBI chr 8:68,595,194...68,623,179
Ensembl chr 8:68,595,248...68,623,178

G

ADP-ribosylhydrolase like 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ADPRHL1 mRNA

NCBI chr16:82,985,355...83,017,240

G

adrenoceptor alpha 1B

decreases expression

EXP

Propylthiouracil results in decreased expression of ADRA1B mRNA

PMID:24780913 PMID:25825206

NCBI chr10:28,756,461...28,874,831
Ensembl chr10:28,756,461...28,814,347

G

adrenoceptor alpha 1D

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of ADRA1D mRNA
Propylthiouracil results in increased expression of ADRA1D mRNA

PMID:24780913 PMID:30047161

NCBI chr 3:139,246,333...139,262,331
Ensembl chr 3:139,246,323...139,262,331

G

adrenoceptor beta 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ADRB2 mRNA

NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803

G

adrenoceptor beta 3

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of ADRB3 mRNA

NCBI chr16:71,544,603...71,547,410
Ensembl chr16:71,542,567...71,547,420

G

adenylosuccinate synthase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ADSS1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 6:137,500,549...137,523,087
Ensembl chr 6:137,501,001...137,523,086

G

androgen-dependent TFPI-regulating protein

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of ADTRP mRNA
Propylthiouracil results in decreased expression of ADTRP mRNA

PMID:19483382 PMID:24780913

NCBI chr17:23,113,578...23,199,616
Ensembl chr17:23,135,809...23,216,622

G

AE binding protein 1

increases expression

EXP

Propylthiouracil results in increased expression of AEBP1 mRNA

NCBI chr14:84,951,577...84,962,840
Ensembl chr14:84,952,822...84,962,843

G

actin filament associated protein 1-like 1

decreases expression

EXP

Propylthiouracil results in decreased expression of AFAP1L1 mRNA

NCBI chr18:57,454,120...57,514,584
Ensembl chr18:57,454,121...57,514,480

G

actin filament associated protein 1-like 2

increases expression

EXP

Propylthiouracil results in increased expression of AFAP1L2 mRNA

NCBI chr 1:265,969,368...266,065,951
Ensembl chr 1:265,969,368...266,065,943

G

afadin, adherens junction formation factor

increases expression

EXP

Propylthiouracil results in increased expression of AFDN mRNA

NCBI chr 1:58,041,065...58,170,505
Ensembl chr 1:58,041,641...58,170,505

G

ALF transcription elongation factor 3

decreases expression

EXP

Propylthiouracil results in decreased expression of AFF3 mRNA

NCBI chr 9:47,894,903...48,352,380
Ensembl chr 9:47,894,903...48,353,000

G

AFG3 (ATPase family gene 3)-like 1

increases expression

EXP

Propylthiouracil results in increased expression of AFG3L1 mRNA

NCBI chr19:68,417,101...68,444,260
Ensembl chr19:68,417,082...68,446,039

G

afamin

affects expression

EXP

Propylthiouracil affects the expression of AFM mRNA

NCBI chr14:17,815,194...17,848,042
Ensembl chr14:17,815,194...17,848,039

G

arylformamidase

decreases expression

EXP

Propylthiouracil results in decreased expression of AFMID mRNA

NCBI chr10:103,544,822...103,560,408
Ensembl chr10:103,544,841...103,560,408

G

ArfGAP with GTPase domain, ankyrin repeat and PH domain 3

increases expression

EXP

Propylthiouracil results in increased expression of AGAP3 mRNA

NCBI chr 4:11,567,191...11,617,610
Ensembl chr 4:11,567,191...11,617,285

G

advanced glycosylation end product-specific receptor

decreases expression

EXP

Propylthiouracil results in decreased expression of AGER mRNA; Propylthiouracil results in decreased expression of H3C7 mRNA

PMID:24780913 PMID:30047161

NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685

G

ArfGAP with FG repeats 1

increases expression

EXP

Propylthiouracil results in increased expression of AGFG1 mRNA

NCBI chr 9:91,572,962...91,630,688
Ensembl chr 9:91,573,157...91,626,910

G

amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of AGL mRNA
Propylthiouracil results in decreased expression of AGL mRNA

PMID:22504374 PMID:24780913

NCBI chr 2:207,389,949...207,445,959
Ensembl chr 2:207,389,949...207,445,724

G

argonaute RISC component 4

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of AGO4 mRNA
Propylthiouracil results in decreased expression of AGO4 mRNA

PMID:24780913 PMID:30047161

NCBI chr 5:144,064,949...144,110,422
Ensembl chr 5:144,064,949...144,110,402

G

1-acylglycerol-3-phosphate O-acyltransferase 5

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of AGPAT5 mRNA
Propylthiouracil results in increased expression of AGPAT5 mRNA

PMID:24780913 PMID:30047161

NCBI chr16:77,641,887...77,688,148
Ensembl chr16:77,641,887...77,688,148

G

anterior gradient 2, protein disulphide isomerase family member

decreases expression

EXP

Propylthiouracil results in decreased expression of AGR2 mRNA

NCBI chr 6:58,435,908...58,456,678
Ensembl chr 6:58,435,908...58,456,677

G

agrin

increases expression

EXP

Propylthiouracil results in increased expression of AGRN mRNA

NCBI chr 5:172,031,528...172,064,429
Ensembl chr 5:172,031,528...172,064,539

G

angiotensinogen

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of AGT mRNA
Propylthiouracil results in decreased expression of AGT mRNA

PMID:19483382 PMID:24780913 PMID:25825206 PMID:30047161 PMID:30085217

NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944

G

ATP/GTP binding carboxypeptidase 1

increases expression
increases methylation
decreases expression

EXP

Propylthiouracil results in increased expression of AGTPBP1 mRNA
Propylthiouracil results in increased methylation of AGTPBP1 gene
Propylthiouracil results in decreased expression of AGTPBP1 mRNA

PMID:22504374 PMID:36843608 PMID:37926403

NCBI chr17:5,092,108...5,244,414
Ensembl chr17:5,126,146...5,244,420

G

angiotensin II receptor, type 1a

increases expression
decreases expression
affects expression

EXP

Propylthiouracil results in increased expression of AGTR1A mRNA
Propylthiouracil results in decreased expression of AGTR1A mRNA
Propylthiouracil affects the expression of AGTR1A mRNA

PMID:19483382 PMID:24780913 PMID:25825206

NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,381,467...34,435,660

G

angiotensin II receptor, type 1b

decreases expression

EXP

Propylthiouracil results in decreased expression of AGTR1B mRNA

NCBI chr 2:104,774,005...104,849,262
Ensembl chr 2:104,773,930...104,849,310

G

angiotensin II receptor, type 2

decreases expression

EXP

Propylthiouracil results in decreased expression of AGTR2 mRNA

NCBI chr X:116,914,320...116,918,504
Ensembl chr X:116,913,656...116,918,745

G

adenosylhomocysteinase-like 2

increases expression

EXP

Propylthiouracil results in increased expression of AHCYL2 mRNA

NCBI chr 4:59,348,747...59,498,503
Ensembl chr 4:59,348,217...59,498,502

G

AHNAK nucleoprotein

increases expression

EXP

Propylthiouracil results in increased expression of AHNAK mRNA

NCBI chr 1:215,311,289...215,400,010
Ensembl chr 1:215,321,931...215,400,675

G

aryl-hydrocarbon receptor repressor

increases expression

EXP

Propylthiouracil results in increased expression of AHRR mRNA

NCBI chr 1:30,822,219...30,917,251
Ensembl chr 1:30,810,866...30,952,866

G

alpha hemoglobin stabilizing protein

decreases expression

EXP

Propylthiouracil results in decreased expression of AHSP mRNA

NCBI chr 1:192,310,306...192,315,943
Ensembl chr 1:192,310,244...192,315,942

G

activation-induced cytidine deaminase

increases expression

EXP

Propylthiouracil results in increased expression of APOBEC3B mRNA

NCBI chr 4:157,446,120...157,455,958
Ensembl chr 4:157,444,697...157,456,356

G

axin interactor, dorsalization associated

increases expression

EXP

Propylthiouracil results in increased expression of AIDA mRNA

NCBI chr13:97,471,931...97,499,531
Ensembl chr13:97,471,604...97,499,535

G

allograft inflammatory factor 1

increases expression

EXP

Propylthiouracil results in increased expression of AIF1 mRNA

NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,652,243...3,657,339

G

allograft inflammatory factor 1-like

increases expression

EXP

Propylthiouracil results in increased expression of AIF1L mRNA

NCBI chr 3:35,627,239...35,651,793
Ensembl chr 3:35,627,239...35,651,793

G

AIF family member 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of AIFM2 mRNA
Propylthiouracil results in decreased expression of AIFM2 mRNA

PMID:24780913 PMID:30047161

NCBI chr20:30,195,781...30,222,014
Ensembl chr20:30,193,829...30,220,957

G

AIF family member 3

decreases expression

EXP

Propylthiouracil results in decreased expression of AIFM3 mRNA

NCBI chr11:97,009,100...97,030,601
Ensembl chr11:97,008,426...97,023,334

G

androgen-induced 1

decreases expression

EXP

Propylthiouracil results in decreased expression of AIG1 mRNA

NCBI chr 1:9,866,546...10,089,454
Ensembl chr 1:9,866,548...10,089,155

G

adherens junctions associated protein 1

increases expression

EXP

Propylthiouracil results in increased expression of AJAP1 mRNA

NCBI chr 5:169,190,477...169,302,938
Ensembl chr 5:169,190,477...169,304,515

G

ajuba LIM protein

decreases expression

EXP

Propylthiouracil results in decreased expression of AJUBA mRNA

NCBI chr15:31,989,796...32,000,042
Ensembl chr15:31,989,799...32,000,042

G

adenylate kinase 2

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of AK2 mRNA
Propylthiouracil results in increased expression of AK2 mRNA

PMID:24780913 PMID:30047161

NCBI chr 5:146,609,469...146,649,008
Ensembl chr 5:146,630,445...146,650,610

G

adenylate kinase 4

decreases expression

EXP

Propylthiouracil results in decreased expression of AK4 mRNA

NCBI chr 5:121,154,565...121,214,403
Ensembl chr 5:121,154,572...121,214,401

G

adenylate kinase 5

increases expression

EXP

Propylthiouracil results in increased expression of AK5 mRNA

NCBI chr 2:244,057,240...244,241,372
Ensembl chr 2:244,057,240...244,241,366

G

adenylate kinase 6

increases expression

EXP

Propylthiouracil results in increased expression of AK6 mRNA

NCBI chr 2:33,528,388...33,540,445
Ensembl chr 2:33,528,035...33,540,441
Ensembl chr20:33,528,035...33,540,441

G

adenylate kinase 7

increases expression

EXP

Propylthiouracil results in increased expression of AK7 mRNA

NCBI chr 6:130,376,499...130,444,674
Ensembl chr 6:130,376,550...130,444,677

G

adenylate kinase 8

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of AK8 mRNA
Propylthiouracil results in decreased expression of AK8 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 3:32,426,892...32,542,432
Ensembl chr 3:32,426,421...32,542,431

G

A-kinase anchoring protein 1

decreases expression

EXP

Propylthiouracil results in decreased expression of AKAP1 mRNA

NCBI chr10:74,118,232...74,151,366
Ensembl chr10:74,119,124...74,138,190

G

A-kinase anchoring protein 10

decreases expression

EXP

Propylthiouracil results in decreased expression of AKAP10 mRNA

NCBI chr10:47,044,819...47,108,153
Ensembl chr10:47,044,819...47,108,203

G

A-kinase anchoring protein 11

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of AKAP11 mRNA
Propylthiouracil results in increased expression of AKAP11 mRNA

PMID:30047161 PMID:36843608

NCBI chr15:60,320,839...60,365,480
Ensembl chr15:60,320,839...60,365,335

G

A-kinase anchoring protein 12

decreases expression

EXP

Propylthiouracil results in decreased expression of AKAP12 mRNA

NCBI chr 1:43,135,515...43,225,245
Ensembl chr 1:43,199,008...43,225,557

G

A-kinase anchoring protein 13

increases expression

EXP

Propylthiouracil results in increased expression of AKAP13 mRNA

NCBI chr 1:138,722,445...139,029,401
Ensembl chr 1:138,724,150...139,029,401

G

A-kinase anchoring protein 14

increases expression

EXP

Propylthiouracil results in increased expression of AKAP14 mRNA

NCBI chr X:121,261,195...121,276,376
Ensembl chr X:121,259,899...121,276,376

G

A-kinase anchoring protein 17A

decreases expression

EXP

Propylthiouracil results in decreased expression of AKAP17A mRNA; Propylthiouracil results in decreased expression of AKAP17B mRNA

NCBI chr12:21,424,202...21,428,308
Ensembl chr12:21,424,202...21,428,247

G

A-kinase anchoring protein 3

increases expression

EXP

Propylthiouracil results in increased expression of AKAP3 mRNA

NCBI chr 4:161,374,198...161,400,062
Ensembl chr 4:161,374,407...161,400,230

G

A-kinase anchoring protein 5

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of AKAP5 mRNA
Propylthiouracil results in increased expression of AKAP5 mRNA

PMID:24780913 PMID:36843608

NCBI chr 6:100,787,169...100,796,712
Ensembl chr 6:100,790,148...100,796,620

G

A-kinase anchoring protein 7

decreases expression

EXP

Propylthiouracil results in decreased expression of AKAP7 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:21,906,503...22,168,663
Ensembl chr 1:21,906,676...22,037,090

G

A-kinase anchoring protein 8 like

decreases expression

EXP

Propylthiouracil results in decreased expression of AKAP8L mRNA

NCBI chr 7:11,983,215...12,012,843
Ensembl chr 7:11,982,721...12,012,811

G

akirin 1

increases expression

EXP

Propylthiouracil results in increased expression of AKIRIN1 mRNA

NCBI chr 5:141,274,174...141,289,617
Ensembl chr 5:141,274,175...141,289,575

G

AT-hook transcription factor

increases expression

EXP

Propylthiouracil results in increased expression of AKNA mRNA

NCBI chr 5:81,792,928...81,839,936
Ensembl chr 5:81,792,929...81,831,528

G

aldo-keto reductase family 1 member A1

affects expression

EXP

Propylthiouracil affects the expression of AKR1A1 mRNA

NCBI chr 5:135,329,605...135,367,037
Ensembl chr 5:135,329,606...135,367,035

G

aldo-keto reductase family 1, member B7

increases expression

EXP

Propylthiouracil results in increased expression of AKR1B7 mRNA

NCBI chr 4:64,043,901...64,083,751
Ensembl chr 4:64,020,686...64,064,909

G

aldo-keto reductase family 1, member C14

increases expression

EXP

Propylthiouracil results in increased expression of AKR1C14 mRNA

NCBI chr17:71,066,197...71,083,184
Ensembl chr17:71,066,200...71,083,157

G

aldo-keto reductase family 1, member C19

decreases expression

EXP

Propylthiouracil results in decreased expression of AKR1C19 mRNA

NCBI chr17:70,913,916...70,934,959
Ensembl chr17:70,919,236...70,934,959

G

aldo-keto reductase family 1, member C3

increases expression

EXP

Propylthiouracil results in increased expression of AKR1C18 mRNA

NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438

G

aldo-keto reductase family 1 member C8

decreases expression

EXP

Propylthiouracil results in decreased expression of AKR1CL mRNA

PMID:24780913 PMID:25825206

NCBI chr17:71,091,398...71,117,985
Ensembl chr17:71,083,080...71,117,957

G

aldo-keto reductase family 1, member E2

decreases expression

EXP

Propylthiouracil results in decreased expression of AKR1E2 mRNA

PMID:24780913 PMID:30047161

NCBI chr17:70,645,835...70,660,366
Ensembl chr17:70,645,869...70,660,360

G

aldo-keto reductase family 7, member A2

affects expression

EXP

Propylthiouracil affects the expression of AKR7A2 mRNA

NCBI chr 5:156,835,589...156,844,127
Ensembl chr 5:156,835,551...156,844,109

G

aldo-keto reductase family 7 member A3

affects expression
increases expression
decreases expression

EXP

Propylthiouracil affects the expression of AKR7A3 mRNA
Propylthiouracil results in increased expression of AKR7A3 mRNA
Propylthiouracil results in decreased expression of AKR7A3 mRNA

PMID:19483382 PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 5:156,876,721...156,884,599
Ensembl chr 5:156,874,086...156,885,153

G

AKT serine/threonine kinase 1

multiple interactions
increases phosphorylation
increases expression
affects response to substance

ISO
EXP

AKT1 protein mutant form promotes the reaction [Propylthiouracil results in increased expression of AMH mRNA]; AKT1 protein mutant form promotes the reaction [Propylthiouracil results in increased expression of INHBB mRNA]
Propylthiouracil results in increased phosphorylation of AKT1 protein
haizao yuhu inhibits the reaction [Propylthiouracil results in increased expression of AKT1 mRNA]; Propylthiouracil results in increased expression of and results in increased phosphorylation of AKT1 protein; Thyroxine inhibits the reaction [Propylthiouracil results in increased expression of AKT1 mRNA]; Thyroxine inhibits the reaction [Propylthiouracil results in increased expression of and results in increased phosphorylation of AKT1 protein]; Thyroxine inhibits the reaction [Propylthiouracil results in increased phosphorylation of AKT1 protein]; xiaoluowan inhibits the reaction [Propylthiouracil results in increased phosphorylation of AKT1 protein]
AKT1 protein affects the susceptibility to Propylthiouracil

PMID:20951798 PMID:30047161 PMID:35101570 PMID:37295576

NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610

G

AKT serine/threonine kinase 3

increases expression

ISO

Propylthiouracil results in increased expression of AKT3 mRNA

NCBI chr13:91,475,839...91,758,060
Ensembl chr13:91,475,839...91,748,020

G

5'-aminolevulinate synthase 1

increases expression

EXP

Propylthiouracil results in increased expression of ALAS1 mRNA

NCBI chr 8:115,755,238...115,768,642
Ensembl chr 8:115,755,238...115,768,642

G

5'-aminolevulinate synthase 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ALAS2 mRNA

PMID:24780913 PMID:25825206

NCBI chr X:22,890,650...22,914,046
Ensembl chr X:22,890,689...22,914,043

G

albumin

increases expression

EXP

Propylthiouracil results in increased expression of ALB protein

NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865

G

activated leukocyte cell adhesion molecule

decreases expression

EXP

Propylthiouracil results in decreased expression of ALCAM mRNA

NCBI chr11:61,804,932...62,005,250
Ensembl chr11:61,805,049...62,006,876

G

aldehyde dehydrogenase 16 family, member A1

increases expression

EXP

Propylthiouracil results in increased expression of ALDH16A1 mRNA

NCBI chr 1:104,763,200...104,776,270
Ensembl chr 1:104,763,055...104,776,270

G

aldehyde dehydrogenase 1 family, member A1

affects expression
multiple interactions
decreases expression

EXP
ISO

Propylthiouracil affects the expression of ALDH1A1 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of ALDH1A1 mRNA
Propylthiouracil results in decreased expression of ALDH1A1 mRNA

PMID:19483382 PMID:24780913 PMID:25825206 PMID:36706583

NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500

G

aldehyde dehydrogenase 1 family, member A2

decreases expression

EXP

Propylthiouracil results in decreased expression of ALDH1A2 mRNA

NCBI chr 8:80,758,641...80,837,891
Ensembl chr 8:80,758,142...80,837,883

G

aldehyde dehydrogenase 1 family, member A3

decreases expression

EXP

Propylthiouracil results in decreased expression of ALDH1A3 mRNA

NCBI chr 1:129,392,516...129,436,552
Ensembl chr 1:129,392,516...129,427,777

G

aldehyde dehydrogenase family 1, subfamily A7

affects expression
increases expression

EXP

Propylthiouracil affects the expression of ALDH1A7 mRNA
Propylthiouracil results in increased expression of ALDH1A7 mRNA

PMID:19483382 PMID:24780913

NCBI chr 1:227,627,977...227,667,877
Ensembl chr 1:227,627,448...227,672,523

G

aldehyde dehydrogenase 1 family, member L1

decreases expression

EXP

Propylthiouracil results in decreased expression of ALDH1L1 mRNA

NCBI chr 4:124,617,182...124,663,674
Ensembl chr 4:124,617,217...124,664,704

G

aldehyde dehydrogenase 1 family, member L2

increases expression

EXP

Propylthiouracil results in increased expression of ALDH1L2 mRNA

PMID:24780913 PMID:30047161

NCBI chr 7:22,141,872...22,193,403
Ensembl chr 7:22,141,842...22,193,398

G

aldehyde dehydrogenase 2 family member

affects expression

EXP

Propylthiouracil affects the expression of ALDH2 mRNA

NCBI chr12:40,610,244...40,643,220
Ensembl chr12:40,610,224...40,643,219

G

aldehyde dehydrogenase 3 family, member A1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of ALDH3A1 mRNA
Propylthiouracil results in decreased expression of ALDH3A1 mRNA

PMID:24780913 PMID:30047161

NCBI chr10:46,392,464...46,402,151
Ensembl chr10:46,392,411...46,402,151

G

aldehyde dehydrogenase 3 family, member B1

decreases expression

EXP

Propylthiouracil results in decreased expression of ALDH3B1 mRNA

NCBI chr 1:210,574,545...210,605,188
Ensembl chr 1:210,573,661...210,610,538

G

aldehyde dehydrogenase 4 family, member A1

decreases expression

EXP

Propylthiouracil results in decreased expression of ALDH4A1 mRNA

NCBI chr 5:157,163,189...157,188,673
Ensembl chr 5:157,162,945...157,188,673

G

aldehyde dehydrogenase 5 family, member A1

increases expression

EXP

Propylthiouracil results in increased expression of ALDH5A1 mRNA

NCBI chr17:40,560,373...40,586,711
Ensembl chr17:40,558,347...40,586,714

G

aldehyde dehydrogenase 7 family, member A1

increases expression

EXP

Propylthiouracil results in increased expression of ALDH7A1 mRNA

NCBI chr18:52,208,035...52,240,293
Ensembl chr18:52,204,161...52,240,467

G

aldehyde dehydrogenase 9 family, member A1

increases expression

EXP

Propylthiouracil results in increased expression of ALDH9A1 mRNA

PMID:24780913 PMID:30047161

NCBI chr13:82,038,679...82,055,478
Ensembl chr13:82,038,533...82,055,481

G

aldolase, fructose-bisphosphate A

decreases expression

EXP

Propylthiouracil results in decreased expression of ALDOA mRNA

NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:190,832,820...190,838,211

G

aldolase, fructose-bisphosphate B

decreases expression

EXP

Propylthiouracil results in decreased expression of ALDOB mRNA

NCBI chr 5:68,684,541...68,697,582
Ensembl chr 5:68,684,542...68,716,740

G

aldolase, fructose-bisphosphate C

decreases expression

EXP

Propylthiouracil results in decreased expression of ALDOC mRNA

NCBI chr10:63,715,544...63,719,133
Ensembl chr10:63,715,489...63,719,133

G

ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase

increases expression

EXP

Propylthiouracil results in increased expression of ALG1 mRNA

NCBI chr10:10,853,014...10,863,250
Ensembl chr10:10,853,014...10,863,239

G

ALG5, dolichyl-phosphate beta-glucosyltransferase

increases expression

EXP

Propylthiouracil results in increased expression of ALG5 mRNA

NCBI chr 2:141,087,126...141,101,397
Ensembl chr 2:141,087,147...141,102,951

G

ALG6, alpha-1,3-glucosyltransferase

increases expression

EXP

Propylthiouracil results in increased expression of ALG6 mRNA

NCBI chr 5:119,520,415...119,606,365
Ensembl chr 5:119,520,430...119,606,659

G

ALG8, alpha-1,3-glucosyltransferase

increases expression

EXP

Propylthiouracil results in increased expression of ALG8 mRNA

NCBI chr 1:161,095,570...161,115,533
Ensembl chr 1:161,095,412...161,115,527

G

ALK receptor tyrosine kinase

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of ALK mRNA
Propylthiouracil results in decreased expression of ALK mRNA

PMID:24780913 PMID:30047161

NCBI chr 6:28,631,431...29,351,321
Ensembl chr 6:28,632,197...29,349,721

G

alkB homolog 1, histone H2A dioxygenase

decreases expression

EXP

Propylthiouracil results in decreased expression of ALKBH1 mRNA

NCBI chr 6:112,799,234...112,819,708
Ensembl chr 6:112,799,234...112,819,708

G

alkB homolog 6

increases expression

EXP

Propylthiouracil results in increased expression of ALKBH6 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:94,690,979...94,696,429
Ensembl chr 1:94,691,822...94,696,427

G

alkB homolog 7

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of ALKBH7 mRNA
Propylthiouracil results in decreased expression of ALKBH7 mRNA

PMID:19483382 PMID:30047161

NCBI chr 9:1,925,896...1,928,048
Ensembl chr 9:1,925,743...1,928,048

G

arachidonate 15-lipoxygenase

decreases expression

EXP

Propylthiouracil results in decreased expression of ALOX15 mRNA

NCBI chr10:55,559,060...55,567,535
Ensembl chr10:55,559,061...55,567,723

G

alpha-kinase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ALPK1 mRNA

NCBI chr 2:218,801,425...218,924,013
Ensembl chr 2:218,780,189...218,921,646

G

alpha-kinase 3

decreases expression

EXP

Propylthiouracil results in decreased expression of ALPK3 mRNA

NCBI chr 1:144,423,690...144,471,534
Ensembl chr 1:144,423,726...144,490,309

G

alkaline phosphatase, biomineralization associated

increases expression

EXP

Propylthiouracil results in increased expression of ALPL mRNA

PMID:22504374 PMID:30047161

NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167

G

alsin Rho guanine nucleotide exchange factor ALS2

decreases expression

EXP

Propylthiouracil results in decreased expression of ALS2 mRNA

NCBI chr 9:68,107,310...68,180,192
Ensembl chr 9:68,107,528...68,179,660

G

ALX homeobox 3

affects expression

EXP

Propylthiouracil affects the expression of ALX3 mRNA

NCBI chr 2:197,919,381...197,929,795
Ensembl chr 2:197,919,381...197,929,795

G

Aly/REF export factor

increases expression

EXP

Propylthiouracil results in increased expression of THOC4 mRNA

NCBI chr10:106,369,750...106,373,395
Ensembl chr10:106,369,750...106,373,395

G

amidohydrolase domain containing 2

increases expression

EXP

Propylthiouracil results in increased expression of AMDHD2 mRNA

NCBI chr10:13,692,136...13,700,632
Ensembl chr10:13,692,146...13,700,632

G

amelogenin, X-linked

decreases expression

EXP

Propylthiouracil results in decreased expression of AMELX mRNA

NCBI chr X:28,648,803...28,660,099
Ensembl chr X:28,648,803...28,660,099

G

anti-Mullerian hormone

multiple interactions
decreases expression
affects expression
increases expression

ISO
EXP

AKT1 protein mutant form promotes the reaction [Propylthiouracil results in increased expression of AMH mRNA]
Propylthiouracil results in decreased expression of AMH mRNA
Thyroxine affects the reaction [Propylthiouracil affects the expression of AMH mRNA]; Triiodothyronine affects the reaction [Propylthiouracil affects the expression of AMH mRNA]

PMID:7819453 PMID:20951798 PMID:25825206 PMID:30047161

NCBI chr 7:9,557,451...9,559,867
Ensembl chr 7:9,557,451...9,559,867

G

adhesion molecule with Ig like domain 2

affects expression

EXP

Propylthiouracil affects the expression of AMIGO2 mRNA

NCBI chr 7:130,270,639...130,273,735
Ensembl chr 7:130,270,554...130,282,218

G

adhesion molecule with Ig like domain 3

decreases expression
increases methylation

EXP

Propylthiouracil results in decreased expression of AMIGO3 mRNA
Propylthiouracil results in increased methylation of AMIGO3 promoter

NCBI chr 8:117,620,499...117,622,025
Ensembl chr 8:117,616,629...117,626,577

G

amnion associated transmembrane protein

affects expression

EXP

Propylthiouracil affects the expression of AMN mRNA

NCBI chr 6:136,132,567...136,140,008
Ensembl chr 6:136,132,567...136,140,008

G

antagonist of mitotic exit network 1 homolog

decreases expression

EXP

Propylthiouracil results in decreased expression of AMN1 mRNA

NCBI chr 4:183,886,469...183,913,411
Ensembl chr 4:183,886,474...183,913,411

G

angiomotin like 2

decreases expression

EXP

Propylthiouracil results in decreased expression of AMOTL2 mRNA

NCBI chr 8:112,182,060...112,198,032
Ensembl chr 8:112,181,863...112,198,030

G

amylase 2a3

increases expression

EXP

Propylthiouracil results in increased expression of AMY1A mRNA; Propylthiouracil results in increased expression of AMY2A3 mRNA

NCBI chr 2:204,005,840...204,014,412
Ensembl chr 2:204,005,840...204,014,413

G

archaelysin family metallopeptidase 1

increases expression

EXP

Propylthiouracil results in increased expression of AMZ1 mRNA

NCBI chr12:19,000,448...19,038,625
Ensembl chr12:19,000,448...19,037,925

G

anaphase promoting complex subunit 10

increases expression

EXP

Propylthiouracil results in increased expression of ANAPC10 mRNA

NCBI chr19:45,057,278...45,109,882
Ensembl chr19:45,029,546...45,109,882

G

angiogenin

decreases expression

EXP

Propylthiouracil results in decreased expression of ANG mRNA

PMID:24780913 PMID:30047161

NCBI chr15:26,786,233...26,796,883
Ensembl chr15:26,786,065...26,801,106

G

angiogenin, ribonuclease A family, member 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ANG2 mRNA

NCBI chr15:26,871,842...26,889,421
Ensembl chr15:26,871,838...26,889,421

G

angel homolog 2

increases expression

EXP

Propylthiouracil results in increased expression of ANGEL2 mRNA

NCBI chr13:105,041,727...105,060,640
Ensembl chr13:105,041,728...105,060,640

G

angiopoietin 1

increases expression

EXP

Propylthiouracil results in increased expression of ANGPT1 mRNA

NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:75,418,218...75,668,696

G

angiopoietin 2

increases expression

EXP

Propylthiouracil results in increased expression of ANGPT2 mRNA

NCBI chr16:77,790,760...77,841,241
Ensembl chr16:77,790,563...77,841,239

G

angiopoietin-like 2

affects expression
multiple interactions
decreases expression

EXP
ISO

Propylthiouracil affects the expression of ANGPTL2 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of ANGPTL2 mRNA
Propylthiouracil results in decreased expression of ANGPTL2 mRNA

PMID:24780913 PMID:25825206 PMID:36706583

NCBI chr 3:36,914,876...36,944,715
Ensembl chr 3:36,914,745...36,945,876

G

angiopoietin-like 4

increases expression

EXP

Propylthiouracil results in increased expression of ANGPTL4 mRNA

NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:15,252,473...15,258,681

G

angiopoietin-like 6

decreases expression

EXP

Propylthiouracil results in decreased expression of ANGPTL6 mRNA

NCBI chr 8:27,689,804...27,696,172
Ensembl chr 8:27,689,806...27,696,111

G

ankyrin 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ANK1 mRNA

NCBI chr16:75,578,824...75,757,464
Ensembl chr16:75,578,824...75,757,464

G

ankyrin 2

increases expression

EXP

Propylthiouracil results in increased expression of ANK2 mRNA

NCBI chr 2:218,052,555...218,628,414
Ensembl chr 2:218,052,555...218,537,259

G

ankyrin 3

decreases expression

EXP

Propylthiouracil results in decreased expression of ANK3 mRNA

NCBI chr20:18,601,307...19,224,790
Ensembl chr20:18,601,826...19,084,879

G

ankyrin repeat and kinase domain containing 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ANKK1 mRNA

NCBI chr 8:58,676,327...58,685,012
Ensembl chr 8:58,676,327...58,684,489

G

ankyrin repeat and MYND domain containing 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ANKMY2 mRNA

NCBI chr 6:58,616,251...58,657,634
Ensembl chr 6:58,615,243...58,657,685

G

ankyrin repeat family A member 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of ANKRA2 mRNA
Propylthiouracil results in decreased expression of ANKRA2 mRNA

PMID:24780913 PMID:30047161

NCBI chr 2:31,347,158...31,358,002
Ensembl chr 2:31,347,090...31,364,394

G

ankyrin repeat domain 1

increases expression

EXP

Propylthiouracil results in increased expression of ANKRD1 mRNA

PMID:24780913 PMID:25825206

NCBI chr 1:243,228,460...243,237,014
Ensembl chr 1:243,228,448...243,263,751

G

ankyrin repeat domain 10

decreases expression

EXP

Propylthiouracil results in decreased expression of ANKRD10 mRNA

NCBI chr16:84,566,021...84,591,849
Ensembl chr16:84,568,506...84,591,846

G

ankyrin repeat domain 12

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of ANKRD12 mRNA
Propylthiouracil results in decreased expression of ANKRD12 mRNA

PMID:22504374 PMID:30047161

NCBI chr 9:113,030,127...113,134,816
Ensembl chr 9:113,030,919...113,134,762

G

ankyrin repeat domain 13a

increases expression

EXP

Propylthiouracil results in increased expression of ANKRD13A mRNA

NCBI chr12:47,458,828...47,488,959
Ensembl chr12:47,458,831...47,489,312

G

ankyrin repeat domain 13D

increases expression

EXP

Propylthiouracil results in increased expression of ANKRD13D mRNA

NCBI chr 1:210,995,012...211,007,430
Ensembl chr 1:210,995,148...211,007,369

G

ankyrin repeat domain 16

decreases expression

EXP

Propylthiouracil results in decreased expression of ANKRD16 mRNA

NCBI chr17:71,645,171...71,658,377
Ensembl chr17:71,647,107...71,658,377

G

ankyrin repeat domain 27

decreases expression

EXP

Propylthiouracil results in decreased expression of ANKRD27 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:97,387,997...97,440,501
Ensembl chr 1:97,388,099...97,440,501

G

ankyrin repeat domain 29

decreases expression

EXP

Propylthiouracil results in decreased expression of ANKRD29 mRNA

NCBI chr18:3,711,052...3,768,997
Ensembl chr18:3,711,059...3,769,098

G

ankyrin repeat domain 33B

decreases expression

EXP

Propylthiouracil results in decreased expression of ANKRD33B mRNA

NCBI chr 2:83,988,505...84,070,311
Ensembl chr 2:83,993,974...84,070,936

G

ankyrin repeat domain 34A

decreases expression

EXP

Propylthiouracil results in decreased expression of ANKRD34A mRNA

NCBI chr 2:186,818,496...186,823,921
Ensembl chr 2:186,817,216...186,824,467

G

ankyrin repeat domain 34B

decreases expression

EXP

Propylthiouracil results in decreased expression of ANKRD34B mRNA

NCBI chr 2:25,386,452...25,402,376
Ensembl chr 2:25,386,158...25,403,265

G

ankyrin repeat domain 34C

decreases expression

EXP

Propylthiouracil results in decreased expression of ANKRD34C mRNA

NCBI chr 8:99,151,112...99,161,607
Ensembl chr 8:99,146,556...99,162,260

G

ankyrin repeat domain 35

decreases expression

EXP

Propylthiouracil results in decreased expression of ANKRD35 mRNA

NCBI chr 2:186,895,896...186,915,903
Ensembl chr 2:186,895,945...186,915,902

G

ankyrin repeat domain 37

decreases expression

EXP

Propylthiouracil results in decreased expression of ANKRD37 mRNA

PMID:24780913 PMID:30047161

NCBI chr16:53,001,487...53,004,545
Ensembl chr16:52,994,740...53,004,545

G

ankyrin repeat domain 40

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of ANKRD40 mRNA
Propylthiouracil results in increased expression of ANKRD40 mRNA

PMID:24780913 PMID:30047161

NCBI chr10:79,778,966...79,792,212
Ensembl chr10:56,415,260...56,416,345
Ensembl chr10:56,415,260...56,416,345

G

ankyrin repeat domain 42

decreases expression

EXP

Propylthiouracil results in decreased expression of ANKRD42 mRNA

NCBI chr 1:156,060,516...156,103,543
Ensembl chr 1:156,060,516...156,103,517

G

ankyrin repeat domain 45

decreases expression

EXP

Propylthiouracil results in decreased expression of ANKRD45 mRNA

NCBI chr13:75,957,047...75,984,868
Ensembl chr13:75,957,926...75,984,910

G

ankyrin repeat domain 55

increases expression

EXP

Propylthiouracil results in increased expression of ANKRD55 mRNA

NCBI chr 2:45,617,011...45,717,086
Ensembl chr 2:45,617,177...45,717,057

G

ankyrin repeat domain 6

increases expression

EXP

Propylthiouracil results in increased expression of ANKRD6 mRNA

NCBI chr 5:51,999,225...52,139,623
Ensembl chr 5:51,999,221...52,139,594

G

ankyrin repeat domain 61

decreases expression

EXP

Propylthiouracil results in decreased expression of ANKRD61 mRNA

NCBI chr12:15,832,567...15,836,925
Ensembl chr12:15,832,108...15,836,923

G

ankyrin repeat domain 66

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of ANKRD66 mRNA
Propylthiouracil results in decreased expression of ANKRD66 mRNA

PMID:24780913 PMID:25825206 PMID:36843608

NCBI chr 9:24,918,206...24,938,481
Ensembl chr 9:24,912,521...24,938,488

G

ankyrin repeat domain 9

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of ANKRD9 mRNA
Propylthiouracil results in increased expression of ANKRD9 mRNA

PMID:24780913 PMID:30047161

NCBI chr 6:135,827,355...135,830,002
Ensembl chr 6:135,775,869...135,837,893

G

ankyrin repeat and sterile alpha motif domain containing 1A

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of ANKS1A mRNA
Propylthiouracil results in decreased expression of ANKS1A mRNA

PMID:24780913 PMID:30047161

NCBI chr20:5,965,421...6,118,875
Ensembl chr20:5,965,028...6,118,875

G

ankyrin repeat and sterile alpha motif domain containing 3

decreases expression

EXP

Propylthiouracil results in decreased expression of ANKS3 mRNA

NCBI chr10:11,121,504...11,142,261
Ensembl chr10:11,121,553...11,142,491

G

ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ANKZF1 mRNA

NCBI chr 9:84,136,862...84,143,830
Ensembl chr 9:84,136,862...84,145,091

G

anoctamin 1

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of ANO1 mRNA
Propylthiouracil results in increased expression of ANO1 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 1:209,180,755...209,329,413
Ensembl chr 1:209,180,755...209,329,550

G

anoctamin 10

increases expression

EXP

Propylthiouracil results in increased expression of ANO10 mRNA

NCBI chr 8:130,719,177...130,838,243
Ensembl chr 8:130,718,755...130,877,636

G

anoctamin 2

affects expression

EXP

Propylthiouracil affects the expression of ANO2 mRNA

NCBI chr 4:160,200,471...160,541,830
Ensembl chr 4:160,182,152...160,541,821

G

anoctamin 3

decreases expression

EXP

Propylthiouracil results in decreased expression of ANO3 mRNA

PMID:24780913 PMID:25825206

NCBI chr 3:117,690,242...118,004,695
Ensembl chr 3:117,692,103...118,004,675

G

anoctamin 4

decreases expression

EXP

Propylthiouracil results in decreased expression of ANO4 mRNA

NCBI chr 7:25,216,389...25,625,811
Ensembl chr 7:25,216,389...25,625,746

G

anoctamin 5

decreases expression

EXP

Propylthiouracil results in decreased expression of ANO5 mRNA

NCBI chr 1:110,222,411...110,323,505
Ensembl chr 1:110,222,446...110,323,501

G

acidic nuclear phosphoprotein 32 family member A

decreases expression

EXP

Propylthiouracil results in decreased expression of ANP32A mRNA

NCBI chr 8:71,724,578...71,760,922
Ensembl chr 8:71,724,531...71,760,922

G

acidic nuclear phosphoprotein 32 family member B

increases expression

EXP

Propylthiouracil results in increased expression of ANP32B mRNA

NCBI chr 5:65,538,872...65,561,305
Ensembl chr 5:65,538,535...65,561,437

G

acidic nuclear phosphoprotein 32 family member E

increases expression

EXP

Propylthiouracil results in increased expression of ANP32E mRNA

NCBI chr 2:186,161,520...186,177,984
Ensembl chr 2:186,161,532...186,177,986

G

alanyl aminopeptidase, membrane

increases expression

EXP

Propylthiouracil results in increased expression of ANPEP mRNA

NCBI chr 1:143,176,645...143,219,447
Ensembl chr 1:143,176,645...143,195,101

G

ANTXR cell adhesion molecule 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of ANTXR1 mRNA
Propylthiouracil results in decreased expression of ANTXR1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 4:121,148,102...121,335,549
Ensembl chr 4:121,148,103...121,336,892

G

ANTXR cell adhesion molecule 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ANTXR2 mRNA

NCBI chr14:11,845,774...11,986,166
Ensembl chr14:11,845,700...11,986,168

G

annexin A1

increases expression

EXP

Propylthiouracil results in increased expression of ANXA1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831

G

annexin A11

decreases expression

EXP

Propylthiouracil results in decreased expression of ANXA11 mRNA

NCBI chr16:1,419,627...1,464,590
Ensembl chr16:1,418,351...1,464,839

G

annexin A2

decreases expression

EXP

Propylthiouracil results in decreased expression of ANXA2 mRNA

NCBI chr 8:78,986,252...79,022,638
Ensembl chr 8:78,986,242...79,022,631

G

annexin A4

affects expression

EXP

Propylthiouracil affects the expression of ANXA4 mRNA

NCBI chr 4:120,741,750...120,798,534
Ensembl chr 4:120,741,750...120,798,513

G

annexin A6

decreases expression

EXP

Propylthiouracil results in decreased expression of ANXA6 mRNA

NCBI chr10:39,602,106...39,657,183
Ensembl chr10:39,602,106...39,657,359

G

annexin A8

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of ANXA8 mRNA

NCBI chr16:9,403,267...9,418,317
Ensembl chr16:9,403,353...9,418,310

G

amine oxidase, copper containing 3

decreases expression

EXP

Propylthiouracil results in decreased expression of AOC3 mRNA

PMID:24780913 PMID:30047161

NCBI chr10:86,773,018...86,780,961

G

aminopeptidase O

decreases expression

EXP

Propylthiouracil results in decreased expression of AOPEP mRNA

NCBI chr17:1,817,001...2,133,008
Ensembl chr17:1,817,001...2,133,104

G

aldehyde oxidase 4

increases expression

EXP

Propylthiouracil results in increased expression of AOX4 mRNA

NCBI chr 9:67,255,437...67,312,364
Ensembl chr 9:67,255,437...67,312,364

G

adaptor related protein complex 1 subunit mu 2

decreases expression

EXP

Propylthiouracil results in decreased expression of AP1M2 mRNA

NCBI chr 8:28,114,748...28,132,767
Ensembl chr 8:28,114,748...28,132,642

G

adaptor related protein complex 1 subunit sigma 1

increases expression

EXP

Propylthiouracil results in increased expression of AP1S1 mRNA

NCBI chr12:25,261,958...25,272,483
Ensembl chr12:25,262,036...25,272,483

G

adaptor related protein complex 1 subunit sigma 2

decreases expression

EXP

Propylthiouracil results in decreased expression of AP1S2 mRNA

NCBI chr X:34,204,601...34,230,819
Ensembl chr X:34,204,603...34,228,529

G

adaptor related protein complex 2 subunit alpha 1

increases expression

EXP

Propylthiouracil results in increased expression of AP2A1 mRNA

NCBI chr 1:104,520,789...104,550,655
Ensembl chr 1:104,520,792...104,550,655

G

adaptor related protein complex 2 subunit mu 1

affects expression

EXP

Propylthiouracil affects the expression of AP2M1 mRNA

NCBI chr11:93,859,690...93,868,600
Ensembl chr11:93,859,690...93,868,480

G

adaptor related protein complex 2 subunit sigma 1

increases expression

EXP

Propylthiouracil results in increased expression of AP2S1 mRNA

NCBI chr 1:86,545,601...86,557,007
Ensembl chr 1:86,545,350...86,557,009

G

adaptor related protein complex 3 subunit beta 1

increases expression

EXP

Propylthiouracil results in increased expression of AP3B1 mRNA

NCBI chr 2:27,331,241...27,535,683
Ensembl chr 2:27,334,900...27,537,702

G

adaptor related protein complex 3 subunit beta 2

increases expression

EXP

Propylthiouracil results in increased expression of AP3B2 mRNA

NCBI chr 1:144,821,819...144,854,533
Ensembl chr 1:144,821,819...144,854,432

G

adaptor related protein complex 3 subunit delta 1

increases expression

EXP

Propylthiouracil results in increased expression of AP3D1 mRNA

NCBI chr 7:9,620,909...9,656,350
Ensembl chr 7:9,620,968...9,656,342

G

adaptor related protein complex 3 subunit sigma 1

increases expression

EXP

Propylthiouracil results in increased expression of AP3S1 mRNA

NCBI chr18:41,649,321...41,718,221
Ensembl chr18:41,648,796...41,767,641

G

adaptor related protein complex 4 subunit mu 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of AP4M1 mRNA
Propylthiouracil results in decreased expression of AP4M1 mRNA

PMID:24780913 PMID:30047161

NCBI chr12:22,163,474...22,171,734
Ensembl chr12:22,163,466...22,171,731

G

adaptor related protein complex 5 subunit beta 1

decreases expression

EXP

Propylthiouracil results in decreased expression of AP5B1 mRNA

NCBI chr 1:212,305,612...212,309,643
Ensembl chr 1:212,305,604...212,309,629

G

apoptotic peptidase activating factor 1

increases expression

EXP

Propylthiouracil results in increased expression of APAF1 mRNA

NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772

G

amyloid beta precursor protein binding family B member 1

decreases expression

EXP

Propylthiouracil results in decreased expression of APBB1 mRNA

NCBI chr 1:169,308,719...169,332,372
Ensembl chr 1:169,308,720...169,332,552

G

amyloid beta precursor protein binding family B member 1 interacting protein

increases expression

EXP

Propylthiouracil results in increased expression of APBB1IP mRNA

NCBI chr17:89,849,474...89,941,099
Ensembl chr17:89,671,716...89,941,089

G

amyloid beta precursor protein binding family B member 2

decreases expression

EXP

Propylthiouracil results in decreased expression of APBB2 mRNA

NCBI chr14:41,849,638...42,232,930
Ensembl chr14:41,911,785...42,232,280

G

amyloid beta precursor protein binding family B member 3

decreases expression

EXP

Propylthiouracil results in decreased expression of APBB3 mRNA

NCBI chr18:28,547,205...28,554,383
Ensembl chr18:28,547,205...28,554,383

G

APC down-regulated 1

increases expression

EXP

Propylthiouracil results in increased expression of APCDD1 mRNA

NCBI chr18:58,655,696...58,686,359
Ensembl chr18:58,655,919...58,686,356

G

amyloid P component, serum

affects expression

EXP

Propylthiouracil affects the expression of APCS mRNA

NCBI chr13:87,905,532...87,906,508
Ensembl chr13:87,905,532...87,928,824

G

acylaminoacyl-peptide hydrolase

increases expression

EXP

Propylthiouracil results in increased expression of APEH mRNA

NCBI chr 8:117,652,390...117,661,502
Ensembl chr 8:117,652,393...117,661,711

G

apurinic/apyrimidinic endodeoxyribonuclease 1

increases expression

EXP

Propylthiouracil results in increased expression of APEX1 mRNA

NCBI chr15:26,618,146...26,620,330
Ensembl chr15:26,618,224...26,620,329

G

apoptosis inhibitor 5

increases expression

EXP

Propylthiouracil results in increased expression of API5 mRNA

NCBI chr 3:100,833,417...100,858,580
Ensembl chr 3:100,833,417...100,858,580

G

APAF1 interacting protein

decreases expression

EXP

Propylthiouracil results in decreased expression of APIP mRNA

NCBI chr 3:109,886,919...109,913,295
Ensembl chr 3:109,886,953...109,915,862

G

aprataxin and PNKP like factor

increases expression

EXP

Propylthiouracil results in increased expression of APLF mRNA

NCBI chr 4:121,627,800...121,679,980
Ensembl chr 4:121,627,800...121,679,961

G

apelin

decreases expression

EXP

Propylthiouracil results in decreased expression of APLN mRNA

PMID:24780913 PMID:25825206

NCBI chr X:132,058,739...132,091,518
Ensembl chr X:132,081,759...132,091,246

G

apelin receptor

decreases expression

EXP

Propylthiouracil results in decreased expression of APLNR mRNA

NCBI chr 3:90,624,055...90,627,700
Ensembl chr 3:90,624,012...90,627,908

G

amyloid beta precursor like protein 1

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of APLP1 mRNA
Propylthiouracil results in increased expression of APLP1 mRNA

PMID:30047161 PMID:36843608

NCBI chr 1:94,824,330...94,834,705
Ensembl chr 1:94,824,072...94,834,610

G

amyloid beta precursor like protein 2

decreases expression

EXP

Propylthiouracil results in decreased expression of APLP2 mRNA

NCBI chr 8:37,857,407...37,920,487
Ensembl chr 8:37,857,407...37,920,031

G

apolipoprotein A1

decreases expression

EXP

Propylthiouracil results in decreased expression of APOA1 mRNA

NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:55,423,825...55,425,729

G

apolipoprotein A2

increases expression

EXP

Propylthiouracil results in increased expression of APOA2 mRNA

NCBI chr13:86,176,767...86,178,819
Ensembl chr13:86,174,741...86,179,410

G

apolipoprotein A4

affects expression

EXP

Propylthiouracil affects the expression of APOA4 mRNA

NCBI chr 8:55,435,779...55,438,160
Ensembl chr 8:55,434,168...55,438,164

G

apolipoprotein B mRNA editing enzyme catalytic subunit 1

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of APOBEC1 mRNA

NCBI chr 4:157,472,879...157,500,496
Ensembl chr 4:157,472,868...157,498,909

G

apolipoprotein B mRNA editing enzyme catalytic subunit 2

decreases expression

EXP

Propylthiouracil results in decreased expression of APOBEC2 mRNA

NCBI chr 9:20,062,561...20,076,074
Ensembl chr 9:20,062,526...20,076,071

G

apolipoprotein C1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of APOC1 mRNA
Propylthiouracil results in decreased expression of APOC1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:88,475,018...88,479,052
Ensembl chr 1:88,474,663...88,478,155

G

apolipoprotein C4

increases expression

EXP

Propylthiouracil results in increased expression of APOC4 mRNA

PMID:24780913 PMID:25825206

NCBI chr 1:88,463,713...88,467,909
Ensembl chr 1:88,463,713...88,468,044

G

apolipoprotein D

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of APOD mRNA
Propylthiouracil results in increased expression of APOD mRNA; Propylthiouracil results in increased expression of APOD protein

PMID:24780913 PMID:25825206 PMID:31414343

NCBI chr11:82,936,216...82,957,264
Ensembl chr11:82,936,038...82,957,263

G

apolipoprotein E

decreases expression
increases methylation

EXP

Propylthiouracil results in decreased expression of APOE mRNA
Propylthiouracil results in increased methylation of APOE promoter

PMID:30047161 PMID:33150595

NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855

G

apolipoprotein H

affects expression

EXP

Propylthiouracil affects the expression of APOH mRNA

NCBI chr10:93,841,992...93,855,897
Ensembl chr10:93,841,966...93,857,127

G

apolipoprotein L2

decreases expression

EXP

Propylthiouracil results in decreased expression of APOL3 mRNA

NCBI chr 7:111,211,944...111,219,209
Ensembl chr 7:111,211,893...111,217,223

G

apolipoprotein L9a

increases expression

EXP

Propylthiouracil results in increased expression of APOL9A mRNA

NCBI chr 7:111,021,452...111,030,380
Ensembl chr 7:111,021,453...111,028,213

G

Apol9a-Apol7a readthrough

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of APOL7B mRNA
Propylthiouracil results in decreased expression of APOL7B mRNA

PMID:22504374 PMID:24780913

NCBI chr 7:111,011,645...111,019,326
Ensembl chr 7:111,011,645...111,017,084

G

apolipoprotein L domain containing 1

increases expression

EXP

Propylthiouracil results in increased expression of APOLD1 mRNA

NCBI chr 4:169,499,728...169,557,075
Ensembl chr 4:169,549,679...169,559,176

G

apolipoprotein M

decreases expression

EXP

Propylthiouracil results in decreased expression of APOM mRNA

NCBI chr20:3,695,618...3,698,218
Ensembl chr20:3,692,737...3,698,218

G

apolipoprotein O

increases expression

EXP

Propylthiouracil results in increased expression of APOO mRNA

NCBI chr X:63,151,736...63,256,696
Ensembl chr X:63,151,814...63,256,690

G

apolipoprotein O-like

affects expression

EXP

Propylthiouracil affects the expression of APOOL mRNA

NCBI chr X:81,569,960...81,635,906
Ensembl chr X:81,570,053...81,640,036

G

adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2

decreases expression

EXP

Propylthiouracil results in decreased expression of APPL2 mRNA

NCBI chr 7:22,019,480...22,072,386
Ensembl chr 7:22,022,963...22,072,385

G

aquaporin 1

increases expression
multiple interactions

EXP
ISO

Propylthiouracil results in increased expression of AQP1 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of AQP1 mRNA

PMID:30047161 PMID:36706583

NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504

G

aquaporin 11

increases expression

EXP

Propylthiouracil results in increased expression of AQP11 mRNA

NCBI chr 1:161,457,752...161,467,918
Ensembl chr 1:161,457,754...161,467,945

G

aquaporin 3 (Gill blood group)

increases expression

EXP

Propylthiouracil results in increased expression of AQP3 mRNA

NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:61,035,166...61,040,685

G

aquaporin 9

decreases expression

EXP

Propylthiouracil results in decreased expression of AQP9 mRNA

NCBI chr 8:80,678,027...80,718,273
Ensembl chr 8:80,678,030...80,717,240

G

aquarius intron-binding spliceosomal factor

increases expression

EXP

Propylthiouracil results in increased expression of AQR mRNA

NCBI chr 3:121,329,287...121,399,375
Ensembl chr 3:121,329,289...121,399,321

G

androgen receptor

decreases expression
multiple interactions
increases expression

ISO
EXP

Propylthiouracil results in decreased expression of AR protein
thymoquinone inhibits the reaction [Propylthiouracil results in decreased expression of AR protein]
Propylthiouracil results in decreased expression of AR mRNA; Propylthiouracil results in decreased expression of AR protein
Propylthiouracil results in increased expression of AR mRNA

PMID:29578053 PMID:29896988 PMID:30047161 PMID:36506574

NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467

G

A-Raf proto-oncogene, serine/threonine kinase

decreases expression

EXP

Propylthiouracil results in decreased expression of ARAF mRNA

NCBI chr X:3,780,932...3,845,919
Ensembl chr X:3,780,932...3,792,611

G

ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ARAP2 mRNA

NCBI chr14:50,921,323...51,120,972
Ensembl chr14:50,921,713...51,120,962

G

activity-regulated cytoskeleton-associated protein

decreases expression
increases methylation
affects expression

EXP

Propylthiouracil results in decreased expression of ARC mRNA
Propylthiouracil results in increased methylation of ARC promoter
Propylthiouracil affects the expression of ARC mRNA

PMID:24780913 PMID:26606422 PMID:33150595

NCBI chr 7:108,444,959...108,448,413
Ensembl chr 7:108,444,692...108,451,220

G

amphiregulin

increases expression

EXP

Propylthiouracil results in increased expression of AREG mRNA

PMID:24780913 PMID:30047161

NCBI chr14:17,256,384...17,265,641
Ensembl chr14:17,256,384...17,265,641

G

ARF GTPase 4

increases expression

EXP

Propylthiouracil results in increased expression of ARF4 mRNA

NCBI chr16:1,903,238...1,920,012
Ensembl chr16:1,903,371...1,920,011

G

ARF GTPase activating protein 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ARFGAP2 mRNA

NCBI chr 3:97,692,105...97,704,246
Ensembl chr 3:97,692,110...97,704,247

G

ARF GTPase activating protein 3

increases expression

EXP

Propylthiouracil results in increased expression of ARFGAP3 mRNA

NCBI chr 7:116,312,996...116,359,300
Ensembl chr 7:116,313,001...116,359,592

G

ARF guanine nucleotide exchange factor 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ARFGEF2 mRNA

NCBI chr 3:175,966,575...176,052,715
Ensembl chr 3:175,966,579...176,052,713

G

ARFGEF family member 3

decreases expression

EXP

Propylthiouracil results in decreased expression of ARFGEF3 mRNA

NCBI chr 1:15,058,574...15,223,742
Ensembl chr 1:15,058,579...15,223,742

G

ARF related protein 1

increases expression

EXP

Propylthiouracil results in increased expression of ARFRP1 mRNA

NCBI chr 3:188,844,013...188,851,473
Ensembl chr 3:188,845,511...188,851,431

G

arginase 1

affects expression

EXP

Propylthiouracil affects the expression of ARG1 mRNA

NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713

G

arginase 2

increases expression

EXP

Propylthiouracil results in increased expression of ARG2 mRNA

NCBI chr 6:103,669,001...103,694,375
Ensembl chr 6:103,668,988...103,694,375

G

Rho GTPase activating protein 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of ARHGAP1 mRNA
Propylthiouracil results in decreased expression of ARHGAP1 mRNA

PMID:22504374 PMID:30047161

NCBI chr 3:98,077,064...98,099,163
Ensembl chr 3:98,077,150...98,099,154

G

Rho GTPase activating protein 10

decreases expression

EXP

Propylthiouracil results in decreased expression of ARHGAP10 mRNA

PMID:24780913 PMID:30047161

NCBI chr19:47,352,783...47,614,532
Ensembl chr19:47,352,276...47,614,531

G

Rho GTPase activating protein 11A

increases expression

EXP

Propylthiouracil results in increased expression of ARHGAP11A mRNA

NCBI chr 3:121,045,187...121,071,985
Ensembl chr 3:121,045,187...121,061,468

G

Rho GTPase activating protein 12

decreases expression

EXP

Propylthiouracil results in decreased expression of ARHGAP12 mRNA

NCBI chr17:56,284,282...56,397,630
Ensembl chr17:56,284,286...56,397,563

G

Rho GTPase activating protein 17

decreases expression

EXP

Propylthiouracil results in decreased expression of ARHGAP17 mRNA

NCBI chr 1:187,238,675...187,328,093
Ensembl chr 1:187,238,380...187,327,936

G

Rho GTPase activating protein 20

decreases expression

EXP

Propylthiouracil results in decreased expression of ARHGAP20 mRNA

NCBI chr 8:60,970,480...61,055,199
Ensembl chr 8:60,970,475...61,055,198

G

Rho GTPase activating protein 25

increases expression

EXP

Propylthiouracil results in increased expression of ARHGAP25 mRNA

PMID:24780913 PMID:30047161

NCBI chr 4:121,454,151...121,532,293
Ensembl chr 4:121,454,151...121,552,913

G

Rho GTPase activating protein 28

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of ARHGAP28 mRNA
Propylthiouracil results in increased expression of ARHGAP28 mRNA

PMID:24780913 PMID:30047161

NCBI chr 9:115,277,849...115,444,789
Ensembl chr 9:115,279,734...115,445,008

G

Rho GTPase activating protein 35

decreases expression

EXP

Propylthiouracil results in decreased expression of ARHGAP35 mRNA

NCBI chr 1:86,330,566...86,447,414
Ensembl chr 1:86,330,566...86,447,414

G

Rho GTPase activating protein 36

decreases expression

EXP

Propylthiouracil results in decreased expression of ARHGAP36 mRNA

NCBI chr X:133,635,996...133,664,995
Ensembl chr X:133,635,973...133,664,888

G

Rho GTPase activating protein 42

affects expression

EXP

Propylthiouracil affects the expression of ARHGAP42 mRNA

NCBI chr 8:14,436,478...14,666,588
Ensembl chr 8:14,419,256...14,666,385

G

Rho GTPase activating protein 8

increases expression

EXP

Propylthiouracil results in increased expression of ARHGAP8 mRNA

NCBI chr 7:117,723,512...117,782,031
Ensembl chr 7:117,730,578...117,782,030

G

Rho GTPase activating protein 9

decreases expression

EXP

Propylthiouracil results in decreased expression of ARHGAP9 mRNA

NCBI chr 7:65,034,023...65,042,336
Ensembl chr 7:65,034,144...65,042,336

G

Rho GDP dissociation inhibitor beta

increases expression

EXP

Propylthiouracil results in increased expression of ARHGDIB mRNA

NCBI chr 4:171,554,139...171,573,057
Ensembl chr 4:171,554,140...171,573,068

G

Rho GDP dissociation inhibitor gamma

increases expression

EXP

Propylthiouracil results in increased expression of ARHGDIG mRNA

NCBI chr10:15,723,525...15,725,719
Ensembl chr10:15,723,525...15,725,688

G

Rho guanine nucleotide exchange factor 10

increases expression

EXP

Propylthiouracil results in increased expression of ARHGEF10 mRNA

NCBI chr16:81,349,429...81,440,439
Ensembl chr16:81,349,429...81,440,054

G

Rho guanine nucleotide exchange factor 11

decreases expression

EXP

Propylthiouracil results in decreased expression of ARHGEF11 mRNA

NCBI chr 2:175,372,269...175,493,852
Ensembl chr 2:175,372,290...175,493,852

G

Rho guanine nucleotide exchange factor 12

decreases expression

EXP

Propylthiouracil results in decreased expression of ARHGEF12 mRNA

NCBI chr 8:52,247,047...52,373,158
Ensembl chr 8:52,247,047...52,372,376

G

Rho/Rac guanine nucleotide exchange factor 18

decreases expression

EXP

Propylthiouracil results in decreased expression of ARHGEF18 mRNA

NCBI chr12:6,192,958...6,300,997
Ensembl chr12:6,128,661...6,300,997

G

Rho guanine nucleotide exchange factor 19

decreases expression

EXP

Propylthiouracil results in decreased expression of ARHGEF19 mRNA

NCBI chr 5:158,818,840...158,837,196
Ensembl chr 5:158,818,932...158,837,196

G

Rho/Rac guanine nucleotide exchange factor 2

decreases expression
increases methylation

EXP

Propylthiouracil results in decreased expression of ARHGEF2 mRNA
Propylthiouracil results in increased methylation of ARHGEF2 promoter

NCBI chr 2:176,358,909...176,416,178
Ensembl chr 2:176,358,904...176,417,646

G

Rho guanine nucleotide exchange factor 25

affects expression

EXP

Propylthiouracil affects the expression of ARHGEF25 mRNA

NCBI chr 7:64,891,260...64,898,382
Ensembl chr 7:64,890,879...64,898,697

G

Rho guanine nucleotide exchange factor 26

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of ARHGEF26 mRNA
Propylthiouracil results in decreased expression of ARHGEF26 mRNA

PMID:22504374 PMID:24780913

NCBI chr 2:148,889,405...149,000,538
Ensembl chr 2:148,889,423...149,000,538

G

Rho guanine nucleotide exchange factor 3

decreases expression

EXP

Propylthiouracil results in decreased expression of ARHGEF3 mRNA

NCBI chr16:2,308,311...2,588,634
Ensembl chr16:2,308,400...2,588,819

G

Rho guanine nucleotide exchange factor 37

decreases expression

EXP

Propylthiouracil results in decreased expression of ARHGEF37 mRNA

NCBI chr18:57,205,621...57,271,284
Ensembl chr18:57,230,117...57,271,031

G

Rho guanine nucleotide exchange factor 38

decreases expression

EXP

Propylthiouracil results in decreased expression of ARHGEF38 mRNA

NCBI chr 2:224,284,238...224,413,974
Ensembl chr 2:224,284,238...224,413,974

G

Rho guanine nucleotide exchange factor 39

increases expression

EXP

Propylthiouracil results in increased expression of ARHGEF39 mRNA

NCBI chr 5:62,548,300...62,551,870
Ensembl chr 5:62,548,303...62,551,870

G

Rho guanine nucleotide exchange factor 5

increases expression

EXP

Propylthiouracil results in increased expression of ARHGEF5 mRNA

NCBI chr 4:73,087,240...73,112,311
Ensembl chr 4:73,087,240...73,112,311

G

Rac/Cdc42 guanine nucleotide exchange factor 6

decreases expression

EXP

Propylthiouracil results in decreased expression of ARHGEF6 mRNA

NCBI chr X:140,182,734...140,302,812
Ensembl chr X:140,182,734...140,344,458

G

Rho guanine nucleotide exchange factor 7

increases expression

EXP

Propylthiouracil results in increased expression of ARHGEF7 mRNA

NCBI chr16:84,373,123...84,484,759
Ensembl chr16:84,373,123...84,484,597

G

Cdc42 guanine nucleotide exchange factor 9

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of ARHGEF9 mRNA
Propylthiouracil results in increased expression of ARHGEF9 mRNA

PMID:30047161 PMID:36843608

NCBI chr X:63,929,168...64,087,267
Ensembl chr X:63,929,176...64,087,104

G

AT-rich interaction domain 3A

increases expression

EXP

Propylthiouracil results in increased expression of ARID3A mRNA

NCBI chr 7:10,403,161...10,431,551
Ensembl chr 7:10,405,631...10,427,926

G

AT-rich interaction domain 3B

decreases expression

EXP

Propylthiouracil results in decreased expression of ARID3B mRNA

PMID:24780913 PMID:25825206

NCBI chr 8:67,089,141...67,136,764
Ensembl chr 8:67,083,802...67,152,245

G

AT-rich interaction domain 3C

increases expression

EXP

Propylthiouracil results in increased expression of ARID3C mRNA

NCBI chr 5:61,685,511...61,692,821
Ensembl chr 5:61,685,511...61,692,821

G

AT-rich interaction domain 4A

decreases expression

EXP

Propylthiouracil results in decreased expression of ARID4A mRNA

NCBI chr 6:95,258,429...95,335,987
Ensembl chr 6:95,258,429...95,329,840

G

AT-rich interaction domain 4B

decreases expression

EXP

Propylthiouracil results in decreased expression of ARID4B mRNA

NCBI chr17:55,833,908...55,958,382
Ensembl chr17:55,833,908...55,958,382

G

ariadne RBR E3 ubiquitin protein ligase 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ARIH2 mRNA

NCBI chr 8:118,175,267...118,234,425
Ensembl chr 8:118,175,267...118,234,284

G

arkadia (RNF111) C-terminal like ring finger ubiquitin ligase 2C

decreases expression

EXP

Propylthiouracil results in decreased expression of ARK2C mRNA

NCBI chr18:73,259,736...73,375,987
Ensembl chr18:73,264,901...73,375,987

G

arkadia (RNF111) N-terminal like PKA signaling regulator 2N

increases expression

EXP

Propylthiouracil results in increased expression of ARK2N mRNA

NCBI chr18:73,431,104...73,520,759
Ensembl chr18:73,431,104...73,518,144

G

ARF like GTPase 10

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of ARL10 mRNA
Propylthiouracil results in increased expression of ARL10 mRNA

PMID:22504374 PMID:24780913

NCBI chr17:10,035,320...10,043,732
Ensembl chr17:10,035,320...10,043,981

G

ARF like GTPase 11

increases expression

EXP

Propylthiouracil results in increased expression of ARL11 mRNA

NCBI chr15:39,659,404...39,661,651
Ensembl chr15:39,656,050...39,664,105

G

ARF like GTPase 13B

decreases expression

EXP

Propylthiouracil results in decreased expression of ARL13B mRNA

NCBI chr11:13,597,538...13,663,681
Ensembl chr11:13,597,538...13,663,546

G

ARF like GTPase 15

increases expression

EXP

Propylthiouracil results in increased expression of ARL15 mRNA

NCBI chr 2:47,171,377...47,555,666
Ensembl chr 2:47,094,900...47,555,666

G

ARF like GTPase 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ARL2 mRNA

NCBI chr 1:212,863,422...212,875,425
Ensembl chr 1:212,863,423...212,875,373

G

ARF like GTPase 4C

increases expression

EXP

Propylthiouracil results in increased expression of ARL4C mRNA

NCBI chr 9:96,748,075...96,751,510
Ensembl chr 9:96,745,069...96,752,772

G

ARF like GTPase 4D

decreases expression

EXP

Propylthiouracil results in decreased expression of ARL4D mRNA

PMID:24780913 PMID:30047161

NCBI chr10:87,092,276...87,103,079
Ensembl chr10:87,077,523...87,106,199

G

ARF like GTPase 5C

decreases expression

EXP

Propylthiouracil results in decreased expression of ARL5C mRNA

NCBI chr10:83,481,540...83,492,915
Ensembl chr10:83,481,540...83,488,406

G

ARF like GTPase 6

increases expression

EXP

Propylthiouracil results in increased expression of ARL6 mRNA

NCBI chr11:54,180,271...54,207,136
Ensembl chr11:54,181,241...54,210,813

G

ARL6 interacting reticulophagy regulator 1

affects expression
increases expression

EXP

Propylthiouracil affects the expression of ARL6IP1 mRNA
Propylthiouracil results in increased expression of ARL6IP1 mRNA

PMID:19483382 PMID:30047161

NCBI chr 1:181,864,717...181,874,232
Ensembl chr 1:181,864,746...181,874,232

G

ARF like GTPase 6 interacting protein 5

decreases expression

EXP

Propylthiouracil results in decreased expression of ARL6IP5 mRNA

NCBI chr 4:131,365,320...131,395,311
Ensembl chr 4:131,367,289...131,400,130

G

ARF like GTPase 9

increases expression

EXP

Propylthiouracil results in increased expression of ARL9 mRNA

NCBI chr14:31,511,845...31,521,038
Ensembl chr14:31,511,330...31,520,988

G

armadillo repeat containing 10

decreases expression

EXP

Propylthiouracil results in decreased expression of ARMC10 mRNA

NCBI chr 4:14,291,211...14,306,799
Ensembl chr 4:14,291,211...14,306,817

G

armadillo repeat containing 12

decreases expression

EXP

Propylthiouracil results in decreased expression of ARMC12 mRNA

NCBI chr20:6,589,573...6,600,059
Ensembl chr20:6,589,563...6,600,056

G

armadillo repeat containing 3

increases expression

EXP

Propylthiouracil results in increased expression of ARMC3 mRNA

NCBI chr17:86,722,436...86,825,899
Ensembl chr17:86,722,441...86,825,899

G

armadillo repeat containing 8

decreases expression

EXP

Propylthiouracil results in decreased expression of ARMC8 mRNA

NCBI chr 8:108,916,274...109,010,877
Ensembl chr 8:108,916,274...109,010,717

G

armadillo repeat containing, X-linked 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of ARMCX2 mRNA
Propylthiouracil results in decreased expression of ARMCX2 mRNA

PMID:24780913 PMID:30047161

NCBI chr X:102,273,915...102,278,789
Ensembl chr X:102,273,565...102,278,905

G

armadillo repeat containing, X-linked 6

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of ARMCX6 mRNA
Propylthiouracil results in decreased expression of ARMCX6 mRNA

PMID:24780913 PMID:30047161

NCBI chr X:102,222,288...102,229,871
Ensembl chr X:102,222,220...102,240,052

G

armadillo-like helical domain containing 1

increases expression

EXP

Propylthiouracil results in increased expression of ARMH1 mRNA

NCBI chr 5:135,919,057...135,958,653
Ensembl chr 5:135,919,057...135,958,626

G

armadillo-like helical domain containing 4

decreases expression

EXP

Propylthiouracil results in decreased expression of ARMH4 mRNA

NCBI chr15:25,455,478...25,556,569
Ensembl chr15:25,455,297...25,556,534

G

aryl hydrocarbon receptor nuclear translocator 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of ARNT2 mRNA
Propylthiouracil results in decreased expression of ARNT2 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:147,645,354...147,801,986
Ensembl chr 1:147,599,058...147,801,997

G

actin related protein 2/3 complex, subunit 1B

increases expression

EXP

Propylthiouracil results in increased expression of ARPC1B mRNA

NCBI chr12:14,595,939...14,609,501
Ensembl chr12:14,595,678...14,609,504

G

actin related protein 2/3 complex, subunit 2

increases expression

EXP

Propylthiouracil results in increased expression of ARPC2 mRNA

NCBI chr 9:83,269,884...83,300,610
Ensembl chr 9:83,269,932...83,305,409

G

actin related protein 2/3 complex, subunit 3

increases expression

EXP

Propylthiouracil results in increased expression of ARPC3 mRNA

NCBI chr12:39,833,569...39,847,436
Ensembl chr12:39,833,569...39,847,436

G

actin related protein 2/3 complex, subunit 5-like

increases expression

EXP

Propylthiouracil results in increased expression of ARPC5L mRNA

NCBI chr 3:43,169,518...43,177,224
Ensembl chr 3:43,169,462...43,177,240
Ensembl chr 9:43,169,462...43,177,240

G

actin-related protein 2/3 complex inhibitor

decreases expression

EXP

Propylthiouracil results in decreased expression of ARPIN mRNA

NCBI chr 1:143,273,590...143,282,426
Ensembl chr 1:143,273,590...143,282,532

G

cAMP regulated phosphoprotein 21

increases expression

EXP

Propylthiouracil results in increased expression of ARPP21 mRNA

NCBI chr 8:120,912,964...121,077,586
Ensembl chr 8:120,912,970...121,031,357

G

arrestin 3

decreases expression

EXP

Propylthiouracil results in decreased expression of ARR3 mRNA

NCBI chr X:69,739,959...69,752,300
Ensembl chr X:69,739,760...69,752,200

G

arrestin domain containing 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ARRDC1 mRNA

NCBI chr 3:28,133,190...28,140,378
Ensembl chr 3:28,133,191...28,140,687

G

arrestin domain containing 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ARRDC2 mRNA

NCBI chr16:18,635,883...18,640,019
Ensembl chr16:18,635,883...18,640,158

G

arrestin domain containing 3

decreases expression

EXP

Propylthiouracil results in decreased expression of ARRDC3 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 2:12,873,202...12,885,716
Ensembl chr 2:12,873,202...12,885,875

G

arrestin domain containing 4

increases expression

EXP

Propylthiouracil results in increased expression of ARRDC4 mRNA

NCBI chr 1:131,779,436...131,793,438
Ensembl chr 1:131,779,437...131,793,565

G

arylsulfatase A

decreases expression

EXP

Propylthiouracil results in decreased expression of ARSA mRNA

NCBI chr 7:122,422,971...122,426,971
Ensembl chr 7:122,422,982...122,428,401

G

arylsulfatase B

increases expression

EXP

Propylthiouracil results in increased expression of ARSB mRNA

NCBI chr 2:26,736,395...26,895,682
Ensembl chr 2:26,736,957...26,897,611

G

arylsulfatase G

decreases expression

EXP

Propylthiouracil results in decreased expression of ARSG mRNA

PMID:24780913 PMID:36843608

NCBI chr10:94,912,094...95,063,021
Ensembl chr10:94,913,152...95,042,447

G

ADP-ribosyltransferase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ART1 mRNA

NCBI chr 1:165,890,032...165,899,154
Ensembl chr 1:165,890,086...165,899,146

G

ADP-ribosyltransferase 3

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of ART3 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of ART3 mRNA

PMID:24780913 PMID:30047161 PMID:36706583

NCBI chr14:15,921,540...16,003,764
Ensembl chr14:15,921,395...15,949,806

G

ADP-ribosyltransferase 5

decreases expression

EXP

Propylthiouracil results in decreased expression of ART5 mRNA

NCBI chr 1:165,885,344...165,895,306
Ensembl chr 1:165,885,280...165,895,306

G

artemin

decreases expression

EXP

Propylthiouracil results in decreased expression of ARTN mRNA

NCBI chr 5:136,750,188...136,755,645
Ensembl chr 5:136,750,188...136,753,457

G

aristaless related homeobox

increases expression
decreases expression
increases methylation

EXP

Propylthiouracil results in increased expression of ARX mRNA
Propylthiouracil results in decreased expression of ARX mRNA
Propylthiouracil results in increased methylation of ARX promoter

PMID:24780913 PMID:33150595

NCBI chr X:62,010,097...62,022,009
Ensembl chr X:62,010,097...62,022,002

G

arsenite methyltransferase

decreases expression

EXP

Propylthiouracil results in decreased expression of AS3MT mRNA

NCBI chr 1:255,536,879...255,569,245
Ensembl chr 1:255,537,109...255,569,249

G

N-acylsphingosine amidohydrolase 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ASAH2 mRNA

NCBI chr 1:239,278,994...239,386,598
Ensembl chr 1:239,278,994...239,382,024

G

ankyrin repeat and SOCS box-containing 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ASB1 mRNA

NCBI chr 9:99,566,852...99,588,321
Ensembl chr 9:99,567,867...99,583,907

G

ankyrin repeat and SOCS box-containing 12

increases expression

EXP

Propylthiouracil results in increased expression of ASB12 mRNA

NCBI chr X:64,338,223...64,487,615
Ensembl chr X:64,338,225...64,425,500

G

ankyrin repeat and SOCS box-containing 13

decreases expression

EXP

Propylthiouracil results in decreased expression of ASB13 mRNA

PMID:24780913 PMID:30047161

NCBI chr17:71,474,531...71,493,238
Ensembl chr17:71,474,531...71,505,633

G

ankyrin repeat and SOCS box-containing 14

increases expression

EXP

Propylthiouracil results in increased expression of ASB14 mRNA

PMID:24780913 PMID:25825206

NCBI chr16:2,102,303...2,131,379
Ensembl chr16:2,102,363...2,130,590

G

ankyrin repeat and SOCS box containing 15

decreases expression

EXP

Propylthiouracil results in decreased expression of ASB15 mRNA

NCBI chr 4:53,987,217...54,014,128
Ensembl chr 4:53,971,712...54,016,369

G

ankyrin repeat and SOCS box-containing 18

decreases expression

EXP

Propylthiouracil results in decreased expression of ASB18 mRNA

NCBI chr 9:97,979,018...98,043,609
Ensembl chr 9:97,979,264...98,043,540

G

ankyrin repeat and SOCS box-containing 5

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of ASB5 mRNA
Propylthiouracil results in decreased expression of ASB5 mRNA

PMID:24780913 PMID:30047161

NCBI chr16:43,970,940...44,038,318
Ensembl chr16:43,970,940...44,010,437

G

activating signal cointegrator 1 complex subunit 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ASCC2 mRNA

NCBI chr14:83,726,975...83,771,312
Ensembl chr14:83,727,049...83,771,316

G

achaete-scute family bHLH transcription factor 1

increases expression

EXP

Propylthiouracil results in increased expression of ASCL1 mRNA

NCBI chr 7:23,790,642...23,793,509
Ensembl chr 7:23,790,360...23,798,231

G

achaete-scute family bHLH transcription factor 2

increases expression

EXP

Propylthiouracil results in increased expression of ASCL2 mRNA

NCBI chr 1:207,578,447...207,665,126
Ensembl chr 1:207,578,449...207,580,856

G

anti-silencing function 1B histone chaperone

increases expression

EXP

Propylthiouracil results in increased expression of ASF1B mRNA

PMID:24780913 PMID:30047161

NCBI chr19:41,085,786...41,100,352
Ensembl chr19:41,086,114...41,100,352

G

asialoglycoprotein receptor 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ASGR1 mRNA

NCBI chr10:55,274,299...55,278,323
Ensembl chr10:55,274,706...55,278,322

G

asialoglycoprotein receptor 2

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of ASGR2 mRNA
Propylthiouracil results in decreased expression of ASGR2 mRNA

PMID:19483382 PMID:24780913 PMID:25825206

NCBI chr10:55,320,082...55,333,294
Ensembl chr10:55,320,091...55,333,263

G

acid sensing ion channel subunit 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ASIC1 mRNA

NCBI chr 7:132,677,158...132,707,379
Ensembl chr 7:132,698,723...132,707,832

G

acid sensing ion channel subunit 2

increases expression

EXP

Propylthiouracil results in increased expression of ASIC2 mRNA

NCBI chr10:66,368,308...67,438,237
Ensembl chr10:66,368,310...66,636,245

G

asparagine synthetase domain containing 1

increases expression

EXP

Propylthiouracil results in increased expression of ASNSD1 mRNA

NCBI chr 9:55,618,799...55,631,064
Ensembl chr 9:55,618,799...55,631,064

G

aspartoacylase

decreases expression

EXP

Propylthiouracil results in decreased expression of ASPA mRNA

PMID:24780913 PMID:25825206

NCBI chr10:58,390,204...58,443,790
Ensembl chr10:58,379,410...58,443,769

G

asparaginase

increases expression

EXP

Propylthiouracil results in increased expression of ASPG mRNA

PMID:22504374 PMID:24780913

NCBI chr 6:136,997,832...137,017,417
Ensembl chr 6:136,998,023...137,017,417

G

aspartate beta-hydroxylase domain containing 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ASPHD1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:190,983,506...190,987,440
Ensembl chr 1:190,983,506...190,987,440

G

aspartate beta-hydroxylase domain containing 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ASPHD2 mRNA

NCBI chr12:49,908,539...49,919,060
Ensembl chr12:49,908,241...49,925,254

G

assembly factor for spindle microtubules

increases expression

EXP

Propylthiouracil results in increased expression of ASPM mRNA

NCBI chr13:53,625,584...53,674,489
Ensembl chr13:53,625,584...53,674,489

G

asporin

increases expression

EXP

Propylthiouracil results in increased expression of ASPN mRNA

PMID:22504374 PMID:24780913 PMID:30047161

NCBI chr17:15,286,338...15,310,567
Ensembl chr17:15,287,065...15,310,632

G

argininosuccinate synthase 1

affects expression

EXP

Propylthiouracil affects the expression of ASS1 mRNA

NCBI chr 3:35,144,765...35,194,632
Ensembl chr 3:35,144,999...35,194,627

G

ASXL transcriptional regulator 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ASXL1 mRNA

NCBI chr 3:162,273,828...162,341,742
Ensembl chr 3:162,273,828...162,341,742

G

ATPase family, AAA domain containing 2

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of ATAD2 mRNA
Propylthiouracil results in decreased expression of ATAD2 mRNA

PMID:24780913 PMID:25825206

NCBI chr 7:91,523,626...91,566,238
Ensembl chr 7:91,523,626...91,566,238

G

alpha tubulin acetyltransferase 1

increases expression

EXP

Propylthiouracil results in increased expression of ATAT1 mRNA

NCBI chr20:2,849,399...2,862,614
Ensembl chr20:2,849,421...2,862,389

G

activating transcription factor 1

increases expression

EXP

Propylthiouracil results in increased expression of ATF1 mRNA

NCBI chr 7:133,240,774...133,283,488
Ensembl chr 7:133,241,197...133,283,485

G

activating transcription factor 2

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of ATF2 mRNA
Propylthiouracil results in increased expression of ATF2 mRNA

PMID:30047161 PMID:36843608

NCBI chr 3:79,125,814...79,202,896
Ensembl chr 3:79,126,705...79,202,745

G

activating transcription factor 3

increases expression

EXP

Propylthiouracil results in increased expression of ATF3 mRNA

PMID:24780913 PMID:30047161

NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750

G

activating transcription factor 4

decreases expression
affects expression

EXP

Propylthiouracil results in decreased expression of ATF4 mRNA
Propylthiouracil affects the expression of ATF4 protein

PMID:30047161 PMID:36038036

NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739

G

activating transcription factor 5

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of ATF5 mRNA
Propylthiouracil results in decreased expression of ATF5 mRNA

PMID:19483382 PMID:24780913 PMID:30047161

NCBI chr 1:104,432,094...104,437,611
Ensembl chr 1:104,432,094...104,436,183

G

activating transcription factor 6

affects expression

EXP

Propylthiouracil affects the expression of ATF6 mRNA

NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033

G

activating transcription factor 7 interacting protein

decreases expression

EXP

Propylthiouracil results in decreased expression of ATF7IP mRNA

NCBI chr 4:171,117,122...171,202,871
Ensembl chr 4:171,117,122...171,202,867

G

autophagy related 10

decreases expression

EXP

Propylthiouracil results in decreased expression of ATG10 mRNA

NCBI chr 2:23,843,695...24,133,459
Ensembl chr 2:23,844,482...24,133,368

G

autophagy related 14

decreases expression

EXP

Propylthiouracil results in decreased expression of ATG14 mRNA

NCBI chr15:23,275,457...23,306,817
Ensembl chr15:23,275,457...23,306,815

G

autophagy related 16-like 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ATG16L2 mRNA

NCBI chr 1:165,100,946...165,123,307
Ensembl chr 1:165,102,936...165,115,473

G

autophagy related 2B

increases expression

EXP

Propylthiouracil results in increased expression of ATG2B mRNA

NCBI chr 6:130,286,979...130,357,109
Ensembl chr 6:130,286,986...130,357,109

G

5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase

increases expression

EXP

Propylthiouracil results in increased expression of ATIC mRNA

PMID:24780913 PMID:30047161

NCBI chr 9:80,614,311...80,634,360
Ensembl chr 9:80,614,283...80,635,756

G

atrophin 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ATN1 mRNA

NCBI chr 4:159,240,573...159,254,378
Ensembl chr 4:159,237,562...159,254,418

G

atonal bHLH transcription factor 1

increases expression

EXP

Propylthiouracil results in increased expression of ATOH1 mRNA

NCBI chr 4:95,241,933...95,244,028
Ensembl chr 4:95,241,933...95,244,019

G

atonal bHLH transcription factor 7

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of ATOH7 mRNA
Propylthiouracil results in decreased expression of ATOH7 mRNA

PMID:22504374 PMID:24780913

NCBI chr20:25,529,528...25,529,977
Ensembl chr20:25,528,906...25,530,368

G

atonal bHLH transcription factor 8

decreases expression

EXP

Propylthiouracil results in decreased expression of ATOH8 mRNA

NCBI chr 4:105,818,203...105,850,379
Ensembl chr 4:105,818,203...105,850,379

G

atos homolog A

decreases expression

EXP

Propylthiouracil results in decreased expression of FAM214A mRNA

NCBI chr 8:84,575,360...84,653,103
Ensembl chr 8:84,575,370...84,653,091

G

ATPase phospholipid transporting 10A (putative)

decreases expression

EXP

Propylthiouracil results in decreased expression of ATP10A mRNA

NCBI chr 1:118,692,456...118,866,117
Ensembl chr 1:118,692,478...118,866,114

G

ATPase phospholipid transporting 11A

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of ATP11A mRNA
Propylthiouracil results in increased expression of ATP11A mRNA

PMID:24780913 PMID:30047161

NCBI chr16:83,359,884...83,469,807
Ensembl chr16:83,359,884...83,469,767

G

ATPase H+/K+ transporting non-gastric alpha2 subunit

decreases expression

EXP

Propylthiouracil results in decreased expression of ATP12A mRNA

NCBI chr15:34,559,209...34,583,866
Ensembl chr15:34,559,209...34,583,866

G

ATPase cation transporting 13A2

decreases expression

EXP

Propylthiouracil results in decreased expression of ATP13A2 mRNA

NCBI chr 5:158,575,727...158,595,157
Ensembl chr 5:158,575,749...158,595,156

G

ATPase 13A4

decreases expression

EXP

Propylthiouracil results in decreased expression of ATP13A4 mRNA

NCBI chr11:84,727,014...84,864,747
Ensembl chr11:84,731,041...84,864,747

G

ATPase 13A5

increases expression

EXP

Propylthiouracil results in increased expression of ATP13A5 mRNA

NCBI chr11:84,881,196...85,020,597
Ensembl chr11:84,881,230...85,020,593

G

ATPase Na+/K+ transporting subunit alpha 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ATP1A1 mRNA

PMID:24780913 PMID:36843608

NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:191,709,311...191,737,425

G

ATPase Na+/K+ transporting subunit alpha 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ATP1A2 mRNA

NCBI chr13:87,261,964...87,286,911
Ensembl chr13:87,261,968...87,286,911

G

ATPase Na+/K+ transporting subunit beta 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ATP1B2 mRNA

NCBI chr10:54,817,473...54,823,708
Ensembl chr10:54,817,476...54,823,708

G

ATPase Na+/K+ transporting subunit beta 3

increases expression

EXP

Propylthiouracil results in increased expression of ATP1B3 mRNA

NCBI chr 8:105,789,824...105,821,151
Ensembl chr 8:65,253,361...65,254,304
Ensembl chr 8:65,253,361...65,254,304

G

ATP23 metallopeptidase and ATP synthase assembly factor homolog

increases expression

EXP

Propylthiouracil results in increased expression of ATP23 mRNA

NCBI chr 7:64,600,100...64,615,240
Ensembl chr 7:64,600,100...64,615,392

G

ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ATP2A1 mRNA

NCBI chr 1:190,457,198...190,475,410
Ensembl chr 1:190,457,198...190,475,423

G

ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2

decreases expression

EXP
ISO

Propylthiouracil results in decreased expression of ATP2A2 mRNA

PMID:24780913 PMID:30769017

NCBI chr12:39,733,519...39,782,942
Ensembl chr12:39,733,458...39,782,934

G

ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3

increases expression

EXP

Propylthiouracil results in increased expression of ATP2A3 mRNA

NCBI chr10:58,079,710...58,111,279
Ensembl chr10:58,079,852...58,111,278

G

ATPase plasma membrane Ca2+ transporting 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ATP2B1 mRNA

NCBI chr 7:35,622,267...35,731,904
Ensembl chr 7:35,622,461...35,731,904

G

ATPase plasma membrane Ca2+ transporting 2

decreases expression
increases methylation
increases expression

EXP

Propylthiouracil results in decreased expression of ATP2B2 mRNA
Propylthiouracil results in increased methylation of ATP2B2 promoter
Propylthiouracil results in increased expression of ATP2B2 mRNA

PMID:24780913 PMID:30047161 PMID:33150595

NCBI chr 4:148,450,207...148,763,653
Ensembl chr 4:148,450,207...148,696,239

G

ATPase plasma membrane Ca2+ transporting 3

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of ATP2B3 mRNA
Propylthiouracil results in decreased expression of ATP2B3 mRNA

PMID:22504374 PMID:24780913

NCBI chr X:156,367,582...156,464,085
Ensembl chr X:156,367,852...156,438,153

G

ATPase plasma membrane Ca2+ transporting 4

increases expression

EXP

Propylthiouracil results in increased expression of ATP2B4 mRNA

NCBI chr13:47,708,157...47,807,389
Ensembl chr13:47,711,121...47,758,876

G

ATPase secretory pathway Ca2+ transporting 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ATP2C1 mRNA

NCBI chr 8:114,913,551...115,034,706
Ensembl chr 8:114,913,415...115,038,826

G

ATPase H+/K+ transporting subunit alpha

decreases expression

EXP

Propylthiouracil results in decreased expression of ATP4A mRNA

NCBI chr 1:95,089,122...95,102,277
Ensembl chr 1:95,089,122...95,102,277

G

ATP synthase F1 subunit alpha

increases expression

EXP

Propylthiouracil results in increased expression of ATP5F1A mRNA

NCBI chr18:73,567,537...73,575,473
Ensembl chr18:73,567,526...73,575,922

G

ATP synthase F1 subunit gamma

increases expression

EXP

Propylthiouracil results in increased expression of ATP5F1C mRNA

NCBI chr17:73,333,584...73,355,872
Ensembl chr17:73,333,588...73,383,073

G

ATP synthase F1 subunit epsilon

affects expression
increases expression

EXP

Propylthiouracil affects the expression of ATP5F1E mRNA
Propylthiouracil results in increased expression of ATP5F1E mRNA

PMID:19483382 PMID:30047161

NCBI chr 3:183,677,270...183,680,172
Ensembl chr 3:183,677,273...183,680,214

G

ATP synthase membrane subunit c locus 1

increases expression

EXP

Propylthiouracil results in increased expression of ATP5MC1 mRNA

NCBI chr10:81,520,762...81,523,735
Ensembl chr10:81,520,765...81,523,363

G

ATP synthase membrane subunit c locus 3

increases expression

EXP

Propylthiouracil results in increased expression of ATP5MC3 mRNA

PMID:30047161 PMID:36843608

NCBI chr 3:79,218,014...79,220,664
Ensembl chr 3:79,218,014...79,220,664

G

ATP synthase membrane subunit e

increases expression

EXP

Propylthiouracil results in increased expression of ATP5I mRNA

NCBI chr14:1,464,788...1,465,989
Ensembl chr14:1,464,800...1,465,988

G

ATP synthase membrane subunit f

increases expression

EXP

Propylthiouracil results in increased expression of ATP5MF mRNA

NCBI chr12:14,535,435...14,542,007
Ensembl chr12:14,522,832...14,542,709

G

ATP synthase membrane subunit G

increases expression

EXP

Propylthiouracil results in increased expression of ATP5MG mRNA

NCBI chr 8:54,122,457...54,130,407
Ensembl chr 8:54,122,457...54,132,831

G

ATP synthase membrane subunit K

increases expression

EXP

Propylthiouracil results in increased expression of ATP5MK mRNA

NCBI chr 1:255,915,255...255,922,185
Ensembl chr 1:255,915,259...255,922,106
Ensembl chr10:255,915,259...255,922,106

G

ATP synthase peripheral stalk-membrane subunit b

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of ATP5PB mRNA
Propylthiouracil results in increased expression of ATP5PB mRNA

PMID:18077114 PMID:30047161

NCBI chr 2:196,112,459...196,123,737
Ensembl chr 2:196,112,108...196,124,387

G

ATP synthase peripheral stalk subunit d

increases expression

EXP

Propylthiouracil results in increased expression of ATP5PD mRNA

NCBI chr10:101,156,673...101,161,926
Ensembl chr10:101,156,673...101,162,954

G

ATP synthase peripheral stalk subunit F6

increases expression

EXP

Propylthiouracil results in increased expression of ATP5PF mRNA

NCBI chr11:37,368,045...37,375,721
Ensembl chr11:37,368,042...37,375,466

G

ATP synthase peripheral stalk subunit OSCP

increases expression

EXP

Propylthiouracil results in increased expression of ATP5PO mRNA

NCBI chr11:44,651,171...44,657,483
Ensembl chr11:44,651,173...44,657,520

G

ATPase H+ transporting accessory protein 1

increases expression

EXP

Propylthiouracil results in increased expression of ATP6AP1 mRNA

NCBI chr X:157,231,243...157,238,323
Ensembl chr X:157,225,327...157,238,323

G

ATPase H+ transporting accessory protein 1 like

decreases expression

EXP

Propylthiouracil results in decreased expression of ATP6AP1L mRNA

NCBI chr 2:23,772,724...23,814,913
Ensembl chr 2:23,772,745...23,814,618

G

ATPase H+ transporting accessory protein 2

affects expression
increases expression

EXP

Propylthiouracil affects the expression of ATP6AP2 mRNA
Propylthiouracil results in increased expression of ATP6AP2 mRNA

PMID:19483382 PMID:24780913 PMID:30047161

NCBI chr X:12,856,708...12,883,670
Ensembl chr X:12,855,859...12,905,875

G

ATPase H+ transporting V0 subunit a2

decreases expression

EXP

Propylthiouracil results in decreased expression of ATP6V0A2 mRNA

NCBI chr12:37,608,211...37,640,860
Ensembl chr12:37,472,813...37,640,860

G

ATPase H+ transporting V0 subunit a4

decreases expression

EXP

Propylthiouracil results in decreased expression of ATP6V0A4 mRNA

NCBI chr 4:67,727,145...67,809,092
Ensembl chr 4:67,727,145...67,809,092

G

ATPase H+ transporting V0 subunit B

increases expression

EXP

Propylthiouracil results in increased expression of ATP6V0B mRNA

NCBI chr 5:136,708,823...136,710,339
Ensembl chr 5:136,708,823...136,716,828

G

ATPase H+ transporting V0 subunit e1

increases expression

EXP

Propylthiouracil results in increased expression of ATP6V0E1 mRNA

NCBI chr10:16,984,084...17,007,156
Ensembl chr10:16,984,084...17,028,858

G

ATPase H+ transporting V1 subunit A

affects expression

EXP

Propylthiouracil affects the expression of ATP6V1A mRNA

NCBI chr11:70,066,800...70,120,603
Ensembl chr11:70,035,134...70,120,603

G

ATPase H+ transporting V1 subunit E1

increases expression

EXP

Propylthiouracil results in increased expression of ATP6V1E1 mRNA

NCBI chr 4:155,694,534...155,716,660
Ensembl chr 4:155,694,534...155,716,678

G

ATPase H+ transporting V1 subunit F

affects expression

EXP

Propylthiouracil affects the expression of ATP6V1F mRNA

NCBI chr 4:59,033,020...59,035,980

G

ATPase H+ transporting V1 subunit G3

increases expression

EXP

Propylthiouracil results in increased expression of ATP6V1G3 mRNA

PMID:22504374 PMID:25825206

NCBI chr13:52,351,787...52,376,784
Ensembl chr13:52,351,801...52,375,594

G

ATPase H+ transporting V1 subunit H

increases expression

EXP

Propylthiouracil results in increased expression of ATP6V1H mRNA

NCBI chr 5:19,176,849...19,282,516
Ensembl chr 5:19,176,849...19,282,516

G

ATPase copper transporting alpha

increases expression

EXP

Propylthiouracil results in increased expression of ATP7A mRNA

NCBI chr X:75,159,635...75,267,094
Ensembl chr X:75,159,782...75,267,093

G

ATPase copper transporting beta

increases expression

EXP

Propylthiouracil results in increased expression of ATP7B mRNA

NCBI chr16:76,654,725...76,726,092
Ensembl chr16:76,653,660...76,728,801

G

ATP synthase mitochondrial F1 complex assembly factor 2

increases expression

EXP

Propylthiouracil results in increased expression of ATPAF2 mRNA

NCBI chr10:45,705,157...45,721,282
Ensembl chr10:45,697,027...45,721,383

G

ATR interacting protein

decreases expression

EXP

Propylthiouracil results in decreased expression of ATRIP mRNA

NCBI chr 8:118,586,909...118,600,975
Ensembl chr 8:118,586,909...118,600,944

G

attractin like 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ATRNL1 mRNA

NCBI chr 1:266,676,051...267,216,847
Ensembl chr 1:266,675,852...267,216,842

G

ataxin 10

increases expression

EXP

Propylthiouracil results in increased expression of ATXN10 mRNA

NCBI chr 7:118,321,516...118,444,967
Ensembl chr 7:118,319,490...118,445,636

G

ataxin 1 like

decreases expression

EXP

Propylthiouracil results in decreased expression of ATXN1L mRNA

PMID:24780913 PMID:30047161

NCBI chr19:54,609,852...54,621,024
Ensembl chr19:54,609,132...54,680,582

G

ataxin 2-like

decreases expression

EXP

Propylthiouracil results in decreased expression of ATXN2L mRNA

NCBI chr 1:190,508,878...190,526,263
Ensembl chr 1:190,508,878...190,520,579

G

ataxin 7-like 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ATXN7L1 mRNA

NCBI chr 6:55,487,309...55,709,751
Ensembl chr 6:55,649,362...55,701,996

G

ataxin 7-like 3B

increases expression

EXP

Propylthiouracil results in increased expression of ATXN7L3B mRNA

NCBI chr 7:50,208,666...50,212,190
Ensembl chr 7:50,208,676...50,212,190

G

aurora kinase A and ninein interacting protein

decreases expression

EXP

Propylthiouracil results in decreased expression of AUNIP mRNA

NCBI chr 5:152,006,021...152,018,614
Ensembl chr 5:152,006,042...152,020,190

G

aurora kinase A

increases expression

EXP

Propylthiouracil results in increased expression of AURKA mRNA

NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:181,546,742...181,562,771

G

aurora kinase A interacting protein 1

increases expression

EXP

Propylthiouracil results in increased expression of AURKAIP1 mRNA

NCBI chr 5:171,717,349...171,719,123

G

aurora kinase B

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of AURKB mRNA
Propylthiouracil results in decreased expression of AURKB mRNA

PMID:24780913 PMID:25825206

NCBI chr10:54,243,116...54,249,675
Ensembl chr10:54,242,850...54,252,285

G

aurora kinase C

decreases expression

EXP

Propylthiouracil results in decreased expression of AURKC mRNA

NCBI chr 1:75,876,773...75,882,893
Ensembl chr 1:75,876,773...75,897,426

G

activator of transcription and developmental regulator AUTS2

increases expression

EXP

Propylthiouracil results in increased expression of AUTS2 mRNA

NCBI chr12:29,739,138...30,830,386
Ensembl chr12:29,740,523...30,830,386

G

advillin

decreases expression

EXP

Propylthiouracil results in decreased expression of AVIL mRNA

PMID:24780913 PMID:30047161

NCBI chr 7:64,711,294...64,729,436
Ensembl chr 7:64,711,403...64,729,436

G

arginine vasopressin receptor 1B

decreases expression

EXP

Propylthiouracil results in decreased expression of AVPR1B mRNA

NCBI chr13:45,598,116...45,611,680
Ensembl chr13:45,598,763...45,611,277

G

arginine vasopressin receptor 2

decreases expression

EXP

Propylthiouracil results in decreased expression of AVPR2 mRNA

NCBI chr X:156,785,009...156,787,477
Ensembl chr X:156,785,139...156,787,477

G

axin 2

decreases expression

EXP

Propylthiouracil results in decreased expression of AXIN2 mRNA

NCBI chr10:94,393,379...94,426,579
Ensembl chr10:94,395,909...94,426,575

G

Axl receptor tyrosine kinase

decreases expression

EXP

Propylthiouracil results in decreased expression of AXL mRNA

NCBI chr 1:90,392,864...90,424,123
Ensembl chr 1:90,392,864...90,424,009

G

5-azacytidine induced 2

increases expression

EXP

Propylthiouracil results in increased expression of AZI2 mRNA

NCBI chr 8:126,651,268...126,674,795
Ensembl chr 8:126,651,206...126,676,182

G

antizyme inhibitor 1

increases expression

EXP

Propylthiouracil results in increased expression of AZIN1 mRNA

NCBI chr 7:71,539,711...71,566,515
Ensembl chr 7:71,539,711...71,566,515

G

antizyme inhibitor 2

decreases expression

EXP

Propylthiouracil results in decreased expression of AZIN2 mRNA

NCBI chr 5:146,568,187...146,594,777
Ensembl chr 5:146,565,437...146,594,777

G

beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)

increases expression

EXP

Propylthiouracil results in increased expression of B3GALNT1 mRNA

NCBI chr 2:156,157,234...156,187,037
Ensembl chr 2:156,156,265...156,188,404

G

Beta-1,3-galactosyltransferase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of B3GALT1 mRNA

NCBI chr 3:72,661,410...73,234,447
Ensembl chr 3:72,660,801...73,235,276

G

Beta-1,3-galactosyltransferase 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of B3GALT2 mRNA
Propylthiouracil results in decreased expression of B3GALT2 mRNA

PMID:24780913 PMID:30047161

NCBI chr13:57,939,724...57,948,735
Ensembl chr13:57,930,539...57,956,539

G

beta-1,3-glucuronyltransferase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of B3GAT1 mRNA

NCBI chr 8:33,362,791...33,390,446
Ensembl chr 8:33,363,048...33,390,443

G

beta-1,3-glucuronyltransferase 2

affects expression

EXP

Propylthiouracil affects the expression of B3GAT2 mRNA

NCBI chr 9:33,663,482...33,746,466
Ensembl chr 9:33,663,482...33,746,466

G

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of B3GNT2 mRNA
Propylthiouracil results in increased expression of B3GNT2 mRNA

PMID:24780913 PMID:30047161

NCBI chr14:101,009,682...101,034,507
Ensembl chr14:100,967,131...101,043,412

G

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4

decreases expression

EXP

Propylthiouracil results in decreased expression of B3GNT4 mRNA

NCBI chr12:38,729,653...38,734,911
Ensembl chr12:38,728,889...38,734,744

G

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7

increases expression

EXP

Propylthiouracil results in increased expression of B3GNT7 mRNA

NCBI chr 9:94,404,197...94,408,148
Ensembl chr 9:94,404,135...94,408,147

G

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9

increases expression

EXP

Propylthiouracil results in increased expression of B3GNT9 mRNA

NCBI chr19:50,039,649...50,042,206
Ensembl chr19:50,030,866...50,043,339

G

beta-1,4-N-acetyl-galactosaminyl transferase 1

increases expression

EXP

Propylthiouracil results in increased expression of B4GALNT1 mRNA

NCBI chr 7:64,873,909...64,881,512
Ensembl chr 7:64,874,022...64,881,516

G

beta-1,4-N-acetyl-galactosaminyl transferase 4

increases expression

EXP

Propylthiouracil results in increased expression of B4GALNT4 mRNA

NCBI chr 1:205,600,989...205,611,889
Ensembl chr 1:205,600,989...205,611,889

G

beta-1,4-galactosyltransferase 1

increases expression

EXP

Propylthiouracil results in increased expression of B4GALT1 mRNA

NCBI chr 5:60,731,601...60,778,456
Ensembl chr 5:60,731,602...60,778,445

G

B9 domain containing 2

increases expression

EXP

Propylthiouracil results in increased expression of B9D2 mRNA

NCBI chr 1:90,315,472...90,323,143
Ensembl chr 1:90,317,200...90,323,175

G

BAALC binder of MAP3K1 and KLF4

increases expression

EXP

Propylthiouracil results in increased expression of BAALC mRNA

NCBI chr 7:71,803,640...71,877,608
Ensembl chr 7:71,774,898...71,879,261

G

bile acid CoA:amino acid N-acyltransferase

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of BAAT mRNA
Propylthiouracil results in decreased expression of BAAT mRNA

PMID:19483382 PMID:24780913

NCBI chr 5:68,647,166...68,656,137
Ensembl chr 5:68,646,203...68,656,181

G

beta-secretase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of BACE1 mRNA

NCBI chr 8:55,038,842...55,061,138
Ensembl chr 8:55,038,823...55,064,918

G

BTB domain and CNC homolog 2

increases expression

EXP

Propylthiouracil results in increased expression of BACH2 mRNA

PMID:24780913 PMID:25825206

NCBI chr 5:51,428,802...51,779,030
Ensembl chr 5:51,434,870...51,774,234

G

BAR/IMD domain containing adaptor protein 2

increases methylation
decreases expression

EXP

Propylthiouracil results in increased methylation of BAIAP2 promoter
Propylthiouracil results in decreased expression of BAIAP2 mRNA

NCBI chr10:105,721,371...105,788,549
Ensembl chr10:105,721,417...105,788,549

G

BAR/IMD domain containing adaptor protein 2 like 2

increases expression

EXP

Propylthiouracil results in increased expression of BAIAP2L2 mRNA

PMID:24780913 PMID:30047161

NCBI chr 7:112,704,798...112,731,691
Ensembl chr 7:112,704,682...112,731,127

G

BANF family member 2

increases expression

EXP

Propylthiouracil results in increased expression of BANF2 mRNA

NCBI chr 3:151,841,506...151,896,205
Ensembl chr 3:151,853,911...151,896,204

G

BRCA1 associated RING domain 1

increases expression

EXP

Propylthiouracil results in increased expression of BARD1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 9:80,069,960...80,144,167
Ensembl chr 9:80,069,960...80,176,873

G

BarH-like homeobox 1

increases expression

EXP

Propylthiouracil results in increased expression of BARHL1 mRNA

NCBI chr 3:32,639,283...32,646,605
Ensembl chr 3:32,638,644...32,646,605

G

BarH-like homeobox 2

increases methylation
decreases expression

EXP

Propylthiouracil results in increased methylation of BARHL2 promoter
Propylthiouracil results in decreased expression of BARHL2 mRNA

NCBI chr14:3,485,309...3,490,206
Ensembl chr14:3,485,309...3,490,197

G

BARX homeobox 2

decreases expression

EXP

Propylthiouracil results in decreased expression of BARX2 mRNA

NCBI chr 8:38,509,277...38,576,978
Ensembl chr 8:38,509,277...38,576,978

G

brain abundant, membrane attached signal protein 1

increases expression

EXP

Propylthiouracil results in increased expression of BASP1 mRNA

PMID:24780913 PMID:39441382

NCBI chr 2:77,546,628...77,594,297
Ensembl chr 2:77,546,092...77,597,178

G

basic leucine zipper ATF-like transcription factor 3

increases expression

EXP

Propylthiouracil results in increased expression of BATF3 mRNA

NCBI chr13:105,220,782...105,232,365
Ensembl chr13:105,220,390...105,232,369

G

bromodomain adjacent to zinc finger domain, 1A

increases expression

EXP

Propylthiouracil results in increased expression of BAZ1A mRNA

NCBI chr 6:78,124,872...78,247,672
Ensembl chr 6:78,124,872...78,247,648

G

bromodomain adjacent to zinc finger domain, 1B

decreases expression

EXP

Propylthiouracil results in decreased expression of BAZ1B mRNA

NCBI chr12:27,068,541...27,126,511
Ensembl chr12:27,068,541...27,126,511

G

bromodomain adjacent to zinc finger domain, 2B

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of BAZ2B mRNA
Propylthiouracil results in decreased expression of BAZ2B mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 3:64,792,984...65,034,547
Ensembl chr 3:64,794,001...65,001,781

G

Bcl-2 binding component 3

increases expression

EXP

Propylthiouracil results in increased expression of BBC3 mRNA

NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:86,141,603...86,150,666

G

bublin coiled coil protein

decreases expression

EXP

Propylthiouracil results in decreased expression of BBLN mRNA

NCBI chr 3:36,072,325...36,075,070
Ensembl chr 3:36,072,328...36,075,093

G

gamma-butyrobetaine hydroxylase 1

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of BBOX1 mRNA
Propylthiouracil results in increased expression of BBOX1 mRNA

NCBI chr 3:117,277,226...117,326,383
Ensembl chr 3:117,277,226...117,326,064

G

Bardet-Biedl syndrome 1

increases expression

EXP

Propylthiouracil results in increased expression of BBS1 mRNA

NCBI chr 1:211,614,195...211,633,504
Ensembl chr 1:211,615,533...211,633,468

G

Bardet-Biedl syndrome 10

decreases expression

EXP

Propylthiouracil results in decreased expression of BBS10 mRNA

NCBI chr 7:48,637,324...48,640,395
Ensembl chr 7:48,637,356...48,640,391

G

Bardet-Biedl syndrome 2

decreases expression

EXP

Propylthiouracil results in decreased expression of BBS2 mRNA

NCBI chr19:10,915,566...10,950,911
Ensembl chr19:10,915,476...10,950,921

G

Bardet-Biedl syndrome 4

decreases expression

EXP

Propylthiouracil results in decreased expression of BBS4 mRNA

NCBI chr 8:68,627,739...68,661,232
Ensembl chr 8:68,627,656...68,661,358

G

Bardet-Biedl syndrome 5

decreases expression

EXP

Propylthiouracil results in decreased expression of BBS5 mRNA

NCBI chr 3:74,818,104...74,839,658
Ensembl chr 3:74,818,473...74,857,023

G

Bardet-Biedl syndrome 9

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of BBS9 mRNA
Propylthiouracil results in decreased expression of BBS9 mRNA

PMID:24780913 PMID:30047161

NCBI chr 8:29,288,846...29,713,889
Ensembl chr 8:29,289,997...29,713,880

G

brevican

affects expression
increases methylation
decreases expression

EXP

Propylthiouracil affects the expression of BCAN mRNA
Propylthiouracil results in increased methylation of BCAN promoter
Propylthiouracil results in decreased expression of BCAN mRNA

PMID:24780913 PMID:33150595

NCBI chr 2:175,752,333...175,765,766
Ensembl chr 2:175,752,336...175,765,314

G

B-cell receptor-associated protein 29

increases expression

EXP

Propylthiouracil results in increased expression of BCAP29 mRNA

NCBI chr 6:53,910,209...53,950,206
Ensembl chr 6:53,910,216...53,949,963

G

BCAR3 adaptor protein, NSP family member

decreases expression

EXP

Propylthiouracil results in decreased expression of BCAR3 mRNA

PMID:24780913 PMID:25825206

NCBI chr 2:213,209,907...213,323,305
Ensembl chr 2:213,209,893...213,323,302

G

brain enriched myelin associated protein 1

decreases expression

EXP

Propylthiouracil results in decreased expression of BCAS1 mRNA

NCBI chr 3:179,554,754...179,637,800
Ensembl chr 3:179,551,704...179,637,743

G

branched chain amino acid transaminase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of BCAT1 mRNA

NCBI chr 4:179,695,662...179,777,973
Ensembl chr 4:179,695,662...179,777,288

G

branched chain amino acid transaminase 2

increases expression

EXP

Propylthiouracil results in increased expression of BCAT2 mRNA

NCBI chr 1:105,175,157...105,196,474
Ensembl chr 1:105,176,977...105,196,463

G

BCDIN3 domain containing RNA methyltransferase

decreases expression

EXP

Propylthiouracil results in decreased expression of BCDIN3D mRNA

NCBI chr 7:132,484,404...132,488,998
Ensembl chr 7:132,484,431...132,488,998

G

branched chain keto acid dehydrogenase E1 subunit alpha

decreases expression

EXP

Propylthiouracil results in decreased expression of BCKDHA mRNA

NCBI chr 1:90,266,731...90,295,521
Ensembl chr 1:90,261,629...90,295,749

G

branched chain keto acid dehydrogenase E1 subunit beta

increases expression

EXP

Propylthiouracil results in increased expression of BCKDHB mRNA

NCBI chr 8:93,725,277...93,907,799
Ensembl chr 8:93,725,275...93,907,798

G

BCL11 transcription factor B

decreases expression

EXP

Propylthiouracil results in decreased expression of BCL11B mRNA

PMID:24780913 PMID:30047161

NCBI chr 6:132,598,968...132,692,123
Ensembl chr 6:132,598,968...132,691,301

G

BCL2, apoptosis regulator

decreases expression
increases expression
multiple interactions

EXP

Propylthiouracil results in decreased expression of BCL2 mRNA
Propylthiouracil results in increased expression of BCL2 protein
Thyroxine inhibits the reaction [Propylthiouracil results in increased expression of BCL2 protein]; xiaoluowan inhibits the reaction [Propylthiouracil results in increased expression of BCL2 protein]

PMID:30047161 PMID:35101570

NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900

G

Bcl2-like 15

decreases expression

EXP

Propylthiouracil results in decreased expression of BCL2L15 mRNA

NCBI chr 2:194,019,158...194,032,516
Ensembl chr 2:194,027,397...194,032,516

G

BCL3, transcription coactivator

decreases expression

EXP

Propylthiouracil results in decreased expression of BCL3 mRNA

PMID:24780913 PMID:25825206

NCBI chr 1:88,599,321...88,613,555
Ensembl chr 1:88,599,321...88,614,368

G

BCL6, transcription repressor

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of BCL6 mRNA
Propylthiouracil results in increased expression of BCL6 mRNA

PMID:24780913 PMID:25825206

NCBI chr11:90,358,753...90,382,049
Ensembl chr11:90,358,753...90,382,047

G

BCL6B, transcription repressor

affects expression

EXP

Propylthiouracil affects the expression of BCL6B mRNA

NCBI chr10:55,439,566...55,444,631
Ensembl chr10:55,432,382...55,444,631

G

BCL9, transcription coactivator

decreases expression

EXP

Propylthiouracil results in decreased expression of BCL9 mRNA

NCBI chr 2:187,449,425...187,475,241
Ensembl chr 2:187,449,425...187,475,241

G

BCLAF1 and THRAP3 family member 3

increases expression

EXP

Propylthiouracil results in increased expression of BCLAF3 mRNA

NCBI chr X:39,065,842...39,137,521
Ensembl chr X:39,072,840...39,137,448

G

BCL6 co-repressor-like 1

decreases expression

EXP

Propylthiouracil results in decreased expression of BCORL1 mRNA

NCBI chr X:132,394,703...132,462,414
Ensembl chr X:132,397,069...132,461,976

G

BCR activator of RhoGEF and GTPase

increases expression

EXP

Propylthiouracil results in increased expression of BCR mRNA

NCBI chr20:13,468,732...13,596,333
Ensembl chr20:13,468,732...13,596,333

G

3-hydroxybutyrate dehydrogenase 2

affects expression

EXP

Propylthiouracil affects the expression of BDH2 mRNA

NCBI chr 2:226,376,346...226,397,010
Ensembl chr 2:226,376,356...226,397,006

G

brain-derived neurotrophic factor

increases expression
affects expression
decreases expression
multiple interactions

EXP

Propylthiouracil results in increased expression of BDNF mRNA
Propylthiouracil affects the expression of BDNF mRNA
Propylthiouracil results in decreased expression of BDNF mRNA; Propylthiouracil results in decreased expression of BDNF protein
Dimethyl Fumarate inhibits the reaction [Propylthiouracil results in decreased expression of BDNF mRNA]; Dimethyl Fumarate inhibits the reaction [Propylthiouracil results in decreased expression of BDNF protein]

PMID:25825206 PMID:26606422 PMID:35869475

NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657

G

brain-enriched guanylate kinase-associated

decreases expression

EXP

Propylthiouracil results in decreased expression of BEGAIN mRNA

NCBI chr 6:133,708,010...133,744,264
Ensembl chr 6:133,708,007...133,744,526

G

BEN domain containing 5

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of BEND5 mRNA
Propylthiouracil results in decreased expression of BEND5 mRNA

PMID:24780913 PMID:30047161

NCBI chr 5:131,519,214...131,565,228
Ensembl chr 5:131,519,214...131,762,906

G

BEN domain containing 6

decreases expression

EXP

Propylthiouracil results in decreased expression of BEND6 mRNA

NCBI chr 9:43,576,982...43,631,437
Ensembl chr 9:43,576,982...43,631,194

G

bestrophin 2

decreases expression

EXP

Propylthiouracil results in decreased expression of BEST2 mRNA

NCBI chr19:40,047,191...40,053,216
Ensembl chr19:40,047,191...40,053,216

G

bestrophin 4

increases expression

EXP

Propylthiouracil results in increased expression of BEST4 mRNA

NCBI chr 5:135,858,774...135,865,624
Ensembl chr 5:135,860,018...135,863,707

G

Bet1 golgi vesicular membrane trafficking protein

increases expression

EXP

Propylthiouracil results in increased expression of BET1 mRNA

NCBI chr 4:33,070,892...33,081,162
Ensembl chr 4:33,070,891...33,081,164

G

Bet1 golgi vesicular membrane trafficking protein-like

decreases expression

EXP

Propylthiouracil results in decreased expression of BET1L mRNA

NCBI chr 1:205,361,041...205,365,036
Ensembl chr 1:205,361,041...205,364,706

G

brain expressed, X-linked 4

increases expression

EXP

Propylthiouracil results in increased expression of BEX4 mRNA

PMID:24780913 PMID:25825206

NCBI chr X:103,923,609...103,925,041
Ensembl chr X:103,923,338...103,925,496

G

beaded filament structural protein 1

increases expression

EXP

Propylthiouracil results in increased expression of BFSP1 mRNA

NCBI chr 3:151,648,588...151,706,153
Ensembl chr 3:151,648,588...151,682,837

G

bone gamma-carboxyglutamate protein

decreases expression

EXP

Propylthiouracil results in decreased expression of BGLAP mRNA

NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:176,136,341...176,137,318

G

biglycan

increases expression

EXP

Propylthiouracil results in increased expression of BGN mRNA

NCBI chr X:156,348,633...156,360,797
Ensembl chr X:156,348,615...156,360,799

G

basic helix-loop-helix family, member a15

increases expression

EXP

Propylthiouracil results in increased expression of BHLHA15 mRNA

NCBI chr12:15,534,123...15,538,299
Ensembl chr12:15,534,123...15,538,515

G

basic helix-loop-helix family, member e22

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of BHLHE22 mRNA
Propylthiouracil results in decreased expression of BHLHE22 mRNA

PMID:24780913 PMID:30047161

NCBI chr 2:102,402,622...102,405,732
Ensembl chr 2:102,400,164...102,420,508

G

basic helix-loop-helix family, member e23

decreases expression

EXP

Propylthiouracil results in decreased expression of BHLHE23 mRNA

PMID:24780913 PMID:25825206

NCBI chr 3:188,266,572...188,268,786
Ensembl chr 3:188,238,188...188,269,089

G

basic helix-loop-helix family, member e40

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of BHLHE40 mRNA
Propylthiouracil results in increased expression of BHLHE40 mRNA

PMID:24780913 PMID:25825206

NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:143,174,048...143,180,783

G

basic helix-loop-helix family, member e41

decreases expression

EXP

Propylthiouracil results in decreased expression of BHLHE41 mRNA

NCBI chr 4:180,565,003...180,569,415
Ensembl chr 4:180,565,003...180,569,355

G

betaine-homocysteine S-methyltransferase

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of BHMT mRNA
Propylthiouracil results in decreased expression of BHMT mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 2:26,594,852...26,614,429
Ensembl chr 2:26,594,854...26,614,715

G

BicC family RNA binding protein 1

decreases expression

EXP

Propylthiouracil results in decreased expression of BICC1 mRNA

NCBI chr20:17,448,745...17,685,887
Ensembl chr20:17,448,765...17,685,885

G

BICD cargo adaptor 1

decreases expression

EXP

Propylthiouracil results in decreased expression of BICD1 mRNA

NCBI chr 4:184,208,891...184,362,840
Ensembl chr 4:184,210,363...184,357,391

G

BICD cargo adaptor 2

increases expression

EXP

Propylthiouracil results in increased expression of BICD2 mRNA

PMID:24780913 PMID:30047161

NCBI chr17:15,449,011...15,511,423
Ensembl chr17:15,435,894...15,511,305

G

BH3 interacting domain death agonist

increases expression

EXP

Propylthiouracil results in increased expression of BID mRNA

NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275

G

BCL2-interacting killer

increases expression

EXP

Propylthiouracil results in increased expression of BIK mRNA

NCBI chr 7:116,552,303...116,571,317
Ensembl chr 7:116,552,303...116,571,317

G

bridging integrator 1

decreases expression

EXP

Propylthiouracil results in decreased expression of BIN1 mRNA

PMID:24780913 PMID:30047161

NCBI chr18:24,282,840...24,341,461
Ensembl chr18:24,283,801...24,341,458

G

baculoviral IAP repeat-containing 3

decreases expression

EXP

Propylthiouracil results in decreased expression of BIRC3 mRNA

NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:13,285,703...13,298,590

G

baculoviral IAP repeat-containing 5

increases expression

EXP

Propylthiouracil results in increased expression of BIRC5 mRNA

PMID:24780913 PMID:30047161

NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155

G

basophilic leukemia expressed protein BLES03

decreases expression

EXP

Propylthiouracil results in decreased expression of BLES03 mRNA

NCBI chr 1:212,163,892...212,166,146
Ensembl chr 1:212,163,892...212,166,141

G

bridge-like lipid transfer protein family member 3B

affects expression

EXP

Propylthiouracil affects the expression of BLTP3B mRNA

NCBI chr 7:26,068,948...26,149,033
Ensembl chr 7:26,068,955...26,149,083

G

biliverdin reductase A

increases expression

EXP

Propylthiouracil results in increased expression of BLVRA mRNA

NCBI chr 3:134,793,397...134,819,367
Ensembl chr 3:134,794,203...134,819,785

G

basic leucine zipper nuclear factor 1

decreases expression

EXP

Propylthiouracil results in decreased expression of BLZF1 mRNA

NCBI chr13:79,174,898...79,190,116
Ensembl chr13:79,174,902...79,190,116

G

bMERB domain containing 1

increases expression

EXP

Propylthiouracil results in increased expression of BMERB1 mRNA

PMID:24780913 PMID:36843608

NCBI chr10:2,286,999...2,453,890
Ensembl chr10:2,287,000...2,453,728

G

Bcl2 modifying factor

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of BMF mRNA
Propylthiouracil results in decreased expression of BMF mRNA

PMID:19483382 PMID:24780913 PMID:25825206

NCBI chr 3:125,953,466...125,974,087
Ensembl chr 3:125,953,466...125,974,258

G

bone morphogenetic protein 1

decreases expression

EXP

Propylthiouracil results in decreased expression of BMP1 mRNA

PMID:24780913 PMID:36843608

NCBI chr15:51,961,310...52,005,597
Ensembl chr15:51,961,310...52,005,485

G

bone morphogenetic protein 2

affects expression

EXP

Propylthiouracil affects the expression of BMP2 mRNA

NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:141,264,646...141,274,760

G

bone morphogenetic protein 3

decreases expression
increases methylation

EXP

Propylthiouracil results in decreased expression of BMP3 mRNA
Propylthiouracil results in increased methylation of BMP3 promoter

PMID:24780913 PMID:33150595

NCBI chr14:11,012,564...11,041,282
Ensembl chr14:11,016,620...11,041,282

G

bone morphogenetic protein 4

decreases expression

EXP

Propylthiouracil results in decreased expression of BMP4 mRNA

NCBI chr15:22,098,191...22,113,145
Ensembl chr15:22,098,470...22,105,172

G

bone morphogenetic protein 5

decreases expression

EXP

Propylthiouracil results in decreased expression of BMP5 mRNA

NCBI chr 8:85,397,629...85,520,374
Ensembl chr 8:85,396,925...85,520,189

G

bone morphogenetic protein 6

decreases expression

EXP

Propylthiouracil results in decreased expression of BMP6 mRNA

NCBI chr17:26,523,704...26,785,558
Ensembl chr17:26,523,704...26,675,261

G

bone morphogenetic protein 7

increases expression

EXP

Propylthiouracil results in increased expression of BMP7 mRNA

NCBI chr 3:182,059,318...182,135,273
Ensembl chr 3:182,052,337...182,135,137

G

bone morphogenetic protein 8a

decreases expression

EXP

Propylthiouracil results in decreased expression of BMP8A mRNA

NCBI chr 5:140,874,942...140,902,881
Ensembl chr 5:140,874,503...140,902,881

G

BMP-binding endothelial regulator

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of BMPER mRNA
Propylthiouracil results in decreased expression of BMPER mRNA

PMID:24780913 PMID:36843608

NCBI chr 8:30,008,049...30,253,201
Ensembl chr 8:30,008,148...30,434,359

G

BMX non-receptor tyrosine kinase

decreases expression

EXP

Propylthiouracil results in decreased expression of BMX mRNA

NCBI chr X:33,859,128...33,921,876
Ensembl chr X:33,859,129...33,921,874

G

basonuclin zinc finger protein 2

decreases expression

EXP

Propylthiouracil results in decreased expression of BNC2 mRNA

NCBI chr 5:103,724,934...104,061,890
Ensembl chr 5:103,724,934...104,125,428

G

BCL2 interacting protein 2

increases expression

EXP

Propylthiouracil results in increased expression of BNIP2 mRNA

NCBI chr 8:79,521,375...79,539,148
Ensembl chr 8:79,521,363...79,547,368

G

BCL2 interacting protein 3

affects expression

EXP

Propylthiouracil affects the expression of BNIP3 mRNA

NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962

G

BCL2 interacting protein 3 like

decreases expression

EXP

Propylthiouracil results in decreased expression of BNIP3L mRNA

NCBI chr15:45,350,081...45,373,213
Ensembl chr15:45,334,537...45,373,282

G

BCL2 family apoptosis regulator BOK

decreases expression

EXP

Propylthiouracil results in decreased expression of BOK mRNA

PMID:24780913 PMID:25825206

NCBI chr 9:101,670,729...101,681,834
Ensembl chr 9:101,670,625...101,681,833

G

bolA family member 1

decreases expression

EXP

Propylthiouracil results in decreased expression of BOLA1 mRNA

NCBI chr 2:186,447,386...186,448,402
Ensembl chr 2:186,443,583...186,501,358

G

bolA family member 3

increases expression

EXP

Propylthiouracil results in increased expression of BOLA3 mRNA

NCBI chr 4:117,411,044...117,420,491
Ensembl chr 4:117,410,680...117,420,491

G

BOP1 ribosomal biogenesis factor

increases expression

EXP

Propylthiouracil results in increased expression of BOP1 mRNA

NCBI chr 7:110,052,716...110,076,529
Ensembl chr 7:110,052,720...110,076,529

G

biphenyl hydrolase like

decreases expression

EXP

Propylthiouracil results in decreased expression of BPHL mRNA

NCBI chr17:31,006,283...31,042,631
Ensembl chr17:31,004,972...31,042,632

G

BPI fold containing family A, member 1

decreases expression

EXP

Propylthiouracil results in decreased expression of BPIFA1 mRNA

NCBI chr 3:163,087,965...163,093,708
Ensembl chr 3:163,087,965...163,093,708

G

BPI fold containing family A, member 5

decreases expression

EXP

Propylthiouracil results in decreased expression of BPIFA5 mRNA

NCBI chr 3:163,106,258...163,113,039
Ensembl chr 3:163,106,258...163,113,038

G

BPI fold containing family B, member 2

decreases expression

EXP

Propylthiouracil results in decreased expression of BPIFB2 mRNA

NCBI chr 3:162,818,223...162,837,219
Ensembl chr 3:162,818,223...162,837,210

G

BPI fold containing family B, member 3

increases expression

EXP

Propylthiouracil results in increased expression of BPIFB3 mRNA

NCBI chr 3:162,861,234...162,875,850
Ensembl chr 3:162,861,234...162,875,850

G

BPI fold containing family C

increases expression

EXP

Propylthiouracil results in increased expression of BPIFC mRNA

NCBI chr 7:19,736,282...19,793,737
Ensembl chr 7:19,736,474...19,793,634

G

bromodomain containing 2

decreases expression

EXP

Propylthiouracil results in decreased expression of BRD2 mRNA

PMID:22504374 PMID:30047161

NCBI chr20:4,728,282...4,737,286
Ensembl chr20:4,728,951...4,737,290

G

bromodomain containing 4

decreases expression

EXP

Propylthiouracil results in decreased expression of BRD4 mRNA

NCBI chr 7:11,866,997...11,946,575
Ensembl chr 7:11,866,997...11,946,923

G

Bri3 binding protein

increases expression

EXP

Propylthiouracil results in increased expression of BRI3BP mRNA

NCBI chr12:36,838,098...36,849,919
Ensembl chr12:36,838,098...36,849,919

G

BMP/retinoic acid inducible neural specific 1

decreases expression

EXP

Propylthiouracil results in decreased expression of BRINP1 mRNA

NCBI chr 5:87,363,621...87,565,580
Ensembl chr 5:87,364,050...87,508,256

G

BRCA1 interacting DNA helicase 1

increases expression

EXP

Propylthiouracil results in increased expression of BRIP1 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr10:71,402,035...71,528,083
Ensembl chr10:71,401,151...71,575,206

G

biogenesis of ribosomes BRX1

increases expression

EXP

Propylthiouracil results in increased expression of BRIX1 mRNA

PMID:30047161 PMID:36843608

NCBI chr 2:61,177,769...61,188,647
Ensembl chr 2:61,177,771...61,188,647

G

BRMS1 like transcriptional repressor

increases expression

EXP

Propylthiouracil results in increased expression of BRMS1L mRNA

NCBI chr 6:79,001,803...79,035,735
Ensembl chr 6:79,000,615...79,035,734

G

bromodomain and PHD finger containing, 1

decreases expression

EXP

Propylthiouracil results in decreased expression of BRPF1 mRNA

NCBI chr 4:148,011,977...148,028,431
Ensembl chr 4:148,011,931...148,028,424

G

BSCL2 lipid droplet biogenesis associated, seipin

decreases expression

EXP

Propylthiouracil results in decreased expression of BSCL2 mRNA

NCBI chr 1:215,160,764...215,172,540
Ensembl chr 1:215,160,957...215,172,536

G

bassoon (presynaptic cytomatrix protein)

decreases expression

EXP

Propylthiouracil results in decreased expression of BSN mRNA

NCBI chr 8:117,663,447...117,754,412
Ensembl chr 8:117,670,334...117,754,412

G

B-box and SPRY domain containing

decreases expression

EXP

Propylthiouracil results in decreased expression of BSPRY mRNA

NCBI chr 5:80,942,974...80,965,157
Ensembl chr 5:80,942,979...80,988,154

G

bone marrow stromal cell antigen 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of BST1 mRNA
Propylthiouracil results in decreased expression of BST1 mRNA

PMID:22504374 PMID:25825206 PMID:30047161

NCBI chr14:71,466,179...71,482,671
Ensembl chr14:71,466,180...71,482,647

G

bone marrow stromal cell antigen 2

decreases expression

EXP

Propylthiouracil results in decreased expression of BST2 mRNA

NCBI chr16:18,250,593...18,254,967
Ensembl chr16:18,251,847...18,254,967

G

BTB domain containing 10

increases expression

EXP

Propylthiouracil results in increased expression of BTBD10 mRNA

NCBI chr 1:176,865,817...176,923,663
Ensembl chr 1:176,865,817...176,923,663

G

BTB domain containing 16

increases expression

EXP

Propylthiouracil results in increased expression of BTBD16 mRNA

PMID:24780913 PMID:25825206

NCBI chr 1:194,765,241...194,819,786
Ensembl chr 1:194,765,903...194,819,785

G

BTB domain containing 17

decreases expression

EXP

Propylthiouracil results in decreased expression of BTBD17 mRNA

NCBI chr10:100,325,177...100,331,669
Ensembl chr10:100,325,177...100,331,771

G

BTB domain containing 2

decreases expression

EXP

Propylthiouracil results in decreased expression of BTBD2 mRNA

NCBI chr 7:9,710,392...9,726,032
Ensembl chr 7:9,712,269...9,726,032

G

BTB domain containing 9

increases expression

EXP

Propylthiouracil results in increased expression of BTBD9 mRNA

NCBI chr20:8,287,813...8,645,437
Ensembl chr20:8,290,456...8,641,292

G

biotinidase

increases expression

EXP

Propylthiouracil results in increased expression of BTD mRNA

NCBI chr16:6,869,448...6,900,711
Ensembl chr16:6,869,291...6,901,410

G

basic transcription factor 3

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of BTF3 mRNA
Propylthiouracil results in decreased expression of BTF3 mRNA

PMID:19483382 PMID:30047161

NCBI chr 2:31,394,010...31,401,138
Ensembl chr 2:31,394,011...31,401,125
Ensembl chr13:31,394,011...31,401,125

G

BTG anti-proliferation factor 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of BTG1 mRNA
Propylthiouracil results in decreased expression of BTG1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 7:33,228,149...33,230,406
Ensembl chr 7:33,227,833...33,230,406

G

BTG anti-proliferation factor 2

increases expression

EXP

Propylthiouracil results in increased expression of BTG2 mRNA

NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690

G

BTG anti-proliferation factor 3

increases expression

EXP

Propylthiouracil results in increased expression of BTG3 mRNA

PMID:24780913 PMID:30047161

NCBI chr11:30,517,068...30,532,981
Ensembl chr11:30,517,072...30,533,082

G

BTG anti-proliferation factor 4

increases expression

EXP

Propylthiouracil results in increased expression of BTG4 mRNA

NCBI chr 8:60,307,090...60,322,167
Ensembl chr 8:60,317,121...60,322,167

G

BUB1 mitotic checkpoint serine/threonine kinase

increases expression

EXP

Propylthiouracil results in increased expression of BUB1 mRNA

NCBI chr 3:135,473,525...135,504,921
Ensembl chr 3:135,472,582...135,504,921

G

BUB1 mitotic checkpoint serine/threonine kinase B

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of BUB1B mRNA
Propylthiouracil results in decreased expression of BUB1B mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 3:126,017,019...126,069,470
Ensembl chr 3:126,017,045...126,069,796

G

BUB3 mitotic checkpoint protein

increases expression

EXP

Propylthiouracil results in increased expression of BUB3 mRNA

NCBI chr 1:195,760,532...195,771,140
Ensembl chr 1:195,758,105...195,791,028

G

BUD23, rRNA methyltransferase and ribosome maturation factor

increases expression

EXP

Propylthiouracil results in increased expression of WBSCR22 mRNA

NCBI chr12:27,266,093...27,277,300
Ensembl chr12:27,265,521...27,277,297

G

BUD31 homolog

increases expression

EXP

Propylthiouracil results in increased expression of BUD31 mRNA

NCBI chr12:14,576,602...14,584,132
Ensembl chr12:14,576,605...14,584,039

G

basic leucine zipper and W2 domains 1

increases expression

EXP

Propylthiouracil results in increased expression of BZW1 mRNA

NCBI chr 9:67,424,860...67,438,656
Ensembl chr 9:67,424,866...67,439,684

G

basic leucine zipper and W2 domains 2

increases expression

EXP

Propylthiouracil results in increased expression of BZW2 mRNA

PMID:24780913 PMID:36843608

NCBI chr 6:58,555,362...58,615,921
Ensembl chr 6:58,554,961...58,615,912

G

similar to human chromosome 21 open reading frame 91

increases expression

EXP

Propylthiouracil results in increased expression of C11H21ORF91 mRNA

NCBI chr11:30,716,034...30,749,292
Ensembl chr11:30,716,034...30,749,415

G

similar to human chromosome 1 open reading frame 115

decreases expression

EXP

Propylthiouracil results in decreased expression of C13H1ORF115 mRNA

NCBI chr13:98,953,841...98,963,577
Ensembl chr13:98,953,843...98,963,810

G

similar to human chromosome 6 open reading frame 52

decreases expression

EXP

Propylthiouracil results in decreased expression of C17H6ORF52 mRNA

NCBI chr17:23,959,124...23,981,978
Ensembl chr17:23,968,478...23,981,976

G

similar to human chromosome 5 open reading frame 46

increases expression

EXP

Propylthiouracil results in increased expression of C18H5ORF46 mRNA

NCBI chr18:36,199,309...36,220,409
Ensembl chr18:36,199,309...36,220,409

G

similar to human chromosome 16 open reading frame 74

increases expression

EXP

Propylthiouracil results in increased expression of C19H16ORF74 mRNA

NCBI chr19:65,568,997...65,594,994
Ensembl chr19:65,568,997...65,595,460

G

C1GALT1-specific chaperone 1, pseudogene 1

increases expression

EXP

Propylthiouracil results in increased expression of C1GALT1C1-PS1 mRNA

NCBI chr14:55,672,375...55,673,587

G

similar to human chromosome 19 open reading frame 81

increases expression

EXP

Propylthiouracil results in increased expression of C1H19ORF81 mRNA

NCBI chr 1:103,993,832...104,008,301
Ensembl chr 1:103,993,832...104,008,577

G

similar to human chromosome 9 open reading frame 85

increases expression

EXP

Propylthiouracil results in increased expression of C1H9ORF85 mRNA

NCBI chr 1:228,562,621...228,624,472
Ensembl chr 1:228,564,731...228,624,278

G

complement C1q binding protein

affects expression
increases expression

EXP

Propylthiouracil affects the expression of C1QBP mRNA
Propylthiouracil results in increased expression of C1QBP mRNA

PMID:19483382 PMID:30047161

NCBI chr10:56,198,534...56,203,185
Ensembl chr10:56,198,540...56,203,235

G

complement C1q like 1

increases expression

EXP

Propylthiouracil results in increased expression of C1QL1 mRNA

NCBI chr10:88,402,219...88,409,649
Ensembl chr10:88,402,219...88,409,649

G

complement C1q like 2

decreases expression

EXP

Propylthiouracil results in decreased expression of C1QL2 mRNA

NCBI chr13:34,023,902...34,025,437
Ensembl chr13:34,023,177...34,026,020

G

complement C1q like 3

increases expression

EXP

Propylthiouracil results in increased expression of C1QL3 mRNA

PMID:22504374 PMID:24780913

NCBI chr17:81,028,418...81,038,244
Ensembl chr17:81,028,418...81,038,244

G

C1q and TNF related 1

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of C1QTNF1 mRNA
Propylthiouracil results in decreased expression of C1QTNF1 mRNA

PMID:24780913 PMID:30047161

NCBI chr10:104,159,021...104,180,253
Ensembl chr10:104,158,886...104,180,251

G

C1q and TNF related 12

decreases expression

EXP

Propylthiouracil results in decreased expression of C1QTNF12 mRNA

NCBI chr 5:171,833,854...171,838,229
Ensembl chr 5:171,833,854...171,838,800

G

C1q and TNF related 2

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of C1QTNF2 mRNA

NCBI chr10:28,443,326...28,460,400
Ensembl chr10:28,443,425...28,460,395

G

C1q and TNF related 3

increases expression

EXP

Propylthiouracil results in increased expression of C1QTNF3 mRNA

PMID:24780913 PMID:30047161

NCBI chr 2:61,644,225...61,666,640
Ensembl chr 2:61,644,276...61,666,559

G

C1q and TNF related 4

decreases expression

EXP

Propylthiouracil results in decreased expression of C1QTNF4 mRNA

NCBI chr 3:97,310,220...97,328,818
Ensembl chr 3:97,327,670...97,342,587

G

C1q and TNF related 5

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of C1QTNF5 mRNA
Propylthiouracil results in increased expression of C1QTNF5 mRNA

PMID:24780913 PMID:30047161 PMID:36843608

NCBI chr 8:53,347,754...53,349,912
Ensembl chr 8:53,347,711...53,349,912

G

C1q and TNF related 9

decreases expression

EXP

Propylthiouracil results in decreased expression of C1QTNF9 mRNA

NCBI chr15:39,083,883...39,099,167
Ensembl chr15:39,087,163...39,099,398

G

complement C1r

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of C1R mRNA
Propylthiouracil results in decreased expression of C1R mRNA

PMID:22504374 PMID:24780913 PMID:36843608

NCBI chr 4:159,099,013...159,109,770
Ensembl chr 4:159,098,918...159,109,714

G

complement C1s

affects expression
increases expression

EXP

Propylthiouracil affects the expression of C1S mRNA
Propylthiouracil results in increased expression of C1S mRNA

PMID:19483382 PMID:22504374 PMID:24780913

NCBI chr 4:159,116,549...159,128,736
Ensembl chr 4:159,116,549...159,128,736

G

similar to human chromosome 21 open reading frame 58

decreases expression

EXP

Propylthiouracil results in decreased expression of C20H21ORF58 mRNA

NCBI chr20:12,165,853...12,187,271
Ensembl chr20:12,174,928...12,186,503

G

similar to human chromosome 6 open reading frame 89

decreases expression

EXP

Propylthiouracil results in decreased expression of C20H6ORF89 mRNA

NCBI chr20:7,324,105...7,368,482
Ensembl chr20:7,324,129...7,363,666

G

C2 calcium-dependent domain containing 2

affects expression
increases expression

EXP

Propylthiouracil affects the expression of C2CD2 mRNA
Propylthiouracil results in increased expression of C2CD2 mRNA

PMID:19483382 PMID:30047161

NCBI chr11:50,694,680...50,759,096
Ensembl chr11:50,694,563...50,759,016

G

C2CD2-like

increases expression

EXP

Propylthiouracil results in increased expression of C2CD2L mRNA

NCBI chr 8:53,544,887...53,557,127
Ensembl chr 8:53,544,892...53,555,153

G

C2 calcium-dependent domain containing 4B

increases expression

EXP

Propylthiouracil results in increased expression of C2CD4B mRNA

NCBI chr 8:77,254,327...77,277,620
Ensembl chr 8:77,238,551...77,279,879

G

C2 calcium-dependent domain containing 4C

increases expression

EXP

Propylthiouracil results in increased expression of C2CD4C mRNA

NCBI chr 7:10,742,534...10,746,033
Ensembl chr 7:10,742,545...10,751,973

G

C2 calcium-dependent domain containing 4D

decreases expression

EXP

Propylthiouracil results in decreased expression of C2CD4D mRNA

NCBI chr 2:184,688,815...184,690,978
Ensembl chr 2:184,677,258...184,691,381

G

C2 calcium-dependent domain containing 5

increases expression

EXP

Propylthiouracil results in increased expression of C2CD5 mRNA

NCBI chr 4:177,700,515...177,790,576
Ensembl chr 4:177,700,516...177,786,717

G

complement C3

decreases expression

EXP

Propylthiouracil results in decreased expression of C3 mRNA

NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339

G

similar to human chromosome 11 open reading frame 91

increases expression

EXP

Propylthiouracil results in increased expression of C3H11ORF91 mRNA

NCBI chr 3:110,934,488...110,941,511
Ensembl chr 3:110,939,526...110,941,508

G

similar to human chromosome 9 open reading frame 50

decreases expression

EXP

Propylthiouracil results in decreased expression of C3H9ORF50 mRNA

NCBI chr 3:34,477,535...34,484,791
Ensembl chr 3:34,478,508...34,484,805

G

complement C4B

increases expression
affects expression

EXP

Propylthiouracil results in increased expression of C4B mRNA
Propylthiouracil affects the expression of C4B mRNA

PMID:22504374 PMID:24780913

NCBI chr20:4,201,979...4,216,292
Ensembl chr20:4,201,961...4,216,289

G

complement component 4 binding protein, alpha

affects expression

EXP

Propylthiouracil affects the expression of C4BPA mRNA

NCBI chr13:44,627,959...44,663,552
Ensembl chr13:44,627,982...44,663,471

G

complement component 4 binding protein, beta

decreases expression

EXP

Propylthiouracil results in decreased expression of C4BPB mRNA

PMID:24780913 PMID:30047161

NCBI chr13:44,673,064...44,683,781
Ensembl chr13:44,673,065...44,683,793

G

complement C5

decreases expression

EXP

Propylthiouracil results in decreased expression of C5 mRNA

NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:38,668,174...38,759,468

G

similar to human chromosome 1 open reading frame 210

decreases expression

EXP

Propylthiouracil results in decreased expression of C5H1ORF210 mRNA

PMID:24780913 PMID:25825206

NCBI chr 5:137,334,142...137,337,300
Ensembl chr 5:137,334,142...137,337,300

G

similar to human chromosome 6 open reading frame 163

increases expression

EXP

Propylthiouracil results in increased expression of C5H6ORF163 mRNA

NCBI chr 5:54,113,073...54,132,787
Ensembl chr 5:54,112,859...54,126,074

G

complement C6

decreases expression

EXP

Propylthiouracil results in decreased expression of C6 mRNA

PMID:24780913 PMID:30047161

NCBI chr 2:55,573,596...55,648,857
Ensembl chr 2:55,573,653...55,649,120

G

complement C7

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of C7 mRNA
Propylthiouracil results in decreased expression of C7 mRNA

PMID:19483382 PMID:24780913

NCBI chr 2:55,815,687...55,892,605
Ensembl chr 2:55,816,807...55,892,672

G

similar to human chromosome 22 open reading frame 23

increases expression

EXP

Propylthiouracil results in increased expression of C7H22ORF23 mRNA

NCBI chr 7:112,585,341...112,592,938
Ensembl chr 7:112,584,818...112,593,109

G

complement C8 beta chain

affects expression
increases expression

EXP

Propylthiouracil affects the expression of C8B mRNA
Propylthiouracil results in increased expression of C8B mRNA

PMID:19483382 PMID:24780913

NCBI chr 5:124,763,974...124,801,522
Ensembl chr 5:124,761,790...124,801,516

G

similar to human chromosome 11 open reading frame 65

increases expression

EXP

Propylthiouracil results in increased expression of C8H11ORF65 mRNA

NCBI chr 8:62,692,123...62,720,951
Ensembl chr 8:62,692,568...62,720,946

G

similar to human chromosome 11 open reading frame 97

increases expression

EXP

Propylthiouracil results in increased expression of C8H11ORF97 mRNA

NCBI chr 8:19,884,682...19,901,931
Ensembl chr 8:19,883,390...19,902,044

G

similar to human chromosome 3 open reading frame 18

decreases expression

EXP

Propylthiouracil results in decreased expression of C8H3ORF18 mRNA

PMID:24780913 PMID:25825206

NCBI chr 8:116,891,081...116,901,122
Ensembl chr 8:116,891,297...116,901,120

G

carbonic anhydrase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CAR1 mRNA

NCBI chr 2:88,550,681...88,593,454
Ensembl chr 2:88,495,475...88,593,454

G

carbonic anhydrase 11

decreases expression

EXP

Propylthiouracil results in decreased expression of CAR11 mRNA

NCBI chr 1:105,306,347...105,311,651
Ensembl chr 1:105,302,289...105,311,832

G

carbonic anhydrase 14

decreases expression

EXP

Propylthiouracil results in decreased expression of CAR14 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 2:186,131,196...186,138,164
Ensembl chr 2:186,129,341...186,138,863

G

carbonic anhydrase 3

affects expression
increases expression

EXP

Propylthiouracil affects the expression of CAR3 mRNA
Propylthiouracil results in increased expression of CAR3 mRNA

PMID:19483382 PMID:22504374

NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:88,491,670...88,500,524

G

carbonic anhydrase 4

decreases expression

EXP

Propylthiouracil results in decreased expression of CAR4 mRNA

NCBI chr10:70,325,102...70,333,916
Ensembl chr10:70,325,358...70,333,916

G

carbonic anhydrase 5A

decreases expression

EXP

Propylthiouracil results in decreased expression of CAR5A mRNA

NCBI chr19:66,881,678...66,911,486
Ensembl chr19:66,881,693...66,911,486

G

carbonic anhydrase 6

affects response to substance
decreases expression

ISO
EXP

CA6 gene polymorphism affects the susceptibility to Propylthiouracil
Propylthiouracil results in decreased expression of CAR6 mRNA

PMID:22312435 PMID:24780913

NCBI chr 5:165,941,028...165,959,566
Ensembl chr 5:165,941,029...165,959,566

G

ciliary associated calcium binding coiled-coil 1

affects expression

EXP

Propylthiouracil affects the expression of CABCOCO1 mRNA

NCBI chr20:20,057,462...20,166,732
Ensembl chr20:20,057,517...20,167,174

G

Cdk5 and Abl enzyme substrate 1

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CABLES1 mRNA
Propylthiouracil results in increased expression of CABLES1 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr18:3,349,681...3,455,956
Ensembl chr18:3,351,652...3,455,956

G

calcium binding protein 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CABP1 mRNA

NCBI chr12:47,045,914...47,109,614
Ensembl chr12:47,085,292...47,109,611

G

calcium binding protein 7

decreases expression

EXP

Propylthiouracil results in decreased expression of CABP7 mRNA

NCBI chr14:83,822,322...83,832,667
Ensembl chr14:83,822,327...83,832,735

G

calcium binding tyrosine phosphorylation regulated

increases expression

EXP

Propylthiouracil results in increased expression of CABYR mRNA

NCBI chr18:4,166,790...4,178,570
Ensembl chr18:4,166,858...4,179,507

G

calcium voltage-gated channel subunit alpha1 A

decreases expression

EXP

Propylthiouracil results in decreased expression of CACNA1A mRNA

NCBI chr19:40,425,560...40,724,810
Ensembl chr19:40,425,560...40,724,599

G

calcium voltage-gated channel subunit alpha1 B

decreases expression

EXP

Propylthiouracil results in decreased expression of CACNA1B mRNA

PMID:25825206 PMID:37926403

NCBI chr 3:27,779,133...27,944,292
Ensembl chr 3:27,779,166...27,944,285

G

calcium voltage-gated channel subunit alpha1 H

decreases expression

EXP

Propylthiouracil results in decreased expression of CACNA1H mRNA

NCBI chr10:14,894,630...14,952,317
Ensembl chr10:14,894,641...14,952,771

G

calcium voltage-gated channel subunit alpha1 I

increases expression

EXP

Propylthiouracil results in increased expression of CACNA1I mRNA

NCBI chr 7:113,716,266...113,827,670
Ensembl chr 7:113,716,266...113,827,670

G

calcium voltage-gated channel subunit alpha1 S

affects expression
increases expression

EXP

Propylthiouracil affects the expression of CACNA1S mRNA
Propylthiouracil results in increased expression of CACNA1S mRNA

PMID:24780913 PMID:25825206

NCBI chr13:50,045,668...50,115,903
Ensembl chr13:50,045,668...50,115,903

G

calcium voltage-gated channel auxiliary subunit alpha2delta 3

decreases expression

EXP

Propylthiouracil results in decreased expression of CACNA2D3 mRNA

NCBI chr16:4,105,048...4,919,037
Ensembl chr16:4,105,048...4,919,098

G

calcium voltage-gated channel auxiliary subunit beta 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CACNB1 mRNA

NCBI chr10:83,494,509...83,515,164
Ensembl chr10:83,494,509...83,515,146

G

calcium voltage-gated channel auxiliary subunit beta 3

increases expression

EXP

Propylthiouracil results in increased expression of CACNB3 mRNA

NCBI chr 7:131,663,810...131,676,085
Ensembl chr 7:131,662,545...131,676,085

G

calcium voltage-gated channel auxiliary subunit beta 4

decreases expression

EXP

Propylthiouracil results in decreased expression of CACNB4 mRNA

PMID:24780913 PMID:30047161

NCBI chr 3:57,315,900...57,578,271
Ensembl chr 3:57,315,900...57,578,220

G

calcium voltage-gated channel auxiliary subunit gamma 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CACNG2 mRNA

PMID:24780913 PMID:30047161

NCBI chr 7:111,451,605...111,579,071
Ensembl chr 7:111,455,006...111,577,757

G

calcium voltage-gated channel auxiliary subunit gamma 4

decreases expression

EXP

Propylthiouracil results in decreased expression of CACNG4 mRNA

PMID:24780913 PMID:25825206

NCBI chr10:93,183,410...93,245,470
Ensembl chr10:93,183,410...93,245,470

G

calcium voltage-gated channel auxiliary subunit gamma 6

increases expression

EXP

Propylthiouracil results in increased expression of CACNG6 mRNA

NCBI chr 1:74,648,342...74,663,351
Ensembl chr 1:74,648,063...74,662,753

G

calcium voltage-gated channel auxiliary subunit gamma 7

decreases expression

EXP

Propylthiouracil results in decreased expression of CACNG7 mRNA

NCBI chr 1:74,715,483...74,746,669
Ensembl chr 1:74,715,483...74,746,669

G

calcium voltage-gated channel auxiliary subunit gamma 8

increases expression

EXP

Propylthiouracil results in increased expression of CACNG8 mRNA

NCBI chr 1:74,670,767...74,691,003
Ensembl chr 1:74,669,766...74,694,015

G

cell adhesion molecule 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CADM1 mRNA
Propylthiouracil results in decreased expression of CADM1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 8:56,744,374...57,075,264
Ensembl chr 8:56,744,372...57,080,192

G

cell adhesion molecule 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CADM2 mRNA

NCBI chr11:17,994,856...18,971,895
Ensembl chr11:17,994,856...18,971,448

G

calcium dependent secretion activator 2

affects expression
increases expression
decreases expression

EXP

Propylthiouracil affects the expression of CADPS2 mRNA
Propylthiouracil results in increased expression of CADPS2 mRNA
Propylthiouracil results in decreased expression of CADPS2 mRNA

PMID:19483382 PMID:24780913 PMID:25825206

NCBI chr 4:52,746,054...53,275,252
Ensembl chr 4:52,746,065...53,275,004

G

cancer antigen 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CAGE1 mRNA
Propylthiouracil results in decreased expression of CAGE1 mRNA

PMID:24780913 PMID:30047161

NCBI chr17:26,995,671...27,033,740
Ensembl chr17:26,995,078...27,033,754

G

calbindin 1

increases expression

EXP

Propylthiouracil results in increased expression of CALB1 mRNA; Propylthiouracil results in increased expression of CALB1 protein

PMID:20347957 PMID:24780913

NCBI chr 5:34,172,612...34,199,555
Ensembl chr 5:34,172,664...34,200,160

G

calbindin 2

affects expression
multiple interactions
increases expression

EXP

Propylthiouracil affects the expression of CALB2 mRNA
Thioctic Acid affects the reaction [Propylthiouracil results in increased expression of CALB2 mRNA]

PMID:24780913 PMID:31068541

NCBI chr19:55,023,849...55,050,858
Ensembl chr19:55,023,838...55,057,952

G

calcitonin-related polypeptide alpha

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CALCA mRNA
Propylthiouracil results in decreased expression of CALCA mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529

G

calcitonin-related polypeptide, beta

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of CALCB mRNA
Propylthiouracil results in decreased expression of CALCB mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:178,399,634...178,404,654
Ensembl chr 1:178,399,785...178,404,654

G

calcitonin receptor like receptor

increases expression

EXP

Propylthiouracil results in increased expression of CALCRL mRNA

PMID:24780913 PMID:36843608

NCBI chr 3:89,835,071...89,932,616
Ensembl chr 3:89,835,077...89,887,350

G

caldesmon 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CALD1 mRNA

NCBI chr 4:64,232,906...64,414,085
Ensembl chr 4:64,233,171...64,414,085

G

calcium homeostasis modulator family member 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CALHM2 mRNA

NCBI chr 1:255,963,661...255,969,387
Ensembl chr 1:255,963,663...255,969,387

G

calcium homeostasis modulator 3

increases expression

EXP

Propylthiouracil results in increased expression of CALHM3 mRNA

NCBI chr 1:255,984,593...255,989,594
Ensembl chr 1:255,983,410...256,007,697

G

calmodulin 1

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CALM1 mRNA
Propylthiouracil results in increased expression of CALM1 mRNA

PMID:18077114 PMID:30047161

NCBI chr 6:125,217,191...125,227,855
Ensembl chr 6:125,217,246...125,225,381

G

calmodulin 2

increases expression

EXP

Propylthiouracil results in increased expression of CALM2 mRNA

PMID:30047161 PMID:36843608

NCBI chr 6:12,845,170...12,857,830
Ensembl chr15:64,519,554...64,520,657
Ensembl chr 6:64,519,554...64,520,657

G

calmodulin-like 4

increases expression
multiple interactions
decreases expression

EXP
ISO

Propylthiouracil results in increased expression of CALML4 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CALML4 mRNA
Propylthiouracil results in decreased expression of CALML4 mRNA

PMID:24780913 PMID:30047161 PMID:36706583

NCBI chr 8:72,218,870...72,230,650
Ensembl chr 8:72,218,613...72,230,650

G

calneuron 1

increases expression

EXP

Propylthiouracil results in increased expression of CALN1 mRNA

NCBI chr12:31,447,964...31,939,847

G

calreticulin

increases expression

EXP

Propylthiouracil results in increased expression of CALR mRNA

NCBI chr19:40,213,367...40,218,262
Ensembl chr19:40,213,239...40,219,236

G

calreticulin 4

increases expression

EXP

Propylthiouracil results in increased expression of CALR4 mRNA

NCBI chr 5:129,216,293...129,251,077
Ensembl chr 5:129,190,608...129,251,060

G

calumenin

increases expression

EXP

Propylthiouracil results in increased expression of CALU mRNA

NCBI chr 4:58,914,456...58,941,957
Ensembl chr 4:58,914,421...58,941,956

G

calcyon neuron-specific vesicular protein

increases expression

EXP

Propylthiouracil results in increased expression of CALY mRNA

NCBI chr 1:204,292,317...204,303,506
Ensembl chr 1:204,292,318...204,303,196

G

calcium/calmodulin-dependent protein kinase I

increases expression

EXP

Propylthiouracil results in increased expression of CAMK1 mRNA

NCBI chr 4:148,036,843...148,047,675
Ensembl chr 4:148,036,824...148,047,245

G

calcium/calmodulin-dependent protein kinase ID

decreases expression

EXP

Propylthiouracil results in decreased expression of CAMK1D mRNA

NCBI chr17:77,491,191...77,892,018
Ensembl chr17:77,491,220...77,892,012

G

calcium/calmodulin-dependent protein kinase IG

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CAMK1G mRNA
Propylthiouracil results in increased expression of CAMK1G mRNA

PMID:24780913 PMID:25825206

NCBI chr13:107,406,583...107,430,332
Ensembl chr13:107,406,584...107,430,230

G

calcium/calmodulin-dependent protein kinase II alpha

increases expression

EXP

Propylthiouracil results in increased expression of CAMK2A mRNA

PMID:22504374 PMID:36843608

NCBI chr18:56,648,779...56,711,505
Ensembl chr18:56,649,025...56,711,504

G

calcium/calmodulin-dependent protein kinase II delta

increases expression

EXP

Propylthiouracil results in increased expression of CAMK2D mRNA

NCBI chr 2:217,698,324...217,961,898
Ensembl chr 2:217,698,551...217,960,276

G

calcium/calmodulin-dependent protein kinase II gamma

decreases expression

EXP

Propylthiouracil results in decreased expression of CAMK2G mRNA

NCBI chr15:3,553,238...3,612,310
Ensembl chr15:3,553,294...3,612,310

G

calcium/calmodulin-dependent protein kinase II inhibitor 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CAMK2N1 mRNA

NCBI chr 5:155,958,116...155,959,897
Ensembl chr 5:155,957,878...155,961,058

G

calcium/calmodulin-dependent protein kinase IV

decreases expression

EXP

Propylthiouracil results in decreased expression of CAMK4 mRNA; Propylthiouracil results in decreased expression of CAMK4 protein

PMID:24780913 PMID:25825206 PMID:29796989

NCBI chr18:24,857,152...25,076,054
Ensembl chr18:24,857,146...25,077,193

G

calcium/calmodulin-dependent protein kinase kinase 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CAMKK2 mRNA

NCBI chr12:39,451,828...39,505,719
Ensembl chr12:39,451,834...39,514,964

G

cathelicidin antimicrobial peptide

increases expression

EXP

Propylthiouracil results in increased expression of CAMP mRNA

NCBI chr 8:118,720,184...118,721,998
Ensembl chr 8:118,720,184...118,721,998

G

calmodulin regulated spectrin-associated protein family, member 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CAMSAP2 mRNA

NCBI chr13:50,274,950...50,354,298
Ensembl chr13:50,274,950...50,354,298

G

calmodulin binding transcription activator 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CAMTA1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 5:166,791,639...167,639,502
Ensembl chr 5:166,793,101...167,639,733

G

calmodulin binding transcription activator 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CAMTA2 mRNA

NCBI chr10:55,882,071...55,900,575
Ensembl chr10:55,882,071...55,900,179

G

cyclase associated actin cytoskeleton regulatory protein 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CAP2 mRNA

NCBI chr17:18,260,462...18,409,681
Ensembl chr17:18,261,646...18,409,563

G

capping actin protein, gelsolin like

increases expression

EXP

Propylthiouracil results in increased expression of CAPG mRNA

NCBI chr 4:106,152,912...106,170,010
Ensembl chr 4:106,152,890...106,170,672

G

calpain 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CAPN1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:212,705,219...212,736,134
Ensembl chr 1:212,705,222...212,729,445

G

calpain 12

increases expression

EXP

Propylthiouracil results in increased expression of CAPN12 mRNA

NCBI chr 1:93,298,571...93,311,220
Ensembl chr 1:93,298,571...93,310,630

G

calpain 13

decreases expression

EXP

Propylthiouracil results in decreased expression of CAPN13 mRNA

PMID:24780913 PMID:30047161

NCBI chr 6:27,823,664...27,918,676
Ensembl chr 6:27,823,517...27,918,665

G

calpain 15

decreases expression

EXP

Propylthiouracil results in decreased expression of CAPN15 mRNA

NCBI chr10:15,477,311...15,503,913
Ensembl chr10:15,477,313...15,503,913

G

calpain 3

increases expression

EXP

Propylthiouracil results in increased expression of CAPN3 mRNA

NCBI chr 3:127,860,002...127,913,677
Ensembl chr 3:127,861,589...127,911,638

G

calpain 6

decreases expression

EXP

Propylthiouracil results in decreased expression of CAPN6 mRNA

NCBI chr X:112,177,467...112,202,178
Ensembl chr X:112,177,467...112,202,178

G

calpain 7

increases expression

EXP

Propylthiouracil results in increased expression of CAPN7 mRNA

NCBI chr16:6,552,048...6,588,317
Ensembl chr16:6,552,049...6,588,316

G

calpain, small subunit 1

increases expression

EXP

Propylthiouracil results in increased expression of CAPNS1 mRNA

NCBI chr 1:94,572,083...94,582,332
Ensembl chr 1:94,572,083...94,583,368

G

calpain, small subunit 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CAPNS2 mRNA
Propylthiouracil results in decreased expression of CAPNS2 mRNA

PMID:24780913 PMID:30047161

NCBI chr19:30,277,324...30,278,266

G

cell cycle associated protein 1

affects expression

EXP

Propylthiouracil affects the expression of CAPRIN1 mRNA

NCBI chr 3:110,606,489...110,685,408
Ensembl chr 3:110,606,489...110,685,562

G

calcyphosine-like

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CAPSL mRNA
Propylthiouracil results in decreased expression of CAPSL mRNA

PMID:24780913 PMID:25825206 PMID:30047161 PMID:36843608

NCBI chr 2:60,122,162...60,152,692
Ensembl chr 2:60,138,589...60,152,838

G

capping actin protein of muscle Z-line subunit alpha 1

increases expression

EXP

Propylthiouracil results in increased expression of CAPZA1 mRNA

NCBI chr 2:195,008,035...195,053,100
Ensembl chr 2:195,008,039...195,053,100

G

capping actin protein of muscle Z-line subunit alpha 2

increases expression

EXP

Propylthiouracil results in increased expression of CAPZA2 mRNA

NCBI chr 4:46,944,040...46,979,930
Ensembl chr 4:46,895,701...46,979,938

G

capping actin protein of muscle Z-line subunit beta

increases expression

EXP

Propylthiouracil results in increased expression of CAPZB mRNA

NCBI chr 5:156,718,619...156,818,623
Ensembl chr 5:156,650,432...156,818,619

G

carbonic anhydrase 2

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of CA2 mRNA
Propylthiouracil results in decreased expression of CAR2 mRNA

PMID:19483382 PMID:24780913

NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:88,462,872...88,478,064

G

carbonic anhydrase 7

decreases expression

EXP

Propylthiouracil results in decreased expression of CAR7 mRNA

NCBI chr19:435,520...444,927
Ensembl chr19:435,522...452,384

G

caspase recruitment domain family, member 19

decreases expression

EXP

Propylthiouracil results in decreased expression of CARD19 mRNA

NCBI chr17:15,638,973...15,651,720
Ensembl chr17:15,639,012...15,651,720

G

caspase recruitment domain family, member 9

increases expression

EXP

Propylthiouracil results in increased expression of CARD9 mRNA

NCBI chr 3:29,569,907...29,578,402
Ensembl chr 3:29,569,959...29,578,402

G

calcium responsive transcription factor

decreases expression

EXP

Propylthiouracil results in decreased expression of CARF mRNA

NCBI chr 9:68,996,419...69,046,480
Ensembl chr 9:68,996,250...69,046,479

G

calcium regulated heat stable protein 1

increases expression

EXP

Propylthiouracil results in increased expression of CARHSP1 mRNA

NCBI chr10:7,453,602...7,467,218
Ensembl chr10:7,452,978...7,467,770

G

capping protein regulator and myosin 1 linker 1

increases expression

EXP

Propylthiouracil results in increased expression of CARMIL1 mRNA

NCBI chr17:41,235,819...41,516,204
Ensembl chr17:41,236,229...41,516,221

G

cysteinyl-tRNA synthetase 1

increases expression

EXP

Propylthiouracil results in increased expression of CARS1 mRNA

NCBI chr 1:208,183,092...208,225,425
Ensembl chr 1:208,182,788...208,225,407

G

CART prepropeptide

decreases expression

EXP

Propylthiouracil results in decreased expression of CARTPT mRNA

NCBI chr 2:32,989,215...32,991,794
Ensembl chr 2:32,989,215...32,999,712

G

CASC3 exon junction complex subunit

decreases expression

EXP

Propylthiouracil results in decreased expression of CASC3 mRNA

NCBI chr10:84,264,157...84,286,639
Ensembl chr10:84,265,033...84,286,637

G

calcium/calmodulin dependent serine protein kinase

increases expression

EXP

Propylthiouracil results in increased expression of CASK mRNA

NCBI chr X:11,572,328...11,915,831
Ensembl chr X:11,572,636...11,911,948

G

caspase 12

decreases expression

EXP

Propylthiouracil results in decreased expression of CASP12 mRNA

NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:10,926,994...10,954,442

G

caspase 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CASP2 mRNA
Propylthiouracil results in decreased expression of CASP2 mRNA

PMID:24780913 PMID:30047161

NCBI chr 4:72,116,265...72,134,023
Ensembl chr 4:72,116,246...72,134,022

G

caspase 3

affects expression
multiple interactions
increases expression

EXP

Propylthiouracil affects the expression of CASP3 mRNA
thymoquinone inhibits the reaction [Propylthiouracil results in increased expression of CASP3 protein]
Propylthiouracil results in increased expression of CASP3 mRNA; Propylthiouracil results in increased expression of CASP3 protein

PMID:19483382 PMID:30047161 PMID:34234489 PMID:36843608

NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732

G

caspase 7

increases expression

EXP

Propylthiouracil results in increased expression of CASP7 mRNA

NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512

G

calsequestrin 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CASQ1 mRNA

NCBI chr13:87,203,021...87,212,710
Ensembl chr13:87,202,485...87,213,463

G

calsequestrin 2

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of CASQ2 mRNA
Propylthiouracil results in decreased expression of CASQ2 mRNA

PMID:24780913 PMID:25825206

NCBI chr 2:192,214,556...192,270,821
Ensembl chr 2:192,214,537...192,270,820

G

calcium-sensing receptor

decreases expression

EXP

Propylthiouracil results in decreased expression of CASR mRNA

PMID:24780913 PMID:25825206

NCBI chr11:77,738,398...77,813,639
Ensembl chr11:77,740,614...77,810,167

G

cytosolic arginine sensor for mTORC1 subunit 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CASTOR1 mRNA; Propylthiouracil results in decreased expression of GATSL3 mRNA

PMID:24780913 PMID:30047161

NCBI chr14:83,309,710...83,314,123
Ensembl chr14:83,309,504...83,314,127

G

cytosolic arginine sensor for mTORC1 subunit 2

increases expression

EXP

Propylthiouracil results in increased expression of CASTOR2 mRNA

NCBI chr12:28,213,927...28,256,593
Ensembl chr12:28,213,935...28,256,593

G

catalase

multiple interactions
affects expression
increases activity
decreases activity
decreases expression

EXP

Propylthiouracil results in decreased expression of and results in decreased activity of CAT protein; syringic acid inhibits the reaction [Propylthiouracil results in decreased activity of CAT protein]; thymoquinone inhibits the reaction [Propylthiouracil results in decreased expression of CAT mRNA]; Thyroxine inhibits the reaction [Propylthiouracil results in decreased activity of CAT protein]
Propylthiouracil affects the expression of CAT mRNA
Propylthiouracil results in increased activity of CAT protein

PMID:26459835 PMID:29896988 PMID:34047416 PMID:34234489 PMID:36038036

NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526

G

cation channel, sperm associated 2

increases expression

EXP

Propylthiouracil results in increased expression of CATSPER2 mRNA

NCBI chr 3:128,822,387...128,842,501
Ensembl chr 3:128,822,391...128,842,261

G

cation channel sperm associated auxiliary subunit gamma

increases expression

EXP

Propylthiouracil results in increased expression of CATSPERG1 mRNA

NCBI chr 1:93,616,209...93,646,970
Ensembl chr 1:93,616,209...93,661,618

G

caveolin 1

increases expression

EXP

Propylthiouracil results in increased expression of CAV1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:46,600,738...46,639,740

G

caveolin 2

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CAV2 mRNA
Propylthiouracil results in increased expression of CAV2 mRNA

PMID:24780913 PMID:25825206

NCBI chr 4:46,582,681...46,590,058
Ensembl chr 4:46,582,096...46,591,425

G

caveolin 3

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CAV3 mRNA
Propylthiouracil results in decreased expression of CAV3 mRNA

PMID:24780913 PMID:25825206

NCBI chr 4:147,137,993...147,153,967
Ensembl chr 4:147,137,797...147,153,967

G

caveolae associated protein 3

increases expression

EXP

Propylthiouracil results in increased expression of PRKCDBP mRNA

NCBI chr 1:169,238,384...169,239,973
Ensembl chr 1:169,238,384...169,239,981

G

CBFA2/RUNX1 partner transcriptional co-repressor 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CBFA2T2 mRNA

NCBI chr 3:163,397,160...163,503,409
Ensembl chr 3:163,397,185...163,503,407

G

core-binding factor subunit beta

increases expression

EXP

Propylthiouracil results in increased expression of CBFB mRNA

NCBI chr19:49,955,133...50,002,661
Ensembl chr19:49,959,096...50,002,657

G

Cbl proto-oncogene like 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CBLL1 mRNA

NCBI chr 6:53,798,712...53,812,890
Ensembl chr 6:53,798,712...53,813,880

G

cerebellin 1 precursor

increases expression

EXP

Propylthiouracil results in increased expression of CBLN1 mRNA

NCBI chr19:35,782,151...35,785,960
Ensembl chr19:35,781,952...35,785,960

G

cerebellin 2 precursor

affects expression

EXP

Propylthiouracil affects the expression of CBLN2 mRNA

NCBI chr18:82,215,210...82,222,648
Ensembl chr18:82,215,220...82,222,648

G

cerebellin 3 precursor

decreases expression

EXP

Propylthiouracil results in decreased expression of CBLN3 mRNA

NCBI chr15:33,331,919...33,334,428
Ensembl chr15:33,331,919...33,334,428

G

carbonyl reductase 1

increases expression
affects expression

EXP

Propylthiouracil results in increased expression of CBR1 mRNA
Propylthiouracil affects the expression of CBR1 mRNA

PMID:19483382 PMID:24780913 PMID:30047161

NCBI chr11:46,346,405...46,348,815
Ensembl chr11:46,378,411...46,381,104
Ensembl chr11:46,378,411...46,381,104

G

carbonyl reductase 2

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CBR2 mRNA

NCBI chr10:106,508,964...106,511,614
Ensembl chr10:106,509,136...106,511,180

G

carbonyl reductase 3

increases expression

EXP

Propylthiouracil results in increased expression of CBR3 mRNA

NCBI chr11:46,478,295...46,486,555
Ensembl chr11:46,478,274...46,486,558

G

cystathionine beta synthase

increases expression

EXP

Propylthiouracil results in increased expression of CBS mRNA

NCBI chr20:9,709,394...9,733,925
Ensembl chr20:9,709,395...9,734,066

G

chromobox 2

increases expression

EXP

Propylthiouracil results in increased expression of CBX2 mRNA

NCBI chr10:104,777,054...104,785,922
Ensembl chr10:104,777,056...104,785,926

G

chromobox 5

increases expression

EXP

Propylthiouracil results in increased expression of CBX5 mRNA

NCBI chr 7:136,203,827...136,254,575
Ensembl chr 7:136,211,649...136,229,118

G

chromobox 6

decreases expression

EXP

Propylthiouracil results in decreased expression of CBX6 mRNA

PMID:24780913 PMID:30047161

NCBI chr 7:113,253,364...113,263,413
Ensembl chr 7:113,253,364...113,263,413

G

chromobox 7

decreases expression

EXP

Propylthiouracil results in decreased expression of CBX7 mRNA

PMID:24780913 PMID:30047161

NCBI chr 7:113,341,030...113,358,716
Ensembl chr 7:113,341,030...113,358,346

G

chromobox 8

increases expression

EXP

Propylthiouracil results in increased expression of CBX8 mRNA

NCBI chr10:104,793,062...104,795,500
Ensembl chr10:104,793,062...104,795,500

G

chibby family member 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CBY2 mRNA

NCBI chr15:57,318,820...57,413,687
Ensembl chr15:57,317,988...57,334,505

G

chibby family member 3

decreases expression

EXP

Propylthiouracil results in decreased expression of CBY3 mRNA

NCBI chr10:35,179,316...35,183,834
Ensembl chr10:35,179,965...35,184,809

G

coiled-coil and C2 domain containing 1A

decreases expression

EXP

Propylthiouracil results in decreased expression of CC2D1A mRNA

NCBI chr19:40,916,587...40,931,702
Ensembl chr19:40,916,532...40,931,701

G

coiled-coil and C2 domain containing 2A

decreases expression

EXP

Propylthiouracil results in decreased expression of CC2D2A mRNA

NCBI chr14:71,563,835...71,648,352
Ensembl chr14:71,563,835...71,648,331

G

cell division cycle and apoptosis regulator 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CCAR1 mRNA
Propylthiouracil results in decreased expression of CCAR1 mRNA

PMID:22504374 PMID:30047161

NCBI chr20:31,228,624...31,271,233
Ensembl chr20:31,228,624...31,271,227

G

coiled-coil domain containing 102A

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC102A mRNA

NCBI chr19:10,108,553...10,124,652
Ensembl chr19:10,109,364...10,124,652

G

coiled-coil domain containing 112

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC112 mRNA

NCBI chr18:41,184,769...41,218,958
Ensembl chr18:41,184,769...41,218,958

G

coiled-coil domain containing 116

increases expression

EXP

Propylthiouracil results in increased expression of CCDC116 mRNA

NCBI chr11:97,346,927...97,354,827
Ensembl chr11:97,346,675...97,354,824

G

coiled-coil domain containing 120

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC120 mRNA

NCBI chr X:17,437,219...17,443,716
Ensembl chr X:17,425,624...17,444,717

G

coiled-coil domain containing 121

increases expression

EXP

Propylthiouracil results in increased expression of CCDC121 mRNA

NCBI chr 6:30,690,831...30,693,437
Ensembl chr 6:30,690,831...30,693,437

G

coiled-coil domain containing 124

increases expression

EXP

Propylthiouracil results in increased expression of CCDC124 mRNA

NCBI chr16:18,600,737...18,606,556
Ensembl chr16:18,600,737...18,606,556

G

coiled-coil domain containing 125

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC125 mRNA

NCBI chr 2:33,542,916...33,568,501
Ensembl chr 2:33,543,300...33,568,288

G

coiled-coil domain containing 127

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC127 mRNA

NCBI chr 1:30,757,010...30,764,473
Ensembl chr 1:30,757,010...30,764,473

G

coiled-coil domain containing 136

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC136 mRNA

NCBI chr 4:58,963,196...58,992,962
Ensembl chr 4:58,962,908...58,992,975

G

coiled-coil domain containing 138

increases expression

EXP

Propylthiouracil results in increased expression of CCDC138 mRNA

NCBI chr20:27,037,256...27,115,454
Ensembl chr20:27,038,349...27,115,452

G

coiled-coil domain containing 141

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC141 mRNA

NCBI chr 3:82,357,046...82,517,199
Ensembl chr 3:82,357,681...82,517,710

G

coiled-coil domain containing 142

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC142 mRNA

NCBI chr 4:117,164,055...117,172,286
Ensembl chr 4:117,166,135...117,173,935

G

coiled-coil domain containing 148

increases expression

EXP

Propylthiouracil results in increased expression of CCDC148 mRNA

NCBI chr 3:63,765,656...64,040,802
Ensembl chr 3:63,765,668...64,040,757

G

coiled-coil domain containing 150

increases expression

EXP

Propylthiouracil results in increased expression of CCDC150 mRNA

NCBI chr 9:63,287,962...63,403,644
Ensembl chr 9:63,288,000...63,391,670

G

coiled-coil domain containing 152

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC152 mRNA

NCBI chr 2:54,236,013...54,260,531
Ensembl chr 2:54,236,013...54,264,065

G

coiled-coil domain containing 162

increases expression

EXP

Propylthiouracil results in increased expression of CCDC162 mRNA

NCBI chr20:46,627,277...46,820,216
Ensembl chr20:46,627,277...46,818,249

G

coiled-coil domain containing 17

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC17 mRNA

NCBI chr 5:135,288,799...135,293,339
Ensembl chr 5:135,289,576...135,293,336

G

coiled-coil domain containing 171

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC171 mRNA

NCBI chr 5:102,965,763...103,449,740
Ensembl chr 5:102,965,911...103,533,290

G

coiled-coil domain containing 181

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC181 mRNA

NCBI chr13:79,157,708...79,171,365
Ensembl chr13:79,157,697...79,171,364

G

coiled-coil domain containing 190

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC190 mRNA

NCBI chr13:84,679,959...84,687,661
Ensembl chr13:84,679,986...84,687,658

G

coiled-coil domain containing 24

increases expression

EXP

Propylthiouracil results in increased expression of CCDC24 mRNA

NCBI chr 5:136,684,206...136,697,855
Ensembl chr 5:136,693,499...136,697,469

G

coiled-coil domain containing 25

increases expression

EXP

Propylthiouracil results in increased expression of CCDC25 mRNA

NCBI chr15:44,230,927...44,263,317
Ensembl chr15:44,230,940...44,265,236

G

coiled-coil domain containing 27

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC27 mRNA

NCBI chr 5:169,867,706...169,881,820
Ensembl chr 5:169,867,709...169,881,888

G

coiled-coil domain containing 28A

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC28A mRNA

NCBI chr 1:14,677,451...14,692,729
Ensembl chr 1:14,677,449...14,692,522

G

coiled-coil domain containing 30

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC30 mRNA

NCBI chr 5:138,212,067...138,305,465
Ensembl chr 5:138,211,227...138,304,992

G

coiled-coil domain containing 33

increases expression

EXP

Propylthiouracil results in increased expression of CCDC33 mRNA

PMID:24780913 PMID:25825206

NCBI chr 8:67,331,519...67,430,194
Ensembl chr 8:67,331,519...67,413,485

G

coiled-coil domain containing 34

increases expression

EXP

Propylthiouracil results in increased expression of CCDC34 mRNA

NCBI chr 3:117,007,652...117,042,885
Ensembl chr 3:117,005,760...117,042,226

G

coiled-coil domain 39 molecular ruler complex subunit

increases expression

EXP

Propylthiouracil results in increased expression of CCDC39 mRNA

NCBI chr 2:118,593,881...118,631,584
Ensembl chr 2:118,593,881...118,631,647

G

coiled-coil domain containing 42

affects expression

EXP

Propylthiouracil affects the expression of CCDC42 mRNA

NCBI chr10:53,788,833...53,799,011
Ensembl chr10:53,787,810...53,808,417

G

coiled-coil domain containing 47

increases expression

EXP

Propylthiouracil results in increased expression of CCDC47 mRNA

NCBI chr10:91,630,101...91,648,626
Ensembl chr10:91,630,106...91,648,626

G

coiled-coil domain containing 6

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CCDC6 mRNA
Propylthiouracil results in increased expression of CCDC6 mRNA

PMID:24780913 PMID:30047161

NCBI chr20:18,431,243...18,527,227
Ensembl chr20:18,431,243...18,527,227

G

coiled-coil domain containing 61

increases expression

EXP

Propylthiouracil results in increased expression of CCDC61 mRNA

NCBI chr 1:87,665,541...87,685,732
Ensembl chr 1:87,665,541...87,685,732

G

coiled-coil domain containing 62

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC62 mRNA

NCBI chr12:38,284,089...38,320,828
Ensembl chr12:38,284,089...38,320,965

G

coiled-coil domain containing 65

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC65 mRNA

NCBI chr 7:131,736,002...131,749,761
Ensembl chr 7:131,736,011...131,749,719

G

coiled-coil domain containing 69

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC69 mRNA

NCBI chr10:39,673,984...39,701,080
Ensembl chr10:39,673,985...39,700,579

G

coiled-coil domain containing 71-like

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC71L mRNA

NCBI chr 6:54,687,474...54,691,566
Ensembl chr 6:54,617,540...55,014,344

G

coiled-coil domain containing 78

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC78 mRNA

PMID:24780913 PMID:25825206

NCBI chr10:15,312,403...15,316,800
Ensembl chr10:15,311,868...15,319,425

G

coiled-coil domain containing 80

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC80 mRNA

NCBI chr11:69,191,188...69,224,844
Ensembl chr11:69,191,189...69,224,844

G

coiled coil domain containing 88A

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CCDC88A mRNA
Propylthiouracil results in increased expression of CCDC88A mRNA

PMID:30047161 PMID:36843608

NCBI chr14:107,304,654...107,456,104
Ensembl chr14:107,305,199...107,453,285

G

coiled-coil domain containing 88B

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC88B mRNA

NCBI chr 1:213,466,139...213,482,099
Ensembl chr 1:213,461,963...213,522,302

G

coiled-coil domain containing 89

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC89 mRNA

NCBI chr 1:153,798,786...153,800,048
Ensembl chr 1:153,797,440...153,803,002

G

coiled-coil domain containing 92

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC92 mRNA

NCBI chr12:37,457,676...37,484,080
Ensembl chr12:37,457,068...37,484,327

G

coiled-coil alpha-helical rod protein 1

increases expression

EXP

Propylthiouracil results in increased expression of CCHCR1 mRNA

NCBI chr20:3,210,383...3,223,187
Ensembl chr20:3,210,384...3,222,765

G

cholecystokinin

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CCK mRNA

NCBI chr 8:130,031,012...130,037,702
Ensembl chr 8:130,031,013...130,037,686

G

cholecystokinin B receptor

increases expression

EXP

Propylthiouracil results in increased expression of CCKBR mRNA

PMID:24780913 PMID:25825206

NCBI chr 1:169,183,578...169,193,583
Ensembl chr 1:169,183,194...169,193,745

G

C-C motif chemokine ligand 11

increases expression

EXP

Propylthiouracil results in increased expression of CCL11 mRNA

NCBI chr10:67,525,975...67,530,576
Ensembl chr10:67,525,862...67,530,575

G

C-C motif chemokine ligand 17

decreases expression

EXP

Propylthiouracil results in decreased expression of CCL17 mRNA

PMID:24780913 PMID:25825206

NCBI chr19:10,208,120...10,218,340
Ensembl chr19:10,208,120...10,209,895

G

C-C motif chemokine ligand 19

decreases expression

EXP

Propylthiouracil results in decreased expression of CCL19 mRNA

NCBI chr 5:61,759,220...61,761,164
Ensembl chr 5:61,759,220...61,772,022

G

C-C motif chemokine ligand 2

decreases expression
increases expression

ISO
EXP

Propylthiouracil results in decreased expression of CCL2 mRNA
Propylthiouracil results in increased expression of CCL2 mRNA

PMID:23397585 PMID:24780913

NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875

G

C-C motif chemokine ligand 21

increases expression

EXP

Propylthiouracil results in increased expression of CCL21 mRNA

NCBI chr 5:61,776,411...61,777,515
Ensembl chr 5:61,776,413...61,777,540

G

C-C motif chemokine ligand 22

decreases expression

EXP

Propylthiouracil results in decreased expression of CCL22 mRNA

NCBI chr19:10,263,589...10,270,359
Ensembl chr19:10,263,589...10,270,359

G

C-C motif chemokine ligand 24

decreases expression

EXP

Propylthiouracil results in decreased expression of CCL24 mRNA

NCBI chr12:26,737,423...26,741,420
Ensembl chr12:26,737,439...26,750,924

G

C-C motif chemokine ligand 25

decreases expression

EXP

Propylthiouracil results in decreased expression of CCL25 mRNA

NCBI chr12:7,505,231...7,514,402
Ensembl chr12:7,505,235...7,514,385

G

C-C motif chemokine ligand 26

increases expression

EXP

Propylthiouracil results in increased expression of CCL26 mRNA

NCBI chr12:26,745,972...26,750,924

G

C-C motif chemokine ligand 27

decreases expression

EXP

Propylthiouracil results in decreased expression of CCL27 mRNA

NCBI chr 5:61,737,261...61,744,375
Ensembl chr 5:61,737,261...61,743,522

G

C-C motif chemokine ligand 28

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of CCL28 mRNA

NCBI chr 2:53,334,071...53,358,709
Ensembl chr 2:53,334,071...53,358,709

G

C-C motif chemokine ligand 3

increases expression
multiple interactions

EXP
ISO

Propylthiouracil results in increased expression of CCL3 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of CCL3 mRNA

PMID:24780913 PMID:36706583

NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439

G

C-C motif chemokine ligand 9

decreases expression

EXP

Propylthiouracil results in decreased expression of CCL6 mRNA

PMID:24780913 PMID:30047161

NCBI chr10:68,863,994...68,868,928
Ensembl chr10:68,863,995...68,868,877

G

cellular communication network factor 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CCN1 mRNA; Propylthiouracil results in increased expression of CYR61 mRNA
Propylthiouracil results in decreased expression of CCN1 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883

G

cellular communication network factor 2

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of CCN2 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CCN2 mRNA

PMID:24780913 PMID:25825206 PMID:36706583

NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976

G

cellular communication network factor 3

increases expression

EXP

Propylthiouracil results in increased expression of CCN3 mRNA

PMID:24780913 PMID:25825206

NCBI chr 7:87,983,788...87,990,810
Ensembl chr 7:87,982,216...87,994,581

G

cellular communication network factor 4

increases expression

EXP

Propylthiouracil results in increased expression of CCN4 mRNA

NCBI chr 7:100,534,578...100,566,287
Ensembl chr 7:100,534,505...100,563,094

G

cellular communication network factor 5

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CCN5 mRNA
Propylthiouracil results in increased expression of WISP2 mRNA

PMID:24780913 PMID:30047161

NCBI chr 3:172,910,670...172,922,064
Ensembl chr 3:172,910,681...172,922,062

G

cellular communication network factor 6

decreases expression

EXP

Propylthiouracil results in decreased expression of CCN6 mRNA

NCBI chr20:44,123,932...44,139,745
Ensembl chr20:44,123,932...44,139,793

G

cyclin A2

increases expression

EXP

Propylthiouracil results in increased expression of CCNA2 mRNA

NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701

G

cyclin B1

increases expression

EXP

Propylthiouracil results in increased expression of CCNB1 mRNA

NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225

G

cyclin B2

increases expression

EXP

Propylthiouracil results in increased expression of CCNB2 mRNA

NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:79,968,465...79,981,682

G

cyclin D1

increases expression
multiple interactions

EXP

Propylthiouracil results in increased expression of CCND1 mRNA; Propylthiouracil results in increased expression of CCND1 protein
haizao yuhu inhibits the reaction [Propylthiouracil results in increased expression of CCND1 mRNA]; haizao yuhu inhibits the reaction [Propylthiouracil results in increased expression of CCND1 protein]

PMID:30047161 PMID:37295576

NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810

G

cyclin D2

increases expression

EXP

Propylthiouracil results in increased expression of CCND2 mRNA

NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:161,653,048...161,680,301
Ensembl chr 4:161,653,048...161,680,301

G

cyclin D3

increases expression

EXP

Propylthiouracil results in increased expression of CCND3 mRNA

NCBI chr 9:20,891,696...20,987,199
Ensembl chr 9:20,891,704...20,987,033

G

cyclin E1

increases expression

EXP

Propylthiouracil results in increased expression of CCNE1 mRNA

NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822

G

cyclin F

increases expression

EXP

Propylthiouracil results in increased expression of CCNF mRNA

NCBI chr10:13,757,884...13,783,669
Ensembl chr10:13,758,421...13,783,837

G

cyclin G1

decreases expression

EXP

Propylthiouracil results in decreased expression of CCNG1 mRNA

NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,677,885...25,683,766

G

cyclin G2

decreases expression

EXP

Propylthiouracil results in decreased expression of CCNG2 mRNA

NCBI chr14:15,088,694...15,097,190
Ensembl chr14:15,088,695...15,096,206

G

cyclin I

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CCNI mRNA
Propylthiouracil results in increased expression of CCNI mRNA

PMID:30047161 PMID:36843608

NCBI chr14:15,164,047...15,186,885
Ensembl chr14:15,164,095...15,186,885

G

cyclin J

decreases expression

EXP

Propylthiouracil results in decreased expression of CCNJ mRNA

NCBI chr 1:249,608,991...249,626,798
Ensembl chr 1:249,608,969...249,626,794

G

cyclin L1

decreases expression

EXP

Propylthiouracil results in decreased expression of CCNL1 mRNA

NCBI chr 2:152,495,169...152,508,855
Ensembl chr 2:152,495,172...152,507,468

G

cyclin L2

decreases expression

EXP

Propylthiouracil results in decreased expression of CCNL2 mRNA

NCBI chr 5:171,698,951...171,711,037
Ensembl chr 5:171,699,689...171,711,231

G

cyclin O

increases expression

EXP

Propylthiouracil results in increased expression of CCNO mRNA

PMID:22504374 PMID:25825206

NCBI chr 2:46,364,074...46,367,113
Ensembl chr 2:46,350,717...46,367,113

G

cyclin T2

decreases expression

EXP

Propylthiouracil results in decreased expression of CCNT2 mRNA

NCBI chr13:41,804,007...41,845,641
Ensembl chr13:41,804,046...41,844,488

G

cyclin Y

increases expression

EXP

Propylthiouracil results in increased expression of CCNY mRNA

NCBI chr17:62,079,925...62,207,780
Ensembl chr17:62,079,925...62,207,979

G

cyclin Y-like 1

increases expression

EXP

Propylthiouracil results in increased expression of CCNYL1 mRNA

NCBI chr 9:73,565,484...73,601,926
Ensembl chr 9:73,565,402...73,601,922

G

centriolar coiled-coil protein 110

decreases expression

EXP

Propylthiouracil results in decreased expression of CCP110 mRNA

NCBI chr 1:182,475,571...182,504,235
Ensembl chr 1:182,476,422...182,504,232

G

C-C motif chemokine receptor 6

decreases expression

EXP

Propylthiouracil results in decreased expression of CCR6 mRNA

NCBI chr 1:55,022,037...55,055,857
Ensembl chr 1:55,021,833...55,046,059

G

C-C motif chemokine receptor 9

decreases expression

EXP

Propylthiouracil results in decreased expression of CCR9 mRNA

NCBI chr 8:132,273,581...132,287,651
Ensembl chr 8:132,273,544...132,287,883

G

C-C motif chemokine receptor like 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CCRL2 mRNA

NCBI chr 8:119,912,671...119,915,313
Ensembl chr 8:119,911,288...119,922,380

G

copper chaperone for superoxide dismutase

decreases expression

EXP

Propylthiouracil results in decreased expression of CCS mRNA

NCBI chr 1:211,543,192...211,564,354
Ensembl chr 1:211,542,701...211,564,260

G

centriole, cilia and spindle-associated protein

decreases expression

EXP

Propylthiouracil results in decreased expression of CCSAP mRNA

NCBI chr19:68,722,417...68,740,908

G

coiled-coil serine-rich protein 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CCSER1 mRNA

NCBI chr 4:91,483,896...92,720,439
Ensembl chr 4:91,483,770...92,718,789

G

chaperonin containing TCP1 subunit 3

increases expression

EXP

Propylthiouracil results in increased expression of CCT3 mRNA

NCBI chr 2:176,063,529...176,088,180
Ensembl chr 2:176,063,526...176,089,925

G

chaperonin containing TCP1 subunit 8

increases expression

EXP

Propylthiouracil results in increased expression of CCT8 mRNA

NCBI chr11:40,196,619...40,208,328
Ensembl chr11:40,196,619...40,208,328

G

chaperonin containing TCP1 subunit 8 like 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CCT8L1 mRNA

NCBI chr 4:10,338,882...10,340,818
Ensembl chr 4:10,336,884...10,344,906

G

CD151 molecule (Raph blood group)

increases expression

EXP

Propylthiouracil results in increased expression of CD151 mRNA

NCBI chr 1:205,994,300...205,998,307
Ensembl chr 1:205,994,738...205,998,784

G

CD1d1 molecule

increases expression

EXP

Propylthiouracil results in increased expression of CD1D1 mRNA

NCBI chr 2:174,721,522...174,725,029
Ensembl chr 2:174,721,522...174,725,029

G

Cd200 molecule

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CD200 mRNA
Propylthiouracil results in decreased expression of CD200 mRNA

PMID:24780913 PMID:30047161

NCBI chr11:68,916,200...68,943,570
Ensembl chr11:68,916,224...68,943,569

G

CD200 receptor 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CD200R1 mRNA

NCBI chr11:69,392,943...69,427,213
Ensembl chr11:69,392,975...69,427,128

G

CD24 molecule

increases expression

EXP

Propylthiouracil results in increased expression of CD24 mRNA

NCBI chr20:48,655,549...48,661,786
Ensembl chr20:48,655,805...48,661,785

G

Cd247 molecule

increases expression

EXP

Propylthiouracil results in increased expression of CD247 mRNA

NCBI chr13:80,576,264...80,651,422
Ensembl chr13:80,576,202...80,655,248

G

Cd276 molecule

increases expression

EXP

Propylthiouracil results in increased expression of CD276 mRNA

PMID:24780913 PMID:30047161

NCBI chr 8:67,833,587...67,863,918
Ensembl chr 8:67,829,048...67,864,505

G

CD2-associated protein

decreases expression

EXP

Propylthiouracil results in decreased expression of CD2AP mRNA

NCBI chr 9:25,580,071...25,679,968
Ensembl chr 9:25,583,975...25,679,968

G

Cd300 molecule-like family member E

increases expression

EXP

Propylthiouracil results in increased expression of CD300LE mRNA

NCBI chr10:100,770,070...100,779,293
Ensembl chr10:100,770,030...100,779,293

G

CD302 molecule

decreases expression

EXP

Propylthiouracil results in decreased expression of CD302 mRNA

NCBI chr 3:65,131,017...65,164,737
Ensembl chr 3:65,113,102...65,164,737

G

CD34 molecule

decreases expression

EXP

Propylthiouracil results in decreased expression of CD34 mRNA

NCBI chr13:109,008,786...109,029,317
Ensembl chr13:109,008,623...109,029,315

G

CD36 molecule

decreases expression

EXP

Propylthiouracil results in decreased expression of CD36 mRNA

NCBI chr 4:18,209,088...18,302,142

G

CD36 molecule like 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CD36L1 mRNA

NCBI chr 4:18,316,806...18,357,863
Ensembl chr 4:18,261,059...18,405,365

G

CD38 molecule

affects expression

EXP

Propylthiouracil affects the expression of CD38 mRNA

NCBI chr14:71,384,532...71,424,794
Ensembl chr14:71,384,532...71,424,505

G

CD3 epsilon subunit of T-cell receptor complex

decreases expression

EXP

Propylthiouracil results in decreased expression of CD3E mRNA

NCBI chr 8:54,200,617...54,211,770
Ensembl chr 8:54,200,617...54,211,876

G

CD3 gamma subunit of T-cell receptor complex

increases expression

EXP

Propylthiouracil results in increased expression of CD3G mRNA

NCBI chr 8:54,177,572...54,184,087
Ensembl chr 8:54,177,977...54,183,918

G

CD40 molecule

increases expression

EXP

Propylthiouracil results in increased expression of CD40 mRNA

NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847

G

CD44 molecule

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CD44 mRNA
Propylthiouracil results in decreased expression of CD44 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424

G

CD46 molecule

increases expression

EXP

Propylthiouracil results in increased expression of CD46 mRNA

NCBI chr13:109,104,122...109,134,903

G

Cd47 molecule

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CD47 mRNA
Propylthiouracil results in decreased expression of CD47 mRNA

PMID:24780913 PMID:30047161

NCBI chr11:64,374,816...64,438,763
Ensembl chr11:64,377,926...64,438,272

G

Cd48 molecule

increases expression

EXP

Propylthiouracil results in increased expression of CD48 mRNA

NCBI chr13:86,717,960...86,741,540
Ensembl chr13:86,717,961...86,742,942

G

CD52 molecule

decreases expression

EXP

Propylthiouracil results in decreased expression of CD52 mRNA

PMID:24780913 PMID:25825206

NCBI chr 5:151,603,537...151,605,096
Ensembl chr 5:151,603,524...151,605,086

G

Cd53 molecule

increases expression

EXP

Propylthiouracil results in increased expression of CD53 mRNA

NCBI chr 2:197,040,369...197,087,925
Ensembl chr 2:197,040,369...197,218,593

G

CD55 molecule (Cromer blood group)

increases expression

EXP

Propylthiouracil results in increased expression of CD55 mRNA

NCBI chr13:44,409,574...44,438,913
Ensembl chr13:44,409,587...44,438,107

G

CD59b molecule

decreases expression

EXP

Propylthiouracil results in decreased expression of CD59 mRNA

NCBI chr 3:110,914,008...110,932,489
Ensembl chr 3:110,914,091...110,935,310

G

Cd5 molecule-like

increases expression

EXP

Propylthiouracil results in increased expression of CD5L mRNA

NCBI chr 2:175,088,915...175,099,928
Ensembl chr 2:175,088,884...175,099,926

G

Cd68 molecule

increases expression

EXP

Propylthiouracil results in increased expression of CD68 mRNA

PMID:24780913 PMID:30047161

NCBI chr10:54,880,562...54,882,441
Ensembl chr10:54,880,563...54,882,540

G

Cd70 molecule

decreases expression

EXP

Propylthiouracil results in decreased expression of CD70 mRNA

NCBI chr 9:2,093,540...2,096,692
Ensembl chr 9:2,086,848...2,096,692

G

CD79a molecule

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CD79A mRNA

NCBI chr 1:89,621,460...89,625,813
Ensembl chr 1:89,621,460...89,625,812

G

Cd81 molecule

increases expression

EXP

Propylthiouracil results in increased expression of CD81 mRNA

NCBI chr 1:207,665,274...207,681,094
Ensembl chr 1:207,664,885...207,681,092

G

Cd82 molecule

increases expression

EXP

Propylthiouracil results in increased expression of CD82 mRNA

NCBI chr 3:99,842,748...99,887,298
Ensembl chr 3:99,842,757...99,886,744

G

CD83 molecule

affects expression

EXP

Propylthiouracil affects the expression of CD83 mRNA

NCBI chr17:21,093,281...21,113,223
Ensembl chr17:21,093,281...21,113,047

G

CD8 subunit alpha

increases expression

EXP

Propylthiouracil results in increased expression of CD8A mRNA

NCBI chr 4:104,924,116...104,928,353
Ensembl chr 4:104,900,833...104,928,358

G

CD8 subunit beta

increases expression

EXP

Propylthiouracil results in increased expression of CD8B mRNA

NCBI chr 4:104,870,911...104,886,838
Ensembl chr 4:104,870,893...104,886,868

G

CD9 molecule

decreases expression

EXP

Propylthiouracil results in decreased expression of CD9 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 4:159,942,553...159,975,463
Ensembl chr 4:159,942,560...159,975,444

G

CD93 molecule

increases expression

EXP

Propylthiouracil results in increased expression of CD93 mRNA

NCBI chr 3:156,345,019...156,351,537
Ensembl chr 3:156,345,019...156,351,537

G

CD96 molecule

increases expression

EXP

Propylthiouracil results in increased expression of CD96 mRNA

NCBI chr11:68,164,926...68,239,266
Ensembl chr11:68,164,872...68,241,937

G

CD99 molecule-like 2

increases expression

EXP

Propylthiouracil results in increased expression of CD99L2 mRNA

NCBI chr15:6,861,242...6,906,838
Ensembl chr15:6,864,268...6,906,952

G

CD99 molecule like 4

increases expression

EXP

Propylthiouracil results in increased expression of CD99L4 mRNA

NCBI chr 5:29,520,061...29,585,317

G

cytidine deaminase

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CDA mRNA
Propylthiouracil results in increased expression of CDA mRNA

PMID:22504374 PMID:24780913

NCBI chr 5:155,839,929...155,866,541
Ensembl chr 5:155,839,929...155,866,541

G

cell division cycle 14B

decreases expression

EXP

Propylthiouracil results in decreased expression of CDC14B mRNA

NCBI chr17:850,272...938,972
Ensembl chr17:850,390...971,164

G

cell division cycle 20

increases expression

EXP

Propylthiouracil results in increased expression of CDC20 mRNA

PMID:24780913 PMID:30047161

NCBI chr 5:137,251,596...137,255,799
Ensembl chr 5:137,251,596...137,255,799

G

cell division cycle 25A

increases expression

EXP

Propylthiouracil results in increased expression of CDC25A mRNA

PMID:18077114 PMID:30047161

NCBI chr 8:118,742,824...118,761,190
Ensembl chr 8:118,742,426...118,761,188

G

cell division cycle 37-like 1

increases expression

EXP

Propylthiouracil results in increased expression of CDC37L1 mRNA

NCBI chr 1:236,118,630...236,147,527
Ensembl chr 1:236,118,555...236,207,079

G

cell division cycle 42

increases expression

EXP

Propylthiouracil results in increased expression of CDC42 mRNA

NCBI chr 5:154,838,478...154,876,629
Ensembl chr 5:154,839,631...154,876,627

G

CDC42 binding protein kinase beta

increases expression

EXP

Propylthiouracil results in increased expression of CDC42BPB mRNA

NCBI chr 6:136,154,905...136,241,259
Ensembl chr 6:136,154,905...136,237,570

G

CDC42 effector protein 1

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CDC42EP1 mRNA
Propylthiouracil results in increased expression of CDC42EP1 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 7:112,275,759...112,283,665
Ensembl chr 7:112,275,792...112,283,664

G

CDC42 effector protein 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CDC42EP2 mRNA

PMID:24780913 PMID:25825206

NCBI chr 1:212,631,317...212,640,231
Ensembl chr 1:212,629,881...212,640,234

G

CDC42 effector protein 3

increases expression

EXP

Propylthiouracil results in increased expression of CDC42EP3 mRNA

NCBI chr 6:21,463,081...21,483,553
Ensembl chr 6:21,461,762...21,508,540

G

CDC42 effector protein 4

decreases expression

EXP

Propylthiouracil results in decreased expression of CDC42EP4 mRNA

NCBI chr10:99,271,750...99,298,551
Ensembl chr10:99,267,540...99,300,168

G

CDC42 effector protein 5

increases expression

EXP

Propylthiouracil results in increased expression of CDC42EP5 mRNA

NCBI chr 1:79,108,036...79,110,550

G

cell division cycle 45

increases expression

EXP

Propylthiouracil results in increased expression of CDC45 mRNA

NCBI chr11:95,689,702...95,714,980
Ensembl chr11:95,689,919...95,714,981

G

cell division cycle 6

increases expression

EXP

Propylthiouracil results in increased expression of CDC6 mRNA

NCBI chr10:84,360,361...84,374,239
Ensembl chr10:84,360,381...84,374,241

G

cell division cycle 7

increases expression

EXP

Propylthiouracil results in increased expression of CDC7 mRNA

NCBI chr14:2,949,538...2,969,656
Ensembl chr14:2,949,539...2,969,656

G

cell division cycle associated 2

increases expression

EXP

Propylthiouracil results in increased expression of CDCA2 mRNA

PMID:24780913 PMID:30047161

NCBI chr15:46,071,360...46,117,524
Ensembl chr15:46,071,360...46,116,639

G

cell division cycle associated 3

increases expression

EXP

Propylthiouracil results in increased expression of CDCA3 mRNA

PMID:24780913 PMID:30047161

NCBI chr 4:159,321,203...159,325,072
Ensembl chr 4:159,321,014...159,325,068

G

cell division cycle associated 7

increases expression

EXP

Propylthiouracil results in increased expression of CDCA7 mRNA

NCBI chr 3:77,730,315...77,740,950
Ensembl chr 3:77,729,970...77,740,947

G

cell division cycle associated 7 like

increases expression

EXP

Propylthiouracil results in increased expression of CDCA7L mRNA

NCBI chr 6:144,936,885...144,982,844
Ensembl chr 6:144,908,171...144,982,843

G

cadherin 1

multiple interactions

ISO

Propylthiouracil inhibits the reaction [Monocrotaline results in decreased expression of CDH1 protein]

NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565

G

cadherin 10

increases expression

EXP

Propylthiouracil results in increased expression of CDH10 mRNA

NCBI chr 2:70,355,521...70,577,880
Ensembl chr 2:70,357,217...70,578,332

G

cadherin 13

increases expression

EXP

Propylthiouracil results in increased expression of CDH13 mRNA

NCBI chr19:63,258,251...64,296,122
Ensembl chr19:63,258,122...64,296,119

G

cadherin 15

decreases expression

EXP

Propylthiouracil results in decreased expression of CDH15 mRNA

NCBI chr19:67,812,169...67,834,986
Ensembl chr19:67,812,164...67,834,985

G

cadherin 19

decreases expression

EXP

Propylthiouracil results in decreased expression of CDH19 mRNA

PMID:24780913 PMID:25825206

NCBI chr13:28,450,361...28,561,932
Ensembl chr13:28,451,283...28,533,753

G

cadherin 2

increases expression
multiple interactions

EXP
ISO

Propylthiouracil results in increased expression of CDH2 mRNA
Propylthiouracil inhibits the reaction [Monocrotaline results in increased expression of CDH2 protein]

PMID:24780913 PMID:36942326

NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288

G

cadherin 22

decreases expression

EXP

Propylthiouracil results in decreased expression of CDH22 mRNA

PMID:24780913 PMID:25825206

NCBI chr 3:174,264,869...174,389,940
Ensembl chr 3:174,264,869...174,390,142

G

cadherin-related 23

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of CDH23 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of CDH23 mRNA

PMID:30047161 PMID:36706583

NCBI chr20:28,783,124...29,165,624
Ensembl chr20:28,783,564...29,165,332

G

cadherin 24

decreases expression

EXP

Propylthiouracil results in decreased expression of CDH24 mRNA

NCBI chr15:32,061,588...32,071,323
Ensembl chr15:32,061,588...32,071,283

G

cadherin 3

increases expression
multiple interactions

EXP
ISO

Propylthiouracil results in increased expression of CDH3 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CDH3 mRNA

PMID:24780913 PMID:36706583

NCBI chr19:51,303,414...51,353,900
Ensembl chr19:51,300,083...51,354,257

G

cadherin 4

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CDH4 mRNA
Propylthiouracil results in decreased expression of CDH4 mRNA

PMID:24780913 PMID:30047161

NCBI chr 3:186,902,763...187,381,020
Ensembl chr 3:186,902,751...187,381,020

G

cadherin 7

decreases expression

EXP

Propylthiouracil results in decreased expression of CDH7 mRNA

NCBI chr13:27,186,223...27,336,076
Ensembl chr13:27,187,257...27,336,023

G

cadherin 8

affects expression

EXP

Propylthiouracil affects the expression of CDH8 mRNA

NCBI chr19:5,494,552...5,901,950
Ensembl chr19:5,500,221...5,902,627

G

cadherin 9

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of CDH9 mRNA
Propylthiouracil results in decreased expression of CDH9 mRNA

PMID:24780913 PMID:25825206

NCBI chr 2:67,954,708...68,094,371
Ensembl chr 2:67,955,166...68,094,365

G

cadherin-related family member 1

increases expression

EXP

Propylthiouracil results in increased expression of CDHR1 mRNA

PMID:24780913 PMID:25825206

NCBI chr16:12,863,696...12,883,579
Ensembl chr16:12,863,696...12,883,579

G

cadherin-related family member 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CDHR2 mRNA

NCBI chr17:9,881,979...9,917,698
Ensembl chr17:9,881,979...9,917,698

G

cadherin-related family member 5

increases expression

EXP

Propylthiouracil results in increased expression of CDHR5 mRNA

NCBI chr 1:205,802,686...205,811,184
Ensembl chr 1:205,802,686...205,811,093

G

cell death-inducing p53 target 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CDIP1 mRNA

NCBI chr10:11,278,213...11,303,415
Ensembl chr10:11,293,827...11,303,415

G

cyclin-dependent kinase 1

increases expression

EXP

Propylthiouracil results in increased expression of CDK1 mRNA

NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455

G

cyclin-dependent kinase 11B

decreases expression

EXP

Propylthiouracil results in decreased expression of CDK11B mRNA

NCBI chr 5:171,495,042...171,521,143
Ensembl chr 5:171,495,776...171,521,145

G

cyclin-dependent kinase 14

decreases expression

EXP

Propylthiouracil results in decreased expression of CDK14 mRNA

NCBI chr 4:29,619,237...30,213,651
Ensembl chr 4:29,621,217...30,213,651

G

cyclin-dependent kinase 18

decreases expression

EXP

Propylthiouracil results in decreased expression of CDK18 mRNA

NCBI chr13:46,107,763...46,140,705
Ensembl chr13:46,108,911...46,140,865

G

cyclin dependent kinase 2

increases expression

EXP

Propylthiouracil results in increased expression of CDK2 mRNA

NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878

G

cyclin-dependent kinase 2 associated protein 1

increases expression

EXP

Propylthiouracil results in increased expression of CDK2AP1 mRNA

NCBI chr12:37,910,718...37,919,446
Ensembl chr12:37,910,718...37,919,446

G

cyclin-dependent kinase 2 associated protein 2

increases expression

EXP

Propylthiouracil results in increased expression of CDK2AP2 mRNA

NCBI chr 1:210,819,155...210,822,604
Ensembl chr 1:210,820,507...210,823,010

G

cyclin-dependent kinase 4

increases expression

EXP

Propylthiouracil results in increased expression of CDK4 mRNA

NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163

G

cyclin-dependent kinase 5 regulatory subunit 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CDK5R1 protein

NCBI chr10:65,981,692...65,985,831
Ensembl chr10:65,978,911...65,989,272

G

cyclin-dependent kinase 6

decreases expression

EXP

Propylthiouracil results in decreased expression of CDK6 mRNA

PMID:24780913 PMID:25825206

NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:31,601,192...31,781,701

G

cyclin dependent kinase like 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CDKL1 mRNA
Propylthiouracil results in decreased expression of CDKL1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 6:93,960,157...94,005,207
Ensembl chr 6:93,959,911...94,006,115

G

cyclin-dependent kinase-like 5

increases expression

EXP

Propylthiouracil results in increased expression of CDKL5 mRNA

NCBI chr X:37,566,320...37,796,766
Ensembl chr X:37,566,378...37,796,760

G

cyclin-dependent kinase inhibitor 1A

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CDKN1A mRNA
Propylthiouracil results in increased expression of CDKN1A mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969

G

cyclin-dependent kinase inhibitor 1B

decreases expression

ISO

Propylthiouracil results in decreased expression of CDKN1B protein

NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498

G

cyclin-dependent kinase inhibitor 1C

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of CDKN1C mRNA
Propylthiouracil results in decreased expression of CDKN1C mRNA

PMID:24780913 PMID:25825206

NCBI chr 1:208,084,801...208,087,680
Ensembl chr 1:208,084,787...208,087,498

G

cyclin-dependent kinase inhibitor 2A

increases expression

EXP

Propylthiouracil results in increased expression of CDKN2A mRNA

PMID:22504374 PMID:24780913 PMID:30047161

NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248

G

CDKN2A interacting protein

decreases expression

EXP

Propylthiouracil results in decreased expression of CDKN2AIP mRNA

NCBI chr16:51,266,613...51,274,051
Ensembl chr16:51,268,896...51,274,049

G

cyclin-dependent kinase inhibitor 2B

increases expression

EXP

Propylthiouracil results in increased expression of CDKN2B mRNA

PMID:30047161 PMID:39441382

NCBI chr 5:109,123,308...109,134,906
Ensembl chr 5:109,114,322...109,134,855

G

cyclin-dependent kinase inhibitor 3

decreases expression

EXP

Propylthiouracil results in decreased expression of CDKN3 mRNA

NCBI chr15:22,502,299...22,513,725
Ensembl chr15:22,502,382...22,513,722

G

cysteine dioxygenase type 1

affects expression
decreases expression
increases expression

EXP

Propylthiouracil affects the expression of CDO1 mRNA
Propylthiouracil results in decreased expression of CDO1 mRNA
Propylthiouracil results in increased expression of CDO1 mRNA

PMID:19483382 PMID:24780913 PMID:39441382

NCBI chr18:41,619,076...41,633,719
Ensembl chr18:41,619,070...41,633,891

G

cell adhesion associated, oncogene regulated

decreases expression
increases methylation

EXP

Propylthiouracil results in decreased expression of CDON mRNA
Propylthiouracil results in increased methylation of CDON promoter

NCBI chr 8:42,032,921...42,119,451
Ensembl chr 8:42,033,042...42,119,345

G

cerebellar degeneration-related protein 2

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CDR2 mRNA
Propylthiouracil results in increased expression of CDR2 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 1:184,934,128...184,959,036
Ensembl chr 1:184,934,129...184,968,863

G

CDP-diacylglycerol synthase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CDS1 mRNA

NCBI chr14:8,126,678...8,187,243
Ensembl chr14:8,124,838...8,187,218

G

chromatin licensing and DNA replication factor 1

increases expression

EXP

Propylthiouracil results in increased expression of CDT1 mRNA

NCBI chr19:67,529,249...67,534,195
Ensembl chr19:67,529,201...67,534,194

G

caudal type homeo box 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CDX1 mRNA

NCBI chr18:56,742,970...56,761,299
Ensembl chr18:56,742,984...56,761,299

G

chromodomain Y-like 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CDYL2 mRNA

NCBI chr19:61,500,702...61,691,746
Ensembl chr19:61,500,702...61,691,746

G

CEA cell adhesion molecule 16, tectorial membrane component

decreases expression

EXP

Propylthiouracil results in decreased expression of CEACAM16 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:88,642,925...88,652,821
Ensembl chr 1:88,642,925...88,652,821

G

CEA cell adhesion molecule 19

decreases expression

EXP

Propylthiouracil results in decreased expression of CEACAM19 mRNA

NCBI chr 1:88,670,054...88,678,900
Ensembl chr 1:88,670,054...88,678,874

G

CEA cell adhesion molecule 4

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of CEACAM10 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of CEACAM10 mRNA

PMID:24780913 PMID:36706583

NCBI chr 1:89,504,555...89,510,831
Ensembl chr 1:89,504,555...89,510,831

G

CEA cell adhesion molecule 6

decreases expression

EXP

Propylthiouracil results in decreased expression of CEACAM6 mRNA

NCBI chr 1:89,544,415...89,562,552
Ensembl chr 1:89,544,400...89,562,552

G

CEA cell adhesion molecule 9

decreases expression

EXP

Propylthiouracil results in decreased expression of CEACAM9 mRNA

NCBI chr 1:86,533,724...86,538,259
Ensembl chr 1:86,533,724...86,538,260

G

CCAAT/enhancer binding protein alpha

increases expression

EXP

Propylthiouracil results in increased expression of CEBPA mRNA

NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309

G

CCAAT/enhancer binding protein beta

decreases expression
increases methylation

EXP

Propylthiouracil results in decreased expression of CEBPB mRNA; Propylthiouracil results in decreased expression of CEBPB protein
Propylthiouracil results in increased methylation of CEBPB promoter

PMID:26459835 PMID:33150595

NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072

G

chymotrypsin like elastase 2A

decreases expression

EXP

Propylthiouracil results in decreased expression of CELA2A mRNA

NCBI chr 5:159,409,900...159,420,282
Ensembl chr 5:159,409,899...159,426,208

G

chymotrypsin like elastase 3B

decreases expression

EXP

Propylthiouracil results in decreased expression of CELA3B mRNA

NCBI chr 5:154,912,170...154,920,333
Ensembl chr 5:154,912,170...154,920,333

G

CUGBP, Elav-like family member 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CELF2 mRNA

NCBI chr17:75,813,928...76,639,300
Ensembl chr17:75,813,704...76,636,362

G

CUGBP, Elav-like family member 3

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CELF3 mRNA
Propylthiouracil results in decreased expression of CELF3 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 2:184,805,078...184,819,189
Ensembl chr 2:184,805,081...184,819,187

G

CUGBP, Elav-like family member 4

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CELF4 mRNA
Propylthiouracil results in decreased expression of CELF4 mRNA

PMID:24780913 PMID:30047161 PMID:36843608

NCBI chr18:17,061,284...17,339,747
Ensembl chr18:17,061,293...17,339,571

G

CUGBP, Elav-like family member 5

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CELF5 mRNA
Propylthiouracil results in increased expression of CELF5 mRNA

PMID:30047161 PMID:36843608

NCBI chr 7:8,876,551...8,901,078
Ensembl chr 7:8,876,564...8,901,069

G

CUGBP, Elav-like family member 6

increases expression

EXP

Propylthiouracil results in increased expression of CELF6 mRNA

NCBI chr 8:68,870,902...68,901,863
Ensembl chr 8:68,871,093...68,901,863

G

cadherin, EGF LAG seven-pass G-type receptor 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CELSR1 mRNA
Propylthiouracil results in decreased expression of CELSR1 mRNA

PMID:30047161 PMID:36843608

NCBI chr 7:118,867,450...119,004,859
Ensembl chr 7:118,867,450...119,004,856

G

cell migration inducing hyaluronidase 1

increases expression

EXP

Propylthiouracil results in increased expression of CEMIP mRNA

NCBI chr 1:147,316,052...147,471,552
Ensembl chr 1:147,316,052...147,471,768

G

cell migration inducing hyaluronidase 2

increases expression

EXP

Propylthiouracil results in increased expression of CEMIP2 mRNA

NCBI chr 1:228,756,826...228,834,313
Ensembl chr 1:228,757,466...228,832,906

G

centromere protein A

increases expression

EXP

Propylthiouracil results in increased expression of CENPA mRNA

PMID:24780913 PMID:30047161

NCBI chr 6:31,420,062...31,431,703

G

centromere protein F

increases expression

EXP

Propylthiouracil results in increased expression of CENPF mRNA

NCBI chr13:103,715,344...103,760,931
Ensembl chr13:103,715,344...103,760,886

G

centromere protein I

increases expression

EXP

Propylthiouracil results in increased expression of CENPI mRNA

NCBI chr X:101,809,192...101,860,935
Ensembl chr X:101,809,659...101,860,934

G

centromere protein L

increases expression

EXP

Propylthiouracil results in increased expression of CENPL mRNA

NCBI chr13:75,870,479...75,885,466
Ensembl chr13:75,870,489...75,905,250

G

centromere protein M

increases expression

EXP

Propylthiouracil results in increased expression of CENPM mRNA

PMID:24780913 PMID:30047161

NCBI chr 7:115,628,117...115,639,401
Ensembl chr 7:115,628,129...115,643,866

G

centromere protein N

increases expression

EXP

Propylthiouracil results in increased expression of CENPN mRNA

NCBI chr19:61,880,101...61,902,850
Ensembl chr19:61,877,148...61,902,918

G

centromere protein O

increases expression

EXP

Propylthiouracil results in increased expression of CENPO mRNA

NCBI chr 6:32,923,127...32,937,879
Ensembl chr 6:32,908,025...32,937,853

G

centromere protein Q

increases expression

EXP

Propylthiouracil results in increased expression of CENPQ mRNA

PMID:24780913 PMID:30047161

NCBI chr 9:27,454,339...27,469,371
Ensembl chr 9:27,454,252...27,469,366

G

centromere protein T

increases expression

EXP

Propylthiouracil results in increased expression of CENPT mRNA

PMID:22504374 PMID:24780913

NCBI chr19:50,644,548...50,651,048
Ensembl chr19:50,634,368...50,651,037

G

centromere protein U

increases expression

EXP

Propylthiouracil results in increased expression of CENPU mRNA

NCBI chr16:52,448,446...52,471,662
Ensembl chr16:52,425,096...52,471,662

G

centromere protein V

decreases expression

EXP

Propylthiouracil results in decreased expression of CENPV mRNA

NCBI chr10:47,713,778...47,746,800
Ensembl chr10:47,713,778...47,727,679

G

centromere protein W

increases expression

EXP

Propylthiouracil results in increased expression of CENPW mRNA

NCBI chr 1:29,353,939...29,359,109
Ensembl chr 1:29,353,970...29,359,109

G

centrosomal protein 162

increases expression

EXP

Propylthiouracil results in increased expression of CEP162 mRNA

NCBI chr 8:97,029,677...97,088,243
Ensembl chr 8:97,029,677...97,088,207

G

centrosomal protein 170B

decreases expression

EXP

Propylthiouracil results in decreased expression of CEP170B mRNA

NCBI chr 6:137,602,707...137,627,750
Ensembl chr 6:137,602,707...137,627,750

G

centrosomal protein 19

decreases expression

EXP

Propylthiouracil results in decreased expression of CEP19 mRNA

NCBI chr11:82,182,868...82,192,134
Ensembl chr11:82,182,868...82,192,032

G

centrosomal protein 290

decreases expression

EXP

Propylthiouracil results in decreased expression of CEP290 mRNA

NCBI chr 7:37,196,765...37,285,955
Ensembl chr 7:37,196,783...37,285,955

G

centrosomal protein 41

increases expression

EXP

Propylthiouracil results in increased expression of CEP41 mRNA

NCBI chr 4:60,238,602...60,279,670
Ensembl chr 4:60,239,539...60,254,419

G

centrosomal protein 55

affects expression
increases expression

EXP

Propylthiouracil affects the expression of CEP55 mRNA
Propylthiouracil results in increased expression of CEP55 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:245,245,272...245,260,835
Ensembl chr 1:245,245,306...245,260,890

G

centrosomal protein 70

increases expression

EXP

Propylthiouracil results in increased expression of CEP70 mRNA

NCBI chr 8:108,689,562...108,742,620
Ensembl chr 8:108,689,671...108,742,617

G

centrosomal protein 72

increases expression

EXP

Propylthiouracil results in increased expression of CEP72 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:31,053,884...31,083,863
Ensembl chr 1:31,053,914...31,083,863

G

centrosomal protein 76

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CEP76 mRNA
Propylthiouracil results in increased expression of CEP76 mRNA

PMID:24780913 PMID:30047161

NCBI chr18:63,444,389...63,478,358
Ensembl chr18:63,443,746...63,478,358

G

centrosomal protein 95

decreases expression

EXP

Propylthiouracil results in decreased expression of CEP95 mRNA

NCBI chr10:92,231,829...92,259,813
Ensembl chr10:92,231,512...92,259,810

G

choline/ethanolamine phosphotransferase 1

affects expression

EXP

Propylthiouracil affects the expression of CEPT1 mRNA

NCBI chr 2:196,682,455...196,724,430
Ensembl chr 2:196,681,681...196,723,812

G

cerebral endothelial cell adhesion molecule

decreases expression

EXP

Propylthiouracil results in decreased expression of CERCAM mRNA

NCBI chr 3:33,515,513...33,553,817
Ensembl chr 3:33,486,664...33,553,813

G

ceramide kinase

increases expression

EXP

Propylthiouracil results in increased expression of CERK mRNA

NCBI chr 7:119,105,674...119,149,885
Ensembl chr 7:119,105,674...119,148,570

G

ceramide synthase 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CERS2 mRNA

NCBI chr 2:185,579,511...185,587,789
Ensembl chr 2:185,579,119...185,588,839

G

ceramide synthase 4

decreases expression

EXP

Propylthiouracil results in decreased expression of CERS4 mRNA

NCBI chr12:7,649,610...7,688,066
Ensembl chr12:7,649,610...7,688,070

G

ceramide synthase 6

decreases expression

EXP

Propylthiouracil results in decreased expression of CERS6 mRNA

NCBI chr 3:74,038,520...74,287,544
Ensembl chr 3:74,038,851...74,287,544

G

ceramide transporter 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CERT1 mRNA

NCBI chr 2:29,617,202...29,721,734
Ensembl chr 2:29,617,023...29,721,729

G

carboxylesterase 1A

decreases expression

EXP

Propylthiouracil results in decreased expression of CES1A mRNA

NCBI chr19:30,132,678...30,159,368
Ensembl chr19:30,132,452...30,159,368

G

carboxylesterase 2H

affects expression

EXP

Propylthiouracil affects the expression of CES2 mRNA

NCBI chr19:49,884,164...49,898,764
Ensembl chr19:49,884,164...49,898,752

G

carboxylesterase 5A

increases expression

EXP

Propylthiouracil results in increased expression of CES5A mRNA

NCBI chr19:11,198,829...11,504,887
Ensembl chr19:11,419,189...11,504,887

G

centrin 2

increases expression

EXP

Propylthiouracil results in increased expression of CETN2 mRNA

NCBI chr X:155,812,212...155,817,186
Ensembl chr X:155,812,003...155,817,744

G

centrin 4

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CETN4 mRNA
Propylthiouracil results in decreased expression of CETN4 mRNA

PMID:24780913 PMID:30047161

NCBI chr 2:122,128,081...122,131,440
Ensembl chr 2:122,128,081...122,131,440

G

cilia and flagella associated protein 100

decreases expression

EXP

Propylthiouracil results in decreased expression of CFAP100 mRNA

NCBI chr 4:124,471,913...124,495,990
Ensembl chr 4:124,472,023...124,495,799

G

cilia and flagella associated protein 126

increases expression

EXP

Propylthiouracil results in increased expression of CFAP126 mRNA

NCBI chr13:86,059,142...86,075,034
Ensembl chr13:86,059,142...86,075,034

G

cilia and flagella associated protein 144

increases expression

EXP

Propylthiouracil results in increased expression of CFAP144 mRNA

PMID:22504374 PMID:24780913

NCBI chr10:44,009,412...44,019,281
Ensembl chr10:44,009,412...44,019,281

G

cilia and flagella associated protein 161

affects expression

EXP

Propylthiouracil affects the expression of CFAP161 mRNA

NCBI chr 1:147,152,923...147,177,821
Ensembl chr 1:147,152,924...147,178,015

G

cilia and flagella associated protein 206

decreases expression

EXP

Propylthiouracil results in decreased expression of CFAP206 mRNA

PMID:24780913 PMID:25825206

NCBI chr 5:54,050,697...54,095,438
Ensembl chr 5:54,050,701...54,095,383

G

cilia and flagella associated protein 210

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of CFAP210 mRNA
Propylthiouracil results in decreased expression of CCDC173 mRNA

PMID:24780913 PMID:30047161

NCBI chr 3:74,928,368...74,962,508
Ensembl chr 3:74,927,880...74,962,497

G

cilia and flagella associated protein 263

decreases expression

EXP

Propylthiouracil results in decreased expression of CCDC113 mRNA

NCBI chr19:9,503,062...9,522,957
Ensembl chr19:9,503,066...9,522,957

G

cilia and flagella associated protein 43

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of CFAP43 mRNA
Propylthiouracil results in decreased expression of CFAP43 mRNA; Propylthiouracil results in decreased expression of WDR96 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 1:256,566,558...256,653,816
Ensembl chr 1:256,566,559...256,653,840

G

cilia and flagella associated protein 45

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CCDC19 mRNA; Propylthiouracil results in increased expression of CFAP45 mRNA
Propylthiouracil results in decreased expression of CFAP45 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr13:87,521,831...87,545,236
Ensembl chr13:87,521,518...87,545,234

G

cilia and flagella associated protein 52

decreases expression

EXP

Propylthiouracil results in decreased expression of CFAP52 mRNA

NCBI chr10:53,112,692...53,153,844
Ensembl chr10:53,112,693...53,153,844

G

cilia and flagella associated protein 73

decreases expression

EXP

Propylthiouracil results in decreased expression of CFAP73 mRNA

NCBI chr12:41,589,297...41,597,334
Ensembl chr12:41,589,526...41,596,245

G

cilia and flagella associated protein 77

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CFAP77 mRNA
Propylthiouracil results in decreased expression of CFAP77 mRNA

PMID:24780913 PMID:25825206

NCBI chr 3:32,656,410...32,779,261
Ensembl chr 3:32,656,410...32,779,261

G

cilia and flagella associated protein 90

increases expression

EXP

Propylthiouracil results in increased expression of CFAP90 mRNA

NCBI chr 1:36,654,287...36,678,303
Ensembl chr 1:36,654,287...36,678,453

G

cilia and flagella associated protein 96

increases expression

EXP

Propylthiouracil results in increased expression of CFAP96 mRNA

NCBI chr16:53,023,623...53,048,176
Ensembl chr16:53,023,878...53,048,965

G

complement factor B

increases expression

EXP

Propylthiouracil results in increased expression of CFB mRNA

NCBI chr20:3,975,271...3,981,138
Ensembl chr20:3,955,776...3,981,740

G

cripto, FRL-1, cryptic family 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CFC1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 9:44,234,997...44,247,846
Ensembl chr 9:44,235,020...44,247,845

G

complement factor D

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CFD mRNA
Propylthiouracil results in decreased expression of CFD mRNA

PMID:24780913 PMID:30047161

NCBI chr 7:10,463,773...10,465,496
Ensembl chr 7:10,463,775...10,465,572

G

complement factor I

affects expression

EXP

Propylthiouracil affects the expression of CFI mRNA

NCBI chr 2:221,062,206...221,104,790
Ensembl chr 2:221,062,212...221,104,786

G

cofilin 1

increases expression

EXP

Propylthiouracil results in increased expression of CFL1 mRNA

NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:212,226,121...212,231,353

G

cofilin 2

increases expression

EXP

Propylthiouracil results in increased expression of CFL2 mRNA

NCBI chr 6:78,090,843...78,094,888
Ensembl chr 6:78,090,843...78,094,888

G

CASP8 and FADD-like apoptosis regulator

increases expression

EXP

Propylthiouracil results in increased expression of CFLAR mRNA

NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:67,679,559...67,726,434

G

complement factor properdin

increases expression

EXP

Propylthiouracil results in increased expression of CFP mRNA

NCBI chr X:3,715,551...3,721,113
Ensembl chr X:3,710,425...3,721,112

G

CF transmembrane conductance regulator

affects expression

EXP

Propylthiouracil affects the expression of CFTR mRNA

NCBI chr 4:47,422,084...47,694,646
Ensembl chr 4:47,526,735...47,694,643

G

glycoprotein hormones, alpha polypeptide

increases expression

EXP

Propylthiouracil results in increased expression of CGA mRNA

NCBI chr 5:54,283,109...54,295,464
Ensembl chr 5:54,235,019...54,295,464

G

cyclic GMP-AMP synthase

increases expression

EXP

Propylthiouracil results in increased expression of CGAS mRNA

NCBI chr 8:88,172,559...88,187,538
Ensembl chr 8:88,174,512...88,185,859

G

cell growth regulator with ring finger domain 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CGRRF1 mRNA

NCBI chr15:22,560,902...22,588,815
Ensembl chr15:22,568,332...22,588,811

G

chondroadherin

decreases expression

EXP

Propylthiouracil results in decreased expression of CHAD mRNA

NCBI chr10:80,009,045...80,012,816
Ensembl chr10:80,008,767...80,012,816

G

chromatin assembly factor 1 subunit A

increases expression

EXP

Propylthiouracil results in increased expression of CHAF1A mRNA

NCBI chr 9:961,225...987,825
Ensembl chr 9:961,084...987,868

G

chromatin assembly factor 1 subunit B

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CHAF1B mRNA
Propylthiouracil results in decreased expression of CHAF1B mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr11:46,670,560...46,690,739
Ensembl chr11:46,670,630...46,690,733

G

coiled-coil-helix-coiled-coil-helix domain containing 1

increases expression

EXP

Propylthiouracil results in increased expression of CHCHD1 mRNA

NCBI chr15:3,641,973...3,643,155
Ensembl chr15:3,641,981...3,643,155

G

coiled-coil-helix-coiled-coil-helix domain containing 2

increases expression

EXP

Propylthiouracil results in increased expression of CHCHD2 mRNA

NCBI chr12:32,464,847...32,470,871
Ensembl chr12:32,464,824...32,470,871

G

CHD1 helical C-terminal domain containing 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CHCT1 mRNA

NCBI chr10:70,537,206...70,548,972
Ensembl chr10:70,537,127...70,548,963

G

chromodomain helicase DNA binding protein 1-like

increases expression

EXP

Propylthiouracil results in increased expression of CHD1L mRNA

NCBI chr 2:187,819,869...187,906,359
Ensembl chr 2:187,811,954...187,890,477

G

chromodomain helicase DNA binding protein 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CHD2 mRNA

NCBI chr 1:136,597,993...136,726,874
Ensembl chr 1:136,599,900...136,710,335

G

chromodomain helicase DNA binding protein 8

decreases expression

EXP

Propylthiouracil results in decreased expression of CHD8 mRNA

NCBI chr15:27,379,285...27,438,959
Ensembl chr15:27,379,285...27,417,851

G

choline dehydrogenase

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CHDH mRNA
Propylthiouracil results in decreased expression of CHDH mRNA

PMID:24780913 PMID:30047161

NCBI chr16:5,199,738...5,232,067
Ensembl chr16:5,200,763...5,232,997

G

checkpoint kinase 1

increases expression

EXP

Propylthiouracil results in increased expression of CHEK1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 8:44,609,417...44,629,867
Ensembl chr 8:44,609,417...44,629,359

G

checkpoint kinase 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CHEK2 mRNA
Propylthiouracil results in decreased expression of CHEK2 mRNA

PMID:24780913 PMID:30047161

NCBI chr12:51,448,838...51,481,159
Ensembl chr12:51,449,140...51,480,667

G

chromogranin A

decreases expression

EXP

Propylthiouracil results in decreased expression of CHGA mRNA

NCBI chr 6:127,460,895...127,472,238
Ensembl chr 6:127,460,854...127,472,237

G

chromogranin B

decreases expression

EXP

Propylthiouracil results in decreased expression of CHGB mRNA

NCBI chr 3:140,496,712...140,510,057
Ensembl chr 3:140,495,951...140,510,054

G

chitinase, acidic

affects expression

EXP

Propylthiouracil affects the expression of CHIA mRNA

NCBI chr 2:196,302,687...196,344,849
Ensembl chr 2:196,302,545...196,344,850

G

chitinase domain containing 1

increases expression

EXP

Propylthiouracil results in increased expression of CHID1 mRNA

NCBI chr 1:206,024,059...206,059,259
Ensembl chr 1:205,998,801...206,059,227

G

chitinase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CHIT1 mRNA

NCBI chr13:48,117,886...48,165,645
Ensembl chr13:48,145,893...48,165,639

G

choline kinase beta

decreases expression

EXP

Propylthiouracil results in decreased expression of CHKB mRNA

NCBI chr 7:122,380,592...122,385,102
Ensembl chr 7:122,380,594...122,383,949

G

CHM like Rab escort protein

decreases expression

EXP

Propylthiouracil results in decreased expression of CHML mRNA

NCBI chr13:90,141,880...90,152,097
Ensembl chr13:90,131,514...90,151,265

G

charged multivesicular body protein 3

increases expression

EXP

Propylthiouracil results in increased expression of CHMP3 mRNA

NCBI chr 4:105,134,860...105,180,862
Ensembl chr 4:105,134,755...105,182,262

G

charged multivesicular body protein 4B

decreases expression

EXP

Propylthiouracil results in decreased expression of CHMP4B mRNA

NCBI chr 3:163,631,054...163,671,569
Ensembl chr 3:163,631,054...163,671,569

G

charged multivesicular body protein 4C

decreases expression

EXP

Propylthiouracil results in decreased expression of CHMP4C mRNA

PMID:24780913 PMID:25825206

NCBI chr 2:93,299,152...93,336,075
Ensembl chr 2:93,299,157...93,360,850

G

chimerin 1

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CHN1 mRNA
Propylthiouracil results in increased expression of CHN1 mRNA

PMID:24780913 PMID:36843608

NCBI chr 3:78,917,329...79,084,040
Ensembl chr 3:78,917,329...79,084,197

G

chimerin 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CHN2 mRNA
Propylthiouracil results in decreased expression of CHN2 mRNA

PMID:25825206 PMID:36843608

NCBI chr 4:84,478,989...84,738,068
Ensembl chr 4:84,704,862...84,738,068

G

chondrolectin

increases expression

EXP

Propylthiouracil results in increased expression of CHODL mRNA

NCBI chr11:31,141,030...31,163,342
Ensembl chr11:31,141,021...31,163,334

G

cysteine and histidine rich domain containing 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CHORDC1 mRNA

NCBI chr 8:23,650,721...23,674,786
Ensembl chr 8:23,650,865...23,677,696

G

calcineurin-like EF-hand protein 1

affects expression

EXP

Propylthiouracil affects the expression of CHP1 mRNA

NCBI chr 3:126,989,800...127,025,071
Ensembl chr 3:126,989,579...127,042,443

G

chondroitin polymerizing factor

increases expression

EXP

Propylthiouracil results in increased expression of CHPF mRNA

NCBI chr 9:84,411,824...84,416,523
Ensembl chr 9:84,411,829...84,416,523

G

chondroitin polymerizing factor 2

increases expression

EXP

Propylthiouracil results in increased expression of CHPF2 mRNA

NCBI chr 4:11,470,917...11,479,096
Ensembl chr 4:11,472,908...11,478,370

G

chordin-like 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CHRDL1 mRNA
Propylthiouracil results in decreased expression of CHRDL1 mRNA

PMID:22504374 PMID:24780913 PMID:25825206 PMID:36843608

NCBI chr X:111,685,864...111,789,684
Ensembl chr X:111,685,866...111,789,661

G

cholinergic receptor, muscarinic 2

decreases expression
increases methylation

EXP

Propylthiouracil results in decreased expression of CHRM2 mRNA
Propylthiouracil results in increased methylation of CHRM2 promoter

PMID:24780913 PMID:25825206 PMID:33150595

NCBI chr 4:65,981,136...66,116,128
Ensembl chr 4:65,981,006...66,126,464

G

cholinergic receptor, muscarinic 3

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of CHRM3 mRNA
Propylthiouracil results in decreased expression of CHRM3 mRNA

PMID:24780913 PMID:25825206

NCBI chr17:64,696,549...65,158,622
Ensembl chr17:64,696,066...65,173,304

G

cholinergic receptor nicotinic alpha 4 subunit

increases expression

EXP

Propylthiouracil results in increased expression of CHRNA4 mRNA

NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:188,501,209...188,535,105

G

cholinergic receptor nicotinic alpha 7 subunit

increases expression

EXP

Propylthiouracil results in increased expression of CHRNA7 mRNA

NCBI chr 1:126,123,425...126,249,181
Ensembl chr 1:126,123,425...126,446,858

G

cholinergic receptor nicotinic beta 1 subunit

increases expression

EXP

Propylthiouracil results in increased expression of CHRNB1 mRNA

NCBI chr10:54,999,943...55,015,137
Ensembl chr10:55,002,788...55,015,107

G

cholinergic receptor nicotinic epsilon subunit

increases expression

EXP

Propylthiouracil results in increased expression of CHRNE mRNA

PMID:24780913 PMID:25825206

NCBI chr10:55,829,835...55,838,853
Ensembl chr10:55,829,836...55,834,154

G

carbohydrate sulfotransferase 1

increases expression

EXP

Propylthiouracil results in increased expression of CHST1 mRNA

NCBI chr 3:99,003,987...99,030,214
Ensembl chr 3:99,009,958...99,031,262

G

carbohydrate sulfotransferase 11

decreases expression

EXP

Propylthiouracil results in decreased expression of CHST11 mRNA

NCBI chr 7:22,412,121...22,630,577
Ensembl chr 7:22,415,686...22,630,441

G

carbohydrate sulfotransferase 2

increases expression

EXP

Propylthiouracil results in increased expression of CHST2 mRNA

NCBI chr 8:104,839,716...104,845,961
Ensembl chr 8:104,831,292...104,860,301

G

carbohydrate sulfotransferase 6

decreases expression

EXP

Propylthiouracil results in decreased expression of CHST5 mRNA

PMID:24780913 PMID:25825206

NCBI chr19:56,769,991...56,790,276
Ensembl chr19:56,769,967...56,790,306

G

carbohydrate sulfotransferase 8

decreases expression

EXP

Propylthiouracil results in decreased expression of CHST8 mRNA

NCBI chr 1:96,431,144...96,572,880
Ensembl chr 1:96,431,145...96,572,880

G

chondroitin sulfate synthase 1

increases expression

EXP

Propylthiouracil results in increased expression of CHSY1 mRNA

NCBI chr 1:129,100,088...129,161,167
Ensembl chr 1:129,100,041...129,161,081

G

chromosome transmission fidelity factor 18

increases expression

EXP

Propylthiouracil results in increased expression of CHTF18 mRNA

PMID:24780913 PMID:30047161

NCBI chr10:15,247,525...15,255,573
Ensembl chr10:15,246,362...15,255,685

G

cytosolic iron-sulfur assembly component 2A

increases expression

EXP

Propylthiouracil results in increased expression of FAM96A mRNA

NCBI chr 8:75,565,620...75,577,542
Ensembl chr 8:75,565,567...75,577,541

G

cytosolic iron-sulfur assembly component 2B

increases expression

EXP

Propylthiouracil results in increased expression of FAM96B mRNA

NCBI chr19:350,644...352,518
Ensembl chr19:350,653...352,518

G

calcium and integrin binding 1

increases expression

EXP

Propylthiouracil results in increased expression of CIB1 mRNA

NCBI chr 1:143,587,591...143,593,153
Ensembl chr 1:143,587,021...143,593,326

G

CBY1 interacting BAR domain containing 2

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CIBAR2 mRNA

NCBI chr19:65,126,231...65,138,015
Ensembl chr19:65,125,383...65,138,032

G

cell death-inducing DFFA-like effector a

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CIDEA mRNA
Propylthiouracil results in decreased expression of CIDEA mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr18:63,164,817...63,190,384
Ensembl chr18:63,164,099...63,190,382

G

ciliogenesis associated kinase 1

increases expression

EXP

Propylthiouracil results in increased expression of CILK1 mRNA

NCBI chr 8:87,868,294...87,922,995
Ensembl chr 8:87,868,156...87,922,995

G

cartilage intermediate layer protein

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CILP mRNA
Propylthiouracil results in increased expression of CILP mRNA

PMID:24780913 PMID:30047161

NCBI chr 8:74,671,696...74,687,420
Ensembl chr 8:74,671,534...74,687,409

G

cartilage intermediate layer protein 2

increases expression

EXP

Propylthiouracil results in increased expression of CILP2 mRNA

NCBI chr16:19,573,821...19,581,100
Ensembl chr16:19,573,908...19,581,100

G

ciliary microtubule associated protein 1B

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of CIMAP1B mRNA
Propylthiouracil results in decreased expression of CIMAP1B mRNA

PMID:24780913 PMID:30047161

NCBI chr 7:122,323,860...122,326,921
Ensembl chr 7:122,323,860...122,326,876

G

ciliary microtubule inner protein 2B

decreases expression

EXP

Propylthiouracil results in decreased expression of CIMIP2B mRNA

NCBI chr 5:62,471,246...62,477,812
Ensembl chr 5:62,470,367...62,478,198

G

ciliary microtubule inner protein 2C

increases expression
multiple interactions

EXP
ISO

Propylthiouracil results in increased expression of CIMIP2C mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of FAM166C mRNA

PMID:24780913 PMID:36706583

NCBI chr 6:31,625,187...31,643,500
Ensembl chr 6:31,625,188...31,643,629

G

cyclin-dependent kinase 2-interacting protein

increases expression

EXP

Propylthiouracil results in increased expression of CINP mRNA

NCBI chr 6:135,698,477...135,720,798
Ensembl chr 6:135,706,793...135,720,689

G

corepressor interacting with RBPJ, CIR1

decreases expression

EXP

Propylthiouracil results in decreased expression of CIR1 mRNA

NCBI chr 3:78,566,438...78,596,309
Ensembl chr 3:78,566,438...78,596,309

G

cold inducible RNA binding protein

increases expression

EXP

Propylthiouracil results in increased expression of CIRBP mRNA

NCBI chr 7:10,184,515...10,189,623

G

CDGSH iron sulfur domain 1

affects expression

EXP

Propylthiouracil affects the expression of CISD1 mRNA

NCBI chr20:17,254,462...17,267,843
Ensembl chr20:17,254,187...17,271,042

G

CDGSH iron sulfur domain 2

increases expression

EXP

Propylthiouracil results in increased expression of CISD2 mRNA

NCBI chr 2:226,502,517...226,527,325
Ensembl chr 2:226,502,517...226,540,080

G

cytokine inducible SH2-containing protein

decreases expression

EXP

Propylthiouracil results in decreased expression of CISH mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 8:116,850,969...116,855,917
Ensembl chr 8:116,850,773...116,855,986

G

Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CITED1 mRNA

NCBI chr X:71,390,328...71,395,023
Ensembl chr X:71,390,331...71,393,649

G

Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2

increases expression

EXP

Propylthiouracil results in increased expression of CITED2 mRNA

NCBI chr 1:14,132,303...14,134,746
Ensembl chr 1:14,103,457...14,134,782

G

Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4

decreases expression

EXP

Propylthiouracil results in decreased expression of CITED4 mRNA

PMID:24780913 PMID:25825206

NCBI chr 5:139,532,165...139,533,056
Ensembl chr 5:139,531,584...139,533,361

G

CDKN1A interacting zinc finger protein 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CIZ1 mRNA

NCBI chr 3:36,055,753...36,071,510
Ensembl chr 3:36,056,370...36,075,192

G

cytoskeleton associated protein 2

increases expression

EXP

Propylthiouracil results in increased expression of CKAP2 mRNA

NCBI chr16:76,542,114...76,567,297
Ensembl chr16:76,542,104...76,567,352

G

cytoskeleton-associated protein 4

increases expression

EXP

Propylthiouracil results in increased expression of CKAP4 mRNA

PMID:24780913 PMID:30047161

NCBI chr 7:21,118,527...21,126,624
Ensembl chr 7:21,118,085...21,126,624

G

creatine kinase B

decreases expression

EXP

Propylthiouracil results in decreased expression of CKB mRNA

NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478

G

chemokine-like factor

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CKLF mRNA
Propylthiouracil results in increased expression of CKLF mRNA

PMID:24780913 PMID:30047161

NCBI chr19:704,528...712,998
Ensembl chr19:697,451...712,998

G

creatine kinase, mitochondrial 1

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CKMT1 mRNA
Propylthiouracil results in increased expression of CKMT1B mRNA

PMID:24780913 PMID:30047161

NCBI chr 3:128,783,408...128,789,485
Ensembl chr 3:128,783,597...128,789,483

G

CDC28 protein kinase regulatory subunit 1B

increases expression

EXP

Propylthiouracil results in increased expression of CKS1B mRNA

NCBI chr 2:177,130,751...177,135,333
Ensembl chr 2:177,130,777...177,135,365

G

CDC28 protein kinase regulatory subunit 2

increases expression

EXP

Propylthiouracil results in increased expression of CKS2 mRNA

PMID:24780913 PMID:30047161

NCBI chr17:13,722,360...13,727,519
Ensembl chr17:13,722,361...13,727,519

G

CLK4-associating serine/arginine rich protein

decreases expression

EXP

Propylthiouracil results in decreased expression of CLASRP mRNA

NCBI chr 1:88,360,235...88,384,343
Ensembl chr 1:88,360,235...88,384,343

G

chloride channel accessory 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CLCA1 mRNA

NCBI chr 2:236,599,022...236,624,714
Ensembl chr 2:236,599,022...236,624,714

G

chloride channel accessory 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CLCA2 mRNA

NCBI chr 2:236,655,419...236,682,669
Ensembl chr 2:236,639,545...236,685,129

G

chloride channel calcium activated 4-like

decreases expression

EXP

Propylthiouracil results in decreased expression of CLCA4L mRNA

NCBI chr 2:236,486,485...236,506,483
Ensembl chr 2:236,486,485...236,506,483

G

chloride channel CLIC-like 1

increases expression

EXP

Propylthiouracil results in increased expression of CLCC1 mRNA

NCBI chr 2:198,984,455...199,015,015
Ensembl chr 2:198,984,495...199,015,014

G

cardiotrophin-like cytokine factor 1

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of CLCF1 mRNA
Propylthiouracil results in decreased expression of CLCF1 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 1:210,937,763...210,947,064
Ensembl chr 1:210,937,255...210,947,064

G

chloride voltage-gated channel 3

increases expression

EXP

Propylthiouracil results in increased expression of CLCN3 mRNA

NCBI chr16:34,138,004...34,210,984
Ensembl chr16:34,137,952...34,210,984

G

chloride voltage-gated channel 4

affects expression
increases expression
decreases expression

EXP

Propylthiouracil affects the expression of CLCN4 mRNA
Propylthiouracil results in increased expression of CLCN4 mRNA
Propylthiouracil results in decreased expression of CLCN4 mRNA

PMID:19483382 PMID:24780913 PMID:30047161

NCBI chr X:27,290,769...27,356,967
Ensembl chr X:27,290,868...27,356,939

G

chloride voltage-gated channel Ka

increases expression

EXP

Propylthiouracil results in increased expression of CLCNKA mRNA

NCBI chr 5:158,974,190...158,989,275
Ensembl chr 5:158,974,193...158,989,128

G

chloride voltage-gated channel Kb

increases expression

EXP

Propylthiouracil results in increased expression of CLCNKB mRNA

NCBI chr 5:158,993,073...159,005,618
Ensembl chr 5:158,993,074...159,004,900

G

claudin 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CLDN1 mRNA
Propylthiouracil results in decreased expression of CLDN1 mRNA

PMID:24780913 PMID:30047161 PMID:36843608

NCBI chr11:87,926,376...87,941,533
Ensembl chr11:87,926,337...87,941,529

G

claudin 10

decreases expression

EXP

Propylthiouracil results in decreased expression of CLDN10 mRNA

NCBI chr15:102,269,858...102,361,589
Ensembl chr15:102,269,858...102,361,589

G

claudin 11

decreases expression

EXP

Propylthiouracil results in decreased expression of CLDN11 mRNA

PMID:22504374 PMID:24780913 PMID:25825206

NCBI chr 2:114,136,234...114,149,539
Ensembl chr 2:114,136,234...114,149,539

G

claudin 12

decreases expression

EXP

Propylthiouracil results in decreased expression of CLDN12 mRNA

NCBI chr 4:29,477,468...29,488,465
Ensembl chr 4:29,477,342...29,493,776

G

claudin 14

affects expression

EXP

Propylthiouracil affects the expression of CLDN14 mRNA

NCBI chr11:46,701,940...46,799,049
Ensembl chr11:46,701,940...46,799,096

G

claudin 18

decreases expression

EXP

Propylthiouracil results in decreased expression of CLDN18 mRNA

NCBI chr 8:109,125,819...109,145,110
Ensembl chr 8:109,126,949...109,152,701

G

claudin 2

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of CLDN2 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CLDN2 mRNA

PMID:25825206 PMID:36706583

NCBI chr X:108,248,383...108,258,847
Ensembl chr X:108,237,676...108,262,377

G

claudin 23

decreases expression

EXP

Propylthiouracil results in decreased expression of CLDN23 mRNA

NCBI chr16:63,117,045...63,118,769
Ensembl chr16:63,116,781...63,118,957

G

claudin 3

increases expression

EXP

Propylthiouracil results in increased expression of CLDN3 mRNA

NCBI chr12:27,345,075...27,346,547
Ensembl chr12:27,345,076...27,348,841

G

claudin 9

decreases expression

EXP

Propylthiouracil results in decreased expression of CLDN9 mRNA

NCBI chr10:13,218,728...13,220,159
Ensembl chr10:13,218,729...13,220,178

G

C-type lectin domain containing 10A

decreases expression

EXP

Propylthiouracil results in decreased expression of CLEC10A mRNA

NCBI chr10:55,374,914...55,379,110
Ensembl chr10:55,374,887...55,379,108

G

C-type lectin domain family 12, member B

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of CLEC12B mRNA
Propylthiouracil results in decreased expression of CLEC12B mRNA

PMID:24780913 PMID:30047161

NCBI chr 4:164,512,893...164,529,846
Ensembl chr 4:164,513,497...164,524,976

G

C-type lectin domain containing 14A

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CLEC14A mRNA
Propylthiouracil results in increased expression of CLEC14A mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 6:81,616,414...81,619,556
Ensembl chr 6:81,612,953...81,619,614

G

C-type lectin domain family 1, member B

increases expression

EXP

Propylthiouracil results in increased expression of CLEC1B mRNA

NCBI chr 4:164,533,987...164,542,320
Ensembl chr 4:164,534,055...164,542,867

G

C-type lectin domain family 2, member D

decreases expression

EXP

Propylthiouracil results in decreased expression of CLEC2D mRNA

NCBI chr 4:163,902,124...163,925,587
Ensembl chr 4:163,902,547...163,925,587

G

C-type lectin domain family 2 member D-like 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CLEC2DL1 mRNA

NCBI chr 4:163,949,688...163,960,935

G

C-type lectin domain family 2, member G

decreases expression

EXP

Propylthiouracil results in decreased expression of CLEC2G mRNA

PMID:24780913 PMID:30047161

NCBI chr 4:164,303,865...164,313,737
Ensembl chr 4:164,300,076...164,314,591

G

C-type lectin domain family 2, member L

decreases expression

EXP

Propylthiouracil results in decreased expression of CLEC2L mRNA

NCBI chr 4:68,359,021...68,381,431
Ensembl chr 4:68,358,973...68,381,432

G

C-type lectin domain family 4, member A1

increases expression

EXP

Propylthiouracil results in increased expression of CLEC4A1 mRNA

NCBI chr 4:157,845,811...157,857,926
Ensembl chr 4:157,845,752...157,858,273

G

C-type lectin domain family 4, member A3

increases expression

EXP

Propylthiouracil results in increased expression of CLEC4A mRNA

NCBI chr 4:157,885,899...157,896,728
Ensembl chr 4:157,885,895...157,896,727

G

C-type lectin domain containing 7A

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of CLEC7A mRNA

NCBI chr 4:164,588,737...164,599,953
Ensembl chr 4:164,588,754...164,599,919

G

calmegin

decreases expression

EXP

Propylthiouracil results in decreased expression of CLGN mRNA

PMID:24780913 PMID:25825206

NCBI chr19:41,601,568...41,633,207
Ensembl chr19:41,601,568...41,633,325

G

chloride intracellular channel 1

increases expression

EXP

Propylthiouracil results in increased expression of CLIC1 mRNA

PMID:24780913 PMID:30047161

NCBI chr20:3,769,522...3,778,367
Ensembl chr20:3,769,527...3,778,367

G

chloride intracellular channel 4

decreases expression

EXP

Propylthiouracil results in decreased expression of CLIC4 mRNA

NCBI chr 5:152,737,371...152,797,118
Ensembl chr 5:152,737,371...152,797,118

G

chloride intracellular channel 5

decreases expression

EXP

Propylthiouracil results in decreased expression of CLIC5 mRNA

NCBI chr 9:24,208,455...24,310,964
Ensembl chr 9:24,208,456...24,358,780

G

clathrin interactor 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CLINT1 mRNA

PMID:22504374 PMID:24780913

NCBI chr10:30,799,936...30,854,513
Ensembl chr10:30,799,971...30,854,508

G

CAP-GLY domain containing linker protein 2

increases expression

EXP

Propylthiouracil results in increased expression of CLIP2 mRNA

NCBI chr12:27,798,289...27,863,486
Ensembl chr12:27,799,524...27,863,484

G

CDC-like kinase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CLK1 mRNA

NCBI chr 9:67,441,962...67,453,180
Ensembl chr 9:67,441,952...67,451,187

G

CDC-like kinase 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CLK2 mRNA

NCBI chr 2:176,868,423...176,880,412
Ensembl chr 2:176,869,490...176,880,411

G

CDC-like kinase 3

decreases expression

EXP

Propylthiouracil results in decreased expression of CLK3 mRNA

NCBI chr 8:67,048,121...67,063,192
Ensembl chr 8:67,048,123...67,062,881

G

CDC-like kinase 4

decreases expression

EXP

Propylthiouracil results in decreased expression of CLK4 mRNA

NCBI chr10:36,024,364...36,042,366
Ensembl chr10:36,024,427...36,042,372

G

calmin

decreases expression

EXP

Propylthiouracil results in decreased expression of CLMN mRNA

NCBI chr 6:129,470,613...129,572,079
Ensembl chr 6:129,478,149...129,572,027

G

CXADR-like membrane protein

increases expression

EXP

Propylthiouracil results in increased expression of CLMP mRNA

NCBI chr 8:49,957,639...50,065,959
Ensembl chr 8:49,957,720...50,065,959

G

CLN5, intracellular trafficking protein

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CLN5 mRNA
Propylthiouracil results in increased expression of CLN5 mRNA

PMID:24780913 PMID:30047161

NCBI chr15:86,308,286...86,321,679
Ensembl chr 2:67,620,667...67,622,952
Ensembl chr15:67,620,667...67,622,952

G

CLN6, transmembrane ER protein

decreases expression

EXP

Propylthiouracil results in decreased expression of CLN6 mRNA

NCBI chr 8:72,198,773...72,213,777
Ensembl chr 8:72,198,712...72,213,776

G

CLN8, transmembrane ER and ERGIC protein

increases expression

EXP

Propylthiouracil results in increased expression of CLN8 mRNA

NCBI chr16:81,451,941...81,462,046
Ensembl chr16:81,451,944...81,461,832

G

clock circadian regulator

decreases expression

EXP

Propylthiouracil results in decreased expression of CLOCK mRNA

NCBI chr14:32,262,747...32,346,872
Ensembl chr14:32,262,750...32,346,872

G

ClpB family mitochondrial disaggregase

increases expression

EXP

Propylthiouracil results in increased expression of CLPB mRNA

NCBI chr 1:165,440,705...165,563,514
Ensembl chr 1:165,440,861...165,583,815

G

caseinolytic mitochondrial matrix peptidase proteolytic subunit

affects expression

EXP

Propylthiouracil affects the expression of CLPP mRNA

NCBI chr 9:1,917,305...1,924,706
Ensembl chr 9:1,918,682...1,924,705

G

CLPTM1-like

affects expression

EXP

Propylthiouracil affects the expression of CLPTM1L mRNA

NCBI chr 1:31,496,094...31,512,148
Ensembl chr 1:31,496,094...31,512,077

G

clarin 1

affects expression

EXP

Propylthiouracil affects the expression of CLRN1 mRNA

NCBI chr 2:145,233,941...145,280,855
Ensembl chr 2:145,233,941...145,280,855

G

clarin 2

increases expression

EXP

Propylthiouracil results in increased expression of CLRN2 mRNA

NCBI chr14:69,868,556...69,878,850
Ensembl chr14:69,868,556...69,878,850

G

claspin

increases expression

EXP

Propylthiouracil results in increased expression of CLSPN mRNA

NCBI chr 5:144,134,619...144,169,531
Ensembl chr 5:144,134,632...144,169,530

G

calsyntenin 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CLSTN2 mRNA

NCBI chr 8:106,899,894...107,516,402
Ensembl chr 8:106,899,894...107,040,053

G

clathrin heavy chain

increases expression

EXP

Propylthiouracil results in increased expression of CLTC mRNA

NCBI chr10:72,014,984...72,073,308
Ensembl chr10:72,014,986...72,070,691

G

clusterin

decreases expression
affects expression

EXP

Propylthiouracil results in decreased expression of CLU mRNA
Propylthiouracil affects the expression of CLU mRNA

PMID:7819453 PMID:24780913 PMID:30047161

NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860

G

calaxin

increases expression

EXP

Propylthiouracil results in increased expression of CLXN mRNA

NCBI chr11:99,410,925...99,500,713
Ensembl chr11:99,487,448...99,500,760

G

carboxymethylenebutenolidase homolog

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of CMBL mRNA
Propylthiouracil results in decreased expression of CMBL mRNA

PMID:19483382 PMID:24780913

NCBI chr 2:84,280,128...84,301,878
Ensembl chr 2:84,242,512...84,301,880

G

C-x(9)-C motif containing 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CMC1 mRNA

NCBI chr 8:126,677,560...126,778,403
Ensembl chr 8:126,677,560...126,778,499

G

C-x(9)-C motif containing 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CMC2 mRNA

NCBI chr19:61,852,126...61,880,768
Ensembl chr19:61,852,126...61,881,019

G

c-Maf-inducing protein

increases expression

EXP

Propylthiouracil results in increased expression of CMIP mRNA

NCBI chr19:62,213,402...62,419,443
Ensembl chr19:62,213,365...62,417,500

G

cytidine/uridine monophosphate kinase 1

affects expression

EXP

Propylthiouracil affects the expression of CMPK1 mRNA

NCBI chr 5:133,717,073...133,744,623
Ensembl chr 5:133,717,086...133,744,596

G

cytidine/uridine monophosphate kinase 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CMPK2 mRNA

NCBI chr 6:48,802,150...48,813,652
Ensembl chr 6:48,802,321...48,813,652

G

CKLF-like MARVEL transmembrane domain containing 3

increases expression

EXP

Propylthiouracil results in increased expression of CMTM3 mRNA

NCBI chr19:629,000...637,152
Ensembl chr19:628,895...636,225

G

CKLF-like MARVEL transmembrane domain containing 5

decreases expression

EXP

Propylthiouracil results in decreased expression of CMTM5 mRNA

PMID:24780913 PMID:30047161

NCBI chr15:32,382,171...32,385,288
Ensembl chr15:32,382,608...32,385,271

G

cap methyltransferase 1

increases expression

EXP

Propylthiouracil results in increased expression of CMTR1 mRNA

NCBI chr20:7,724,286...7,784,787
Ensembl chr20:7,683,946...7,784,263

G

cyclic nucleotide binding domain containing 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CNBD2 mRNA

NCBI chr 3:165,279,157...165,357,582
Ensembl chr 3:165,279,204...165,361,688

G

carnosine dipeptidase 1

increases expression

EXP

Propylthiouracil results in increased expression of CNDP1 mRNA

NCBI chr18:80,254,499...80,305,845
Ensembl chr18:80,255,784...80,282,643

G

cyclic nucleotide gated channel subunit alpha 1

increases expression

EXP

Propylthiouracil results in increased expression of CNGA1 mRNA

NCBI chr14:35,920,948...35,959,065
Ensembl chr14:35,926,854...35,959,056

G

cyclic nucleotide gated channel subunit beta 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CNGB1 mRNA

NCBI chr19:9,732,646...9,798,864
Ensembl chr19:9,732,646...9,797,224

G

cornichon family AMPA receptor auxiliary protein 2

increases expression

EXP

Propylthiouracil results in increased expression of CNIH2 mRNA

NCBI chr 1:211,828,791...211,834,474
Ensembl chr 1:211,828,794...211,834,437

G

cornichon family member 4

increases expression

EXP

Propylthiouracil results in increased expression of CNIH4 mRNA

NCBI chr13:95,442,054...95,458,163
Ensembl chr13:95,442,054...95,459,590

G

connector enhancer of kinase suppressor of Ras 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CNKSR1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 5:151,731,222...151,742,049
Ensembl chr 5:151,731,224...151,742,203

G

Cnksr family member 3

decreases expression

EXP

Propylthiouracil results in decreased expression of CNKSR3 mRNA

NCBI chr 1:45,904,581...45,996,921
Ensembl chr 1:45,904,581...45,996,921

G

chondromodulin

decreases expression

EXP

Propylthiouracil results in decreased expression of CNMD mRNA

NCBI chr15:61,450,617...61,475,382
Ensembl chr15:61,450,450...61,475,350

G

calponin 2

increases expression

EXP

Propylthiouracil results in increased expression of CNN2 mRNA

NCBI chr 7:10,363,141...10,370,312
Ensembl chr 7:10,363,102...10,370,312

G

calponin 3

increases expression

EXP

Propylthiouracil results in increased expression of CNN3 mRNA

NCBI chr 2:212,203,661...212,234,772
Ensembl chr 2:212,226,640...212,234,815

G

cyclin and CBS domain divalent metal cation transport mediator 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CNNM1 mRNA

NCBI chr 1:252,245,377...252,304,205
Ensembl chr 1:252,245,623...252,304,205

G

CCR4-NOT transcription complex, subunit 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CNOT2 mRNA

NCBI chr 7:54,016,447...54,117,511
Ensembl chr 7:54,016,447...54,107,960

G

2',3'-cyclic nucleotide 3' phosphodiesterase

decreases expression

EXP

Propylthiouracil results in decreased expression of CNP mRNA

PMID:24780913 PMID:25825206

NCBI chr10:86,011,504...86,018,063
Ensembl chr10:86,011,495...86,018,063

G

canopy FGF signaling regulator 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CNPY2 mRNA

NCBI chr 7:1,332,293...1,338,081
Ensembl chr 7:1,334,335...1,340,333

G

cannabinoid receptor 1

increases expression

EXP

Propylthiouracil results in increased expression of CNR1 mRNA

NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:53,204,260...53,239,252

G

consortin, connexin sorting protein

decreases expression

EXP

Propylthiouracil results in decreased expression of CNST mRNA

NCBI chr13:93,828,694...93,905,497
Ensembl chr13:93,828,687...93,905,490

G

contactin 2

affects expression
increases methylation
decreases expression

EXP

Propylthiouracil affects the expression of CNTN2 mRNA
Propylthiouracil results in increased methylation of CNTN2 promoter
Propylthiouracil results in decreased expression of CNTN2 mRNA

PMID:24780913 PMID:33150595

NCBI chr13:46,497,269...46,528,112
Ensembl chr13:46,499,396...46,528,027

G

contactin 3

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CNTN3 mRNA
Propylthiouracil results in increased expression of CNTN3 mRNA

PMID:24780913 PMID:25825206

NCBI chr 4:136,397,575...136,770,765
Ensembl chr 4:136,398,572...136,770,717

G

contactin 4

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CNTN4 mRNA
Propylthiouracil results in increased expression of CNTN4 mRNA

PMID:24780913 PMID:25825206

NCBI chr 4:140,180,696...141,177,771
Ensembl chr 4:140,596,284...141,177,766

G

contactin 5

increases expression

EXP

Propylthiouracil results in increased expression of CNTN5 mRNA

NCBI chr 8:15,017,424...16,249,418
Ensembl chr 8:15,018,927...15,969,060

G

contactin associated protein 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CNTNAP1 mRNA

NCBI chr10:86,610,140...86,625,896
Ensembl chr10:86,611,890...86,631,730

G

contactin associated protein family member 4

increases expression

EXP

Propylthiouracil results in increased expression of CNTNAP4 mRNA

NCBI chr19:57,477,447...57,765,173
Ensembl chr19:57,477,310...57,821,701

G

centriolin

decreases expression

EXP

Propylthiouracil results in decreased expression of CNTRL mRNA

NCBI chr 3:38,825,575...38,897,835
Ensembl chr 3:38,825,624...38,897,833

G

cytochrome c oxidase assembly factor 7

decreases expression

EXP

Propylthiouracil results in decreased expression of COA7 mRNA

NCBI chr 5:128,298,084...128,308,935
Ensembl chr 5:128,298,093...128,309,664

G

cochlin

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of COCH mRNA
Propylthiouracil results in decreased expression of COCH mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 6:74,766,485...74,780,504
Ensembl chr 6:74,766,419...74,780,502

G

collagen type XI alpha 1 chain

affects expression
increases expression

EXP

Propylthiouracil affects the expression of COL11A1 mRNA
Propylthiouracil results in increased expression of COL11A1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 2:204,509,136...204,702,264
Ensembl chr 2:204,509,136...204,702,264

G

collagen type XI alpha 2 chain

decreases expression

EXP

Propylthiouracil results in decreased expression of COL11A2 mRNA

PMID:24780913 PMID:25825206 PMID:30047161 PMID:30085217

NCBI chr20:4,788,829...4,818,492
Ensembl chr20:4,788,829...4,817,648

G

collagen type XII alpha 1 chain

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of COL12A1 mRNA
Propylthiouracil results in decreased expression of COL12A1 mRNA

PMID:24780913 PMID:30047161 PMID:36843608

NCBI chr 8:89,427,834...89,545,886
Ensembl chr 8:89,427,834...89,545,711

G

collagen type XIII alpha 1 chain

decreases expression

EXP

Propylthiouracil results in decreased expression of COL13A1 mRNA

NCBI chr20:30,326,744...30,466,800
Ensembl chr20:30,326,744...30,466,800

G

collagen type XIV alpha 1 chain

increases expression

EXP

Propylthiouracil results in increased expression of COL14A1 mRNA

NCBI chr 7:88,611,827...88,826,939
Ensembl chr 7:88,611,828...88,826,938

G

collagen type XV alpha 1 chain

decreases expression

EXP

Propylthiouracil results in decreased expression of COL15A1 mRNA

NCBI chr 5:66,297,546...66,403,172
Ensembl chr 5:66,297,461...66,403,170

G

collagen type XVI alpha 1 chain

increases expression

EXP

Propylthiouracil results in increased expression of COL16A1 mRNA

NCBI chr 5:147,672,559...147,727,007
Ensembl chr 5:147,672,601...147,727,011

G

collagen type XVIII alpha 1 chain

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of COL18A1 mRNA
Propylthiouracil results in increased expression of COL18A1 mRNA

PMID:24780913 PMID:30047161

NCBI chr20:11,473,645...11,582,111
Ensembl chr20:11,473,645...11,582,112

G

collagen type I alpha 1 chain

decreases expression

EXP

Propylthiouracil results in decreased expression of COL1A1 mRNA

PMID:24780913 PMID:30047161

NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460

G

collagen type I alpha 2 chain

affects expression

EXP

Propylthiouracil affects the expression of COL1A2 mRNA

NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995

G

collagen type XXII alpha 1 chain

increases expression

EXP

Propylthiouracil results in increased expression of COL22A1 mRNA

NCBI chr 7:105,619,776...105,857,246
Ensembl chr 7:105,619,757...105,856,960

G

collagen type XXIII alpha 1 chain

increases expression

EXP

Propylthiouracil results in increased expression of COL23A1 mRNA

NCBI chr10:36,050,327...36,337,279
Ensembl chr10:36,050,259...36,337,897

G

collagen type XXIV alpha 1 chain

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of COL24A1 mRNA

NCBI chr 2:236,872,583...237,129,768
Ensembl chr 2:236,872,265...237,129,447

G

collagen type XXVI alpha 1 chain

increases expression

EXP

Propylthiouracil results in increased expression of COL26A1 mRNA

NCBI chr12:25,429,362...25,575,205
Ensembl chr12:25,429,387...25,575,206

G

collagen type XXVII alpha 1 chain

decreases expression

EXP

Propylthiouracil results in decreased expression of COL27A1 mRNA

PMID:24780913 PMID:25825206

NCBI chr 5:81,662,822...81,781,502
Ensembl chr 5:81,661,685...81,781,502

G

collagen type II alpha 1 chain

increases expression
decreases expression
affects expression

EXP

Propylthiouracil results in increased expression of COL2A1 mRNA
Propylthiouracil results in decreased expression of COL2A1 mRNA
Propylthiouracil affects the expression of COL2A1 mRNA

PMID:22504374 PMID:24780913 PMID:36843608

NCBI chr 7:130,977,561...131,006,627
Ensembl chr 7:130,977,561...131,006,627

G

collagen type III alpha 1 chain

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of COL3A1 mRNA
Propylthiouracil results in decreased expression of COL3A1 mRNA

PMID:24780913 PMID:25825206

NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232

G

collagen type IV alpha 2 chain

increases expression

EXP

Propylthiouracil results in increased expression of COL4A2 mRNA

NCBI chr16:84,749,672...84,885,520
Ensembl chr16:84,749,672...84,885,520

G

collagen type IV alpha 3 chain

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of COL4A3 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of COL4A3 mRNA

PMID:30047161 PMID:36706583

NCBI chr 9:91,323,990...91,453,088
Ensembl chr 9:91,323,990...91,453,077

G

collagen type IV alpha 4 chain

decreases expression

EXP

Propylthiouracil results in decreased expression of COL4A4 mRNA

NCBI chr 9:91,281,324...91,323,577
Ensembl chr 9:91,203,670...91,323,577

G

collagen type IV alpha 5 chain

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of COL4A5 mRNA
Propylthiouracil results in decreased expression of COL4A5 mRNA

PMID:24780913 PMID:30047161

NCBI chr X:109,907,251...110,111,214
Ensembl chr X:109,907,346...110,111,214

G

collagen type IV alpha 6 chain

decreases expression

EXP

Propylthiouracil results in decreased expression of COL4A6 mRNA

NCBI chr X:109,554,945...109,905,987
Ensembl chr X:109,552,651...109,905,944

G

collagen type V alpha 1 chain

increases expression

EXP

Propylthiouracil results in increased expression of COL5A1 mRNA

NCBI chr 3:31,606,475...31,755,097
Ensembl chr 3:31,606,486...31,753,020

G

collagen type V alpha 2 chain

increases expression

EXP

Propylthiouracil results in increased expression of COL5A2 mRNA

NCBI chr 9:54,940,768...55,090,151
Ensembl chr 9:54,940,764...55,090,150

G

collagen type V alpha 3 chain

increases expression

EXP

Propylthiouracil results in increased expression of COL5A3 mRNA

PMID:24780913 PMID:30047161

NCBI chr 8:27,580,768...27,626,002
Ensembl chr 8:27,580,768...27,626,122

G

collagen type VI alpha 1 chain

decreases expression

EXP

Propylthiouracil results in decreased expression of COL6A1 mRNA

NCBI chr20:11,905,690...11,924,111
Ensembl chr20:11,905,457...11,924,107

G

collagen type VI alpha 5 chain

affects expression

EXP

Propylthiouracil affects the expression of COL6A5 mRNA

NCBI chr 8:115,362,532...115,462,844
Ensembl chr 8:115,361,906...115,462,859

G

collagen type VII alpha 1 chain

decreases expression

EXP

Propylthiouracil results in decreased expression of COL7A1 mRNA

PMID:24780913 PMID:25825206

NCBI chr 8:118,483,364...118,515,736
Ensembl chr 8:118,483,364...118,517,439

G

collagen type VIII alpha 1 chain

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of COL8A1 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of COL8A1 mRNA

PMID:24780913 PMID:36706583

NCBI chr11:56,245,998...56,378,586
Ensembl chr11:56,369,868...56,376,229

G

collagen type VIII alpha 2 chain

decreases expression

EXP

Propylthiouracil results in decreased expression of COL8A2 mRNA

NCBI chr 5:143,870,754...143,897,372
Ensembl chr 5:143,870,742...143,897,884

G

collagen type IX alpha 2 chain

decreases expression

EXP

Propylthiouracil results in decreased expression of COL9A2 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 5:139,892,798...139,910,131
Ensembl chr 5:139,892,798...139,909,855

G

collectin sub-family member 12

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of COLEC12 mRNA
Propylthiouracil results in decreased expression of COLEC12 mRNA

PMID:24780913 PMID:25825206

NCBI chr18:1,005,787...1,193,455
Ensembl chr18:1,005,741...1,195,297

G

collagen like tail subunit of asymmetric acetylcholinesterase

increases expression
multiple interactions

EXP
ISO

Propylthiouracil results in increased expression of COLQ mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of COLQ mRNA

PMID:24780913 PMID:25825206 PMID:36706583

NCBI chr16:6,738,251...6,830,492
Ensembl chr16:6,738,251...6,793,501

G

copper metabolism domain containing 1

increases expression

EXP

Propylthiouracil results in increased expression of COMMD1 mRNA

NCBI chr14:101,081,667...101,185,738
Ensembl chr14:101,081,667...101,185,639

G

COMM domain containing 10

increases expression

EXP

Propylthiouracil results in increased expression of COMMD10 mRNA

NCBI chr18:41,927,802...42,061,384
Ensembl chr18:41,921,694...42,086,729

G

COMM domain containing 2

increases expression

EXP

Propylthiouracil results in increased expression of COMMD2 mRNA

NCBI chr 2:143,998,672...144,002,918
Ensembl chr 2:143,998,672...144,002,918

G

COMM domain containing 3

increases expression

EXP

Propylthiouracil results in increased expression of COMMD3 mRNA

NCBI chr17:86,235,863...86,239,610
Ensembl chr17:86,235,863...86,239,610

G

COMM domain containing 7

increases expression

EXP

Propylthiouracil results in increased expression of COMMD7 mRNA

NCBI chr 3:162,559,762...162,574,543
Ensembl chr 3:162,554,374...162,574,692

G

COMM domain containing 8

increases expression

EXP

Propylthiouracil results in increased expression of COMMD8 mRNA

NCBI chr14:36,403,000...36,413,577
Ensembl chr14:36,403,022...36,413,574

G

cartilage oligomeric matrix protein

decreases expression

EXP

Propylthiouracil results in decreased expression of COMP mRNA

NCBI chr16:19,081,172...19,089,548
Ensembl chr16:19,081,172...19,089,605

G

catechol-O-methyltransferase

decreases expression

EXP

Propylthiouracil results in decreased expression of COMT mRNA

NCBI chr11:96,072,371...96,091,956
Ensembl chr11:96,072,489...96,092,533

G

catechol-O-methyltransferase domain containing 1

increases expression

EXP

Propylthiouracil results in increased expression of COMTD1 mRNA

NCBI chr15:2,509,121...2,512,232
Ensembl chr15:2,509,032...2,512,232

G

COPI coat complex subunit alpha

increases expression

EXP

Propylthiouracil results in increased expression of COPA mRNA

NCBI chr13:87,078,853...87,119,256
Ensembl chr13:87,078,383...87,119,256

G

COPI coat complex subunit beta 2

increases expression

EXP

Propylthiouracil results in increased expression of COPB2 mRNA

NCBI chr 8:108,040,687...108,062,810
Ensembl chr 8:108,040,693...108,064,550

G

COPI coat complex subunit gamma 1

affects expression
increases expression

EXP

Propylthiouracil affects the expression of COPG1 mRNA
Propylthiouracil results in increased expression of COPG1 mRNA

PMID:19483382 PMID:30047161

NCBI chr 4:121,923,644...121,949,819
Ensembl chr 4:121,923,873...121,949,812

G

COP9 signalosome subunit 2

decreases expression

EXP

Propylthiouracil results in decreased expression of COPS2 mRNA

NCBI chr 3:133,537,729...133,563,493
Ensembl chr 3:133,537,732...133,563,369

G

COP9 signalosome subunit 3

increases expression

EXP

Propylthiouracil results in increased expression of COPS3 mRNA

NCBI chr10:45,117,664...45,151,868
Ensembl chr10:45,117,657...45,152,074

G

COP9 signalosome subunit 4

affects expression

EXP

Propylthiouracil affects the expression of COPS4 mRNA

NCBI chr14:9,382,897...9,413,216
Ensembl chr14:9,382,900...9,413,107

G

COP9 signalosome subunit 5

increases expression

EXP

Propylthiouracil results in increased expression of COPS5 mRNA

NCBI chr 5:13,975,198...13,993,391
Ensembl chr 5:13,975,052...13,993,387

G

COP9 signalosome subunit 7B

decreases expression

EXP

Propylthiouracil results in decreased expression of COPS7B mRNA

NCBI chr 9:94,686,314...94,711,903
Ensembl chr 9:94,686,314...94,711,903

G

COP9 signalosome subunit 9

increases expression

EXP

Propylthiouracil results in increased expression of MYEOV2 mRNA

NCBI chr 9:100,657,276...100,662,206
Ensembl chr 9:100,657,276...100,662,206

G

coenzyme Q10B

increases expression

EXP

Propylthiouracil results in increased expression of COQ10B mRNA

NCBI chr 9:64,048,168...64,068,082
Ensembl chr 9:64,048,103...64,068,322

G

coenzyme Q3 methyltransferase

affects expression
increases expression

EXP

Propylthiouracil affects the expression of COQ3 mRNA
Propylthiouracil results in increased expression of COQ3 mRNA

PMID:19483382 PMID:30047161

NCBI chr 5:40,226,313...40,257,383
Ensembl chr 5:40,226,368...40,257,617

G

coenzyme Q7, hydroxylase

increases expression

EXP

Propylthiouracil results in increased expression of COQ7 mRNA

NCBI chr 1:182,270,570...182,285,959
Ensembl chr 1:182,269,399...182,285,508

G

coronin 1C

increases expression

EXP

Propylthiouracil results in increased expression of CORO1C mRNA

NCBI chr12:48,373,573...48,445,718
Ensembl chr12:48,373,597...48,445,716

G

coronin 2B

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CORO2B mRNA
Propylthiouracil results in increased expression of CORO2B mRNA

PMID:24780913 PMID:30047161

NCBI chr 8:71,802,329...71,912,739
Ensembl chr 8:71,802,329...71,912,739

G

coronin 6

decreases expression

EXP

Propylthiouracil results in decreased expression of CORO6 mRNA

PMID:24780913 PMID:30047161

NCBI chr10:62,808,172...62,817,788
Ensembl chr10:62,809,689...62,817,787

G

coronin 7

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CORO7 mRNA
Propylthiouracil results in increased expression of CORO7 mRNA

PMID:24780913 PMID:30047161

NCBI chr10:11,386,683...11,447,422
Ensembl chr10:11,391,613...11,447,866

G

cortistatin

increases expression
multiple interactions

EXP
ISO

Propylthiouracil results in increased expression of CORT mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CORT mRNA

PMID:24780913 PMID:36706583

NCBI chr 5:164,843,682...164,845,796

G

coactosin-like F-actin binding protein 1

increases expression

EXP

Propylthiouracil results in increased expression of COTL1 mRNA

NCBI chr19:64,780,309...64,814,629
Ensembl chr19:64,780,322...64,814,840

G

cytochrome c oxidase copper chaperone COX11

decreases expression

EXP

Propylthiouracil results in decreased expression of COX11 mRNA

PMID:24780913 PMID:30047161

NCBI chr10:75,955,825...75,962,398
Ensembl chr10:75,955,783...75,963,489

G

cytochrome c oxidase assembly factor COX16

increases expression

EXP

Propylthiouracil results in increased expression of COX16 mRNA

NCBI chr 6:106,745,424...106,912,523
Ensembl chr 6:106,899,494...106,912,484

G

cytochrome c oxidase copper chaperone COX17

increases expression

EXP

Propylthiouracil results in increased expression of COX17 mRNA

NCBI chr11:75,906,245...75,912,036
Ensembl chr11:75,906,248...75,912,019

G

cytochrome c oxidase subunit 4i1

affects expression

EXP

Propylthiouracil affects the expression of COX4I1 mRNA

NCBI chr19:65,630,383...65,636,623
Ensembl chr19:65,630,432...65,636,624

G

cytochrome c oxidase subunit 5B

increases expression

EXP

Propylthiouracil results in increased expression of COX5B mRNA

NCBI chr 9:46,417,735...46,419,664
Ensembl chr 9:46,417,838...46,420,403

G

cytochrome c oxidase subunit 6A1

increases expression

EXP

Propylthiouracil results in increased expression of COX6A1 mRNA

NCBI chr12:46,922,709...46,925,762
Ensembl chr12:46,912,648...46,925,768

G

cytochrome c oxidase subunit 6A2

increases expression

EXP

Propylthiouracil results in increased expression of COX6A2 mRNA

NCBI chr 1:192,218,970...192,221,188
Ensembl chr 1:192,218,970...192,219,716

G

cytochrome c oxidase subunit 6B2

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of COX6B2 mRNA
Propylthiouracil results in increased expression of COX6B2 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:78,122,871...78,124,096
Ensembl chr 1:78,122,453...78,124,094

G

cytochrome c oxidase subunit VIc, pseudogene

decreases expression

EXP

Propylthiouracil results in decreased expression of COX6C-PS1 mRNA

NCBI chr19:69,090,047...69,090,905
Ensembl chr19:69,090,047...69,090,905

G

cytochrome c oxidase subunit 7A2

increases expression

EXP

Propylthiouracil results in increased expression of COX7A2 mRNA

NCBI chr 8:89,597,051...89,611,032
Ensembl chr14:55,514,261...55,514,512
Ensembl chr 8:55,514,261...55,514,512

G

cytochrome c oxidase subunit 7A2 like

decreases expression

EXP

Propylthiouracil results in decreased expression of COX7A2L mRNA

NCBI chr 6:16,936,574...16,950,797
Ensembl chr 6:16,936,795...16,950,798

G

cytochrome c oxidase subunit 7B

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of COX7B mRNA
Propylthiouracil results in increased expression of COX7B mRNA

PMID:24780913 PMID:30047161

NCBI chr X:75,149,036...75,155,285
Ensembl chr X:75,148,996...75,155,284

G

cytochrome c oxidase subunit 8A

increases expression

EXP

Propylthiouracil results in increased expression of COX8A mRNA

NCBI chr 1:213,831,302...213,833,623
Ensembl chr 1:213,831,298...213,833,623

G

cytochrome c oxidase, subunit VIIIb

decreases expression

EXP

Propylthiouracil results in decreased expression of COX8B mRNA

NCBI chr 1:205,406,813...205,408,273
Ensembl chr 1:205,406,813...205,408,311

G

ceruloplasmin

multiple interactions
decreases expression
increases expression

EXP

[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of CP protein
Propylthiouracil results in decreased expression of CP mRNA
Propylthiouracil results in increased expression of CP mRNA

PMID:19497425 PMID:24780913 PMID:30047161

NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:104,368,456...104,427,087

G

centrosome assembly and centriole elongation protein

decreases expression

EXP

Propylthiouracil results in decreased expression of CPAP mRNA

NCBI chr15:34,742,838...34,806,020
Ensembl chr15:34,742,838...34,802,421

G

carboxypeptidase D

decreases expression

EXP

Propylthiouracil results in decreased expression of CPD mRNA

NCBI chr10:62,121,681...62,185,638
Ensembl chr10:62,121,679...62,185,638

G

carboxypeptidase E

decreases expression

EXP

Propylthiouracil results in decreased expression of CPE mRNA

NCBI chr16:29,796,707...29,908,647
Ensembl chr16:29,796,689...29,909,524

G

cytoplasmic polyadenylation element binding protein 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CPEB1 mRNA

NCBI chr 1:144,709,278...144,817,388
Ensembl chr 1:144,709,691...144,815,880

G

cytoplasmic polyadenylation element binding protein 4

decreases expression

EXP

Propylthiouracil results in decreased expression of CPEB4 mRNA

NCBI chr10:16,222,271...16,284,248
Ensembl chr10:16,225,672...16,283,787

G

cadherin-like and PC-esterase domain containing 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CPED1 mRNA

NCBI chr 4:51,482,497...51,755,440
Ensembl chr 4:51,482,545...51,755,442

G

complexin 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CPLX1 mRNA

NCBI chr14:1,329,073...1,360,781
Ensembl chr14:1,329,032...1,360,769

G

complexin 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CPLX2 mRNA

PMID:24780913 PMID:30047161

NCBI chr17:10,224,673...10,297,974
Ensembl chr17:10,228,449...10,297,467

G

complexin 3

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CPLX3 mRNA

NCBI chr 8:66,899,438...66,906,200
Ensembl chr 8:66,899,438...66,906,200

G

carboxypeptidase M

decreases expression

EXP

Propylthiouracil results in decreased expression of CPM mRNA

PMID:24780913 PMID:25825206

NCBI chr 7:55,111,599...55,172,114
Ensembl chr 7:55,111,599...55,172,114

G

carboxypeptidase N subunit 1

affects expression

EXP

Propylthiouracil affects the expression of CPN1 mRNA

NCBI chr 1:252,793,786...252,822,675
Ensembl chr 1:252,793,423...252,822,664

G

copine 4

affects expression

EXP

Propylthiouracil affects the expression of CPNE4 mRNA

PMID:24780913 PMID:25825206

NCBI chr 8:114,056,152...114,531,855
Ensembl chr 8:113,993,703...114,531,855

G

copine 6

increases expression

EXP

Propylthiouracil results in increased expression of CPNE6 mRNA

NCBI chr15:32,968,047...32,975,008
Ensembl chr15:32,968,046...32,975,007

G

copine 7

increases expression

EXP

Propylthiouracil results in increased expression of CPNE7 mRNA

PMID:24780913 PMID:25825206

NCBI chr19:68,072,165...68,091,197
Ensembl chr19:68,074,545...68,091,197

G

copine 8

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CPNE8 mRNA
Propylthiouracil results in decreased expression of CPNE8 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 7:123,494,864...123,669,060
Ensembl chr 7:123,494,865...123,669,060

G

copine family member 9

decreases expression

EXP

Propylthiouracil results in decreased expression of CPNE9 mRNA

PMID:24780913 PMID:30047161

NCBI chr 4:147,985,900...148,009,987
Ensembl chr 4:147,986,452...148,009,986

G

coproporphyrinogen oxidase

increases expression

EXP

Propylthiouracil results in increased expression of CPOX mRNA

NCBI chr11:55,405,778...55,415,761
Ensembl chr11:55,405,784...55,415,761

G

carboxypeptidase Q

affects expression

EXP

Propylthiouracil affects the expression of CPQ mRNA

NCBI chr 7:66,148,973...66,719,189
Ensembl chr 7:66,149,377...66,716,137

G

cleavage and polyadenylation specific factor 2

increases expression

EXP

Propylthiouracil results in increased expression of CPSF2 mRNA

NCBI chr 6:126,885,417...126,917,634
Ensembl chr 6:126,885,476...126,917,632

G

cleavage and polyadenylation specific factor 4

decreases expression

EXP

Propylthiouracil results in decreased expression of CPSF4 mRNA

NCBI chr12:14,543,536...14,559,350
Ensembl chr12:14,543,338...14,559,350

G

carnitine palmitoyltransferase 1c

decreases expression

EXP

Propylthiouracil results in decreased expression of CPT1C mRNA

NCBI chr 1:104,579,297...104,593,824
Ensembl chr 1:104,579,298...104,593,763

G

carboxypeptidase, vitellogenic-like

decreases expression

EXP

Propylthiouracil results in decreased expression of CPVL mRNA

NCBI chr 4:84,311,853...84,422,098
Ensembl chr 4:84,311,854...84,416,033

G

carboxypeptidase X (M14 family), member 1

increases expression

EXP

Propylthiouracil results in increased expression of CPXM1 mRNA

PMID:22504374 PMID:24780913

NCBI chr 3:138,041,645...138,048,443
Ensembl chr 3:138,041,645...138,048,857

G

carboxypeptidase X (M14 family), member 2

increases expression

EXP

Propylthiouracil results in increased expression of CPXM2 mRNA

NCBI chr 1:196,266,930...196,377,350
Ensembl chr 1:196,266,930...196,377,347

G

carboxypeptidase Z

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of CPZ mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CPZ mRNA

PMID:24780913 PMID:25825206 PMID:30047161 PMID:36706583

NCBI chr14:79,448,242...79,471,557
Ensembl chr14:79,448,139...79,471,556

G

cellular retinoic acid binding protein 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CRABP1 mRNA
Propylthiouracil results in decreased expression of CRABP1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 8:64,047,431...64,055,469
Ensembl chr 8:64,047,060...64,055,470

G

carnitine O-acetyltransferase

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CRAT mRNA
Propylthiouracil results in decreased expression of CRAT mRNA

PMID:30047161 PMID:36843608

NCBI chr 3:34,073,504...34,087,099
Ensembl chr 3:34,073,506...34,087,099

G

crumbs cell polarity complex component 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CRB1 mRNA

NCBI chr13:53,352,932...53,540,019
Ensembl chr13:53,352,932...53,540,019

G

crumbs cell polarity complex component 3

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CRB3 mRNA
Propylthiouracil results in increased expression of CRB3 mRNA

PMID:24780913 PMID:30047161

NCBI chr 9:1,985,504...1,990,855
Ensembl chr 9:1,983,619...1,993,486

G

cereblon

decreases expression

EXP

Propylthiouracil results in decreased expression of CRBN mRNA

NCBI chr 4:141,255,400...141,276,722
Ensembl chr 4:141,257,243...141,276,038

G

CGRP receptor component

decreases expression

EXP

Propylthiouracil results in decreased expression of CRCP mRNA

NCBI chr12:32,260,108...32,315,116
Ensembl chr12:32,260,143...32,315,237

G

cAMP responsive element binding protein 1

increases expression
increases methylation
decreases expression

EXP

Propylthiouracil results in increased expression of CREB1 mRNA
Propylthiouracil results in increased methylation of CREB1 promoter
Propylthiouracil results in decreased expression of CREB1 mRNA

PMID:22504374 PMID:33150595

NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339

G

cAMP responsive element binding protein 3-like 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CREB3L1 mRNA

NCBI chr 3:98,408,240...98,449,104
Ensembl chr 3:98,408,058...98,449,104

G

cAMP responsive element binding protein 3-like 2

increases expression

EXP

Propylthiouracil results in increased expression of CREB3L2 mRNA

NCBI chr 4:66,874,623...66,990,962
Ensembl chr 4:66,387,126...66,990,832

G

cAMP responsive element binding protein 5

decreases expression

EXP

Propylthiouracil results in decreased expression of CREB5 mRNA

NCBI chr 4:83,723,587...84,124,786
Ensembl chr 4:83,723,194...84,120,793

G

cAMP responsive element binding protein-like 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CREBL2 mRNA
Propylthiouracil results in decreased expression of CREBL2 mRNA

PMID:22504374 PMID:24780913 PMID:30047161

NCBI chr 4:169,404,630...169,430,618
Ensembl chr 4:169,376,495...169,430,611

G

CREB3 regulatory factor

decreases expression

EXP

Propylthiouracil results in decreased expression of CREBRF mRNA

NCBI chr10:16,903,607...16,967,450
Ensembl chr10:16,903,547...16,966,430

G

cAMP responsive element modulator

affects expression
increases expression

EXP

Propylthiouracil affects the expression of CREM mRNA
Propylthiouracil results in increased expression of CREM mRNA

PMID:19483382 PMID:30047161

NCBI chr17:58,932,011...59,001,160
Ensembl chr17:58,934,147...59,001,160

G

corticotropin releasing hormone binding protein

increases expression

EXP

Propylthiouracil results in increased expression of CRHBP mRNA

NCBI chr 2:28,427,139...28,439,446
Ensembl chr 2:28,427,139...28,439,446

G

corticotropin releasing hormone receptor 2

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of CRHR2 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of CRHR2 mRNA

PMID:24780913 PMID:36706583

NCBI chr 4:85,553,163...85,596,203
Ensembl chr 4:85,554,268...85,596,318

G

cysteine rich protein 1

increases expression
affects expression

EXP

Propylthiouracil results in increased expression of CRIP1 mRNA
Propylthiouracil affects the expression of CRIP mRNA

PMID:22504374 PMID:24780913 PMID:30047161

NCBI chr 6:138,047,801...138,055,672
Ensembl chr 6:138,047,801...138,055,672

G

cysteine-rich protein 2

increases expression

EXP

Propylthiouracil results in increased expression of CRIP2 mRNA

NCBI chr 6:138,042,175...138,047,121
Ensembl chr 6:138,041,906...138,047,120

G

cysteine-rich secretory protein 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CRISP1 mRNA
Propylthiouracil results in decreased expression of CRISP1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 9:28,238,326...28,265,344
Ensembl chr 9:28,238,328...28,265,344

G

cysteine-rich secretory protein LCCL domain containing 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CRISPLD1 mRNA

NCBI chr 5:6,050,970...6,098,265
Ensembl chr 5:6,051,891...6,098,265

G

cysteine-rich secretory protein LCCL domain containing 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CRISPLD2 mRNA
Propylthiouracil results in decreased expression of CRISPLD2 mRNA

PMID:22504374 PMID:24780913

NCBI chr19:64,961,764...65,020,099
Ensembl chr19:64,961,771...65,020,349

G

cytokine receptor-like factor 1

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CRLF1 mRNA
Propylthiouracil results in increased expression of CRLF1 mRNA

PMID:24780913 PMID:30047161

NCBI chr16:18,958,695...18,970,026
Ensembl chr16:18,957,956...18,969,970

G

cytokine receptor-like factor 2

increases expression

EXP

Propylthiouracil results in increased expression of CRLF2 mRNA

NCBI chr14:118,932...123,632
Ensembl chr14:115,497...123,631

G

collapsin response mediator protein 1

increases expression

EXP

Propylthiouracil results in increased expression of CRMP1 mRNA

NCBI chr14:77,734,675...77,780,916
Ensembl chr14:77,734,675...77,780,916

G

ciliary rootlet coiled-coil, rootletin

increases expression

EXP

Propylthiouracil results in increased expression of CROCC mRNA

NCBI chr 5:158,603,979...158,646,728
Ensembl chr 5:158,603,556...158,640,238

G

carnitine O-octanoyltransferase

increases expression

EXP

Propylthiouracil results in increased expression of CROT mRNA

NCBI chr 4:26,031,729...26,088,057
Ensembl chr 4:26,052,516...26,088,064

G

cytotoxic and regulatory T cell molecule

decreases expression

EXP

Propylthiouracil results in decreased expression of CRTAM mRNA

NCBI chr 8:50,237,210...50,274,472
Ensembl chr 8:50,237,210...50,274,472

G

cartilage associated protein

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CRTAP mRNA
Propylthiouracil results in decreased expression of CRTAP mRNA

PMID:24780913 PMID:30047161

NCBI chr 8:122,926,117...122,945,843
Ensembl chr 8:122,926,117...122,945,843

G

Crx opposite strand transcript 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CRXOS1 mRNA

NCBI chr 1:85,705,982...85,708,806
Ensembl chr 1:85,706,012...85,708,813

G

cryptochrome circadian regulator 1

increases expression

EXP

Propylthiouracil results in increased expression of CRY1 mRNA

NCBI chr 7:20,417,526...20,481,791
Ensembl chr 7:20,417,107...20,481,822

G

crystallin, alpha A

decreases expression

EXP

Propylthiouracil results in decreased expression of CRYAA mRNA

NCBI chr20:9,784,872...9,788,656
Ensembl chr20:9,784,857...9,788,654

G

crystallin, alpha B

decreases expression

EXP

Propylthiouracil results in decreased expression of CRYAB mRNA

PMID:24780913 PMID:25825206

NCBI chr 8:59,989,885...59,995,532
Ensembl chr 8:59,989,814...59,995,528

G

crystallin, beta A1

decreases expression

EXP

Propylthiouracil results in decreased expression of CRYBA1 mRNA

NCBI chr10:63,106,465...63,113,020
Ensembl chr10:63,106,475...63,112,817

G

crystallin, beta B3

decreases expression

EXP

Propylthiouracil results in decreased expression of CRYBB3 mRNA

NCBI chr12:49,217,554...49,222,565
Ensembl chr12:49,217,554...49,222,565

G

crystallin beta-gamma domain containing 2

increases expression

EXP

Propylthiouracil results in increased expression of CRYBG2 mRNA

NCBI chr 5:151,570,154...151,602,164
Ensembl chr 5:151,570,540...151,602,163

G

crystallin, gamma A

increases expression

EXP

Propylthiouracil results in increased expression of CRYGA mRNA

NCBI chr 9:73,975,914...74,006,614
Ensembl chr 9:73,975,914...74,003,290

G

crystallin, gamma D

affects expression

EXP

Propylthiouracil affects the expression of CRYGD mRNA

NCBI chr 9:73,935,798...73,937,409
Ensembl chr 9:73,935,795...73,937,808

G

crystallin, gamma N

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CRYGN mRNA

NCBI chr 4:11,286,475...11,294,002
Ensembl chr 4:11,286,475...11,294,002

G

crystallin, mu

increases expression

EXP

Propylthiouracil results in increased expression of CRYM mRNA

PMID:24780913 PMID:30047161 PMID:36843608

NCBI chr 1:183,991,752...184,006,923
Ensembl chr 1:183,991,745...184,006,962

G

cysteine sulfinic acid decarboxylase

decreases expression

EXP

Propylthiouracil results in decreased expression of CSAD mRNA

PMID:18077114 PMID:24780913 PMID:39441382

NCBI chr 7:135,187,175...135,216,495
Ensembl chr 7:135,187,175...135,215,581

G

common salivary protein 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CSAP1 mRNA

NCBI chr10:13,414,952...13,420,913
Ensembl chr10:13,416,336...13,420,908

G

chromosome segregation 1 like

increases expression

EXP

Propylthiouracil results in increased expression of CSE1L mRNA

NCBI chr 3:176,060,183...176,097,909
Ensembl chr 3:176,060,215...176,108,734

G

colony stimulating factor 1

increases expression

EXP

Propylthiouracil results in increased expression of CSF1 mRNA

NCBI chr 2:198,065,400...198,084,774
Ensembl chr 2:198,065,405...198,084,468

G

colony stimulating factor 1 receptor

increases expression

EXP

Propylthiouracil results in increased expression of CSF1R mRNA

NCBI chr18:56,834,152...56,860,804
Ensembl chr18:56,817,049...56,860,806

G

chondroitin sulfate N-acetylgalactosaminyltransferase 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CSGALNACT2 mRNA

NCBI chr 4:152,944,154...152,981,237
Ensembl chr 4:152,950,028...152,981,220

G

C-terminal Src kinase

increases expression

EXP

Propylthiouracil results in increased expression of CSK mRNA

NCBI chr 8:66,925,650...66,944,861
Ensembl chr 8:66,925,651...66,930,274

G

CUB and Sushi multiple domains 1

increases expression

EXP

Propylthiouracil results in increased expression of CSMD1 mRNA

PMID:24780913 PMID:25825206

NCBI chr16:78,920,549...80,520,710
Ensembl chr16:78,921,002...80,519,944

G

casein alpha s1

increases expression

EXP

Propylthiouracil results in increased expression of CSN1S1 mRNA

NCBI chr14:20,622,858...20,638,849

G

casein alpha s2-like B

decreases expression

EXP

Propylthiouracil results in decreased expression of CSN1S2B mRNA

NCBI chr14:20,529,498...20,545,618
Ensembl chr14:20,529,498...20,545,749

G

casein kinase 1, delta

increases expression

EXP

Propylthiouracil results in increased expression of CSNK1D mRNA

NCBI chr10:106,713,497...106,754,953
Ensembl chr10:106,694,279...106,754,953

G

casein kinase 1, epsilon

increases expression

EXP

Propylthiouracil results in increased expression of CSNK1E mRNA

NCBI chr 7:112,863,726...112,887,338
Ensembl chr 7:112,863,731...112,884,101

G

casein kinase 1, gamma 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CSNK1G1 mRNA

NCBI chr 8:75,334,751...75,472,339
Ensembl chr 8:75,334,895...75,467,515

G

casein kinase 2 alpha 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CSNK2A2 mRNA

NCBI chr19:9,562,340...9,602,136
Ensembl chr19:9,562,321...9,602,136

G

casein kinase 2 beta

affects expression

EXP

Propylthiouracil affects the expression of CSNK2B mRNA

NCBI chr20:3,704,833...3,709,999
Ensembl chr20:3,704,904...3,710,525

G

chondroitin sulfate proteoglycan 4

increases expression

EXP

Propylthiouracil results in increased expression of CSPG4 mRNA

PMID:24780913 PMID:30047161

NCBI chr 8:66,160,942...66,195,987
Ensembl chr 8:66,160,942...66,200,806

G

cysteine and serine rich nuclear protein 1

increases expression

EXP

Propylthiouracil results in increased expression of CSRNP1 mRNA

NCBI chr 8:128,582,364...128,594,163
Ensembl chr 8:128,582,365...128,588,469

G

cysteine and serine rich nuclear protein 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CSRNP2 mRNA

NCBI chr 7:133,473,027...133,488,868
Ensembl chr 7:133,473,027...133,488,868

G

cysteine and serine rich nuclear protein 3

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CSRNP3 mRNA
Propylthiouracil results in increased expression of H3C10 mRNA

PMID:24780913 PMID:30047161

NCBI chr 3:70,906,587...71,102,596
Ensembl chr 3:70,906,380...71,094,009

G

cysteine and glycine-rich protein 1

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of CSRP1 mRNA
Propylthiouracil results in decreased expression of CSRP1 mRNA

PMID:19483382 PMID:24780913

NCBI chr13:49,709,928...49,731,141
Ensembl chr13:49,709,914...49,731,139

G

cysteine and glycine-rich protein 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CSRP2 mRNA

NCBI chr 7:48,235,415...48,254,049
Ensembl chr 7:48,235,383...48,266,238

G

cystatin C

decreases expression

EXP

Propylthiouracil results in decreased expression of CST3 mRNA

NCBI chr 3:156,790,061...156,794,116
Ensembl chr 3:156,790,079...156,793,937

G

cystatin E/M

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of CST6 mRNA
Propylthiouracil results in decreased expression of CST6 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 1:212,084,676...212,086,384
Ensembl chr 1:212,084,676...212,086,384

G

cystatin F

decreases expression

EXP

Propylthiouracil results in decreased expression of CST7 mRNA

NCBI chr 3:159,857,221...159,865,987
Ensembl chr 3:159,857,052...159,866,919

G

cleavage stimulation factor subunit 2

increases expression

EXP

Propylthiouracil results in increased expression of CSTF2 mRNA

NCBI chr X:101,546,809...101,572,760
Ensembl chr X:101,546,819...101,572,764

G

C-terminal binding protein 1

increases expression

EXP

Propylthiouracil results in increased expression of CTBP1 mRNA

NCBI chr14:81,679,956...81,707,331
Ensembl chr14:81,679,765...81,707,554

G

C-terminal binding protein 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CTBP2 mRNA

NCBI chr 1:197,208,536...197,348,802
Ensembl chr 1:197,212,133...197,254,261

G

chitobiase

increases expression

EXP

Propylthiouracil results in increased expression of CTBS mRNA

NCBI chr 2:238,000,800...238,015,368
Ensembl chr 2:238,000,842...238,015,475

G

CTD small phosphatase like

increases expression

EXP

Propylthiouracil results in increased expression of CTDSPL mRNA

NCBI chr 8:127,520,478...127,644,999
Ensembl chr 8:127,520,499...127,644,999

G

cardiotrophin 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CTF1 mRNA
Propylthiouracil results in decreased expression of CTF1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:191,758,512...191,771,259
Ensembl chr 1:191,757,477...191,776,395

G

cystathionine gamma-lyase

increases expression

EXP

Propylthiouracil results in increased expression of CTH mRNA

NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:249,634,731...249,661,066

G

collagen triple helix repeat containing 1

increases expression

EXP

Propylthiouracil results in increased expression of CTHRC1 mRNA

NCBI chr 7:72,007,372...72,017,654
Ensembl chr 7:72,007,372...72,017,654

G

catenin alpha 1

affects expression

EXP

Propylthiouracil affects the expression of CTNNA1 mRNA

NCBI chr18:27,002,330...27,135,009
Ensembl chr18:26,999,820...27,135,007

G

catenin alpha 3

decreases expression

EXP

Propylthiouracil results in decreased expression of CTNNA3 mRNA

PMID:24780913 PMID:25825206

NCBI chr20:23,613,016...25,198,699
Ensembl chr20:23,613,016...25,198,805

G

catenin alpha-like 1

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of CTNNAL1 mRNA
Propylthiouracil results in decreased expression of CTNNAL1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 5:76,309,546...76,375,869
Ensembl chr 5:76,309,546...76,364,637

G

catenin beta 1

increases expression
decreases expression
multiple interactions

EXP

Propylthiouracil results in increased expression of CTNNB1 mRNA
Propylthiouracil results in decreased expression of CTNNB1 mRNA
thymoquinone inhibits the reaction [Propylthiouracil results in decreased expression of CTNNB1 mRNA]

PMID:24780913 PMID:30047161 PMID:34234489

NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662

G

catenin delta 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CTNND1 mRNA
Propylthiouracil results in decreased expression of CTNND1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 3:90,090,025...90,141,247
Ensembl chr 3:90,090,564...90,141,189

G

CTP synthase 1

increases expression

EXP

Propylthiouracil results in increased expression of CTPS1 mRNA

NCBI chr 5:139,372,349...139,440,441
Ensembl chr 5:139,410,249...139,440,465

G

chymotrypsin C

decreases expression

EXP

Propylthiouracil results in decreased expression of CTRC mRNA

NCBI chr 5:159,430,333...159,439,557
Ensembl chr 5:159,430,335...159,439,545

G

cathepsin 7 like 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CTS7L1 mRNA

NCBI chr17:3,313,381...3,317,312
Ensembl chr17:3,312,327...3,317,312

G

cathepsin B

decreases expression

ISO
EXP

Propylthiouracil results in decreased expression of CTSB mRNA
Propylthiouracil results in decreased expression of CTSB mRNA; Propylthiouracil results in decreased expression of CTSB protein

PMID:22342233 PMID:39441382

NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478

G

cathepsin E

decreases expression

EXP

Propylthiouracil results in decreased expression of CTSE mRNA

NCBI chr13:45,644,168...45,666,722
Ensembl chr13:45,644,147...45,666,722

G

cathepsin H

increases expression

EXP

Propylthiouracil results in increased expression of CTSH mRNA

NCBI chr 8:99,488,756...99,507,639
Ensembl chr 8:99,488,874...99,509,181

G

cathepsin K

increases expression

EXP

Propylthiouracil results in increased expression of CTSK mRNA

NCBI chr 2:185,747,548...185,758,512
Ensembl chr 2:185,747,165...185,765,582

G

cathepsin Q-like 2

increases expression

EXP

Propylthiouracil results in increased expression of CTSQL2 mRNA

NCBI chr17:3,704,585...3,710,404

G

cortactin

increases expression

EXP

Propylthiouracil results in increased expression of CTTN mRNA

NCBI chr 1:209,029,048...209,064,577
Ensembl chr 1:209,029,048...209,058,211

G

cortactin binding protein 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CTTNBP2 mRNA

NCBI chr 4:47,766,867...47,930,598
Ensembl chr 4:47,766,870...47,930,540

G

CTTNBP2 N-terminal like

increases expression

EXP

Propylthiouracil results in increased expression of CTTNBP2NL mRNA

PMID:22504374 PMID:24780913 PMID:30047161

NCBI chr 2:195,196,318...195,244,792
Ensembl chr 2:195,196,318...195,243,181

G

cytosolic thiouridylase subunit 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CTU1 mRNA

NCBI chr 1:103,251,983...103,257,778
Ensembl chr 1:103,251,995...103,257,775

G

cortexin 1

increases expression

EXP

Propylthiouracil results in increased expression of CTXN1 mRNA

NCBI chr12:7,408,308...7,409,919
Ensembl chr12:7,408,309...7,409,919

G

cortexin 2

increases expression

EXP

Propylthiouracil results in increased expression of CTXN2 mRNA

NCBI chr 3:132,842,237...132,854,774
Ensembl chr 3:132,854,331...132,854,770

G

cortexin 3

decreases expression

EXP

Propylthiouracil results in decreased expression of CTXN3 mRNA

PMID:24780913 PMID:30047161

NCBI chr18:53,129,505...53,138,694
Ensembl chr18:53,129,489...53,138,693

G

cubilin

increases expression

EXP

Propylthiouracil results in increased expression of CUBN mRNA

PMID:22504374 PMID:30047161

NCBI chr17:81,293,619...81,501,694
Ensembl chr17:81,293,619...81,501,694

G

CUE domain containing 2

increases expression

EXP

Propylthiouracil results in increased expression of CUEDC2 mRNA

NCBI chr 1:255,133,479...255,142,016
Ensembl chr 1:255,133,421...255,141,956

G

cullin 9

decreases expression

EXP

Propylthiouracil results in decreased expression of CUL9 mRNA

NCBI chr 9:21,933,699...21,977,145
Ensembl chr 9:21,933,803...21,977,145

G

cut-like homeobox 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CUX1 mRNA

NCBI chr12:25,728,393...26,062,497
Ensembl chr12:25,743,733...26,062,497

G

cut-like homeobox 2

increases expression

EXP

Propylthiouracil results in increased expression of CUX2 mRNA

NCBI chr12:40,168,402...40,368,303
Ensembl chr12:40,149,292...40,366,528

G

cell wall biogenesis 43 C-terminal homolog

affects expression
multiple interactions

EXP
ISO

Propylthiouracil affects the expression of CWH43 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CWH43 mRNA

PMID:24780913 PMID:36706583

NCBI chr14:35,108,328...35,154,578
Ensembl chr14:35,108,338...35,154,863

G

C-X3-C motif chemokine receptor 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CX3CR1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 8:128,661,294...128,679,048
Ensembl chr 8:128,654,833...128,685,983

G

CXADR, Ig-like cell adhesion molecule

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CXADR mRNA
Propylthiouracil results in decreased expression of CXADR mRNA

PMID:24780913 PMID:30047161

NCBI chr11:30,469,778...30,516,990
Ensembl chr11:30,469,526...30,516,988

G

coxsackie virus and adenovirus receptor-like 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CXADRL1 mRNA
Propylthiouracil results in decreased expression of CXADRL1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 8:108,444,792...108,470,345
Ensembl chr 8:108,444,792...108,470,345

G

C-X-C motif chemokine ligand 1

increases expression

EXP

Propylthiouracil results in increased expression of CXCL1 mRNA

NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,477,549...17,479,811

G

C-X-C motif chemokine ligand 12

increases expression

EXP

Propylthiouracil results in increased expression of CXCL12 mRNA

NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627

G

C-X-C motif chemokine ligand 14

decreases expression

EXP

Propylthiouracil results in decreased expression of CXCL14 mRNA

PMID:24780913 PMID:30047161

NCBI chr17:8,323,150...8,331,176
Ensembl chr17:8,323,143...8,331,172

G

C-X-C motif chemokine ligand 16

increases expression

EXP

Propylthiouracil results in increased expression of CXCL16 mRNA

NCBI chr10:55,665,355...55,669,950
Ensembl chr10:55,664,742...55,670,226

G

C-X-C motif chemokine ligand 17

increases expression

EXP

Propylthiouracil results in increased expression of CXCL17 mRNA

NCBI chr 1:90,112,561...90,124,648
Ensembl chr 1:90,112,771...90,124,535

G

C-X-C motif chemokine ligand 3

decreases expression

EXP

Propylthiouracil results in decreased expression of CXCL3 mRNA

NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624

G

C-X-C motif chemokine receptor 4

increases expression
increases methylation
decreases expression

EXP

Propylthiouracil results in increased expression of CXCR4 mRNA
Propylthiouracil results in increased methylation of CXCR4 promoter
Propylthiouracil results in decreased expression of CXCR4 mRNA

PMID:24780913 PMID:30047161 PMID:33150595

NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459

G

similar to human chromosome X open reading frame 38

increases expression

EXP

Propylthiouracil results in increased expression of CXHXORF38 mRNA

NCBI chr X:12,800,935...12,823,632
Ensembl chr X:12,802,377...12,814,198

G

CXXC finger protein 4

increases expression

EXP

Propylthiouracil results in increased expression of CXXC4 mRNA

NCBI chr 2:225,329,044...225,363,347

G

cytochrome b-561

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CYB561 mRNA
Propylthiouracil results in increased expression of CYB561 mRNA

PMID:25825206 PMID:30047161

NCBI chr10:91,377,866...91,388,548
Ensembl chr10:91,377,866...91,385,097

G

cytochrome b561 family, member D1

decreases expression

EXP

Propylthiouracil results in decreased expression of CYB561D1 mRNA

NCBI chr 2:198,523,031...198,525,671
Ensembl chr 2:198,523,031...198,525,676

G

cytochrome b561 family, member D2

increases expression

EXP

Propylthiouracil results in increased expression of CYB561D2 mRNA

NCBI chr 8:117,091,844...117,094,434
Ensembl chr 8:117,091,845...117,094,366

G

cytochrome b5 reductase 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of CYB5R2 mRNA
Propylthiouracil results in decreased expression of CYB5R2 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:171,062,083...171,076,183
Ensembl chr 1:171,067,614...171,075,904

G

cytochrome b-245 beta chain

increases expression

EXP

Propylthiouracil results in increased expression of CYBB mRNA

PMID:23921912 PMID:24780913

NCBI chr X:16,030,596...16,065,065
Ensembl chr X:16,030,596...16,065,065

G

cytochrome b reductase 1

increases expression

EXP

Propylthiouracil results in increased expression of CYBRD1 mRNA

NCBI chr 3:76,342,231...76,369,846
Ensembl chr 3:76,342,404...76,370,061

G

cytochrome c-1

increases expression

EXP

Propylthiouracil results in increased expression of CYC1 mRNA

NCBI chr 7:109,947,750...109,950,142
Ensembl chr 7:109,947,766...109,950,657

G

cytochrome c, somatic

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CYCS mRNA
Propylthiouracil results in increased expression of CYCS mRNA

PMID:24780913 PMID:30047161

NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816
Ensembl chr18:80,982,668...80,984,816

G

cytoplasmic FMR1 interacting protein 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CYFIP2 mRNA

NCBI chr10:31,122,653...31,242,440
Ensembl chr10:31,122,653...31,242,440

G

chymosin

decreases expression

EXP

Propylthiouracil results in decreased expression of CYM mRNA; Propylthiouracil results in decreased expression of PGA5 mRNA

PMID:24780913 PMID:30047161

NCBI chr 2:197,516,947...197,527,307
Ensembl chr 2:197,516,950...197,527,837

G

cytochrome P450, family 11, subfamily a, polypeptide 1

decreases expression
multiple interactions

ISO

Propylthiouracil results in decreased expression of CYP11A1 protein
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CYP11A1 mRNA

PMID:29578053 PMID:36706583

NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:67,270,556...67,330,196

G

cytochrome P450, family 11, subfamily b, polypeptide 3

decreases expression

EXP

Propylthiouracil results in decreased expression of CYP11B2 mRNA; Propylthiouracil results in decreased expression of CYP11B3 mRNA

NCBI chr 7:108,689,319...108,694,808
Ensembl chr 7:108,689,165...108,694,921

G

cytochrome P450, family 19, subfamily a, polypeptide 1

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CYP19A1 mRNA

NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917

G

cytochrome P450, family 1, subfamily b, polypeptide 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CYP1B1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142

G

cytochrome P450, family 20, subfamily a, polypeptide 1

increases expression

EXP

Propylthiouracil results in increased expression of CYP20A1 mRNA

NCBI chr 9:69,249,841...69,299,146
Ensembl chr 9:69,249,844...69,299,291

G

cytochrome P450, family 26, subfamily a, polypeptide 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CYP26A1 mRNA

NCBI chr 1:244,883,822...244,887,657
Ensembl chr 1:244,883,752...244,887,657

G

cytochrome P450, family 26, subfamily b, polypeptide 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CYP26B1 mRNA

PMID:24780913 PMID:25825206

NCBI chr 4:118,599,356...118,616,176
Ensembl chr 4:118,599,356...118,616,176

G

cytochrome P450, family 27, subfamily a, polypeptide 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CYP27A1 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:83,713,293...83,743,215

G

cytochrome P450, family 2, subfamily a, polypeptide 1

affects expression
increases expression

EXP

Propylthiouracil affects the expression of CYP2A1 mRNA
Propylthiouracil results in increased expression of CYP2A1 mRNA

PMID:19483382 PMID:22504374

NCBI chr 1:91,359,278...91,372,554
Ensembl chr 1:91,359,272...91,389,730

G

cytochrome P450, family 2, subfamily ab, polypeptide 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CYP2AB1 mRNA

NCBI chr11:94,085,653...94,095,280
Ensembl chr11:94,087,353...94,095,597

G

cytochrome P450, family 2, subfamily b, polypeptide 2

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of CYP2B2 mRNA
Propylthiouracil results in decreased expression of CYP2B2 mRNA

PMID:19483382 PMID:30047161

NCBI chr 1:90,722,243...90,736,272

G

cytochrome P450, family 2, subfamily b, polypeptide 3

affects expression
multiple interactions

EXP
ISO

Propylthiouracil affects the expression of CYP2B3 mRNA
[Iodine deficiency co-treated with Propylthiouracil] results in increased expression of CYP2B10 mRNA

PMID:19483382 PMID:22503787

NCBI chr 1:90,780,468...90,859,852

G

cytochrome P450, subfamily 2, polypeptide 11

increases expression

EXP

Propylthiouracil results in increased expression of CYP2C11 mRNA

NCBI chr 1:246,175,216...246,211,445
Ensembl chr 1:246,174,711...246,211,853

G

cytochrome P450, family 2, subfamily c, polypeptide 23

decreases expression

EXP

Propylthiouracil results in decreased expression of CYP2C23 mRNA

NCBI chr 1:252,838,427...252,863,081
Ensembl chr 1:252,838,433...252,863,067

G

cytochrome P450, family 2, subfamily C, polypeptide 6

decreases expression

EXP

Propylthiouracil results in decreased expression of CYP2C6 mRNA

NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798

G

cytochrome P450, family 2, subfamily c, polypeptide 79

decreases expression

EXP

Propylthiouracil results in decreased expression of CYP2C79 mRNA

G

cytochrome P450, family 2, subfamily d, polypeptide 1

increases expression

EXP

Propylthiouracil results in increased expression of CYP2D1 mRNA

NCBI chr 7:115,789,026...115,793,430
Ensembl chr 7:115,789,023...115,793,479

G

cytochrome P450, family 2, subfamily d, polypeptide 3

affects expression

EXP

Propylthiouracil affects the expression of CYP2D3 mRNA

NCBI chr 7:115,797,785...115,802,142
Ensembl chr 7:115,797,789...115,802,158

G

cytochrome P450, family 2, subfamily d, polypeptide 4

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of CYP2D4 mRNA
Propylthiouracil results in decreased expression of CYP2D4 mRNA

PMID:19483382 PMID:24780913

NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837

G

cytochrome P450, family 2, subfamily d, polypeptide 5

increases expression

EXP

Propylthiouracil results in increased expression of CYP2D5 mRNA

NCBI chr 7:115,779,981...115,784,554

G

cytochrome P450, family 2, subfamily f, polypeptide 4

affects expression
multiple interactions

EXP
ISO

Propylthiouracil affects the expression of CYP2F4 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CYP2F2 mRNA

PMID:19483382 PMID:36706583

NCBI chr 1:91,543,768...91,557,553
Ensembl chr 1:91,543,768...91,557,553

G

cytochrome P450, family 2, subfamily j, polypeptide 10

decreases expression

EXP

Propylthiouracil results in decreased expression of CYP2J10 mRNA

PMID:24780913 PMID:25825206

NCBI chr 5:116,076,012...116,110,914
Ensembl chr 5:116,023,198...116,110,897

G

cytochrome P450, family 2, subfamily j, polypeptide 3

decreases expression

EXP

Propylthiouracil results in decreased expression of CYP2J3 mRNA

PMID:24780913 PMID:30047161

NCBI chr 5:116,335,755...116,360,677
Ensembl chr 5:116,335,755...116,360,499

G

cytochrome P450, family 2, subfamily j, polypeptide 4

affects expression

EXP

Propylthiouracil affects the expression of CYP2J4 mRNA

NCBI chr 5:116,295,691...116,323,219
Ensembl chr 5:116,295,694...116,323,042

G

cytochrome P450, family 2, subfamily r, polypeptide 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CYP2R1 mRNA

NCBI chr 1:178,166,984...178,232,191
Ensembl chr 1:178,219,704...178,232,423

G

cytochrome P450, family 2, subfamily t, polypeptide 1

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of CYP2T1 mRNA
Propylthiouracil results in decreased expression of CYP2T1 mRNA

PMID:19483382 PMID:24780913

NCBI chr 1:91,573,923...91,579,215
Ensembl chr 1:91,574,572...91,579,215

G

cytochrome P450, family 2, subfamily u, polypeptide 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CYP2U1 mRNA

NCBI chr 2:222,523,516...222,541,055
Ensembl chr 2:222,523,518...222,541,124

G

cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1

affects expression

EXP

Propylthiouracil affects the expression of CYP3A23-3A1 mRNA

NCBI chr12:14,369,950...14,398,803
Ensembl chr12:14,368,266...14,398,813

G

cytochrome P450, family 3, subfamily a, polypeptide 9

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of CYP3A9 mRNA
Propylthiouracil results in decreased expression of CYP3A9 mRNA

PMID:19483382 PMID:24780913 PMID:25825206

NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154

G

cytochrome P450, family 46, subfamily a, polypeptide 1

decreases expression
increases methylation

EXP

Propylthiouracil results in decreased expression of CYP46A1 mRNA
Propylthiouracil results in increased methylation of CYP46A1 gene

PMID:36843608 PMID:37926403

NCBI chr 6:133,011,948...133,039,167
Ensembl chr 6:133,011,989...133,041,971

G

cytochrome P450, family 4, subfamily a, polypeptide 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CYP4A1 mRNA

NCBI chr 5:134,360,096...134,374,233
Ensembl chr 5:134,360,111...134,374,231

G

cytochrome P450, family 4, subfamily a, polypeptide 8

affects expression

EXP

Propylthiouracil affects the expression of CYP4A8 mRNA

NCBI chr 5:133,938,882...133,970,226
Ensembl chr 5:133,938,883...133,970,226

G

cytochrome P450, family 4, subfamily b, polypeptide 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CYP4B1 mRNA

NCBI chr 5:134,375,807...134,413,635
Ensembl chr 5:134,375,807...134,393,116

G

cytochrome P450, family 4, subfamily f, polypeptide 18

decreases expression

EXP

Propylthiouracil results in decreased expression of CYP4F18 mRNA

PMID:24780913 PMID:30047161

NCBI chr16:17,797,558...17,838,958
Ensembl chr16:17,740,001...17,838,958

G

cytochrome P450, family 4, subfamily f, polypeptide 6

affects expression

EXP

Propylthiouracil affects the expression of CYP4F6 mRNA

NCBI chr 7:12,680,799...12,708,378
Ensembl chr 7:12,680,806...12,708,402

G

cytochrome P450, family 4, subfamily v, polypeptide 3

decreases expression

EXP

Propylthiouracil results in decreased expression of CYP4V3 mRNA

NCBI chr16:53,650,978...53,675,916
Ensembl chr16:53,650,569...53,676,746

G

cytochrome P450, family 4, subfamily x, polypeptide 1

increases expression

EXP

Propylthiouracil results in increased expression of CYP4X1 mRNA

NCBI chr 5:133,888,439...133,923,254
Ensembl chr 5:133,888,439...133,919,642

G

cytochrome P450, family 51

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of CYP51 mRNA
Propylthiouracil results in increased expression of CYP51 mRNA

PMID:24780913 PMID:30047161

NCBI chr 4:30,991,693...31,010,147
Ensembl chr 4:30,991,613...31,010,450

G

cytohesin 1 interacting protein

decreases expression

EXP

Propylthiouracil results in decreased expression of CYTIP mRNA

NCBI chr 3:63,106,895...63,183,769
Ensembl chr 3:63,107,607...63,134,832

G

cytokine like 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CYTL1 mRNA

NCBI chr14:77,278,635...77,283,645
Ensembl chr14:77,278,636...77,283,645

G

cysteine and tyrosine rich 1

decreases expression

EXP

Propylthiouracil results in decreased expression of CYYR1 mRNA

NCBI chr11:38,044,003...38,150,391
Ensembl chr11:38,001,699...38,164,473

G

DAB adaptor protein 1

multiple interactions

EXP

[Thioctic Acid co-treated with Propylthiouracil] results in increased expression of DAB1 mRNA

NCBI chr 5:123,621,510...124,742,585
Ensembl chr 5:124,369,415...124,742,584

G

DAB adaptor protein 2

decreases expression

EXP

Propylthiouracil results in decreased expression of DAB2 mRNA

PMID:24780913 PMID:25825206

NCBI chr 2:57,241,947...57,294,893
Ensembl chr 2:57,242,064...57,294,888

G

DAB2 interacting protein

increases expression
increases methylation
decreases expression

EXP

Propylthiouracil results in increased expression of DAB2IP mRNA
Propylthiouracil results in increased methylation of DAB2IP promoter
Propylthiouracil results in decreased expression of DAB2IP mRNA

PMID:30047161 PMID:33150595

NCBI chr 3:39,312,745...39,483,730
Ensembl chr 3:39,312,745...39,483,730

G

dishevelled-binding antagonist of beta-catenin 1

increases expression

EXP

Propylthiouracil results in increased expression of DACT1 mRNA

NCBI chr 6:95,526,645...95,538,625
Ensembl chr 6:95,526,690...95,551,053

G

dishevelled-binding antagonist of beta-catenin 2

decreases expression

EXP

Propylthiouracil results in decreased expression of DACT2 mRNA

NCBI chr 1:63,854,182...63,864,153
Ensembl chr 1:63,854,182...63,864,255

G

defender against cell death 1

increases expression

EXP

Propylthiouracil results in increased expression of DAD1 mRNA

NCBI chr15:31,647,326...31,667,159
Ensembl chr15:31,647,326...31,667,287

G

dystroglycan 1

decreases expression

EXP

Propylthiouracil results in decreased expression of DAG1 mRNA

NCBI chr 8:117,769,517...117,834,347
Ensembl chr 8:117,769,517...117,782,199

G

diacylglycerol lipase, alpha

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of DAGLA mRNA
Propylthiouracil results in increased expression of DAGLA mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:216,315,515...216,372,219
Ensembl chr 1:216,315,516...216,372,111

G

DALR anticodon binding domain containing 3

decreases expression

EXP

Propylthiouracil results in decreased expression of DALRD3 mRNA

PMID:24780913 PMID:30047161

NCBI chr 8:118,142,009...118,147,082
Ensembl chr 8:118,144,197...118,147,822

G

D-amino-acid oxidase

decreases expression
increases methylation

EXP

Propylthiouracil results in decreased expression of DAO mRNA
Propylthiouracil results in increased methylation of DAO promoter

PMID:24780913 PMID:25825206 PMID:33150595

NCBI chr12:48,252,900...48,275,964
Ensembl chr12:48,252,902...48,273,300

G

death-associated protein

increases expression

EXP

Propylthiouracil results in increased expression of DAP mRNA

NCBI chr 2:83,910,113...83,962,673
Ensembl chr 2:83,910,060...83,962,673

G

death associated protein kinase 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of DAPK1 mRNA
Propylthiouracil results in decreased expression of DAPK1 mRNA

PMID:25825206 PMID:30047161

NCBI chr17:3,935,826...4,096,858
Ensembl chr17:3,935,625...4,096,581

G

death-associated protein kinase 2

decreases expression

EXP

Propylthiouracil results in decreased expression of DAPK2 mRNA

PMID:24780913 PMID:25825206

NCBI chr 8:75,601,621...75,720,619
Ensembl chr 8:75,601,634...75,720,617

G

death-associated protein kinase 3

increases methylation
decreases expression

EXP

Propylthiouracil results in increased methylation of DAPK3 promoter
Propylthiouracil results in decreased expression of DAPK3 mRNA

NCBI chr 7:9,174,903...9,183,272
Ensembl chr 7:9,174,904...9,183,272

G

death associated protein-like 1

decreases expression

EXP

Propylthiouracil results in decreased expression of DAPL1 mRNA

NCBI chr 3:64,369,734...64,389,677
Ensembl chr 3:64,369,546...64,389,677

G

dual adaptor of phosphotyrosine and 3-phosphoinositides 1

increases expression

EXP

Propylthiouracil results in increased expression of DAPP1 mRNA

NCBI chr 2:229,099,319...229,148,868
Ensembl chr 2:229,099,319...229,148,843

G

DAZ associated protein 2

increases expression

EXP

Propylthiouracil results in increased expression of DAZAP2 mRNA

NCBI chr 7:133,593,503...133,599,044
Ensembl chr 7:133,593,512...133,599,047

G

deleted in azoospermia-like

decreases expression

EXP

Propylthiouracil results in decreased expression of DAZL mRNA

NCBI chr 9:18,193,363...18,210,100
Ensembl chr 9:18,193,363...18,210,100

G

DBF4-CDC7 kinase regulatory subunit

increases expression

EXP

Propylthiouracil results in increased expression of DBF4 mRNA

NCBI chr 4:26,631,491...26,656,080
Ensembl chr 4:26,631,514...26,656,562

G

dopamine beta-hydroxylase

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of DBH mRNA
Propylthiouracil results in decreased expression of DBH mRNA

PMID:24780913 PMID:37926403

NCBI chr 3:30,886,313...30,903,313
Ensembl chr 3:30,886,328...30,903,316

G

diazepam binding inhibitor

affects expression

EXP

Propylthiouracil affects the expression of DBI mRNA

NCBI chr13:33,794,231...33,802,632
Ensembl chr13:33,759,845...33,821,450

G

drebrin 1

increases expression

EXP

Propylthiouracil results in increased expression of DBN1 mRNA

NCBI chr17:9,155,729...9,170,121
Ensembl chr17:9,155,787...9,170,122

G

dysbindin domain containing 2

decreases expression

EXP

Propylthiouracil results in decreased expression of DBNDD2 mRNA

PMID:24780913 PMID:25825206

NCBI chr 3:173,634,551...173,639,999

G

drebrin-like

increases expression

EXP

Propylthiouracil results in increased expression of DBNL mRNA

NCBI chr14:84,880,085...84,895,122
Ensembl chr14:84,880,142...84,897,133

G

D-box binding PAR bZIP transcription factor

decreases expression

EXP

Propylthiouracil results in decreased expression of DBP mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:105,312,256...105,317,205
Ensembl chr 1:105,312,108...105,317,205

G

dihydrolipoamide branched chain transacylase E2

decreases expression

EXP

Propylthiouracil results in decreased expression of DBT mRNA

NCBI chr 2:207,166,660...207,195,528
Ensembl chr 2:207,166,652...207,195,525

G

developing brain homeobox 2

decreases expression

EXP

Propylthiouracil results in decreased expression of DBX2 mRNA

NCBI chr 7:128,651,603...128,681,886
Ensembl chr 7:128,651,635...128,681,973

G

DDB1 and CUL4 associated factor 11

affects expression

EXP

Propylthiouracil affects the expression of DCAF11 mRNA

NCBI chr15:33,015,370...33,027,407
Ensembl chr15:33,016,762...33,027,672

G

DDB1 and CUL4 associated factor 12-like 1

increases expression

EXP

Propylthiouracil results in increased expression of DCAF12L1 mRNA

NCBI chr X:128,572,969...128,576,588
Ensembl chr X:128,572,811...128,577,222

G

DDB1 and CUL4 associated factor 13

increases expression

EXP

Propylthiouracil results in increased expression of DCAF13 mRNA

NCBI chr 7:72,045,828...72,081,039
Ensembl chr 7:72,045,872...72,083,629

G

DDB1 and CUL4 associated factor 4

decreases expression

EXP

Propylthiouracil results in decreased expression of DCAF4 mRNA

NCBI chr 6:108,885,970...108,912,116
Ensembl chr 6:108,885,932...108,912,110

G

DDB1 and CUL4 associated factor 5

increases expression

EXP

Propylthiouracil results in increased expression of DCAF5 mRNA

NCBI chr 6:104,904,423...104,993,150
Ensembl chr 6:104,904,423...104,993,103

G

DDB1 and CUL4 associated factor 7

increases expression

EXP

Propylthiouracil results in increased expression of DCAF7 mRNA

NCBI chr10:91,473,900...91,496,080
Ensembl chr10:91,473,900...91,496,080

G

dephospho-CoA kinase domain containing

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of DCAKD mRNA
Propylthiouracil results in decreased expression of DCAKD mRNA

PMID:24780913 PMID:36843608

NCBI chr10:88,457,829...88,489,011
Ensembl chr10:88,457,829...88,480,118

G

discoidin, CUB and LCCL domain containing 2

decreases expression

EXP

Propylthiouracil results in decreased expression of DCBLD2 mRNA

NCBI chr11:55,594,691...55,649,113
Ensembl chr11:55,594,691...55,649,085

G

DCC netrin 1 receptor

increases expression

EXP

Propylthiouracil results in increased expression of DCC mRNA; Propylthiouracil results in increased expression of DCC protein

PMID:22504374 PMID:24780913

NCBI chr18:67,144,272...68,248,159
Ensembl chr18:67,149,179...68,247,541

G

doublecortin domain containing 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of DCDC2 mRNA
Propylthiouracil results in decreased expression of DCDC2 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr17:40,274,009...40,459,757
Ensembl chr17:40,274,009...40,458,790

G

dachsous cadherin-related 1

increases expression

EXP

Propylthiouracil results in increased expression of DCHS1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:169,516,758...169,550,789
Ensembl chr 1:169,516,762...169,536,639

G

deoxycytidine kinase

decreases expression

EXP

Propylthiouracil results in decreased expression of DCK mRNA

NCBI chr14:19,589,298...19,610,326
Ensembl chr14:19,589,298...19,610,326

G

doublecortin-like kinase 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of DCLK1 mRNA
Propylthiouracil results in decreased expression of DCLK1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 2:141,567,215...141,861,088
Ensembl chr 2:141,571,983...141,861,090

G

doublecortin-like kinase 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of DCLK2 mRNA
Propylthiouracil results in decreased expression of DCLK2 mRNA

PMID:24780913 PMID:30047161

NCBI chr 2:174,506,660...174,636,353
Ensembl chr 2:174,506,660...174,636,192

G

doublecortin-like kinase 3

decreases expression

EXP

Propylthiouracil results in decreased expression of DCLK3 mRNA

PMID:24780913 PMID:25825206

NCBI chr 8:120,279,916...120,332,362
Ensembl chr 8:120,279,757...120,332,432

G

DNA cross-link repair 1C

decreases expression

EXP

Propylthiouracil results in decreased expression of DCLRE1C mRNA

NCBI chr17:79,684,988...79,718,399
Ensembl chr17:79,678,698...79,718,734

G

decorin

decreases expression

EXP

Propylthiouracil results in decreased expression of DCN mRNA

NCBI chr 7:34,167,973...34,208,004
Ensembl chr 7:34,163,011...34,218,926

G

DC-STAMP domain containing 2

decreases expression

EXP

Propylthiouracil results in decreased expression of DCST2 mRNA

NCBI chr 2:177,079,574...177,093,566
Ensembl chr 2:177,079,480...177,093,567

G

dCMP deaminase

increases expression

EXP

Propylthiouracil results in increased expression of DCTD mRNA

PMID:24780913 PMID:30047161

NCBI chr16:50,799,699...50,831,398
Ensembl chr16:50,787,875...50,831,186

G

dynactin subunit 4

decreases expression

EXP

Propylthiouracil results in decreased expression of DCTN4 mRNA

NCBI chr18:56,251,187...56,279,844
Ensembl chr18:56,252,780...56,279,842

G

dynactin subunit 5

increases expression

EXP

Propylthiouracil results in increased expression of DCTN5 mRNA

NCBI chr 1:186,120,415...186,137,146
Ensembl chr 1:186,119,913...186,137,146

G

dCTP pyrophosphatase 1

increases expression

EXP

Propylthiouracil results in increased expression of DCTPP1 mRNA

NCBI chr 1:191,307,933...191,311,326
Ensembl chr 1:191,307,935...191,313,405

G

defective in cullin neddylation 1 domain containing 2

decreases expression

EXP

Propylthiouracil results in decreased expression of DCUN1D2 mRNA

NCBI chr16:82,956,493...82,983,308
Ensembl chr16:82,956,339...82,983,307

G

defective in cullin neddylation 1 domain containing 4

decreases expression

EXP

Propylthiouracil results in decreased expression of DCUN1D4 mRNA

NCBI chr14:35,006,792...35,087,285
Ensembl chr14:35,006,792...35,088,520

G

defective in cullin neddylation 1 domain containing 5

increases expression

EXP

Propylthiouracil results in increased expression of DCUN1D5 mRNA

NCBI chr 8:12,697,160...12,718,242
Ensembl chr 8:12,697,127...12,718,991

G

doublecortin

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of DCX mRNA
Propylthiouracil results in decreased expression of DCX mRNA

PMID:24780913 PMID:30047161

NCBI chr X:112,227,455...112,370,291
Ensembl chr X:112,227,455...112,304,161

G

dicarbonyl and L-xylulose reductase

affects expression

EXP

Propylthiouracil affects the expression of DCXR mRNA

NCBI chr10:106,504,730...106,506,619

G

DET1 and DDB1 associated 1

increases expression

EXP

Propylthiouracil results in increased expression of DDA1 mRNA

NCBI chr16:18,190,280...18,197,914
Ensembl chr16:18,190,306...18,197,913

G

dimethylarginine dimethylaminohydrolase 1

increases expression

EXP

Propylthiouracil results in increased expression of DDAH1 mRNA

NCBI chr 2:237,327,812...237,460,624
Ensembl chr 2:237,327,766...237,460,626

G

DDAH family member 2, ADMA-independent

increases expression

EXP

Propylthiouracil results in increased expression of DDAH2 mRNA

NCBI chr20:3,766,115...3,769,161
Ensembl chr20:3,766,120...3,769,183

G

DDHD domain containing 1

decreases expression

EXP

Propylthiouracil results in decreased expression of DDHD1 mRNA

NCBI chr15:21,304,053...21,370,608
Ensembl chr15:21,303,826...21,370,608

G

DDHD domain containing 2

decreases expression

EXP

Propylthiouracil results in decreased expression of DDHD2 mRNA

PMID:24780913 PMID:30047161

NCBI chr16:73,022,136...73,051,746
Ensembl chr16:73,022,193...73,051,745

G

DNA damage-induced apoptosis suppressor

increases expression

EXP

Propylthiouracil results in increased expression of DDIAS mRNA

PMID:22504374 PMID:24780913

NCBI chr 1:156,318,559...156,342,869
Ensembl chr 1:156,318,563...156,342,869

G

DNA-damage inducible transcript 3

affects expression

EXP

Propylthiouracil affects the expression of DDIT3 mRNA; Propylthiouracil affects the expression of DDIT3 protein

NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509

G

DNA-damage-inducible transcript 4

decreases expression

EXP

Propylthiouracil results in decreased expression of DDIT4 mRNA

NCBI chr20:28,434,938...28,437,037
Ensembl chr20:28,434,944...28,437,037

G

dendrin

increases expression

EXP

Propylthiouracil results in increased expression of DDN mRNA

NCBI chr 7:131,832,270...131,836,252
Ensembl chr 7:131,832,271...131,836,294

G

discoidin domain receptor tyrosine kinase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of DDR1 mRNA

NCBI chr20:3,047,269...3,069,277
Ensembl chr20:3,050,375...3,069,276

G

discoidin domain receptor tyrosine kinase 2

affects expression

EXP

Propylthiouracil affects the expression of DDR2 mRNA

NCBI chr13:84,726,412...84,851,032
Ensembl chr13:84,731,180...84,850,288

G

DEAD-box helicase 1

increases expression

EXP

Propylthiouracil results in increased expression of DDX1 mRNA

NCBI chr 6:41,725,365...41,756,236
Ensembl chr 6:41,725,367...41,758,302

G

DEAD-box helicase 17

decreases expression

EXP

Propylthiouracil results in decreased expression of DDX17 mRNA

NCBI chr 7:112,971,522...112,989,747
Ensembl chr 7:112,971,523...112,989,747

G

DEAD-box helicase 20

decreases expression

EXP

Propylthiouracil results in decreased expression of DDX20 mRNA

NCBI chr 2:195,847,105...195,859,989
Ensembl chr 2:195,847,105...195,855,461

G

DExD-box helicase 21

increases expression

EXP

Propylthiouracil results in increased expression of DDX21 mRNA

NCBI chr20:31,077,044...31,097,238
Ensembl chr20:31,077,045...31,097,238

G

DExD-box helicase 39A

increases expression

EXP

Propylthiouracil results in increased expression of DDX39A mRNA

NCBI chr19:41,323,465...41,331,413
Ensembl chr19:41,322,836...41,332,306

G

DEAD-box helicase 43

increases expression

EXP

Propylthiouracil results in increased expression of DDX43 mRNA

NCBI chr 8:88,135,255...88,172,872
Ensembl chr 8:88,135,882...88,164,749

G

DEAD-box helicase 47

decreases expression

EXP

Propylthiouracil results in decreased expression of DDX47 mRNA

NCBI chr 4:169,577,013...169,589,473
Ensembl chr 4:169,577,003...169,590,474

G

DEAD-box helicase 5

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of DDX5 mRNA
Propylthiouracil results in increased expression of DDX5 mRNA

PMID:30047161 PMID:36843608

NCBI chr10:92,224,393...92,231,928
Ensembl chr10:92,224,395...92,231,300

G

DEAD-box helicase 54

increases expression

EXP

Propylthiouracil results in increased expression of DDX54 mRNA

NCBI chr12:41,595,298...41,610,560
Ensembl chr12:41,595,555...41,611,053

G

DEXD/H-box helicase 60

increases expression

EXP

Propylthiouracil results in increased expression of DDX60 mRNA

NCBI chr16:33,087,940...33,208,843
Ensembl chr16:33,087,988...33,208,839

G

dual endothelin 1, angiotensin II receptor

decreases expression

EXP

Propylthiouracil results in decreased expression of DEAR mRNA

NCBI chr 2:172,594,990...172,598,242
Ensembl chr 2:172,594,990...172,598,242

G

2,4-dienoyl-CoA reductase 1

affects expression
increases expression

EXP

Propylthiouracil affects the expression of DECR1 mRNA
Propylthiouracil results in increased expression of DECR1 mRNA

PMID:19483382 PMID:30047161

NCBI chr 5:34,208,195...34,236,074
Ensembl chr 5:34,208,195...34,236,033

G

differentially expressed in FDCP 8 homolog

decreases expression

EXP

Propylthiouracil results in decreased expression of DEF8 mRNA

PMID:24780913 PMID:30047161

NCBI chr19:68,383,293...68,404,133
Ensembl chr19:68,383,349...68,404,125

G

defensin alpha 24

decreases expression

EXP

Propylthiouracil results in decreased expression of DEFA24 mRNA

PMID:24780913 PMID:25825206

NCBI chr16:77,052,014...77,053,046
Ensembl chr16:77,052,014...77,053,046

G

defensin beta 1

decreases expression

EXP

Propylthiouracil results in decreased expression of DEFB1 mRNA

NCBI chr16:77,001,326...77,016,068
Ensembl chr16:77,001,326...77,016,068

G

defensin beta 10

affects expression

EXP

Propylthiouracil affects the expression of DEFB10 mRNA

NCBI chr16:76,905,070...76,915,205
Ensembl chr16:76,905,070...76,915,205

G

defensin beta 11

increases expression

EXP

Propylthiouracil results in increased expression of DEFB11 mRNA

NCBI chr16:76,858,512...76,865,529
Ensembl chr16:76,858,512...76,865,529

G

defensin beta 24

increases expression

EXP

Propylthiouracil results in increased expression of DEFB24 mRNA

NCBI chr 3:161,506,850...161,512,983
Ensembl chr 3:161,506,851...161,512,983

G

defensin beta 25

decreases expression

EXP

Propylthiouracil results in decreased expression of DEFB25 mRNA

NCBI chr 3:161,559,086...161,560,025
Ensembl chr 3:161,559,086...161,560,025

G

defensin beta 27

decreases expression

EXP

Propylthiouracil results in decreased expression of DEFB27 mRNA

NCBI chr 3:161,525,407...161,530,485
Ensembl chr 3:161,525,408...161,529,040

G

defensin beta 51

decreases expression

EXP

Propylthiouracil results in decreased expression of DEFB51 mRNA

NCBI chr16:77,273,373...77,277,495
Ensembl chr16:77,273,373...77,277,495

G

delta(4)-desaturase, sphingolipid 1

decreases expression

EXP

Propylthiouracil results in decreased expression of DEGS1 mRNA

NCBI chr13:96,478,645...96,485,302
Ensembl chr13:96,478,646...96,485,302

G

delta(4)-desaturase, sphingolipid 2

decreases expression

EXP

Propylthiouracil results in decreased expression of DEGS2 mRNA

NCBI chr 6:133,360,449...133,377,677
Ensembl chr 6:133,360,457...133,364,422

G

DEK proto-oncogene

increases expression

EXP

Propylthiouracil results in increased expression of DEK mRNA

NCBI chr17:17,786,989...17,809,096
Ensembl chr17:17,787,139...17,810,122

G

DENN domain containing 2B

decreases expression

EXP

Propylthiouracil results in decreased expression of DENND2B mRNA

NCBI chr 1:172,978,895...173,129,623
Ensembl chr 1:172,978,895...173,129,810

G

DENN domain containing 2D

increases expression

EXP

Propylthiouracil results in increased expression of DENND2D mRNA

PMID:24780913 PMID:30047161

NCBI chr 2:196,661,465...196,680,505
Ensembl chr 2:196,661,345...196,682,397

G

DENN domain containing 3

increases expression

EXP

Propylthiouracil results in increased expression of DENND3 mRNA

NCBI chr 7:107,304,860...107,362,573
Ensembl chr 7:107,220,192...107,362,573

G

DENN domain containing 5A

decreases expression

EXP

Propylthiouracil results in decreased expression of DENND5A mRNA

NCBI chr 1:173,362,959...173,428,973
Ensembl chr 1:173,362,959...173,428,926

G

DENN domain containing 6A

decreases expression

EXP

Propylthiouracil results in decreased expression of DENND6A mRNA

NCBI chr16:1,843,803...1,892,165
Ensembl chr16:1,843,752...1,892,163

G

DEP domain containing 1

increases expression

EXP

Propylthiouracil results in increased expression of DEPDC1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 2:251,343,250...251,376,709
Ensembl chr 2:251,343,281...251,376,709

G

DEP domain containing 1B

increases expression

EXP

Propylthiouracil results in increased expression of DEPDC1B mRNA

NCBI chr 2:41,605,686...41,697,207
Ensembl chr 2:41,624,922...41,697,202

G

DEP domain containing 7

decreases expression

EXP

Propylthiouracil results in decreased expression of DEPDC7 mRNA

PMID:24780913 PMID:25825206

NCBI chr 3:111,554,701...111,575,979
Ensembl chr 3:111,554,706...111,575,979

G

DEPP autophagy regulator 1

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of DEPP1 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of DEPP1 mRNA

PMID:25825206 PMID:36706583

NCBI chr 4:151,583,105...151,585,455
Ensembl chr 4:151,581,502...151,586,233

G

DEP domain containing MTOR-interacting protein

decreases expression

EXP

Propylthiouracil results in decreased expression of DEPTOR mRNA

PMID:24780913 PMID:25825206

NCBI chr 7:88,404,745...88,574,065
Ensembl chr 7:88,404,620...88,574,041

G

deoxyribose-phosphate aldolase

increases expression

EXP

Propylthiouracil results in increased expression of DERA mRNA

NCBI chr 4:172,394,971...172,473,746
Ensembl chr 4:172,394,962...172,490,142

G

derlin 3

decreases expression

EXP

Propylthiouracil results in decreased expression of DERL3 mRNA

PMID:24780913 PMID:25825206

NCBI chr20:12,753,926...12,766,478
Ensembl chr20:12,762,981...12,766,477

G

desumoylating isopeptidase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of DESI1 mRNA

NCBI chr 7:115,401,613...115,422,974
Ensembl chr 7:115,401,624...115,423,172

G

deuterosome assembly protein 1

increases expression

EXP

Propylthiouracil results in increased expression of DEUP1 mRNA

PMID:22504374 PMID:24780913

NCBI chr 8:20,661,687...20,724,083
Ensembl chr 8:20,661,689...20,723,585

G

Dexi homolog

affects expression

EXP

Propylthiouracil affects the expression of DEXI mRNA

NCBI chr10:5,632,400...5,645,653
Ensembl chr10:5,632,961...5,645,648

G

DNA fragmentation factor subunit beta

decreases expression

EXP

Propylthiouracil results in decreased expression of DFFB mRNA

NCBI chr 5:169,804,873...169,817,157
Ensembl chr 5:169,804,889...169,817,225

G

diacylglycerol O-acyltransferase 1

affects expression

EXP

Propylthiouracil affects the expression of DGAT1 mRNA

NCBI chr 7:110,104,514...110,119,091
Ensembl chr 7:110,098,906...110,115,016

G

diacylglycerol kinase, alpha

decreases expression

EXP

Propylthiouracil results in decreased expression of DGKA mRNA

NCBI chr 7:1,733,247...1,761,181
Ensembl chr 7:1,733,248...1,759,569

G

diacylglycerol kinase, beta

decreases expression

EXP

Propylthiouracil results in decreased expression of DGKB mRNA

NCBI chr 6:60,368,101...61,124,420
Ensembl chr 6:60,368,519...61,124,420

G

diacylglycerol kinase, gamma

increases expression

EXP

Propylthiouracil results in increased expression of DGKG mRNA

NCBI chr11:91,888,957...92,083,715
Ensembl chr11:91,888,782...92,082,105

G

diacylglycerol kinase, eta

decreases expression

EXP

Propylthiouracil results in decreased expression of DGKH mRNA

NCBI chr15:60,390,279...60,559,777
Ensembl chr15:60,402,004...60,560,218

G

diacylglycerol kinase, iota

decreases expression

EXP

Propylthiouracil results in decreased expression of DGKI mRNA

NCBI chr 4:66,377,897...66,839,790
Ensembl chr 4:66,387,126...66,990,832

G

diacylglycerol kinase zeta

decreases expression

EXP

Propylthiouracil results in decreased expression of DGKZ mRNA

NCBI chr 3:98,359,804...98,401,847
Ensembl chr 3:98,359,804...98,401,951

G

24-dehydrocholesterol reductase

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of DHCR24 mRNA
Propylthiouracil results in decreased expression of DHCR24 mRNA

PMID:19483382 PMID:24780913 PMID:25825206

NCBI chr 5:126,573,366...126,599,940
Ensembl chr 5:126,573,338...126,599,936

G

7-dehydrocholesterol reductase

affects expression

EXP

Propylthiouracil affects the expression of DHCR7 mRNA

NCBI chr 1:208,444,434...208,460,408
Ensembl chr 1:208,444,434...208,461,382

G

dihydrofolate reductase

increases expression

EXP

Propylthiouracil results in increased expression of DHFR mRNA

NCBI chr 2:25,320,895...25,346,004

G

desert hedgehog signaling molecule

increases expression

EXP

Propylthiouracil results in increased expression of DHH mRNA

NCBI chr 7:131,929,857...131,935,352
Ensembl chr 7:131,929,857...131,935,352

G

dihydroorotate dehydrogenase

increases expression

EXP

Propylthiouracil results in increased expression of DHODH mRNA

NCBI chr19:54,460,636...54,483,049
Ensembl chr19:54,468,690...54,514,496

G

deoxyhypusine synthase

increases expression

EXP

Propylthiouracil results in increased expression of DHPS mRNA

NCBI chr19:39,987,328...39,991,418
Ensembl chr19:39,987,324...39,991,432

G

dehydrogenase/reductase 3

decreases expression

EXP

Propylthiouracil results in decreased expression of DHRS3 mRNA

NCBI chr 5:162,031,853...162,065,655
Ensembl chr 5:162,031,386...162,065,653

G

dehydrogenase/reductase 4

affects expression
increases expression

EXP

Propylthiouracil affects the expression of DHRS4 mRNA
Propylthiouracil results in increased expression of DHRS4 mRNA

PMID:19483382 PMID:24780913

NCBI chr15:32,924,482...32,948,103
Ensembl chr15:32,936,522...32,948,101

G

dehydrogenase/reductase 7

decreases expression

EXP

Propylthiouracil results in decreased expression of DHRS7 mRNA

NCBI chr 6:97,068,149...97,083,744
Ensembl chr 6:97,068,149...97,083,744

G

dehydrogenase/reductase 7B

affects expression

EXP

Propylthiouracil affects the expression of DHRS7B mRNA

NCBI chr10:46,003,845...46,036,498
Ensembl chr10:46,003,845...46,036,499

G

dehydrogenase/reductase X-linked

decreases expression

EXP

Propylthiouracil results in decreased expression of DHRSX mRNA

NCBI chr12:21,413,563...21,418,319
Ensembl chr12:21,413,575...21,418,319

G

DEAH-box helicase 16

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of DHX16 mRNA
Propylthiouracil results in decreased expression of DHX16 mRNA

PMID:19483382 PMID:24780913

NCBI chr20:2,866,804...2,879,790
Ensembl chr20:2,866,804...2,879,751

G

DEXH-box helicase 58

increases expression

EXP

Propylthiouracil results in increased expression of DHX58 mRNA

NCBI chr10:86,120,677...86,132,095
Ensembl chr10:86,120,677...86,131,844

G

diaphanous-related formin 1

increases expression

EXP

Propylthiouracil results in increased expression of DIAPH1 mRNA

NCBI chr18:29,920,889...30,020,280
Ensembl chr18:29,920,889...30,020,280

G

diaphanous-related formin 3

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of DIAPH3 mRNA
Propylthiouracil results in decreased expression of DIAPH3 mRNA

PMID:24780913 PMID:25825206

NCBI chr15:68,951,992...69,421,623
Ensembl chr15:68,951,989...69,421,552

G

death inducer-obliterator 1

increases expression

EXP

Propylthiouracil results in increased expression of DIDO1 mRNA

NCBI chr 3:188,150,100...188,203,445
Ensembl chr 3:188,150,100...188,194,823

G

iodothyronine deiodinase 1

decreases activity
multiple interactions
decreases expression
increases expression

ISO
EXP

Propylthiouracil results in decreased activity of DIO1 protein
[Propylthiouracil results in decreased activity of DIO1 protein] which affects the metabolism of Triiodothyronine, Reverse
Propylthiouracil results in decreased expression of DIO1 mRNA
Propylthiouracil results in increased expression of DIO1 mRNA

PMID:16131326 PMID:22342233 PMID:24780913 PMID:25060363 PMID:25962824 More...

NCBI chr 5:127,303,089...127,319,784
Ensembl chr 5:127,303,083...127,319,771

G

iodothyronine deiodinase 2

increases expression

EXP

Propylthiouracil results in increased expression of DIO2 mRNA

NCBI chr 6:115,396,308...115,410,594
Ensembl chr 6:115,396,308...115,410,594

G

iodothyronine deiodinase 3

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of DIO3 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of DIO3 mRNA

PMID:24780913 PMID:25825206 PMID:36706583

NCBI chr 6:135,107,072...135,108,933
Ensembl chr 6:135,107,074...135,107,985

G

DIO3 opposite strand upstream RNA

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of DIO3OS mRNA

G

disco-interacting protein 2 homolog C

decreases expression

EXP

Propylthiouracil results in decreased expression of DIP2C mRNA

NCBI chr17:65,338,711...65,724,111
Ensembl chr17:65,338,711...65,723,344

G

divergent protein kinase domain 1B

decreases expression

EXP

Propylthiouracil results in decreased expression of FAM69B mRNA

NCBI chr 3:29,852,710...29,862,248
Ensembl chr 3:29,853,973...29,862,255

G

divergent protein kinase domain 1C

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of DIPK1C mRNA
Propylthiouracil results in increased expression of FAM69C mRNA

PMID:24780913 PMID:30047161

NCBI chr18:80,362,854...80,384,774
Ensembl chr18:80,362,982...80,386,551

G

divergent protein kinase domain 2A

decreases expression

EXP

Propylthiouracil results in decreased expression of DIPK2A mRNA

NCBI chr 8:103,950,345...103,969,461
Ensembl chr 8:103,909,931...103,969,461

G

dispatched RND transporter family member 2

decreases expression

EXP

Propylthiouracil results in decreased expression of DISP2 mRNA

NCBI chr 3:126,216,194...126,231,724
Ensembl chr 3:126,216,218...126,231,711

G

DIX domain containing 1

decreases expression

EXP

Propylthiouracil results in decreased expression of DIXDC1 mRNA

PMID:24780913 PMID:25825206

NCBI chr 8:59,904,218...59,977,595
Ensembl chr 8:59,904,218...59,978,447

G

dickkopf WNT signaling pathway inhibitor 1

increases expression

EXP

Propylthiouracil results in increased expression of DKK1 mRNA

NCBI chr 1:237,794,969...237,798,650
Ensembl chr 1:237,794,969...237,798,650

G

dickkopf WNT signaling pathway inhibitor 3

decreases expression

EXP

Propylthiouracil results in decreased expression of DKK3 mRNA

NCBI chr 1:175,672,834...175,715,867
Ensembl chr 1:175,672,834...175,715,186

G

DLC1 Rho GTPase activating protein

decreases expression

EXP

Propylthiouracil results in decreased expression of DLC1 mRNA

NCBI chr16:61,954,177...62,374,819
Ensembl chr16:61,995,001...62,374,819

G

deleted in lymphocytic leukemia, 7

increases expression

EXP

Propylthiouracil results in increased expression of DLEU7 mRNA

NCBI chr15:40,655,563...40,671,759
Ensembl chr15:40,655,563...40,671,759

G

discs large MAGUK scaffold protein 1

decreases expression

EXP

Propylthiouracil results in decreased expression of DLG1 mRNA

PMID:24780913 PMID:36843608

NCBI chr11:82,416,853...82,607,797
Ensembl chr11:82,416,853...82,607,797

G

discs large MAGUK scaffold protein 3

decreases expression

EXP

Propylthiouracil results in decreased expression of DLG3 mRNA

NCBI chr X:69,899,694...69,951,928
Ensembl chr X:69,900,003...69,950,696

G

discs large MAGUK scaffold protein 5

increases expression

EXP

Propylthiouracil results in increased expression of DLG5 mRNA

NCBI chr15:125,287...237,334
Ensembl chr15:125,290...237,332

G

DLG associated protein 2

decreases expression

EXP

Propylthiouracil results in decreased expression of DLGAP2 mRNA

PMID:24780913 PMID:37926403

NCBI chr16:81,489,059...82,198,693
Ensembl chr16:81,494,649...82,198,684

G

DLG associated protein 3

decreases expression

EXP

Propylthiouracil results in decreased expression of DLGAP3 mRNA

NCBI chr 5:144,776,414...144,847,097
Ensembl chr 5:144,777,295...144,847,097

G

DLG associated protein 5

increases expression

EXP

Propylthiouracil results in increased expression of DLGAP5 mRNA

NCBI chr15:23,113,678...23,144,281
Ensembl chr15:23,113,678...23,144,176

G

delta like non-canonical Notch ligand 1

decreases expression

EXP

Propylthiouracil results in decreased expression of DLK1 mRNA

NCBI chr 6:134,192,491...134,199,779
Ensembl chr 6:134,192,518...134,200,529

G

delta like non-canonical Notch ligand 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of DLK2 mRNA
Propylthiouracil results in decreased expression of DLK2 mRNA

PMID:24780913 PMID:30047161

NCBI chr 9:22,174,667...22,179,149
Ensembl chr 9:22,173,158...22,179,149

G

delta like canonical Notch ligand 1

increases expression

EXP

Propylthiouracil results in increased expression of DLL1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:64,985,161...64,993,274
Ensembl chr 1:64,985,161...64,993,276

G

delta like canonical Notch ligand 3

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of DLL3 mRNA
Propylthiouracil results in decreased expression of DLL3 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:92,689,577...92,698,125
Ensembl chr 1:92,689,577...92,697,406

G

delta like canonical Notch ligand 4

decreases expression
increases methylation

EXP

Propylthiouracil results in decreased expression of DLL4 mRNA
Propylthiouracil results in increased methylation of DLL4 promoter

NCBI chr 3:126,770,945...126,780,769
Ensembl chr 3:126,770,794...126,780,763

G

dihydrolipoamide S-succinyltransferase

increases expression

EXP

Propylthiouracil results in increased expression of DLST mRNA

NCBI chr 6:110,489,576...110,512,841
Ensembl chr 6:110,489,392...110,514,357

G

distal-less homeobox 1

increases expression

EXP

Propylthiouracil results in increased expression of DLX1 mRNA

NCBI chr 3:76,763,864...76,768,454
Ensembl chr 3:76,763,500...76,768,447

G

distal-less homeobox 5

increases expression

EXP

Propylthiouracil results in increased expression of DLX5 mRNA

PMID:24780913 PMID:30047161

NCBI chr 4:35,965,579...35,969,973
Ensembl chr 4:35,965,579...35,969,845

G

distal membrane arm assembly component 2 like

affects expression

EXP

Propylthiouracil affects the expression of DMAC2L mRNA

NCBI chr 6:93,941,605...93,959,932
Ensembl chr 6:93,941,690...93,960,662

G

deleted in malignant brain tumors 1 like 1

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CDCP3 mRNA

NCBI chr 1:195,380,082...195,514,521
Ensembl chr 1:195,380,001...195,514,710

G

diencephalon/mesencephalon homeobox 1

increases expression

EXP

Propylthiouracil results in increased expression of DMBX1 mRNA

NCBI chr 5:134,630,968...134,639,781
Ensembl chr 5:134,630,968...134,639,781

G

dystrophin

decreases expression

EXP

Propylthiouracil results in decreased expression of DMD mRNA

NCBI chr X:51,070,098...53,437,845
Ensembl chr X:51,070,273...53,437,835

G

dimethylglycine dehydrogenase

increases expression

EXP

Propylthiouracil results in increased expression of DMGDH mRNA

NCBI chr 2:26,647,540...26,722,496
Ensembl chr 2:26,647,565...26,723,071

G

dermokine

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of DMKN mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of DMKN mRNA

PMID:24780913 PMID:36706583

NCBI chr 1:95,140,737...95,158,676
Ensembl chr 1:95,141,620...95,157,439

G

dentin matrix acidic phosphoprotein 1

decreases expression

EXP

Propylthiouracil results in decreased expression of DMP1 mRNA

NCBI chr14:5,833,111...5,867,154
Ensembl chr14:5,833,111...5,843,993

G

doublesex and mab-3 related transcription factor 2

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of DMRT2 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of DMRT2 mRNA

PMID:22504374 PMID:36706583

NCBI chr 1:232,743,935...232,750,431
Ensembl chr 1:232,743,942...232,750,431

G

DMRT-like family C1a

decreases expression

EXP

Propylthiouracil results in decreased expression of DMRTC1A mRNA

NCBI chr X:71,861,910...71,892,508
Ensembl chr X:71,861,661...71,892,507

G

dematin actin binding protein

decreases expression

EXP

Propylthiouracil results in decreased expression of DMTN mRNA

NCBI chr15:52,087,667...52,111,956
Ensembl chr15:52,087,667...52,112,128

G

DNA replication helicase/nuclease 2

decreases expression

EXP

Propylthiouracil results in decreased expression of DNA2 mRNA

NCBI chr20:25,660,339...25,689,285

G

dynein, axonemal, assembly factor 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of DNAAF1 mRNA
Propylthiouracil results in decreased expression of DNAAF1 mRNA

PMID:24780913 PMID:30047161

NCBI chr19:64,532,859...64,560,942
Ensembl chr19:64,532,860...64,561,435

G

dynein axonemal assembly factor 11

increases expression

EXP

Propylthiouracil results in increased expression of DNAAF11 mRNA

NCBI chr 7:100,033,843...100,134,979
Ensembl chr 7:100,034,202...100,135,179

G

dynein axonemal assembly factor 4

increases expression

EXP

Propylthiouracil results in increased expression of DNAAF4 mRNA

NCBI chr 8:82,577,044...82,601,653
Ensembl chr 8:82,578,755...82,592,205

G

dynein, axonemal, heavy chain 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of DNAH1 mRNA
Propylthiouracil results in decreased expression of DNAH1 mRNA

PMID:22504374 PMID:24780913 PMID:25825206

NCBI chr16:6,462,419...6,523,545
Ensembl chr16:6,462,419...6,524,760

G

dynein, axonemal, heavy chain 10

decreases expression

EXP

Propylthiouracil results in decreased expression of DNAH10 mRNA

NCBI chr12:37,484,444...37,607,810
Ensembl chr12:37,472,813...37,640,860

G

dynein, axonemal, heavy chain 11

decreases expression

EXP

Propylthiouracil results in decreased expression of DNAH11 mRNA

NCBI chr 6:144,982,130...145,298,523
Ensembl chr 6:144,973,797...145,298,692

G

dynein, axonemal, heavy chain 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of DNAH2 mRNA
Propylthiouracil results in decreased expression of DNAH2 mRNA

PMID:24780913 PMID:25825206

NCBI chr10:54,641,450...54,766,502
Ensembl chr10:54,641,450...54,766,026

G

dynein, axonemal, heavy chain 9

increases expression

EXP

Propylthiouracil results in increased expression of DNAH9 mRNA

NCBI chr10:50,996,796...51,363,977
Ensembl chr10:50,996,796...51,363,963

G

dynein, axonemal, intermediate chain 1

increases expression

EXP

Propylthiouracil results in increased expression of DNAI1 mRNA

NCBI chr 5:61,526,079...61,596,806
Ensembl chr 5:61,525,999...61,596,810

G

dynein, axonemal, intermediate chain 2

affects expression

EXP

Propylthiouracil affects the expression of DNAI2 mRNA

NCBI chr10:100,259,022...100,292,427
Ensembl chr10:100,258,994...100,292,426

G

dynein axonemal intermediate chain 3

decreases expression

EXP

Propylthiouracil results in decreased expression of DNAI3 mRNA

NCBI chr 2:237,608,202...237,666,465
Ensembl chr 2:237,604,068...237,666,465

G

dynein axonemal intermediate chain 7

decreases expression

EXP

Propylthiouracil results in decreased expression of CASC1 mRNA; Propylthiouracil results in decreased expression of DNAI7 mRNA

PMID:24780913 PMID:30047161

NCBI chr 4:179,874,338...179,910,716
Ensembl chr 4:179,873,522...179,910,780

G

DnaJ heat shock protein family (Hsp40) member A2

increases expression

EXP

Propylthiouracil results in increased expression of DNAJA2 mRNA

NCBI chr19:37,671,019...37,689,163
Ensembl chr19:37,670,945...37,690,120

G

DnaJ heat shock protein family (Hsp40) member A4

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of DNAJA4 mRNA
Propylthiouracil results in increased expression of DNAJA4 mRNA

PMID:24780913 PMID:30047161

NCBI chr 8:63,975,177...63,998,836
Ensembl chr 8:63,981,559...63,998,836

G

DnaJ heat shock protein family (Hsp40) member B11

increases expression

EXP

Propylthiouracil results in increased expression of DNAJB11 mRNA

NCBI chr11:91,656,334...91,672,800
Ensembl chr11:91,656,335...91,672,800

G

DnaJ heat shock protein family (Hsp40) member B13

decreases expression

EXP

Propylthiouracil results in decreased expression of DNAJB13 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 1:164,260,716...164,275,172
Ensembl chr 1:164,260,724...164,275,093

G

DnaJ heat shock protein family (Hsp40) member B2

decreases expression

EXP

Propylthiouracil results in decreased expression of DNAJB2 mRNA

NCBI chr 9:84,179,702...84,187,942
Ensembl chr 9:84,179,695...84,187,942

G

DnaJ heat shock protein family (Hsp40) member B3

increases expression

EXP

Propylthiouracil results in increased expression of DNAJB3 mRNA

NCBI chr 9:96,243,345...96,244,358
Ensembl chr 9:96,243,071...96,244,408

G

DnaJ heat shock protein family (Hsp40) member C12

increases expression

EXP

Propylthiouracil results in increased expression of DNAJC12 mRNA

NCBI chr20:25,245,475...25,266,238
Ensembl chr20:25,222,298...25,266,251

G

DnaJ heat shock protein family (Hsp40) member C16

increases expression

EXP

Propylthiouracil results in increased expression of DNAJC16 mRNA

NCBI chr 5:159,355,279...159,389,267
Ensembl chr 5:159,361,314...159,389,298

G

DnaJ heat shock protein family (Hsp40) member C19

increases expression

EXP

Propylthiouracil results in increased expression of DNAJC19 mRNA

NCBI chr 2:118,851,497...118,875,813
Ensembl chr 2:118,869,413...118,873,781

G

DnaJ heat shock protein family (Hsp40) member C27

decreases expression

EXP

Propylthiouracil results in decreased expression of DNAJC27 mRNA

NCBI chr 6:32,788,215...32,842,418
Ensembl chr 6:32,788,184...32,817,940

G

DnaJ heat shock protein family (Hsp40) member C28

decreases expression

EXP

Propylthiouracil results in decreased expression of DNAJC28 mRNA

NCBI chr11:44,341,528...44,344,348
Ensembl chr11:44,338,646...44,344,482

G

DnaJ heat shock protein family (Hsp40) member C3

affects expression

EXP

Propylthiouracil affects the expression of DNAJC3 mRNA

NCBI chr15:102,432,667...102,475,643
Ensembl chr15:102,432,663...102,475,643

G

DnaJ heat shock protein family (Hsp40) member C30

increases expression

EXP

Propylthiouracil results in increased expression of DNAJC30 mRNA

NCBI chr12:27,264,861...27,265,940
Ensembl chr12:27,262,802...27,266,169

G

DnaJ heat shock protein family (Hsp40) member C4

decreases expression

EXP

Propylthiouracil results in decreased expression of DNAJC4 mRNA

NCBI chr 1:213,607,397...213,611,614
Ensembl chr 1:213,607,399...213,611,729

G

DnaJ heat shock protein family (Hsp40) member C5

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of DNAJC5 mRNA
Propylthiouracil results in increased expression of DNAJC5 mRNA

PMID:24780913 PMID:30047161

NCBI chr 3:188,999,508...189,033,455
Ensembl chr 3:188,999,470...189,034,089

G

DnaJ heat shock protein family (Hsp40) member C8

increases expression

EXP

Propylthiouracil results in increased expression of DNAJC8 mRNA

NCBI chr 5:150,029,064...150,047,115
Ensembl chr 5:150,026,286...150,047,117

G

dynein, axonemal, light chain 1

increases expression

EXP

Propylthiouracil results in increased expression of DNAL1 mRNA

NCBI chr 6:109,478,941...109,515,201
Ensembl chr 6:109,478,858...109,513,148

G

dynein, axonemal, light intermediate chain 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of DNALI1 mRNA
Propylthiouracil results in decreased expression of DNALI1 mRNA

PMID:22504374 PMID:24780913 PMID:25825206

NCBI chr 5:142,603,132...142,611,970
Ensembl chr 5:142,603,134...142,611,993

G

deoxyribonuclease 1

increases expression

EXP

Propylthiouracil results in increased expression of DNASE1 mRNA

NCBI chr10:12,005,305...12,030,615
Ensembl chr10:12,005,306...12,010,497

G

deoxyribonuclease 1L3

decreases expression

EXP

Propylthiouracil results in decreased expression of DNASE1L3 mRNA

NCBI chr15:19,351,683...19,378,536
Ensembl chr15:19,352,493...19,378,531

G

deoxyribonuclease 2 beta

decreases expression

EXP

Propylthiouracil results in decreased expression of DNASE2B mRNA

NCBI chr 2:238,131,182...238,168,041
Ensembl chr 2:238,131,185...238,146,558

G

delta/notch-like EGF repeat containing

decreases expression

EXP

Propylthiouracil results in decreased expression of DNER mRNA

NCBI chr 9:93,035,108...93,350,568
Ensembl chr 9:93,035,108...93,350,568

G

dynamin 1

decreases expression

EXP

Propylthiouracil results in decreased expression of DNM1 mRNA

NCBI chr 3:36,002,535...36,055,220
Ensembl chr 3:36,002,064...36,046,289

G

dynamin 1-like

decreases expression

EXP

Propylthiouracil results in decreased expression of DNM1L mRNA

NCBI chr11:98,084,049...98,135,663
Ensembl chr11:98,085,397...98,137,420

G

dynamin 2

increases expression

EXP

Propylthiouracil results in increased expression of DNM2 mRNA

NCBI chr 8:28,254,344...28,336,297
Ensembl chr 8:28,254,529...28,336,295

G

DNA methyltransferase 3 beta

increases expression

EXP

Propylthiouracil results in increased expression of DNMT3B mRNA

NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:162,604,037...162,629,313

G

2'-deoxynucleoside 5'-phosphate N-hydrolase 1

increases expression

EXP

Propylthiouracil results in increased expression of DNPH1 mRNA

NCBI chr 9:21,978,894...21,981,631
Ensembl chr 9:21,978,894...21,981,631

G

double C2 domain alpha

increases expression

EXP

Propylthiouracil results in increased expression of DOC2A mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:190,887,306...190,893,057
Ensembl chr 1:190,888,214...190,893,384

G

double C2 domain beta

increases expression

EXP

Propylthiouracil results in increased expression of DOC2B mRNA

NCBI chr10:61,126,295...61,151,533
Ensembl chr10:61,126,295...61,151,533

G

dedicator of cytokinesis 11

increases expression

EXP

Propylthiouracil results in increased expression of DOCK11 mRNA

NCBI chr X:119,997,523...120,180,643
Ensembl chr X:119,997,552...120,180,634

G

dedicator of cytokinesis 7

decreases expression

EXP

Propylthiouracil results in decreased expression of DOCK7 mRNA

NCBI chr 5:118,714,863...118,898,362
Ensembl chr 5:118,714,863...118,898,335

G

dedicator of cytokinesis 8

increases expression

EXP

Propylthiouracil results in increased expression of DOCK8 mRNA

NCBI chr 1:232,075,468...232,268,830
Ensembl chr 1:232,075,588...232,268,833

G

dedicator of cytokinesis 9

decreases expression

EXP

Propylthiouracil results in decreased expression of DOCK9 mRNA

NCBI chr15:105,018,341...105,289,799
Ensembl chr15:105,024,912...105,289,799

G

docking protein 4

increases expression

EXP

Propylthiouracil results in increased expression of DOK4 mRNA

PMID:24780913 PMID:30047161

NCBI chr19:10,152,511...10,163,182
Ensembl chr19:10,152,458...10,164,190

G

docking protein 5

affects expression

EXP

Propylthiouracil affects the expression of DOK5 mRNA

NCBI chr 3:179,934,419...180,071,334
Ensembl chr 3:179,934,552...180,071,333

G

docking protein 6

increases expression

EXP

Propylthiouracil results in increased expression of DOK6 mRNA

NCBI chr18:84,847,491...85,290,647
Ensembl chr18:84,847,491...85,290,647

G

DOT1 like histone lysine methyltransferase

decreases expression

EXP

Propylthiouracil results in decreased expression of DOT1L mRNA

NCBI chr 7:9,569,439...9,607,095
Ensembl chr 7:9,569,439...9,607,095

G

double PHD fingers 1

affects expression

EXP

Propylthiouracil affects the expression of DPF1 mRNA

NCBI chr 1:93,729,683...93,743,425
Ensembl chr 1:93,726,970...93,743,425

G

double PHD fingers 2

decreases expression

EXP

Propylthiouracil results in decreased expression of DPF2 mRNA

NCBI chr 1:212,612,986...212,628,376
Ensembl chr 1:212,612,986...212,628,289

G

diphthamide biosynthesis 1

increases expression

EXP

Propylthiouracil results in increased expression of DPH1 mRNA

NCBI chr10:60,526,417...60,538,102
Ensembl chr10:60,527,680...60,535,816

G

diphthamide biosynthesis 3

increases expression

EXP

Propylthiouracil results in increased expression of DPH3 mRNA

NCBI chr16:7,294,580...7,299,996
Ensembl chr16:7,294,580...7,299,996

G

diphthamine biosynthesis 6

increases expression

EXP

Propylthiouracil results in increased expression of DPH6 mRNA

NCBI chr 3:121,761,495...121,891,727
Ensembl chr 3:121,676,141...121,891,658

G

dolichyl-phosphate mannosyltransferase subunit 1, catalytic

increases expression

EXP

Propylthiouracil results in increased expression of DPM1 mRNA

NCBI chr 3:177,338,855...177,358,398
Ensembl chr 3:177,338,855...177,358,412

G

dolichyl-phosphate mannosyltransferase subunit 3, regulatory

increases expression

EXP

Propylthiouracil results in increased expression of DPM3 mRNA

NCBI chr 2:176,974,290...176,974,805
Ensembl chr15:52,612,418...52,612,696

G

dipeptidyl peptidase like 10

decreases expression

EXP

Propylthiouracil results in decreased expression of DPP10 mRNA

NCBI chr13:37,145,531...38,821,987
Ensembl chr13:37,145,531...38,822,801

G

dipeptidylpeptidase 4

affects expression
increases expression

EXP

Propylthiouracil affects the expression of DPP4 mRNA
Propylthiouracil results in increased expression of DPP4 mRNA

PMID:19483382 PMID:24780913

NCBI chr 3:67,370,794...67,452,422
Ensembl chr 3:67,370,804...67,452,422

G

developmental pluripotency-associated 2

decreases expression

EXP

Propylthiouracil results in decreased expression of DPPA2 mRNA

NCBI chr11:66,008,002...66,020,044
Ensembl chr11:66,011,628...66,020,994

G

developmental pluripotency associated 3-like 1

decreases expression

EXP

Propylthiouracil results in decreased expression of DPPA3L1 mRNA

NCBI chr 8:65,317,653...65,318,321
Ensembl chr 8:65,317,869...65,318,321

G

dermatopontin

decreases expression

EXP

Propylthiouracil results in decreased expression of DPT mRNA

NCBI chr13:79,656,341...79,684,759
Ensembl chr13:79,655,985...79,684,758

G

dpy-19 like C-mannosyltransferase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of DPY19L1 mRNA

PMID:24780913 PMID:36843608

NCBI chr 8:31,209,025...31,297,485
Ensembl chr 8:31,209,025...31,297,518

G

dpy-30 histone methyltransferase complex regulatory subunit

increases expression

EXP

Propylthiouracil results in increased expression of DPY30 mRNA

NCBI chr 6:26,872,812...26,893,580
Ensembl chr 6:26,872,732...26,894,930

G

dihydropyrimidine dehydrogenase

affects expression
decreases expression
increases expression

EXP

Propylthiouracil affects the expression of DPYD mRNA
Propylthiouracil results in decreased expression of DPYD mRNA
Propylthiouracil results in increased expression of DPYD mRNA

PMID:19483382 PMID:24780913 PMID:30047161

NCBI chr 2:209,293,902...210,159,777
Ensembl chr 2:209,293,929...210,159,778

G

dihydropyrimidinase-like 2

decreases expression

EXP

Propylthiouracil results in decreased expression of DPYSL2 mRNA

NCBI chr15:45,181,041...45,287,065
Ensembl chr15:45,181,041...45,287,065

G

dihydropyrimidinase-like 3

increases expression

EXP

Propylthiouracil results in increased expression of DPYSL3 mRNA

NCBI chr18:35,625,357...35,731,152
Ensembl chr18:35,625,357...35,731,152

G

dihydropyrimidinase-like 4

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of DPYSL4 mRNA
Propylthiouracil results in increased expression of DPYSL4 mRNA

PMID:30047161 PMID:36843608

NCBI chr 1:203,312,646...203,328,523
Ensembl chr 1:203,311,694...203,328,523

G

dihydropyrimidinase-like 5

increases expression

EXP

Propylthiouracil results in increased expression of DPYSL5 mRNA

NCBI chr 6:31,295,035...31,379,348
Ensembl chr 6:31,295,035...31,379,348

G

DEAQ box RNA-dependent ATPase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of DQX1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 4:117,121,216...117,130,315
Ensembl chr 4:117,121,452...117,130,307

G

DNA-damage regulated autophagy modulator 1

increases expression

EXP

Propylthiouracil results in increased expression of DRAM1 mRNA

NCBI chr 7:24,630,233...24,665,270
Ensembl chr 7:24,630,238...24,664,354

G

dynein regulatory complex subunit 1

increases expression

EXP

Propylthiouracil results in increased expression of DRC1 mRNA

PMID:22504374 PMID:24780913

NCBI chr 6:31,744,849...31,779,996
Ensembl chr 6:31,744,850...31,779,256

G

dynein regulatory complex subunit 12 homolog

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of CCDC153 mRNA
Propylthiouracil results in decreased expression of CCDC153 mRNA

PMID:24780913 PMID:25825206

NCBI chr 8:53,468,344...53,481,168
Ensembl chr 8:53,472,849...53,486,567

G

dynein regulatory complex subunit 3

increases expression

EXP

Propylthiouracil results in increased expression of DRC3 mRNA

NCBI chr10:45,620,045...45,698,902
Ensembl chr10:45,648,410...45,698,900

G

dynein regulatory complex subunit 7

increases expression

EXP

Propylthiouracil results in increased expression of CCDC135 mRNA

NCBI chr19:9,949,484...9,967,296
Ensembl chr19:9,949,486...9,967,192

G

dopamine receptor D3

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of DRD3 mRNA

NCBI chr11:70,385,586...70,437,793
Ensembl chr11:70,385,586...70,446,760

G

dopamine receptor D5

decreases expression

EXP

Propylthiouracil results in decreased expression of DRD5 mRNA

NCBI chr14:76,700,244...76,703,344
Ensembl chr14:76,700,241...76,703,466

G

dorsal root ganglia homeobox

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of DRGX mRNA
Propylthiouracil results in decreased expression of DRGX mRNA

PMID:24780913 PMID:30047161

NCBI chr16:7,861,024...7,891,607
Ensembl chr16:7,861,157...7,906,904

G

drosha ribonuclease III

decreases expression

EXP

Propylthiouracil results in decreased expression of DROSHA mRNA

NCBI chr 2:63,591,885...63,703,688
Ensembl chr 2:63,591,968...63,703,687

G

desmocollin 1

decreases expression

EXP

Propylthiouracil results in decreased expression of DSC1 mRNA

NCBI chr18:11,774,711...11,831,868
Ensembl chr18:11,775,010...11,803,522

G

desmocollin 2

increases expression

EXP

Propylthiouracil results in increased expression of DSC2 mRNA

NCBI chr18:11,725,466...11,757,591
Ensembl chr18:11,725,466...11,757,466

G

desmocollin 3

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of DSC3 mRNA

NCBI chr18:11,654,833...11,688,871
Ensembl chr18:11,653,832...11,688,871

G

DS cell adhesion molecule

decreases expression

EXP

Propylthiouracil results in decreased expression of DSCAM mRNA

NCBI chr11:49,391,385...49,976,861
Ensembl chr11:49,347,531...49,976,238

G

DS cell adhesion molecule-like 1

increases expression

EXP

Propylthiouracil results in increased expression of DSCAML1 mRNA

NCBI chr 8:54,637,054...54,954,042
Ensembl chr 8:54,636,932...54,954,040

G

DNA replication and sister chromatid cohesion 1

increases expression

EXP

Propylthiouracil results in increased expression of DSCC1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 7:88,372,349...88,390,815
Ensembl chr 7:88,372,146...88,387,973

G

DSN1 component of MIS12 kinetochore complex

increases expression

EXP

Propylthiouracil results in increased expression of DSN1 mRNA

NCBI chr 3:166,072,775...166,089,029
Ensembl chr 3:166,074,033...166,085,890

G

dystonin

decreases expression

EXP

Propylthiouracil results in decreased expression of DST mRNA

NCBI chr 9:43,631,716...44,025,535
Ensembl chr 9:43,631,517...44,025,533

G

destrin, actin depolymerizing factor

increases expression

EXP

Propylthiouracil results in increased expression of DSTN mRNA

NCBI chr 3:151,737,711...151,764,752
Ensembl chr 3:151,737,849...151,764,769

G

dual serine/threonine and tyrosine protein kinase

decreases expression

EXP

Propylthiouracil results in decreased expression of DSTYK mRNA

NCBI chr13:46,409,412...46,457,426
Ensembl chr13:46,409,412...46,457,424

G

death domain containing 1

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of DTHD1 mRNA

NCBI chr14:50,773,694...50,877,217

G

denticleless E3 ubiquitin protein ligase homolog

decreases expression

EXP

Propylthiouracil results in decreased expression of DTL mRNA

NCBI chr13:105,646,908...105,685,921
Ensembl chr13:105,646,908...105,686,174

G

DTW domain containing 1

decreases expression

EXP

Propylthiouracil results in decreased expression of DTWD1 mRNA

NCBI chr 3:133,845,768...133,859,965
Ensembl chr 3:133,841,935...133,860,316

G

deltex E3 ubiquitin ligase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of DTX1 mRNA

NCBI chr12:41,510,252...41,541,433
Ensembl chr12:41,510,264...41,541,430

G

deltex E3 ubiquitin ligase 2

increases expression

EXP

Propylthiouracil results in increased expression of DTX2 mRNA

NCBI chr12:26,279,899...26,319,541
Ensembl chr12:26,279,899...26,319,507

G

deltex E3 ubiquitin ligase 3

decreases expression

EXP

Propylthiouracil results in decreased expression of DTX3 mRNA

NCBI chr 7:64,898,693...64,904,636
Ensembl chr 7:64,898,866...64,903,752

G

deltex E3 ubiquitin ligase 4

increases expression

EXP

Propylthiouracil results in increased expression of DTX4 mRNA

NCBI chr 1:218,882,391...218,969,837
Ensembl chr 1:218,832,284...218,917,130

G

deoxythymidylate kinase

increases expression

EXP

Propylthiouracil results in increased expression of DTYMK mRNA

NCBI chr 9:101,762,899...101,771,733
Ensembl chr 9:101,762,899...101,774,504

G

dual oxidase 1

increases expression

EXP

Propylthiouracil results in increased expression of DUOX1 mRNA

NCBI chr 3:129,714,125...129,749,186
Ensembl chr 3:129,714,149...129,749,187

G

dual oxidase 2

increases expression

EXP

Propylthiouracil results in increased expression of DUOX2 mRNA

PMID:24780913 PMID:25825206

NCBI chr 3:129,680,543...129,698,886
Ensembl chr 3:129,680,546...129,699,203

G

dual specificity phosphatase 1

increases expression

EXP

Propylthiouracil results in increased expression of DUSP1 mRNA

NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644

G

dual specificity phosphatase 10

decreases expression

EXP

Propylthiouracil results in decreased expression of DUSP10 mRNA

NCBI chr13:98,145,317...98,183,304
Ensembl chr13:98,145,893...98,183,304

G

dual specificity phosphatase 13B

increases expression

EXP

Propylthiouracil results in increased expression of DUSP13B mRNA

NCBI chr15:2,616,761...2,624,434
Ensembl chr15:2,609,049...2,624,887

G

dual specificity phosphatase 16

increases expression

EXP

Propylthiouracil results in increased expression of DUSP16 mRNA

NCBI chr 4:169,278,118...169,361,508
Ensembl chr 4:169,278,118...169,361,508

G

dual specificity phosphatase 2

increases expression

EXP

Propylthiouracil results in increased expression of DUSP2 mRNA

PMID:25825206 PMID:30047161

NCBI chr 3:135,009,636...135,011,821
Ensembl chr 3:135,009,590...135,011,809

G

dual specificity phosphatase 26

increases expression

EXP

Propylthiouracil results in increased expression of DUSP26 mRNA

NCBI chr16:67,744,830...67,752,673
Ensembl chr16:67,744,842...67,752,101

G

dual specificity phosphatase 3

increases expression

EXP

Propylthiouracil results in increased expression of DUSP3 mRNA

NCBI chr10:87,420,213...87,434,202
Ensembl chr10:87,419,494...87,434,063

G

dual specificity phosphatase 5

increases expression

EXP

Propylthiouracil results in increased expression of DUSP5 mRNA

NCBI chr 1:262,543,774...262,557,201
Ensembl chr 1:262,543,738...262,562,417

G

dual specificity phosphatase 6

affects expression
increases expression

EXP

Propylthiouracil affects the expression of DUSP6 mRNA
Propylthiouracil results in increased expression of DUSP6 mRNA

PMID:25825206 PMID:30047161

NCBI chr 7:35,979,502...35,983,834
Ensembl chr 7:35,977,921...35,983,833

G

dual specificity phosphatase 8

increases expression

EXP

Propylthiouracil results in increased expression of DUSP8 mRNA

NCBI chr 1:206,596,912...206,613,728
Ensembl chr 1:206,598,942...206,612,441

G

dual specificity phosphatase 9

decreases expression

EXP

Propylthiouracil results in decreased expression of DUSP9 mRNA

NCBI chr X:156,503,237...156,507,162
Ensembl chr X:156,503,190...156,507,161

G

deoxyuridine triphosphatase

increases expression

EXP

Propylthiouracil results in increased expression of DUT mRNA

NCBI chr 3:132,952,258...132,963,433
Ensembl chr 3:132,952,394...132,964,956

G

DPY30 domain containing 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of DYDC2 mRNA
Propylthiouracil results in decreased expression of DYDC2 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr16:16,962,273...16,976,034
Ensembl chr16:16,962,290...16,970,258

G

dynein cytoplasmic 1 intermediate chain 1

increases expression

EXP

Propylthiouracil results in increased expression of DYNC1I1 mRNA

NCBI chr 4:34,819,313...35,132,647
Ensembl chr 4:34,819,430...35,142,319

G

dynein, cytoplasmic 1 light intermediate chain 2

increases expression

EXP

Propylthiouracil results in increased expression of DYNC1LI2 mRNA

NCBI chr19:538,207...561,110
Ensembl chr19:538,211...561,107

G

dynein cytoplasmic 2 heavy chain 1

decreases expression

EXP

Propylthiouracil results in decreased expression of DYNC2H1 mRNA

NCBI chr 8:12,473,955...12,697,075
Ensembl chr 8:12,473,955...12,697,058

G

dynein light chain LC8-type 1

increases expression

EXP

Propylthiouracil results in increased expression of DYNLL1 mRNA

NCBI chr12:46,945,291...46,976,867
Ensembl chr12:46,973,050...46,976,861

G

dynein light chain roadblock-type 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of DYNLRB2 mRNA
Propylthiouracil results in decreased expression of DYNLRB2 mRNA

PMID:22504374 PMID:24780913 PMID:36843608

NCBI chr19:61,428,782...61,440,331
Ensembl chr19:61,429,065...61,441,071

G

dynein light chain Tctex-type 1

increases expression

EXP

Propylthiouracil results in increased expression of DYNLT1 mRNA

NCBI chr 1:49,292,093...49,299,051
Ensembl chr 1:49,282,243...49,298,951

G

dynein light chain Tctex-type 2B

decreases expression

EXP

Propylthiouracil results in decreased expression of TCTEX1D2 mRNA

NCBI chr11:81,864,195...81,872,555
Ensembl chr11:81,864,195...81,872,555

G

dynein light chain Tctex-type family member 5

decreases expression

EXP

Propylthiouracil results in decreased expression of DYNLT5 mRNA

NCBI chr 5:122,964,568...122,987,304
Ensembl chr 5:122,964,845...122,987,304

G

dual specificity tyrosine phosphorylation regulated kinase 2

increases expression

EXP

Propylthiouracil results in increased expression of DYRK2 mRNA

NCBI chr 7:56,235,276...56,265,741
Ensembl chr 7:56,235,276...56,265,942

G

dual specificity tyrosine phosphorylation regulated kinase 3

increases expression

EXP

Propylthiouracil results in increased expression of DYRK3 mRNA

NCBI chr13:45,146,383...45,157,082
Ensembl chr13:45,146,384...45,157,249

G

double zinc ribbon and ankyrin repeat domains 1

decreases expression

EXP

Propylthiouracil results in decreased expression of DZANK1 mRNA

NCBI chr 3:152,309,228...152,361,548
Ensembl chr 3:152,309,228...152,361,548

G

E2F transcription factor 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of E2F1 mRNA
Propylthiouracil results in decreased expression of E2F1 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:163,524,739...163,535,563

G

E2F transcription factor 3

increases expression

EXP

Propylthiouracil results in increased expression of E2F3 mRNA

NCBI chr17:34,810,355...34,887,725
Ensembl chr17:34,809,998...34,887,725

G

E2F transcription factor 6

decreases expression

EXP

Propylthiouracil results in decreased expression of E2F6 mRNA

NCBI chr 6:45,320,993...45,337,437
Ensembl chr 6:45,320,996...45,337,428

G

E2F transcription factor 8

affects expression

EXP

Propylthiouracil affects the expression of E2F8 mRNA

NCBI chr 1:107,701,985...107,720,538
Ensembl chr 1:107,701,985...107,720,009

G

ELL associated factor 1

increases expression

EXP

Propylthiouracil results in increased expression of EAF1 mRNA

NCBI chr16:6,704,727...6,719,476
Ensembl chr16:6,704,727...6,719,476

G

glutamyl-tRNA synthetase 2, mitochondrial

affects expression

EXP

Propylthiouracil affects the expression of EARS2 mRNA

NCBI chr 1:186,025,740...186,057,165

G

EBP, cholestenol delta-isomerase

decreases expression

EXP

Propylthiouracil results in decreased expression of EBP mRNA

NCBI chr X:16,971,372...16,977,782
Ensembl chr X:16,971,405...16,977,781

G

EBP like

decreases expression

EXP

Propylthiouracil results in decreased expression of EBPL mRNA

NCBI chr15:39,684,140...39,707,537
Ensembl chr15:39,684,140...39,707,537

G

endothelin converting enzyme 1

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of ECE1 mRNA
Propylthiouracil results in increased expression of ECE1 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 5:155,361,031...155,462,723
Ensembl chr 5:155,360,639...155,462,719

G

endothelin-converting enzyme 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ECE2 mRNA

NCBI chr11:93,767,559...93,782,896
Ensembl chr11:93,767,559...93,793,292

G

endothelin converting enzyme-like 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of ECEL1 mRNA
Propylthiouracil results in decreased expression of ECEL1 mRNA

PMID:22504374 PMID:24780913

NCBI chr 9:95,267,417...95,276,508
Ensembl chr 9:95,264,618...95,274,575

G

enoyl-CoA hydratase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ECH1 mRNA

PMID:30047161 PMID:36843608

NCBI chr 1:93,241,076...93,248,314
Ensembl chr 1:93,241,734...93,248,440

G

enoyl CoA hydratase domain containing 2

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of ECHDC2 mRNA
Propylthiouracil results in decreased expression of ECHDC2 mRNA

PMID:24780913 PMID:30047161

NCBI chr 5:128,144,241...128,163,611
Ensembl chr 5:128,144,425...128,163,610

G

enoyl CoA hydratase domain containing 3

decreases expression

EXP

Propylthiouracil results in decreased expression of ECHDC3 mRNA

NCBI chr17:76,980,112...77,002,934
Ensembl chr17:76,980,083...77,002,934

G

enoyl-CoA hydratase, short chain 1

affects expression

EXP

Propylthiouracil affects the expression of ECHS1 mRNA

NCBI chr 1:204,324,679...204,333,506
Ensembl chr 1:204,324,682...204,333,506

G

enoyl-CoA delta isomerase 1

affects expression
increases expression

EXP

Propylthiouracil affects the expression of ECI1 mRNA
Propylthiouracil results in increased expression of ECI1 mRNA

PMID:19483382 PMID:24780913

NCBI chr10:13,961,250...13,974,595
Ensembl chr10:13,961,218...13,974,773

G

enoyl-CoA delta isomerase 2

affects expression

EXP

Propylthiouracil affects the expression of ECI2 mRNA

NCBI chr17:30,056,274...30,092,169
Ensembl chr17:30,076,524...30,092,161

G

ECSIT signaling integrator

increases expression

EXP

Propylthiouracil results in increased expression of ECSIT mRNA

NCBI chr 8:28,881,594...28,894,443
Ensembl chr 8:28,881,594...28,894,397

G

ectodysplasin-A

decreases expression

EXP

Propylthiouracil results in decreased expression of EDA mRNA

NCBI chr X:69,118,577...69,520,274
Ensembl chr X:69,118,796...69,520,274

G

ectodysplasin-A receptor

decreases expression

EXP

Propylthiouracil results in decreased expression of EDAR mRNA

NCBI chr20:27,130,934...27,209,672
Ensembl chr20:27,130,934...27,209,630

G

EDAR associated via death domain

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of EDARADD mRNA

NCBI chr17:92,850,791...92,894,808
Ensembl chr17:92,831,613...92,894,361

G

enhancer of mRNA decapping 4

decreases expression

EXP

Propylthiouracil results in decreased expression of EDC4 mRNA

NCBI chr19:50,683,924...50,695,916
Ensembl chr19:50,683,897...50,697,620

G

endothelial differentiation-related factor 1

increases expression

EXP

Propylthiouracil results in increased expression of EDF1 mRNA

NCBI chr 3:28,764,906...28,779,499

G

endothelin 1

increases expression

EXP

Propylthiouracil results in increased expression of EDN1 mRNA

NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687

G

endothelin 3

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of EDN3 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of EDN3 mRNA

PMID:24780913 PMID:30047161 PMID:36706583

NCBI chr 3:183,980,458...184,004,958
Ensembl chr 3:183,980,668...184,005,329

G

endothelin receptor type A

increases expression

EXP

Propylthiouracil results in increased expression of EDNRA mRNA

PMID:24780913 PMID:25825206

NCBI chr19:47,137,360...47,207,961
Ensembl chr19:47,137,771...47,201,284

G

endothelin receptor type B

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of EDNRB mRNA
Propylthiouracil results in increased expression of EDNRB mRNA

PMID:24780913 PMID:30047161

NCBI chr15:87,055,490...87,086,765
Ensembl chr15:87,057,691...87,086,765

G

eukaryotic translation elongation factor 1 alpha 1

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of EEF1A1 mRNA
Propylthiouracil results in increased expression of EEF1A1 mRNA

PMID:18077114 PMID:24780913 PMID:30047161

NCBI chr 8:88,221,839...88,225,688
Ensembl chr 8:88,221,843...88,225,072

G

EEF1A lysine methyltransferase 2

decreases expression

EXP

Propylthiouracil results in decreased expression of METTL10 mRNA

NCBI chr 1:197,009,919...197,071,033
Ensembl chr 1:197,046,930...197,071,013

G

eukaryotic translation elongation factor 1 epsilon 1

increases expression

EXP

Propylthiouracil results in increased expression of EEF1E1 mRNA

NCBI chr17:26,354,247...26,364,953
Ensembl chr17:26,354,228...26,370,687

G

eukaryotic translation elongation factor 1 gamma

affects expression

EXP

Propylthiouracil affects the expression of EEF1G mRNA

NCBI chr 1:215,289,815...215,300,421
Ensembl chr 1:215,277,860...215,301,479

G

eukaryotic translation elongation factor 2

decreases expression

EXP

Propylthiouracil results in decreased expression of EEF2 mRNA

PMID:18077114 PMID:30047161

NCBI chr 7:9,183,836...9,196,255
Ensembl chr 7:9,183,961...9,189,544

G

eukaryotic elongation factor-2 kinase

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of EEF2K mRNA
Propylthiouracil results in decreased expression of EEF2K mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:184,824,420...184,888,048
Ensembl chr 1:184,824,420...184,888,048

G

EEIG family member 2

decreases expression

EXP

Propylthiouracil results in decreased expression of FAM102B mRNA

NCBI chr 2:199,296,582...199,351,449
Ensembl chr 2:199,296,582...199,351,449

G

endonuclease/exonuclease/phosphatase family domain containing 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of EEPD1 mRNA
Propylthiouracil results in decreased expression of EEPD1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 8:32,233,834...32,340,148
Ensembl chr 8:32,233,070...32,340,147

G

EF-hand calcium binding domain 10

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of EFCAB10 mRNA
Propylthiouracil results in decreased expression of EFCAB10 mRNA

PMID:24780913 PMID:25825206

NCBI chr 6:55,731,902...55,738,821
Ensembl chr 6:55,731,902...55,738,821

G

EF-hand calcium binding domain 2

increases expression

EXP

Propylthiouracil results in increased expression of EFCAB2 mRNA

NCBI chr13:92,683,182...92,769,939
Ensembl chr13:92,684,086...92,782,558

G

EF-hand and coiled-coil domain containing 1

decreases expression

EXP

Propylthiouracil results in decreased expression of EFCC1 mRNA

NCBI chr 4:121,745,547...121,778,475
Ensembl chr 4:121,745,633...121,775,220

G

EGF containing fibulin extracellular matrix protein 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of EFEMP1 mRNA
Propylthiouracil results in decreased expression of EFEMP1 mRNA

PMID:24780913 PMID:30047161

NCBI chr14:106,811,769...106,890,961
Ensembl chr14:106,802,304...106,892,808

G

EF-hand domain containing 1

decreases expression

EXP

Propylthiouracil results in decreased expression of EFHC1 mRNA

NCBI chr 9:30,872,238...30,910,703
Ensembl chr 9:30,871,565...30,910,703

G

EF-hand domain containing 2

decreases expression

EXP

Propylthiouracil results in decreased expression of EFHC2 mRNA

NCBI chr X:7,943,603...8,144,073
Ensembl chr X:7,943,725...8,144,215

G

EF-hand domain family, member D1

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of EFHD1 mRNA
Propylthiouracil results in increased expression of EFHD1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 9:95,386,155...95,432,800
Ensembl chr 9:95,386,169...95,432,798

G

EF-hand domain family, member D2

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of EFHD2 mRNA
Propylthiouracil results in increased expression of EFHD2 mRNA

PMID:24780913 PMID:30047161 PMID:36843608

NCBI chr 5:159,443,959...159,459,993
Ensembl chr 5:159,443,960...159,460,369

G

ephrin A1

increases expression

EXP

Propylthiouracil results in increased expression of EFNA1 mRNA

NCBI chr 2:176,979,434...176,988,675
Ensembl chr 2:176,979,434...176,988,726

G

ephrin A2

increases expression

EXP

Propylthiouracil results in increased expression of EFNA2 mRNA

NCBI chr 7:10,167,091...10,177,719
Ensembl chr 7:10,167,091...10,177,719

G

ephrin A4

increases expression

EXP

Propylthiouracil results in increased expression of EFNA4 mRNA

NCBI chr 2:177,046,463...177,050,713
Ensembl chr 2:177,046,463...177,050,713

G

ephrin B1

increases expression

EXP

Propylthiouracil results in increased expression of EFNB1 mRNA

NCBI chr X:68,297,529...68,310,335
Ensembl chr X:68,297,492...68,349,546

G

ephrin B3

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of EFNB3 mRNA
Propylthiouracil results in decreased expression of EFNB3 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr10:54,773,282...54,780,727
Ensembl chr10:54,773,282...54,797,651

G

EFR3 homolog A

decreases expression

EXP

Propylthiouracil results in decreased expression of EFR3A mRNA

NCBI chr 7:99,441,764...99,522,454
Ensembl chr 7:99,441,767...99,522,454

G

embryonal Fyn-associated substrate

increases expression

EXP

Propylthiouracil results in increased expression of EFS mRNA

NCBI chr15:32,362,401...32,374,490
Ensembl chr15:32,361,843...32,371,743

G

epidermal growth factor

increases methylation
decreases expression

EXP

Propylthiouracil results in increased methylation of EGF promoter
Propylthiouracil results in decreased expression of EGF mRNA

NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297

G

EGF-like and EMI domain containing 1

increases expression

EXP

Propylthiouracil results in increased expression of EGFEM1 mRNA

NCBI chr 2:115,601,768...116,253,029
Ensembl chr 2:115,607,664...116,252,866

G

EGF-like-domain, multiple 6

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of EGFL6 mRNA
Propylthiouracil results in decreased expression of EGFL6 mRNA

PMID:24780913 PMID:30047161

NCBI chr X:31,515,752...31,573,699
Ensembl chr X:31,515,767...31,574,632

G

EGF-like-domain, multiple 8

decreases expression

EXP

Propylthiouracil results in decreased expression of EGFL8 mRNA

NCBI chr20:4,137,531...4,140,632
Ensembl chr20:4,138,053...4,141,681

G

epidermal growth factor receptor

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of EGFR mRNA
Propylthiouracil results in decreased expression of EGFR mRNA

PMID:24780913 PMID:30047161

NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358

G

egl-9 family hypoxia-inducible factor 1

decreases expression

EXP

Propylthiouracil results in decreased expression of EGLN1 mRNA

NCBI chr19:69,765,276...69,804,681

G

early growth response 1

decreases expression

EXP

Propylthiouracil results in decreased expression of EGR1 mRNA

PMID:24780913 PMID:25825206

NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843

G

early growth response 4

decreases expression

EXP

Propylthiouracil results in decreased expression of EGR4 mRNA

NCBI chr 4:119,605,358...119,607,817
Ensembl chr 4:119,605,357...119,608,368

G

EH domain binding protein 1

decreases expression

EXP

Propylthiouracil results in decreased expression of EHBP1 mRNA

NCBI chr14:100,294,585...100,581,764
Ensembl chr14:100,294,585...100,546,579

G

EH-domain containing 1

increases expression

EXP

Propylthiouracil results in increased expression of EHD1 mRNA

NCBI chr 1:213,009,113...213,031,488
Ensembl chr 1:213,008,049...213,031,485

G

EH-domain containing 4

increases expression

EXP

Propylthiouracil results in increased expression of EHD4 mRNA

NCBI chr 3:127,511,973...127,575,856
Ensembl chr 3:127,511,954...127,576,072

G

enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of EHHADH mRNA
Propylthiouracil results in decreased expression of EHHADH mRNA

PMID:19483382 PMID:24780913 PMID:25825206

NCBI chr11:92,746,409...92,779,647
Ensembl chr11:92,746,420...92,779,662

G

euchromatic histone lysine methyltransferase 2

decreases expression

EXP

Propylthiouracil results in decreased expression of EHMT2 mRNA

NCBI chr20:3,924,263...3,941,238
Ensembl chr20:3,924,263...3,941,384

G

EP300 interacting inhibitor of differentiation 2

increases expression

EXP

Propylthiouracil results in increased expression of EID2 mRNA

NCBI chr 1:92,665,837...92,667,162
Ensembl chr 1:92,665,481...92,675,307

G

EP300 interacting inhibitor of differentiation 3

decreases expression

EXP

Propylthiouracil results in decreased expression of EID3 mRNA

NCBI chr 7:22,747,645...22,748,967
Ensembl chr 7:22,747,656...22,749,177

G

eukaryotic translation initiation factor 1

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of EIF1 mRNA
Propylthiouracil results in increased expression of EIF1 mRNA

PMID:30047161 PMID:36843608

NCBI chr10:85,747,064...85,749,447
Ensembl chr 5:25,895,968...25,896,654
Ensembl chr10:25,895,968...25,896,654

G

eukaryotic translation initiation factor 2 alpha kinase 3

affects expression

EXP

Propylthiouracil affects the expression of EIF2AK3 mRNA

NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268

G

eukaryotic translation initiation factor 2B subunit beta

increases expression

EXP

Propylthiouracil results in increased expression of EIF2B2 mRNA

NCBI chr 6:110,597,979...110,604,403
Ensembl chr 6:110,597,729...110,604,403

G

eukaryotic translation initiation factor 2B subunit gamma

increases expression

EXP

Propylthiouracil results in increased expression of EIF2B3 mRNA

NCBI chr 5:135,728,764...135,795,276
Ensembl chr 5:135,728,959...135,799,914

G

eukaryotic translation initiation factor 2 subunit alpha

increases expression

EXP

Propylthiouracil results in increased expression of EIF2S1 mRNA

NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649

G

eukaryotic translation initiation factor 2 subunit beta

increases expression

EXP

Propylthiouracil results in increased expression of EIF2S2 mRNA

NCBI chr 3:163,834,846...163,855,733
Ensembl chr 3:163,834,851...163,855,570

G

eukaryotic translation initiation factor 2 subunit gamma

decreases expression

EXP

Propylthiouracil results in decreased expression of EIF2S3X mRNA

NCBI chr X:62,910,292...62,933,936
Ensembl chr X:62,910,293...62,934,489

G

eukaryotic translation initiation factor 4A1

increases expression

EXP

Propylthiouracil results in increased expression of EIF4A1 mRNA

PMID:30047161 PMID:36843608

NCBI chr10:54,883,093...54,888,602
Ensembl chr10:54,883,093...54,888,602

G

eukaryotic translation initiation factor 4A2

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of EIF4A2 mRNA
Propylthiouracil results in decreased expression of EIF4A2 mRNA

PMID:19483382 PMID:30047161

NCBI chr11:91,268,730...91,276,738
Ensembl chr11:91,268,731...91,275,323

G

eukaryotic translation initiation factor 4A3

increases expression

EXP

Propylthiouracil results in increased expression of EIF4A3 mRNA

NCBI chr10:105,047,567...105,057,561
Ensembl chr10:105,047,568...105,058,207

G

eukaryotic translation initiation factor 4E

increases expression

EXP

Propylthiouracil results in increased expression of EIF4E mRNA

NCBI chr 2:229,736,309...229,772,628
Ensembl chr 2:229,739,897...229,774,105

G

eukaryotic translation initiation factor 4E family member 2

increases expression

EXP

Propylthiouracil results in increased expression of EIF4E2 mRNA

NCBI chr 9:95,333,439...95,362,366
Ensembl chr 9:95,333,989...95,362,362

G

eukaryotic translation initiation factor 4E binding protein 1

affects expression

EXP

Propylthiouracil affects the expression of EIF4EBP1 mRNA

NCBI chr16:71,495,457...71,508,845
Ensembl chr16:71,487,930...71,508,874

G

eukaryotic translation initiation factor 4E binding protein 2

increases expression

EXP

Propylthiouracil results in increased expression of EIF4EBP2 mRNA

NCBI chr20:29,922,260...29,942,922
Ensembl chr20:29,922,260...29,942,922

G

eukaryotic translation initiation factor 4, gamma 2

increases expression

EXP

Propylthiouracil results in increased expression of EIF4G2 mRNA

NCBI chr 1:174,616,102...174,628,252
Ensembl chr 1:174,616,103...174,628,252

G

eukaryotic translation initiation factor 4 gamma, 3

decreases expression

EXP

Propylthiouracil results in decreased expression of EIF4G3 mRNA

NCBI chr 5:155,481,378...155,702,194
Ensembl chr 5:155,481,378...155,702,194

G

eukaryotic translation initiation factor 4H

affects expression

EXP

Propylthiouracil affects the expression of EIF4H mRNA

NCBI chr12:27,719,527...27,736,350
Ensembl chr12:27,719,321...27,736,346

G

eukaryotic translation initiation factor 5A

increases expression

EXP

Propylthiouracil results in increased expression of EIF5A mRNA

NCBI chr10:55,138,821...55,143,272
Ensembl chr10:55,138,823...55,143,330

G

eukaryotic translation initiation factor 5A2

decreases expression

EXP

Propylthiouracil results in decreased expression of EIF5A2 mRNA

PMID:24780913 PMID:25825206

NCBI chr 2:113,656,748...113,674,598
Ensembl chr 2:113,657,797...113,674,594

G

elaC ribonuclease Z 1

increases expression

EXP

Propylthiouracil results in increased expression of ELAC1 mRNA

NCBI chr18:69,596,475...69,617,206
Ensembl chr18:69,598,827...69,616,175

G

endosome-lysosome associated apoptosis and autophagy regulator family member 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ELAPOR2 mRNA

NCBI chr 4:25,565,298...25,760,684
Ensembl chr 4:25,568,122...25,760,684

G

ELAV like RNA binding protein 1

increases expression

EXP

Propylthiouracil results in increased expression of ELAVL1 mRNA

NCBI chr12:7,441,699...7,482,625
Ensembl chr12:7,441,699...7,482,631

G

ELAV like RNA binding protein 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of ELAVL2 mRNA
Propylthiouracil results in decreased expression of ELAVL2 mRNA

PMID:24780913 PMID:30047161

NCBI chr 5:111,076,705...111,202,341
Ensembl chr 5:111,076,705...111,224,918

G

ELAV like RNA binding protein 3

decreases expression

EXP

Propylthiouracil results in decreased expression of ELAVL3 mRNA

NCBI chr 8:28,823,120...28,859,395
Ensembl chr 8:28,825,707...28,859,659

G

ELAV like RNA binding protein 4

decreases expression

EXP

Propylthiouracil results in decreased expression of ELAVL4 mRNA

NCBI chr 5:130,285,418...130,429,106
Ensembl chr 5:130,285,418...130,429,096

G

E74 like ETS transcription factor 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ELF1 mRNA

NCBI chr15:61,354,026...61,395,762
Ensembl chr15:61,330,877...61,395,758

G

E74 like ETS transcription factor 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ELF2 mRNA

NCBI chr 2:137,445,787...137,536,512
Ensembl chr 2:137,445,788...137,470,355

G

E74 like ETS transcription factor 3

increases expression

EXP

Propylthiouracil results in increased expression of ELF3 mRNA

NCBI chr13:49,242,265...49,247,102
Ensembl chr13:49,242,267...49,247,380

G

E74 like ETS transcription factor 5

increases expression

EXP

Propylthiouracil results in increased expression of ELF5 mRNA

NCBI chr 3:110,264,460...110,291,926
Ensembl chr 3:110,252,797...110,291,926

G

ETS transcription factor ELK4

decreases expression

EXP

Propylthiouracil results in decreased expression of ELK4 mRNA

NCBI chr13:46,004,145...46,027,206
Ensembl chr13:46,004,182...46,027,199

G

elongation factor for RNA polymerase II

decreases expression

EXP

Propylthiouracil results in decreased expression of ELL mRNA

NCBI chr16:18,877,751...18,925,449
Ensembl chr16:18,877,751...18,925,076

G

engulfment and cell motility 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ELMO2 mRNA

NCBI chr 3:174,442,965...174,716,723
Ensembl chr 3:174,442,965...174,480,459

G

ELMO domain containing 3

decreases expression

EXP

Propylthiouracil results in decreased expression of ELMOD3 mRNA

NCBI chr 4:106,172,819...106,211,286
Ensembl chr 4:106,172,828...106,211,229

G

elastin

affects expression
increases expression

EXP

Propylthiouracil affects the expression of ELN mRNA
Propylthiouracil results in increased expression of ELN mRNA

PMID:24780913 PMID:30047161

NCBI chr12:27,604,983...27,648,413
Ensembl chr12:27,604,680...27,648,413

G

elongin B

increases expression

EXP

Propylthiouracil results in increased expression of TCEB2 mRNA

NCBI chr10:13,353,413...13,358,484
Ensembl chr10:13,353,417...13,358,563

G

ELOVL fatty acid elongase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ELOVL1 mRNA

NCBI chr 5:137,246,781...137,251,351
Ensembl chr 5:137,246,849...137,251,352

G

ELOVL fatty acid elongase 2

increases expression

EXP

Propylthiouracil results in increased expression of ELOVL2 mRNA

NCBI chr17:23,750,350...23,790,601
Ensembl chr17:23,750,350...23,790,601

G

ELOVL fatty acid elongase 6

decreases expression

EXP

Propylthiouracil results in decreased expression of ELOVL6 mRNA

NCBI chr 2:220,738,095...220,845,528
Ensembl chr 2:220,738,064...220,845,549

G

ELOVL fatty acid elongase 7

decreases expression

EXP

Propylthiouracil results in decreased expression of ELOVL7 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 2:41,522,695...41,592,021
Ensembl chr 2:41,522,738...41,592,020

G

elongator acetyltransferase complex subunit 1

decreases expression

EXP

Propylthiouracil results in decreased expression of IKBKAP mRNA

NCBI chr 5:76,248,545...76,300,985
Ensembl chr 5:76,248,550...76,300,985

G

elongator acetyltransferase complex subunit 5

increases expression

EXP

Propylthiouracil results in increased expression of ELP5 mRNA

NCBI chr10:55,191,223...55,202,949
Ensembl chr10:55,191,227...55,203,617

G

ER membrane protein complex subunit 1

decreases expression

EXP

Propylthiouracil results in decreased expression of EMC1 mRNA

NCBI chr 5:156,891,773...156,917,092
Ensembl chr 5:156,891,773...156,917,092

G

essential meiotic structure-specific endonuclease subunit 2

increases expression

EXP

Propylthiouracil results in increased expression of EME2 mRNA

NCBI chr10:14,413,661...14,420,489
Ensembl chr10:14,417,735...14,420,489

G

EMG1 N1-specific pseudouridine methyltransferase

increases expression

EXP

Propylthiouracil results in increased expression of EMG1 mRNA

NCBI chr 4:159,195,545...159,203,826
Ensembl chr 4:159,195,564...159,203,826

G

EMI domain containing 1

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of EMID1 mRNA
Propylthiouracil results in increased expression of EMID1 mRNA

PMID:24780913 PMID:25825206 PMID:30047161 PMID:36843608

NCBI chr14:84,214,530...84,257,628
Ensembl chr14:84,214,530...84,257,579

G

elastin microfibril interfacer 1

increases expression

EXP

Propylthiouracil results in increased expression of EMILIN1 mRNA

NCBI chr 6:31,175,919...31,183,657
Ensembl chr 6:31,175,919...31,183,657

G

EMAP like 4

decreases expression

EXP

Propylthiouracil results in decreased expression of EML4 mRNA

NCBI chr 6:16,972,054...17,087,365
Ensembl chr 6:16,972,075...17,087,439

G

EMAP like 5

decreases expression

EXP

Propylthiouracil results in decreased expression of EML5 mRNA

NCBI chr 6:123,775,269...123,905,585
Ensembl chr 6:123,776,368...123,905,538

G

epithelial membrane protein 1

affects expression
increases expression

EXP

Propylthiouracil affects the expression of EMP1 mRNA
Propylthiouracil results in increased expression of EMP1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 4:169,931,537...169,964,366
Ensembl chr 4:169,931,440...169,964,365

G

empty spiracles homeobox 1

decreases expression
multiple interactions
increases expression

EXP
ISO

Propylthiouracil results in decreased expression of EMX1 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of EMX1 mRNA
Propylthiouracil results in increased expression of EMX1 mRNA

PMID:24780913 PMID:30047161 PMID:36706583

NCBI chr 4:119,282,692...119,300,822
Ensembl chr 4:119,282,692...119,300,817

G

empty spiracles homeobox 2

decreases expression

EXP

Propylthiouracil results in decreased expression of EMX2 mRNA

PMID:30047161 PMID:36843608

NCBI chr 1:268,612,663...268,619,671
Ensembl chr 1:268,612,663...268,619,671

G

ectodermal-neural cortex 1

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of ENC1 mRNA
Propylthiouracil results in decreased expression of ENC1 mRNA

PMID:19483382 PMID:30047161

NCBI chr 2:30,285,274...30,297,194
Ensembl chr 2:30,283,736...30,315,721

G

endonuclease domain containing 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ENDOD1 mRNA

NCBI chr 8:19,490,615...19,520,007
Ensembl chr 8:19,490,615...19,520,007

G

endonuclease, poly(U)-specific

decreases expression

EXP

Propylthiouracil results in decreased expression of ENDOU mRNA

NCBI chr 7:130,723,972...130,745,672
Ensembl chr 7:130,723,972...130,745,672

G

endoglin

increases expression

EXP

Propylthiouracil results in increased expression of ENG mRNA

NCBI chr 3:36,332,190...36,370,324
Ensembl chr 3:36,326,202...36,370,933

G

endo-beta-N-acetylglucosaminidase

decreases expression

EXP

Propylthiouracil results in decreased expression of ENGASE mRNA

NCBI chr10:104,205,753...104,218,416
Ensembl chr10:104,205,752...104,218,411

G

enkurin domain containing 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ENKD1 mRNA

NCBI chr19:50,501,963...50,506,447
Ensembl chr19:50,501,963...50,506,942

G

enkurin, TRPC channel interacting protein

increases expression

EXP

Propylthiouracil results in increased expression of ENKUR mRNA

NCBI chr17:88,599,057...88,622,668
Ensembl chr17:88,599,057...88,622,668

G

enolase 1

affects expression
increases expression

EXP

Propylthiouracil affects the expression of ENO1 mRNA
Propylthiouracil results in increased expression of ENO1 mRNA

PMID:19483382 PMID:30047161

NCBI chr 5:166,002,867...166,014,252
Ensembl chr 3:77,946,261...77,986,003
Ensembl chr 5:77,946,261...77,986,003

G

enolase 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ENO2 mRNA

NCBI chr 4:159,258,371...159,267,220
Ensembl chr 4:159,258,371...159,267,220

G

enolase 3

decreases expression

EXP

Propylthiouracil results in decreased expression of ENO3 mRNA

NCBI chr10:55,868,880...55,876,099
Ensembl chr10:55,866,101...55,874,540

G

glutamyl aminopeptidase

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of ENPEP mRNA
Propylthiouracil results in decreased expression of ENPEP mRNA

PMID:19483382 PMID:24780913

NCBI chr 2:220,456,258...220,526,218
Ensembl chr 2:220,456,278...220,526,218

G

ectonucleotide pyrophosphatase/phosphodiesterase 1

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of ENPP1 mRNA
Propylthiouracil results in decreased expression of ENPP1 mRNA

PMID:19483382 PMID:24780913

NCBI chr 1:22,518,051...22,583,044
Ensembl chr 1:22,518,069...22,583,044

G

ectonucleotide pyrophosphatase/phosphodiesterase 2

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of ENPP2 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of ENPP2 mRNA

PMID:24780913 PMID:30047161 PMID:36706583

NCBI chr 7:88,092,140...88,214,758
Ensembl chr 7:88,092,140...88,214,957

G

ectonucleotide pyrophosphatase/phosphodiesterase 3

increases expression

EXP

Propylthiouracil results in increased expression of ENPP3 mRNA

NCBI chr 1:22,382,717...22,454,324
Ensembl chr 1:22,382,964...22,454,314

G

ectonucleotide pyrophosphatase/phosphodiesterase 4

decreases expression

EXP

Propylthiouracil results in decreased expression of ENPP4 mRNA

NCBI chr 9:24,386,351...24,396,248
Ensembl chr 9:24,360,272...24,396,152

G

ectonucleotide pyrophosphatase/phosphodiesterase family member 5

decreases expression

EXP

Propylthiouracil results in decreased expression of ENPP5 mRNA

NCBI chr 9:24,407,574...24,415,029
Ensembl chr 9:24,408,218...24,414,867

G

ectonucleotide pyrophosphatase/phosphodiesterase 6

decreases expression

EXP

Propylthiouracil results in decreased expression of ENPP6 mRNA

PMID:24780913 PMID:25825206

NCBI chr16:51,898,557...52,026,789
Ensembl chr16:51,898,557...52,026,728

G

ENTH domain containing 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ENTHD1 mRNA

PMID:24780913 PMID:25825206

NCBI chr 7:113,875,018...113,989,970
Ensembl chr 7:113,875,027...113,989,461

G

ectonucleoside triphosphate diphosphohydrolase 2

increases expression

EXP

Propylthiouracil results in increased expression of ENTPD2 mRNA

NCBI chr 3:28,611,722...28,617,237
Ensembl chr 3:28,611,772...28,618,184

G

ectonucleoside triphosphate diphosphohydrolase 3

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of ENTPD3 mRNA
Propylthiouracil results in increased expression of ENTPD3 mRNA

PMID:24780913 PMID:30047161

NCBI chr 8:129,124,540...129,155,528
Ensembl chr 8:129,124,709...129,156,252

G

ectonucleoside triphosphate diphosphohydrolase 5

increases expression

EXP

Propylthiouracil results in increased expression of ENTPD5 mRNA

NCBI chr 6:109,750,210...109,786,376
Ensembl chr 6:109,753,204...109,786,495

G

endosomal transmembrane epsin interactor 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ENTREP1 mRNA; Propylthiouracil results in decreased expression of FAM189A2 mRNA

PMID:24780913 PMID:36843608

NCBI chr 1:231,018,987...231,073,474
Ensembl chr 1:231,018,987...231,102,708

G

eomesodermin

decreases expression

EXP

Propylthiouracil results in decreased expression of EOMES mRNA

NCBI chr 8:127,059,215...127,067,070
Ensembl chr 8:127,059,215...127,067,070

G

E1A binding protein p300

decreases expression

EXP

Propylthiouracil results in decreased expression of EP300 mRNA

NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:114,946,982...115,058,574

G

endothelial PAS domain protein 1

decreases expression

EXP

Propylthiouracil results in decreased expression of EPAS1 mRNA

NCBI chr 6:13,543,252...13,626,147
Ensembl chr 6:13,544,389...13,624,729

G

erythrocyte membrane protein band 4.1-like 2

increases expression

EXP

Propylthiouracil results in increased expression of EPB41L2 mRNA

NCBI chr 1:21,682,336...21,857,106
Ensembl chr 1:21,682,335...21,857,105

G

erythrocyte membrane protein band 4.1-like 3

decreases expression

EXP

Propylthiouracil results in decreased expression of EPB41L3 mRNA

NCBI chr 9:116,502,864...116,707,274
Ensembl chr 9:116,462,807...116,707,274

G

erythrocyte membrane protein band 4.1 like 4A

decreases expression

EXP

Propylthiouracil results in decreased expression of EPB41L4A mRNA

NCBI chr18:25,680,169...25,890,998
Ensembl chr18:25,680,171...25,888,498

G

erythrocyte membrane protein band 4.1 like 5

affects expression

EXP

Propylthiouracil affects the expression of EPB41L5 mRNA

NCBI chr13:33,221,705...33,321,400
Ensembl chr13:33,223,589...33,321,133

G

erythrocyte membrane protein band 4.2

decreases expression

EXP

Propylthiouracil results in decreased expression of EPB42 mRNA

NCBI chr 3:128,433,460...128,451,683
Ensembl chr 3:128,433,464...128,451,683

G

enhancer of polycomb homolog 1

increases expression

EXP

Propylthiouracil results in increased expression of EPC1 mRNA

NCBI chr17:59,198,513...59,289,535
Ensembl chr17:59,197,677...59,289,519

G

enhancer of polycomb homolog 2

decreases expression

EXP

Propylthiouracil results in decreased expression of EPC2 mRNA

NCBI chr 3:54,276,187...54,376,373
Ensembl chr 3:54,276,239...54,376,916

G

epithelial cell adhesion molecule

affects expression
increases expression

EXP

Propylthiouracil affects the expression of EPCAM mRNA
Propylthiouracil results in increased expression of EPCAM mRNA

PMID:19483382 PMID:24780913

NCBI chr 6:12,633,715...12,649,678
Ensembl chr 6:12,631,611...12,649,702

G

ependymin related 1

decreases expression

EXP

Propylthiouracil results in decreased expression of EPDR1 mRNA

NCBI chr17:50,029,591...50,054,254
Ensembl chr17:50,029,256...50,054,250

G

epithelial mitogen

increases expression

EXP

Propylthiouracil results in increased expression of EPGN mRNA

NCBI chr14:17,360,968...17,369,000
Ensembl chr14:17,360,968...17,369,000

G

Eph receptor A2

increases expression

EXP

Propylthiouracil results in increased expression of EPHA2 mRNA

NCBI chr 5:158,888,629...158,917,100
Ensembl chr 5:158,888,629...158,917,234

G

Eph receptor A4

decreases expression

EXP

Propylthiouracil results in decreased expression of EPHA4 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 9:86,263,982...86,406,744
Ensembl chr 9:86,263,982...86,406,755

G

EPH receptor A5

decreases expression
increases methylation

EXP

Propylthiouracil results in decreased expression of EPHA5 mRNA
Propylthiouracil results in increased methylation of EPHA5 promoter

NCBI chr14:24,007,400...24,374,854
Ensembl chr14:24,008,122...24,374,848

G

Eph receptor A6

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of EPHA6 mRNA
Propylthiouracil results in increased expression of EPHA6 mRNA

PMID:24780913 PMID:36843608

NCBI chr11:53,226,784...54,178,120
Ensembl chr11:53,226,954...54,166,987

G

Eph receptor A7

affects expression
increases methylation
decreases expression
increases expression

EXP

Propylthiouracil affects the expression of EPHA7 mRNA
Propylthiouracil results in increased methylation of EPHA7 promoter
Propylthiouracil results in decreased expression of EPHA7 mRNA
Propylthiouracil results in increased expression of EPHA7 mRNA

PMID:24780913 PMID:25825206 PMID:33150595

NCBI chr 5:47,771,776...47,925,189
Ensembl chr 5:47,771,865...47,925,058

G

Eph receptor B1

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of EPHB1 mRNA
Propylthiouracil results in decreased expression of EPHB1 mRNA

PMID:24780913 PMID:25825206

NCBI chr 8:111,386,432...111,823,759
Ensembl chr 8:111,386,432...111,823,759

G

Eph receptor B2

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of EPHB2 mRNA
Propylthiouracil results in decreased expression of EPHB2 mRNA

NCBI chr 5:154,179,065...154,360,459
Ensembl chr 5:154,179,065...154,360,615

G

Eph receptor B3

affects expression
increases expression

EXP

Propylthiouracil affects the expression of EPHB3 mRNA
Propylthiouracil results in increased expression of EPHB3 mRNA

NCBI chr11:93,345,098...93,363,775
Ensembl chr11:93,345,098...93,363,775

G

Eph receptor B6

decreases expression

EXP

Propylthiouracil results in decreased expression of EPHB6 mRNA

NCBI chr 4:71,458,632...71,473,889
Ensembl chr 4:71,458,971...71,476,659

G

epoxide hydrolase 2

decreases expression

EXP

Propylthiouracil results in decreased expression of EPHX2 mRNA

NCBI chr15:44,465,447...44,503,157
Ensembl chr15:44,465,448...44,503,160

G

epoxide hydrolase 4

decreases expression

EXP

Propylthiouracil results in decreased expression of EPHX4 mRNA

NCBI chr14:2,488,282...2,517,558
Ensembl chr14:2,488,290...2,517,757

G

EPM2A interacting protein 1

decreases expression

EXP

Propylthiouracil results in decreased expression of EPM2AIP1 mRNA

NCBI chr 8:120,112,265...120,119,613
Ensembl chr 8:120,112,084...120,121,458

G

Epsin 1

decreases expression

EXP

Propylthiouracil results in decreased expression of EPN1 mRNA

NCBI chr 1:77,771,335...77,789,411
Ensembl chr 1:77,771,335...77,789,411

G

epsin 2

decreases expression

EXP

Propylthiouracil results in decreased expression of EPN2 mRNA

NCBI chr10:46,697,238...46,759,128
Ensembl chr10:46,697,238...46,759,092

G

epsin 3

decreases expression
multiple interactions
increases expression

EXP
ISO

Propylthiouracil results in decreased expression of EPN3 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of EPN3 mRNA
Propylthiouracil results in increased expression of EPN3 mRNA

PMID:24780913 PMID:25825206 PMID:30047161 PMID:36706583

NCBI chr10:79,935,857...79,946,121
Ensembl chr10:79,935,857...79,944,235

G

epididymal peptidase inhibitor

decreases expression

EXP

Propylthiouracil results in decreased expression of EPPIN mRNA

NCBI chr 3:173,731,739...173,738,651
Ensembl chr 3:173,731,739...173,738,651

G

epiplakin 1

decreases expression

EXP

Propylthiouracil results in decreased expression of EPPK1 mRNA

NCBI chr 7:109,697,607...109,718,468
Ensembl chr 7:109,697,607...109,718,468

G

epidermal growth factor receptor pathway substrate 15

decreases expression

EXP

Propylthiouracil results in decreased expression of EPS15 mRNA

NCBI chr 5:129,274,487...129,374,856
Ensembl chr 5:129,274,502...129,374,856

G

EPS8 signaling adaptor L1

decreases expression

EXP

Propylthiouracil results in decreased expression of EPS8L1 mRNA

NCBI chr 1:78,386,916...78,409,972
Ensembl chr 1:78,386,916...78,406,187

G

EPS8 signaling adaptor L2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of EPS8L2 mRNA
Propylthiouracil results in decreased expression of EPS8L2 mRNA

PMID:22504374 PMID:24780913 PMID:30047161

NCBI chr 1:205,875,825...205,901,109
Ensembl chr 1:205,875,801...205,901,101

G

epithelial stromal interaction 1

increases expression

EXP

Propylthiouracil results in increased expression of EPSTI1 mRNA

NCBI chr15:59,692,712...59,791,376
Ensembl chr15:59,693,142...59,791,380

G

Era-like 12S mitochondrial rRNA chaperone 1

increases expression

EXP

Propylthiouracil results in increased expression of ERAL1 mRNA

NCBI chr10:63,459,774...63,466,829
Ensembl chr10:63,459,774...63,468,225

G

endoplasmic reticulum aminopeptidase 1

increases expression

EXP

Propylthiouracil results in increased expression of ERAP1 mRNA

NCBI chr 2:5,666,337...5,705,256
Ensembl chr 2:5,666,436...5,740,056

G

ES cell expressed Ras

increases expression

EXP

Propylthiouracil results in increased expression of ERAS mRNA

PMID:24780913 PMID:25825206

NCBI chr X:17,245,915...17,250,301
Ensembl chr X:17,245,789...17,250,293

G

erb-b2 receptor tyrosine kinase 2

increases expression

EXP

Propylthiouracil results in increased expression of ERBB2 mRNA

PMID:24780913 PMID:30047161

NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,907,460...83,931,481

G

erb-b2 receptor tyrosine kinase 3

decreases expression

EXP

Propylthiouracil results in decreased expression of ERBB3 mRNA

PMID:24780913 PMID:25825206

NCBI chr 7:1,579,079...1,600,379
Ensembl chr 7:1,579,816...1,601,120

G

erb-b2 receptor tyrosine kinase 4

increases expression

EXP

Propylthiouracil results in increased expression of ERBB4 mRNA

NCBI chr 9:76,973,386...78,045,633
Ensembl chr 9:76,973,227...78,045,772

G

ELKS/RAB6-interacting/CAST family member 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of ERC2 mRNA
Propylthiouracil results in decreased expression of ERC2 mRNA

PMID:24780913 PMID:30047161 PMID:36843608

NCBI chr16:2,819,399...3,680,258
Ensembl chr16:2,819,512...3,680,258

G

ERCC excision repair 3, TFIIH core complex helicase subunit

increases expression

EXP

Propylthiouracil results in increased expression of ERCC3 mRNA

NCBI chr18:24,157,831...24,188,543
Ensembl chr18:24,148,084...24,190,898

G

ERCC excision repair 6 like 2

decreases expression

EXP

Propylthiouracil results in decreased expression of ERCC6L2 mRNA

NCBI chr17:1,055,881...1,323,207
Ensembl chr17:1,222,139...1,316,056

G

epiregulin

decreases expression

EXP

Propylthiouracil results in decreased expression of EREG mRNA

NCBI chr14:17,311,485...17,325,260
Ensembl chr14:17,311,485...17,325,260

G

ETS repressor factor like

decreases expression

EXP

Propylthiouracil results in decreased expression of ERFL mRNA

NCBI chr 1:89,649,244...89,654,379
Ensembl chr 1:89,649,303...89,665,872

G

ETS transcription factor ERG

increases expression

EXP

Propylthiouracil results in increased expression of ERG mRNA

NCBI chr11:48,148,149...48,370,472
Ensembl chr11:48,148,153...48,370,688

G

endoplasmic reticulum-golgi intermediate compartment 1

increases expression

EXP

Propylthiouracil results in increased expression of ERGIC1 mRNA

NCBI chr10:17,035,615...17,131,411
Ensembl chr10:17,035,615...17,131,376

G

ERH, mRNA splicing and mitosis factor

increases expression

EXP

Propylthiouracil results in increased expression of ERH mRNA

NCBI chr 6:106,012,255...106,022,521
Ensembl chr 6:106,012,255...106,022,623

G

ER lipid raft associated 1

increases expression

EXP

Propylthiouracil results in increased expression of ERLIN1 mRNA

NCBI chr 1:252,870,356...252,905,681
Ensembl chr 1:252,870,356...252,905,947

G

ermin

decreases expression

EXP

Propylthiouracil results in decreased expression of ERMN mRNA

PMID:24780913 PMID:25825206

NCBI chr 3:63,037,001...63,042,657
Ensembl chr 3:63,035,150...63,042,585

G

endoplasmic reticulum to nucleus signaling 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ERN1 mRNA

NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,830,428...91,920,791

G

endoplasmic reticulum protein 27

increases expression

EXP

Propylthiouracil results in increased expression of ERP27 mRNA

NCBI chr 4:171,535,845...171,552,848
Ensembl chr 4:171,535,847...171,553,072

G

endoplasmic reticulum protein 29

affects expression
increases expression

EXP

Propylthiouracil affects the expression of ERP29 mRNA
Propylthiouracil results in increased expression of ERP29 mRNA

PMID:19483382 PMID:30047161

NCBI chr12:40,750,177...40,756,607
Ensembl chr12:40,750,314...40,757,010

G

endoplasmic reticulum protein 44

increases expression

EXP

Propylthiouracil results in increased expression of ERP44 mRNA

NCBI chr 5:67,313,245...67,406,207
Ensembl chr 5:67,312,098...67,406,444

G

ERBB receptor feedback inhibitor 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ERRFI1 mRNA

NCBI chr 5:166,606,841...166,620,124
Ensembl chr 5:166,606,834...166,620,432

G

endogenous retrovirus group FRD member 1, envelope

increases expression

EXP

Propylthiouracil results in increased expression of SYNA mRNA

NCBI chr12:27,787,680...27,794,732
Ensembl chr12:27,787,680...27,794,732

G

endothelial cell adhesion molecule

increases expression

EXP

Propylthiouracil results in increased expression of ESAM mRNA

NCBI chr 8:45,426,985...45,437,976
Ensembl chr 8:45,425,731...45,437,973

G

establishment of sister chromatid cohesion N-acetyltransferase 2

increases expression

EXP

Propylthiouracil results in increased expression of ESCO2 mRNA

NCBI chr15:44,210,124...44,230,785
Ensembl chr15:44,210,641...44,231,304
Ensembl chr15:44,210,641...44,231,304

G

esterase D

affects expression

EXP

Propylthiouracil affects the expression of ESD mRNA

NCBI chr15:56,453,082...56,472,582
Ensembl chr15:56,453,044...56,473,508

G

extra spindle pole bodies like 1, separase

increases expression

EXP

Propylthiouracil results in increased expression of ESPL1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 7:135,302,460...135,329,570
Ensembl chr 7:135,302,716...135,329,570

G

estrogen related receptor, alpha

increases expression

EXP

Propylthiouracil results in increased expression of ESRRA mRNA

NCBI chr 1:213,533,309...213,543,432
Ensembl chr 1:213,533,310...213,543,811

G

extended synaptotagmin 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ESYT1 mRNA

NCBI chr 7:1,513,381...1,530,836
Ensembl chr 7:1,513,381...1,530,732

G

ETAA1 activator of ATR kinase

decreases expression

EXP

Propylthiouracil results in decreased expression of ETAA1 mRNA

NCBI chr14:96,500,899...96,515,617
Ensembl chr14:96,500,899...96,517,796

G

eukaryotic translation termination factor 1

increases expression

EXP

Propylthiouracil results in increased expression of ETF1 mRNA

NCBI chr18:26,776,518...26,804,857
Ensembl chr18:26,777,858...26,804,613

G

electron transfer flavoprotein subunit beta

affects expression

EXP

Propylthiouracil affects the expression of ETFB mRNA

NCBI chr 1:102,988,499...103,002,663
Ensembl chr 1:102,988,499...103,002,659

G

electron transfer flavoprotein subunit beta lysine methyltransferase

decreases expression

EXP

Propylthiouracil results in decreased expression of ETFBKMT mRNA

NCBI chr 4:183,871,819...183,936,843
Ensembl chr 4:183,871,827...183,881,621

G

enhancer trap locus 4

decreases expression

EXP

Propylthiouracil results in decreased expression of ETL4 mRNA

PMID:24780913 PMID:30047161

NCBI chr17:87,749,486...88,213,158
Ensembl chr17:87,403,819...88,213,158

G

ETS proto-oncogene 2, transcription factor

decreases expression

EXP

Propylthiouracil results in decreased expression of ETS2 mRNA

NCBI chr11:48,491,057...48,507,843
Ensembl chr11:48,491,394...48,507,842

G

ETS variant transcription factor 1

increases expression

EXP

Propylthiouracil results in increased expression of ETV1 mRNA

NCBI chr 6:61,316,836...61,408,985
Ensembl chr 6:61,317,429...61,408,959

G

ETS variant transcription factor 3

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of ETV3 mRNA
Propylthiouracil results in increased expression of ETV3 mRNA

PMID:24780913 PMID:30047161

NCBI chr 2:175,263,389...175,278,217
Ensembl chr 2:175,263,459...175,278,208

G

ETS variant transcription factor 4

increases expression

EXP

Propylthiouracil results in increased expression of ETV4 mRNA

NCBI chr10:87,206,977...87,222,202
Ensembl chr10:87,206,977...87,222,318

G

ETS variant transcription factor 5

affects expression

EXP

Propylthiouracil affects the expression of ETV5 mRNA

NCBI chr11:92,113,171...92,170,758
Ensembl chr11:92,113,224...92,170,767

G

eva-1 homolog A, regulator of programmed cell death

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of EVA1A mRNA
Propylthiouracil results in increased expression of EVA1A mRNA

PMID:24780913 PMID:30047161

NCBI chr 4:116,151,595...116,200,827
Ensembl chr 4:116,151,173...116,200,827

G

eva-1 homolog B

decreases expression

EXP

Propylthiouracil results in decreased expression of EVA1B mRNA

NCBI chr 5:143,711,627...143,716,963
Ensembl chr 5:143,711,395...143,717,551

G

eva-1 homolog C

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of EVA1C mRNA
Propylthiouracil results in increased expression of EVA1C mRNA

PMID:24780913 PMID:30047161

NCBI chr11:43,575,613...43,649,677
Ensembl chr11:43,576,332...43,649,834

G

ecotropic viral integration site 2A

decreases expression

EXP

Propylthiouracil results in decreased expression of EVI2A mRNA

PMID:24780913 PMID:25825206

NCBI chr10:64,983,727...64,987,627
Ensembl chr10:64,983,705...64,999,516

G

envoplakin

decreases expression

EXP

Propylthiouracil results in decreased expression of EVPL mRNA

NCBI chr10:101,957,107...101,973,656
Ensembl chr10:101,941,064...101,973,656

G

even-skipped homeobox 1

decreases expression

EXP

Propylthiouracil results in decreased expression of EVX1 mRNA

NCBI chr 4:82,747,192...82,751,569
Ensembl chr 4:82,746,993...82,751,569

G

exonuclease 1

increases expression

EXP

Propylthiouracil results in increased expression of EXO1 mRNA

NCBI chr13:90,341,947...90,366,861
Ensembl chr13:90,342,018...90,366,861

G

exocyst complex component 3-like 4

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of EXOC3L4 mRNA
Propylthiouracil results in increased expression of EXOC3L4 mRNA

PMID:24780913 PMID:30047161

NCBI chr 6:136,273,857...136,287,877
Ensembl chr 6:136,273,854...136,287,881

G

exocyst complex component 6

decreases expression

EXP

Propylthiouracil results in decreased expression of EXOC6 mRNA

NCBI chr 1:244,727,084...244,870,263
Ensembl chr 1:244,711,981...244,870,396

G

exocyst complex component 6B

decreases expression

EXP

Propylthiouracil results in decreased expression of EXOC6B mRNA

NCBI chr 4:118,652,279...119,107,725
Ensembl chr 4:118,652,279...119,107,683

G

exostosin glycosyltransferase 1

increases expression

EXP

Propylthiouracil results in increased expression of EXT1 mRNA

NCBI chr 7:86,265,651...86,544,488
Ensembl chr 7:86,259,900...86,544,567

G

exostosin-like glycosyltransferase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of EXTL1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 5:151,857,629...151,872,830
Ensembl chr 5:151,857,629...151,872,830

G

exostosin-like glycosyltransferase 3

decreases expression

EXP

Propylthiouracil results in decreased expression of EXTL3 mRNA

PMID:24780913 PMID:30047161

NCBI chr15:43,469,293...43,559,760
Ensembl chr15:43,471,366...43,495,356

G

EYA transcriptional coactivator and phosphatase 2

decreases expression

EXP

Propylthiouracil results in decreased expression of EYA2 mRNA

NCBI chr 3:174,754,772...174,938,035
Ensembl chr 3:174,818,554...174,938,034

G

enhancer of zeste 1 polycomb repressive complex 2 subunit

decreases expression

EXP

Propylthiouracil results in decreased expression of EZH1 mRNA

NCBI chr10:86,626,307...86,662,257
Ensembl chr10:86,626,308...86,652,620

G

enhancer of zeste 2 polycomb repressive complex 2 subunit

increases expression

EXP

Propylthiouracil results in increased expression of EZH2 mRNA

NCBI chr 4:77,624,223...77,698,598
Ensembl chr 4:77,624,223...77,687,183

G

ezrin

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of EZR mRNA
Propylthiouracil results in decreased expression of EZR mRNA

PMID:24780913 PMID:36843608

NCBI chr 1:49,373,033...49,416,573
Ensembl chr 1:49,373,035...49,416,573

G

coagulation factor X

increases expression

EXP

Propylthiouracil results in increased expression of F10 mRNA

NCBI chr16:83,170,973...83,190,280
Ensembl chr16:83,170,977...83,190,280

G

coagulation factor XII

decreases expression

EXP

Propylthiouracil results in decreased expression of F12 mRNA

NCBI chr17:9,212,819...9,220,664
Ensembl chr17:9,212,819...9,220,664

G

coagulation factor II, thrombin

increases expression

EXP

Propylthiouracil results in increased expression of F2 mRNA

NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:98,051,960...98,065,246

G

coagulation factor II (thrombin) receptor

increases expression

EXP

Propylthiouracil results in increased expression of F2R mRNA

PMID:24780913 PMID:25825206

NCBI chr 2:28,604,066...28,620,579
Ensembl chr 2:28,604,066...28,620,579

G

F2R like trypsin receptor 1

increases expression

EXP

Propylthiouracil results in increased expression of F2RL1 mRNA

NCBI chr 2:28,507,003...28,519,954
Ensembl chr 2:28,507,003...28,519,954

G

F2R like thrombin or trypsin receptor 3

increases expression

EXP

Propylthiouracil results in increased expression of F2RL3 mRNA

NCBI chr16:17,151,516...17,153,509
Ensembl chr16:17,151,516...17,153,823

G

coagulation factor III, tissue factor

decreases expression

EXP

Propylthiouracil results in decreased expression of F3 mRNA

PMID:24780913 PMID:25825206

NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369

G

coagulation factor V

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of F5 mRNA

NCBI chr13:79,046,657...79,116,247
Ensembl chr13:79,046,448...79,116,247

G

coagulation factor VIII

increases expression

EXP

Propylthiouracil results in increased expression of F8 mRNA

NCBI chr18:155,237...187,186
Ensembl chr18:155,309...186,683

G

fatty acid 2-hydroxylase

decreases expression

EXP

Propylthiouracil results in decreased expression of FA2H mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr19:56,222,240...56,273,480
Ensembl chr19:56,222,242...56,273,623

G

fatty acid amide hydrolase

decreases expression
affects expression

EXP

Propylthiouracil results in decreased expression of FAAH mRNA
Propylthiouracil affects the expression of FAAH mRNA

PMID:19483382 PMID:24780913

NCBI chr 5:134,716,545...134,735,396
Ensembl chr 5:134,716,545...134,735,396

G

fatty acid binding protein 5

increases expression

EXP

Propylthiouracil results in increased expression of FABP5 mRNA

PMID:24780913 PMID:30047161

NCBI chr 2:93,672,451...93,676,186
Ensembl chr 2:93,672,458...93,676,127

G

fatty acid binding protein 7

increases expression

EXP

Propylthiouracil results in increased expression of FABP7 mRNA

NCBI chr20:37,667,125...37,673,299
Ensembl chr20:37,669,601...37,675,907

G

fatty acid desaturase 1

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of FADS1 mRNA
Propylthiouracil results in increased expression of FADS1 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 1:216,252,605...216,267,618
Ensembl chr 1:216,252,602...216,267,615

G

fatty acid desaturase 2

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of FADS2 mRNA
Propylthiouracil results in decreased expression of FADS2 mRNA

PMID:19483382 PMID:24780913 PMID:25825206

NCBI chr 1:216,132,277...216,172,190
Ensembl chr 1:216,133,676...216,172,066

G

fatty acid desaturase 3

increases expression

EXP

Propylthiouracil results in increased expression of FADS3 mRNA

NCBI chr 1:216,110,547...216,127,431
Ensembl chr 1:216,110,201...216,141,758

G

fatty acid desaturase 6

decreases expression

EXP

Propylthiouracil results in decreased expression of FADS6 mRNA

NCBI chr10:101,020,921...101,037,281
Ensembl chr10:101,021,960...101,037,160

G

Fas associated factor family member 2

increases expression

EXP

Propylthiouracil results in increased expression of FAF2 mRNA

NCBI chr17:9,952,329...9,994,596
Ensembl chr17:9,952,329...9,994,711

G

fumarylacetoacetate hydrolase

decreases expression

EXP

Propylthiouracil results in decreased expression of FAH mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:147,957,931...147,980,708
Ensembl chr 1:147,957,935...147,981,046

G

Fas apoptotic inhibitory molecule

increases expression

EXP

Propylthiouracil results in increased expression of FAIM mRNA

NCBI chr 8:108,423,259...108,445,365
Ensembl chr 8:108,423,221...108,440,151

G

family with sequence similarity 107, member A

decreases expression

EXP

Propylthiouracil results in decreased expression of FAM107A mRNA

PMID:24780913 PMID:25825206

NCBI chr15:19,038,726...19,060,644
Ensembl chr15:19,038,616...19,065,219

G

family with sequence similarity 110, member A

increases expression

EXP

Propylthiouracil results in increased expression of FAM110A mRNA

PMID:24780913 PMID:30047161

NCBI chr 3:160,934,815...160,945,405
Ensembl chr 3:160,931,777...160,949,897

G

family with sequence similarity 110, member B

decreases expression

EXP

Propylthiouracil results in decreased expression of FAM110B mRNA

NCBI chr 5:23,587,093...23,727,188
Ensembl chr 5:23,586,867...23,799,583

G

family with sequence similarity 110, member D

increases expression

EXP

Propylthiouracil results in increased expression of FAM110D mRNA

NCBI chr 5:151,754,773...151,757,743
Ensembl chr 5:151,753,891...151,757,768

G

family with sequence similarity 117, member B

decreases expression

EXP

Propylthiouracil results in decreased expression of FAM117B mRNA

NCBI chr 9:68,834,334...68,902,543
Ensembl chr 9:68,834,354...68,902,543

G

family with sequence similarity 120 member B

increases expression

EXP

Propylthiouracil results in increased expression of FAM120B mRNA

NCBI chr 1:64,993,104...65,058,160
Ensembl chr 1:65,012,060...65,058,160

G

family with sequence similarity 124 member A

decreases expression

EXP

Propylthiouracil results in decreased expression of FAM124A mRNA

NCBI chr15:40,975,789...41,031,069
Ensembl chr15:40,975,877...41,029,628

G

family with sequence similarity 135, member B

decreases expression

EXP

Propylthiouracil results in decreased expression of FAM135B mRNA

NCBI chr 7:105,269,831...105,538,716
Ensembl chr 7:105,269,831...105,538,165

G

family with sequence similarity 136, member A

increases expression

EXP

Propylthiouracil results in increased expression of FAM136A mRNA

PMID:24780913 PMID:36843608

NCBI chr 4:120,362,563...120,368,479
Ensembl chr 4:120,362,561...120,368,479

G

family with sequence similarity 13, member B

decreases expression

EXP

Propylthiouracil results in decreased expression of FAM13B mRNA

NCBI chr18:26,314,440...26,395,260
Ensembl chr18:26,314,440...26,380,732

G

family with sequence similarity 151, member A

decreases expression

EXP

Propylthiouracil results in decreased expression of FAM151A mRNA

NCBI chr 5:126,743,624...126,756,375
Ensembl chr 5:126,743,555...126,756,373

G

family with sequence similarity 151, member B

decreases expression

EXP

Propylthiouracil results in decreased expression of FAM151B mRNA

NCBI chr 2:25,409,382...25,446,225
Ensembl chr 2:25,409,383...25,445,466

G

FAM161 centrosomal protein A

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of FAM161A mRNA
Propylthiouracil results in decreased expression of FAM161A mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr14:101,210,694...101,256,020
Ensembl chr14:101,210,662...101,229,535

G

FAM161 centrosomal protein B

decreases expression

EXP

Propylthiouracil results in decreased expression of FAM161B mRNA

NCBI chr 6:109,722,073...109,750,003
Ensembl chr 6:109,722,569...109,750,036

G

family with sequence similarity 163, member A

increases expression

EXP

Propylthiouracil results in increased expression of FAM163A mRNA

NCBI chr13:70,813,129...70,891,410
Ensembl chr13:70,813,134...70,891,316

G

family with sequence similarity 167, member A

increases expression

EXP

Propylthiouracil results in increased expression of FAM167A mRNA

NCBI chr15:41,861,271...41,891,427
Ensembl chr15:41,861,227...41,891,418

G

family with sequence similarity 167, member B

increases expression

EXP

Propylthiouracil results in increased expression of FAM167B mRNA

NCBI chr 5:147,205,018...147,206,660
Ensembl chr 5:147,204,653...147,206,652

G

family with sequence similarity 171, member A1

increases expression

EXP

Propylthiouracil results in increased expression of FAM171A1 mRNA

NCBI chr17:79,933,742...80,057,495
Ensembl chr17:79,934,050...80,057,495

G

family with sequence similarity 180, member A

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of FAM180A mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of FAM180A mRNA

PMID:24780913 PMID:25825206 PMID:36706583

NCBI chr 4:64,959,999...64,975,176
Ensembl chr 4:64,959,999...64,975,176

G

family with sequence similarity 181, member B

decreases expression

EXP

Propylthiouracil results in decreased expression of FAM181B mRNA

PMID:24780913 PMID:25825206

NCBI chr 1:156,578,821...156,580,318
Ensembl chr 1:156,491,094...156,595,845

G

family with sequence similarity 184, member A

decreases expression

EXP

Propylthiouracil results in decreased expression of FAM184A mRNA

NCBI chr20:33,477,089...33,599,296
Ensembl chr20:33,477,089...33,599,293

G

FAM20A, golgi associated secretory pathway pseudokinase

decreases expression

EXP

Propylthiouracil results in decreased expression of FAM20A mRNA

PMID:24780913 PMID:25825206

NCBI chr10:95,136,799...95,197,176
Ensembl chr10:95,142,458...95,197,053

G

FAM20B, glycosaminoglycan xylosylkinase

increases expression

EXP

Propylthiouracil results in increased expression of FAM20B mRNA

NCBI chr13:71,351,834...71,390,192
Ensembl chr13:71,351,834...71,387,882

G

family with sequence similarity 210, member B

increases expression

EXP

Propylthiouracil results in increased expression of FAM210B mRNA

NCBI chr 3:181,536,665...181,546,830
Ensembl chr 3:181,536,673...181,546,834

G

family with sequence similarity 227, member A

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of FAM227A mRNA
Propylthiouracil results in decreased expression of FAM227A mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 7:113,054,751...113,096,898
Ensembl chr 7:113,054,751...113,096,868

G

family with sequence similarity 227, member B

decreases expression

EXP

Propylthiouracil results in decreased expression of FAM227B mRNA

NCBI chr 3:133,686,602...133,845,793
Ensembl chr 3:133,686,605...133,845,717

G

family with sequence similarity 24 member B

decreases expression

EXP

Propylthiouracil results in decreased expression of FAM24B mRNA

NCBI chr 1:195,542,729...195,546,140
Ensembl chr 1:195,542,729...195,546,140

G

FAM3 metabolism regulating signaling molecule A

decreases expression

EXP

Propylthiouracil results in decreased expression of FAM3A mRNA

NCBI chr X:157,317,993...157,326,640
Ensembl chr X:157,317,990...157,326,612

G

family with sequence similarity 53, member A

decreases expression

EXP

Propylthiouracil results in decreased expression of FAM53A mRNA

NCBI chr14:81,308,127...81,348,930
Ensembl chr14:81,319,375...81,348,923

G

family with sequence similarity 53, member B

decreases expression

EXP

Propylthiouracil results in decreased expression of FAM53B mRNA

NCBI chr 1:196,930,170...197,021,290
Ensembl chr 1:196,930,175...197,021,290

G

family with sequence similarity 72, member A

increases expression

EXP

Propylthiouracil results in increased expression of FAM72A mRNA

PMID:24780913 PMID:30047161

NCBI chr13:45,519,940...45,531,322
Ensembl chr13:45,519,818...45,531,324

G

family with sequence similarity 78, member A

decreases expression

EXP

Propylthiouracil results in decreased expression of FAM78A mRNA

NCBI chr 3:35,753,712...35,771,600
Ensembl chr 3:35,753,712...35,770,448

G

family with sequence similarity 78, member B

increases expression

EXP

Propylthiouracil results in increased expression of FAM78B mRNA

NCBI chr13:81,695,329...81,783,881
Ensembl chr13:81,695,329...81,781,784

G

family with sequence similarity 83, member D

affects expression
increases expression

EXP

Propylthiouracil affects the expression of FAM83D mRNA
Propylthiouracil results in increased expression of FAM83D mRNA

PMID:24780913 PMID:30047161

NCBI chr 3:167,841,748...167,861,062
Ensembl chr 3:167,841,791...167,861,061

G

family with sequence similarity 83, member E

decreases expression

EXP

Propylthiouracil results in decreased expression of FAM83E mRNA

NCBI chr 1:105,328,297...105,337,641
Ensembl chr 1:105,328,247...105,337,638

G

family with sequence similarity 83, member F

decreases expression

EXP

Propylthiouracil results in decreased expression of FAM83F mRNA

NCBI chr 7:114,091,356...114,120,640
Ensembl chr 7:114,091,335...114,120,638

G

family with sequence similarity 83, member H

decreases expression

EXP

Propylthiouracil results in decreased expression of FAM83H mRNA

NCBI chr 7:109,597,129...109,605,317
Ensembl chr 7:109,597,129...109,609,188

G

family with sequence similarity 89, member A

increases expression

EXP

Propylthiouracil results in increased expression of FAM89A mRNA

NCBI chr19:69,607,391...69,620,019
Ensembl chr19:69,607,391...69,620,019

G

family with sequence similarity 8, member A1

decreases expression

EXP

Propylthiouracil results in decreased expression of FAM8A1 mRNA

NCBI chr17:18,232,834...18,241,736
Ensembl chr17:18,232,834...18,241,703

G

family with sequence similarity 91, member A1

increases expression

EXP

Propylthiouracil results in increased expression of FAM91A1 mRNA

NCBI chr 7:91,857,261...91,897,019
Ensembl chr 7:91,859,062...91,898,195

G

FA complementation group A

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of FANCA mRNA
Propylthiouracil results in increased expression of FANCA mRNA

PMID:24780913 PMID:30047161

NCBI chr19:68,210,562...68,271,080
Ensembl chr19:68,212,643...68,271,019

G

FA complementation group D2

increases expression

EXP

Propylthiouracil results in increased expression of FANCD2 mRNA

NCBI chr 4:148,234,633...148,299,035
Ensembl chr 4:148,234,708...148,299,035

G

FA complementation group E

decreases expression

EXP

Propylthiouracil results in decreased expression of FANCE mRNA

NCBI chr20:6,371,153...6,388,366
Ensembl chr20:6,377,234...6,388,365

G

FA complementation group I

increases expression

EXP

Propylthiouracil results in increased expression of FANCI mRNA

NCBI chr 1:142,736,636...142,792,999
Ensembl chr 1:142,736,653...142,792,999

G

FA complementation group L

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of FANCL mRNA
Propylthiouracil results in decreased expression of FANCL mRNA

PMID:24780913 PMID:30047161

NCBI chr14:104,449,403...104,515,297
Ensembl chr14:104,394,590...104,515,297

G

fibronectin type III and ankyrin repeat domains 1

increases expression

EXP

Propylthiouracil results in increased expression of FANK1 mRNA

NCBI chr 1:198,007,496...198,114,790
Ensembl chr 1:198,007,547...198,115,561

G

fibroblast activation protein, alpha

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of FAP mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of FAP mRNA

PMID:24780913 PMID:36706583

NCBI chr 3:67,547,398...67,616,271
Ensembl chr 3:67,546,921...67,617,601

G

FERM, ARH/RhoGEF and pleckstrin domain protein 1

increases expression

EXP

Propylthiouracil results in increased expression of FARP1 mRNA

NCBI chr15:104,531,196...104,770,148
Ensembl chr15:104,531,813...104,770,147

G

FERM, ARH/RhoGEF and pleckstrin domain protein 2

decreases expression

EXP

Propylthiouracil results in decreased expression of FARP2 mRNA

NCBI chr 9:101,501,061...101,609,092
Ensembl chr 9:101,501,102...101,609,086

G

FAST kinase domains 1

increases expression

EXP

Propylthiouracil results in increased expression of FASTKD1 mRNA

NCBI chr 3:74,857,539...74,883,483
Ensembl chr 3:74,845,261...74,883,367

G

FAST kinase domains 2

increases expression

EXP

Propylthiouracil results in increased expression of FASTKD2 mRNA

NCBI chr 9:72,659,961...72,681,986
Ensembl chr 9:72,661,764...72,721,338

G

FAST kinase domains 3

decreases expression

EXP

Propylthiouracil results in decreased expression of FASTKD3 mRNA

NCBI chr 1:36,686,727...36,695,376
Ensembl chr 1:36,686,730...36,695,259

G

FAT atypical cadherin 1

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of FAT1 mRNA
Propylthiouracil results in increased expression of FAT1 mRNA

PMID:24780913 PMID:30047161

NCBI chr16:53,909,759...54,029,175
Ensembl chr16:53,909,556...54,028,609

G

FAT atypical cadherin 2

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of FAT2 mRNA

NCBI chr10:39,864,765...39,957,027
Ensembl chr10:39,864,766...39,956,902

G

FAT atypical cadherin 4

increases expression

EXP

Propylthiouracil results in increased expression of FAT4 mRNA

NCBI chr 2:123,855,289...123,984,716
Ensembl chr 2:123,855,289...123,984,716

G

fatty acid hydroxylase domain containing 2

decreases expression

EXP

Propylthiouracil results in decreased expression of FAXDC2 mRNA

NCBI chr10:42,747,323...42,772,156
Ensembl chr10:42,747,524...42,781,458

G

fibrillarin

increases expression

EXP

Propylthiouracil results in increased expression of FBL mRNA

NCBI chr 1:92,597,407...92,606,507
Ensembl chr 1:92,597,258...92,606,506

G

fibulin 1

increases expression

EXP

Propylthiouracil results in increased expression of FBLN1 mRNA

NCBI chr 7:118,190,347...118,269,965
Ensembl chr 7:118,190,478...118,269,965

G

fibulin 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of FBLN2 mRNA
Propylthiouracil results in decreased expression of FBLN2 mRNA

PMID:24780913 PMID:25825206

NCBI chr 4:125,261,464...125,321,030
Ensembl chr 4:125,261,607...125,321,029

G

fibulin 5

increases expression

EXP

Propylthiouracil results in increased expression of FBLN5 mRNA

NCBI chr 6:126,664,100...126,742,847
Ensembl chr 6:126,664,100...126,746,296

G

fibrillin 1

affects expression
increases expression

EXP

Propylthiouracil affects the expression of FBN1 mRNA
Propylthiouracil results in increased expression of FBN1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 3:133,007,693...133,204,277
Ensembl chr 3:133,008,361...133,204,283

G

fibrillin 2

increases expression
multiple interactions

EXP
ISO

Propylthiouracil results in increased expression of FBN2 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of FBN2 mRNA

PMID:22504374 PMID:24780913 PMID:30047161 PMID:36706583

NCBI chr18:53,696,197...53,901,992
Ensembl chr18:53,697,708...53,902,191

G

fructose-bisphosphatase 1

affects expression

EXP

Propylthiouracil affects the expression of FBP1 mRNA

NCBI chr17:2,212,941...2,235,749
Ensembl chr17:2,213,492...2,235,746

G

fructose-bisphosphatase 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of FBP2 mRNA
Propylthiouracil results in decreased expression of FBP2 mRNA

PMID:24780913 PMID:25825206

NCBI chr17:2,241,767...2,259,371
Ensembl chr17:2,241,975...2,259,366

G

F-box and leucine-rich repeat protein 13

decreases expression

EXP

Propylthiouracil results in decreased expression of FBXL13 mRNA

NCBI chr 4:14,307,032...14,505,491
Ensembl chr 4:14,307,096...14,499,585

G

F-box and leucine-rich repeat protein 15

increases expression

EXP

Propylthiouracil results in increased expression of FBXL15 mRNA

NCBI chr 1:255,131,154...255,133,395
Ensembl chr 1:255,131,154...255,133,427

G

F-box and leucine-rich repeat protein 20

decreases expression

EXP

Propylthiouracil results in decreased expression of FBXL20 mRNA

NCBI chr10:83,577,038...83,640,022
Ensembl chr10:83,577,038...83,639,977

G

F-box and leucine-rich repeat protein 22

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of FBXL22 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of FBXL22 mRNA

PMID:30047161 PMID:36706583

NCBI chr 8:75,965,027...75,971,714
Ensembl chr 8:75,965,027...75,971,714

G

F-box and leucine-rich repeat protein 3

decreases expression

EXP

Propylthiouracil results in decreased expression of FBXL3 mRNA

NCBI chr15:86,321,504...86,341,387
Ensembl chr15:86,321,504...86,341,387

G

F-box and leucine-rich repeat protein 4

decreases expression

EXP

Propylthiouracil results in decreased expression of FBXL4 mRNA

NCBI chr 5:40,752,513...40,826,154
Ensembl chr 5:40,752,521...40,850,826

G

F-box protein 10

increases expression

EXP

Propylthiouracil results in increased expression of FBXO10 mRNA

NCBI chr 5:64,092,709...64,139,054
Ensembl chr 5:64,092,709...64,160,923

G

F-box protein 17

affects expression
increases expression

EXP

Propylthiouracil affects the expression of FBXO17 mRNA
Propylthiouracil results in increased expression of FBXO17 mRNA

PMID:24780913 PMID:25825206

NCBI chr 1:93,129,776...93,151,983
Ensembl chr 1:93,129,849...93,151,981

G

F-box protein 2

decreases expression

EXP

Propylthiouracil results in decreased expression of FBXO2 mRNA

NCBI chr 5:163,876,079...163,881,508
Ensembl chr 5:163,875,757...163,881,508

G

F-box protein 27

decreases expression

EXP

Propylthiouracil results in decreased expression of FBXO27 mRNA

NCBI chr 1:93,092,900...93,115,312
Ensembl chr 1:93,093,024...93,122,181

G

F-box protein 3

decreases expression

EXP

Propylthiouracil results in decreased expression of FBXO3 mRNA

NCBI chr 3:110,872,185...110,904,479
Ensembl chr 3:110,872,220...110,904,479

G

F-box protein 32

decreases expression

EXP

Propylthiouracil results in decreased expression of FBXO32 mRNA

NCBI chr 7:91,620,925...91,654,491
Ensembl chr 7:91,620,925...91,654,491

G

F-box protein 34

decreases expression

EXP

Propylthiouracil results in decreased expression of FBXO34 mRNA

NCBI chr15:23,199,103...23,266,929
Ensembl chr15:23,171,312...23,270,071

G

F-box protein 36

increases expression

EXP

Propylthiouracil results in increased expression of FBXO36 mRNA

NCBI chr 9:93,490,618...93,555,298
Ensembl chr 9:93,489,865...93,555,305

G

F-box protein 42

increases expression

EXP

Propylthiouracil results in increased expression of FBXO42 mRNA

NCBI chr 5:158,734,165...158,792,560
Ensembl chr 5:158,734,175...158,792,565

G

F-box protein 46

decreases expression

EXP

Propylthiouracil results in decreased expression of FBXO46 mRNA

NCBI chr 1:87,898,029...87,914,615
Ensembl chr 1:87,897,888...87,926,021

G

F-box protein 5

increases expression

EXP

Propylthiouracil results in increased expression of FBXO5 mRNA

NCBI chr 1:44,601,412...44,607,781
Ensembl chr 1:44,601,412...44,607,781

G

F-box and WD repeat domain containing 8

decreases expression

EXP

Propylthiouracil results in decreased expression of FBXW8 mRNA

NCBI chr12:44,087,375...44,177,985
Ensembl chr12:44,087,375...44,177,985

G

Fc epsilon receptor Ig

increases expression

EXP

Propylthiouracil results in increased expression of FCER1G mRNA

NCBI chr13:86,181,908...86,186,766
Ensembl chr13:86,181,908...86,186,859

G

Fc fragment of IgG binding protein-like 1

decreases expression

EXP

Propylthiouracil results in decreased expression of FCGBPL1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:92,552,363...92,590,377
Ensembl chr 1:92,552,363...92,590,374

G

Fc gamma receptor 1A

increases expression

EXP

Propylthiouracil results in increased expression of FCGR1A mRNA

PMID:24780913 PMID:30047161

NCBI chr 2:186,539,941...186,548,941
Ensembl chr 2:186,539,942...186,548,858

G

Fc gamma receptor 2A

increases expression

EXP

Propylthiouracil results in increased expression of FCGR2A mRNA

NCBI chr13:85,813,516...85,830,269
Ensembl chr13:85,855,437...85,864,394
Ensembl chr13:85,855,437...85,864,394

G

Fc gamma receptor 2B

increases expression

EXP

Propylthiouracil results in increased expression of FCGR2B mRNA

NCBI chr13:85,725,897...85,740,517
Ensembl chr13:85,725,897...85,740,517

G

FCH and double SH3 domains 1

increases expression

EXP

Propylthiouracil results in increased expression of FCHSD1 mRNA

NCBI chr18:30,043,466...30,056,326
Ensembl chr18:30,045,106...30,055,673

G

FCH and double SH3 domains 2

increases expression

EXP

Propylthiouracil results in increased expression of FCHSD2 mRNA

NCBI chr 1:164,775,916...165,097,391
Ensembl chr 1:164,775,926...165,097,391

G

Fc mu receptor

decreases expression

EXP

Propylthiouracil results in decreased expression of FCMR mRNA

NCBI chr13:44,889,628...44,903,926
Ensembl chr13:44,889,697...44,906,314

G

ficolin B

increases expression

EXP

Propylthiouracil results in increased expression of FCN1 mRNA

NCBI chr 3:31,791,750...31,800,188
Ensembl chr 3:31,791,750...31,800,188

G

Fc receptor-like 2

increases expression

EXP

Propylthiouracil results in increased expression of FCRL2 mRNA

NCBI chr 2:174,992,226...175,005,177
Ensembl chr 2:174,992,226...175,004,967

G

Fc receptor-like 5

increases expression

EXP

Propylthiouracil results in increased expression of FCRL1 mRNA

PMID:24780913 PMID:25825206

NCBI chr 2:175,179,630...175,211,180
Ensembl chr 2:175,179,690...175,211,039

G

Fc receptor-like A

affects expression

EXP

Propylthiouracil affects the expression of FCRLA mRNA

NCBI chr13:85,693,177...85,702,875
Ensembl chr13:85,693,122...85,703,176

G

farnesyl diphosphate farnesyl transferase 1

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of FDFT1 mRNA
Propylthiouracil results in decreased expression of FDFT1 mRNA

PMID:19483382 PMID:24780913

NCBI chr15:41,588,114...41,616,168
Ensembl chr15:41,588,117...41,616,168

G

farnesyl diphosphate synthase

affects expression
increases expression
decreases expression

EXP

Propylthiouracil affects the expression of FDPS mRNA
Propylthiouracil results in increased expression of FDPS mRNA
Propylthiouracil results in decreased expression of FDPS mRNA

PMID:19483382 PMID:24780913 PMID:30047161

NCBI chr 2:176,795,192...176,804,816
Ensembl chr 2:176,795,192...176,807,136

G

ferredoxin 1

increases expression

EXP

Propylthiouracil results in increased expression of FDX1 mRNA

NCBI chr 8:61,164,839...61,183,645
Ensembl chr 8:61,164,839...61,183,583

G

ferredoxin 2

affects expression

EXP

Propylthiouracil affects the expression of FDX2 mRNA

NCBI chr 8:27,881,091...27,886,230
Ensembl chr 8:27,881,091...27,886,015

G

fem-1 homolog B

increases expression

EXP

Propylthiouracil results in increased expression of FEM1B mRNA

NCBI chr 8:72,160,722...72,173,996
Ensembl chr 8:72,160,722...72,173,996

G

flap structure-specific endonuclease 1

increases expression

EXP

Propylthiouracil results in increased expression of FEN1 mRNA

NCBI chr 1:216,270,016...216,274,873
Ensembl chr 1:216,269,163...216,275,016

G

Fer3-like bHLH transcription factor

decreases expression

EXP

Propylthiouracil results in decreased expression of FERD3L mRNA

NCBI chr 6:56,372,778...56,373,667
Ensembl chr 6:56,372,479...56,373,501

G

FERM domain containing kindlin 1

increases expression

EXP

Propylthiouracil results in increased expression of FERMT1 mRNA

NCBI chr 3:140,624,434...140,666,419
Ensembl chr 3:140,624,434...140,666,419

G

FERM domain containing kindlin 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of FERMT2 mRNA
Propylthiouracil results in decreased expression of FERMT2 mRNA

PMID:30047161 PMID:36843608

NCBI chr15:21,162,603...21,257,995
Ensembl chr15:21,162,605...21,258,115

G

FES proto-oncogene, tyrosine kinase

decreases expression
increases methylation

EXP

Propylthiouracil results in decreased expression of FES mRNA
Propylthiouracil results in increased methylation of FES promoter

NCBI chr 1:143,746,945...143,756,181
Ensembl chr 1:143,746,945...143,756,181

G

fasciculation and elongation protein zeta 1

decreases expression

EXP

Propylthiouracil results in decreased expression of FEZ1 mRNA

NCBI chr 8:44,733,288...44,778,519
Ensembl chr 8:44,733,300...44,784,097

G

fasciculation and elongation protein zeta 2

increases expression

EXP

Propylthiouracil results in increased expression of FEZ2 mRNA

NCBI chr 6:22,406,685...22,446,745
Ensembl chr 6:22,406,632...22,447,041

G

Fez family zinc finger 2

increases expression
multiple interactions

EXP
ISO

Propylthiouracil results in increased expression of FEZF2 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of FEZF2 mRNA

PMID:24780913 PMID:36706583

NCBI chr15:15,199,045...15,207,982
Ensembl chr15:15,204,193...15,207,982

G

free fatty acid receptor 2

decreases expression

EXP

Propylthiouracil results in decreased expression of FFAR2 mRNA

NCBI chr 1:95,199,277...95,202,599
Ensembl chr 1:95,199,271...95,202,623

G

free fatty acid receptor 3

increases expression

EXP

Propylthiouracil results in increased expression of FFAR3 mRNA

NCBI chr 1:95,232,804...95,234,144
Ensembl chr 1:95,232,336...95,234,354

G

free fatty acid receptor 4

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of FFAR4 mRNA
Propylthiouracil results in decreased expression of FFAR4 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:245,286,009...245,304,029
Ensembl chr 1:245,285,883...245,304,031

G

fibrinogen alpha chain

increases expression

EXP

Propylthiouracil results in increased expression of FGA mRNA

PMID:22504374 PMID:24780913

NCBI chr 2:170,672,169...170,679,572
Ensembl chr 2:170,672,012...170,679,577

G

fibroblast growth factor 1

decreases expression

EXP

Propylthiouracil results in decreased expression of FGF1 mRNA

NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,939,870...30,961,393

G

fibroblast growth factor 10

decreases expression

EXP

Propylthiouracil results in decreased expression of FGF10 mRNA

NCBI chr 2:52,533,939...52,610,980
Ensembl chr 2:52,533,939...52,610,980

G

fibroblast growth factor 12

decreases expression

EXP

Propylthiouracil results in decreased expression of FGF12 mRNA

NCBI chr11:85,501,947...86,069,543
Ensembl chr11:85,501,936...86,069,543

G

fibroblast growth factor 13

increases expression
increases methylation
decreases expression

EXP

Propylthiouracil results in increased expression of FGF13 mRNA
Propylthiouracil results in increased methylation of FGF13 promoter
Propylthiouracil results in decreased expression of FGF13 mRNA

PMID:24780913 PMID:33150595

NCBI chr X:142,312,381...142,838,581
Ensembl chr X:142,312,391...142,423,536

G

fibroblast growth factor 2

decreases expression
increases methylation

EXP

Propylthiouracil results in decreased expression of FGF2 mRNA
Propylthiouracil results in increased methylation of FGF2 promoter

PMID:24780913 PMID:33150595

NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493

G

fibroblast growth factor 21

increases expression

EXP

Propylthiouracil results in increased expression of FGF21 mRNA

NCBI chr 1:105,219,825...105,221,376
Ensembl chr 1:105,219,825...105,232,056

G

fibroblast growth factor 22

increases expression

EXP

Propylthiouracil results in increased expression of FGF22 mRNA

NCBI chr 7:10,598,254...10,600,945
Ensembl chr 7:10,597,538...10,600,945

G

fibroblast growth factor 3

decreases expression

EXP

Propylthiouracil results in decreased expression of FGF3 mRNA

NCBI chr 1:209,430,457...209,434,832
Ensembl chr 1:209,430,457...209,434,832

G

fibroblast growth factor 5

affects expression
increases expression

EXP

Propylthiouracil affects the expression of FGF5 mRNA
Propylthiouracil results in increased expression of FGF5 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr14:11,627,906...11,650,243
Ensembl chr14:11,627,906...11,650,243

G

fibroblast growth factor 7

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of FGF7 mRNA

NCBI chr 3:133,734,557...133,786,678
Ensembl chr 3:133,734,673...133,786,328

G

fibroblast growth factor 9

decreases expression

EXP

Propylthiouracil results in decreased expression of FGF9 mRNA

NCBI chr15:36,325,552...36,369,995
Ensembl chr15:36,325,599...36,367,926

G

fibroblast growth factor binding protein 3

increases expression

EXP

Propylthiouracil results in increased expression of FGFBP3 mRNA

NCBI chr 1:244,056,569...244,058,574
Ensembl chr 1:244,056,307...244,065,654

G

Fibroblast growth factor receptor 1

decreases expression

EXP

Propylthiouracil results in decreased expression of FGFR1 mRNA

PMID:24780913 PMID:30047161

NCBI chr16:73,194,631...73,249,855
Ensembl chr16:73,194,631...73,249,855

G

fibroblast growth factor receptor 2

decreases expression

EXP

Propylthiouracil results in decreased expression of FGFR2 mRNA

NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:194,175,705...194,280,914

G

fibroblast growth factor receptor 3

decreases expression

EXP

Propylthiouracil results in decreased expression of FGFR3 mRNA

NCBI chr14:81,211,800...81,227,215
Ensembl chr14:81,211,800...81,227,209

G

fibrinogen gamma chain

increases expression

EXP

Propylthiouracil results in increased expression of FGG mRNA

NCBI chr 2:170,652,929...170,660,372
Ensembl chr 2:170,652,234...170,661,170

G

FGGY carbohydrate kinase domain containing

decreases expression

EXP

Propylthiouracil results in decreased expression of FGGY mRNA

NCBI chr 5:115,514,573...115,901,713
Ensembl chr 5:115,472,211...115,901,714

G

fibrinogen-like 2

decreases expression

EXP

Propylthiouracil results in decreased expression of FGL2 mRNA

NCBI chr 4:14,602,762...14,608,405
Ensembl chr 4:14,602,771...14,608,405

G

FGR proto-oncogene, Src family tyrosine kinase

decreases expression

EXP

Propylthiouracil results in decreased expression of FGR mRNA

NCBI chr 5:150,473,767...150,503,524
Ensembl chr 5:150,473,792...150,503,169

G

FH2 domain containing 1

decreases expression

EXP

Propylthiouracil results in decreased expression of FHDC1 mRNA

PMID:24780913 PMID:30047161 PMID:36843608

NCBI chr 2:172,088,987...172,127,838
Ensembl chr 2:172,089,010...172,125,956

G

FHF complex subunit HOOK interacting protein 1A

decreases expression

EXP

Propylthiouracil results in decreased expression of FHIP1A mRNA

NCBI chr 2:173,319,252...173,489,514
Ensembl chr 2:173,319,257...173,453,902

G

four and a half LIM domains 1

increases expression

EXP

Propylthiouracil results in increased expression of FHL1 mRNA

NCBI chr X:139,592,794...139,652,290
Ensembl chr X:139,592,604...139,652,282

G

four and a half LIM domains 2

increases expression

EXP

Propylthiouracil results in increased expression of FHL2 mRNA

NCBI chr 9:52,881,091...52,954,540
Ensembl chr 9:52,880,998...52,923,326

G

formin homology 2 domain containing 1

increases expression

EXP

Propylthiouracil results in increased expression of FHOD1 mRNA

NCBI chr19:50,116,415...50,135,868
Ensembl chr19:50,116,415...50,135,330

G

formin homology 2 domain containing 3

decreases expression

EXP

Propylthiouracil results in decreased expression of FHOD3 mRNA

NCBI chr18:16,267,830...16,700,508
Ensembl chr18:16,267,977...16,700,508

G

fibrinogen C domain containing 1

increases expression

EXP

Propylthiouracil results in increased expression of FIBCD1 mRNA

NCBI chr 3:35,490,459...35,524,142
Ensembl chr 3:35,490,459...35,524,142

G

fin bud initiation factor homolog

decreases expression

EXP

Propylthiouracil results in decreased expression of FIBIN mRNA

NCBI chr 3:117,396,973...117,399,244
Ensembl chr 3:117,391,724...117,399,479

G

fidgetin, microtubule severing factor

increases expression

EXP

Propylthiouracil results in increased expression of FIGN mRNA

NCBI chr 3:69,045,918...69,169,148
Ensembl chr 3:69,045,050...69,169,988

G

fidgetin-like 2

decreases expression

EXP

Propylthiouracil results in decreased expression of FIGNL2 mRNA

NCBI chr 7:134,038,734...134,066,626
Ensembl chr 7:134,038,672...134,067,893

G

filamin A interacting protein 1

affects expression

EXP

Propylthiouracil affects the expression of FILIP1 mRNA

NCBI chr 8:89,641,509...89,836,772
Ensembl chr 8:89,644,579...89,802,771

G

filamin A interacting protein 1-like

increases expression

EXP

Propylthiouracil results in increased expression of FILIP1L mRNA

NCBI chr11:56,403,467...56,646,422
Ensembl chr11:56,410,582...56,646,402

G

FLT3-interacting zinc finger 1

decreases expression

EXP

Propylthiouracil results in decreased expression of FIZ1 mRNA

NCBI chr 1:77,856,901...77,864,562
Ensembl chr 1:77,851,451...77,864,563

G

FKBP prolyl isomerase 10

increases expression

EXP

Propylthiouracil results in increased expression of FKBP10 mRNA

PMID:24780913 PMID:25825206

NCBI chr10:85,845,801...85,858,361
Ensembl chr10:85,844,703...85,858,355

G

FKBP prolyl isomerase 11

increases expression

EXP

Propylthiouracil results in increased expression of FKBP11 mRNA

PMID:24780913 PMID:30047161

NCBI chr 7:131,750,828...131,757,784
Ensembl chr 7:131,750,672...131,770,123

G

FKBP prolyl isomerase 14

decreases expression

EXP

Propylthiouracil results in decreased expression of FKBP14 mRNA

NCBI chr 4:85,035,840...85,051,917
Ensembl chr 4:85,037,145...85,051,808

G

FKBP prolyl isomerase 1A

increases expression

EXP

Propylthiouracil results in increased expression of FKBP1A mRNA

NCBI chr 3:160,500,748...160,520,492
Ensembl chr 3:160,500,726...160,524,233

G

FKBP prolyl isomerase 4

decreases expression

EXP

Propylthiouracil results in decreased expression of FKBP4 mRNA

NCBI chr 4:163,389,464...163,397,918
Ensembl chr 4:163,389,464...163,397,918

G

FKBP prolyl isomerase 5

affects expression

EXP

Propylthiouracil affects the expression of FKBP5 mRNA

NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,458,940...6,543,118

G

fukutin

decreases expression

EXP

Propylthiouracil results in decreased expression of FKTN mRNA

NCBI chr 5:73,134,746...73,191,772
Ensembl chr 5:73,135,361...73,189,181

G

flagellum associated containing coiled-coil domains 1

increases expression

EXP

Propylthiouracil results in increased expression of FLACC1 mRNA

NCBI chr 9:67,809,731...67,837,793
Ensembl chr 9:67,809,739...67,837,793

G

Fli-1 proto-oncogene, ETS transcription factor

increases expression

EXP

Propylthiouracil results in increased expression of FLI1 mRNA

NCBI chr 8:39,089,526...39,209,511
Ensembl chr 8:39,089,533...39,208,557

G

fibronectin leucine rich transmembrane protein 3

decreases expression

EXP

Propylthiouracil results in decreased expression of FLRT3 mRNA

NCBI chr 3:148,448,115...148,461,458
Ensembl chr 3:148,439,354...148,461,650

G

Fms related receptor tyrosine kinase 1

increases expression

EXP

Propylthiouracil results in increased expression of FLT1 mRNA

NCBI chr12:12,333,050...12,504,750
Ensembl chr12:12,333,430...12,504,750

G

Fms related receptor tyrosine kinase 3

decreases expression

EXP

Propylthiouracil results in decreased expression of FLT3 mRNA

PMID:22504374 PMID:24780913

NCBI chr12:12,660,035...12,735,584
Ensembl chr12:12,659,946...12,735,581

G

Fms related receptor tyrosine kinase 4

decreases expression

EXP

Propylthiouracil results in decreased expression of FLT4 mRNA

NCBI chr10:34,414,834...34,455,878
Ensembl chr10:34,414,733...34,456,645

G

FLVCR choline and heme transporter 1

decreases expression

EXP

Propylthiouracil results in decreased expression of FLVCR1 mRNA

NCBI chr13:105,117,402...105,139,780
Ensembl chr13:105,117,402...105,139,759

G

FLYWCH-type zinc finger 1

decreases expression

EXP

Propylthiouracil results in decreased expression of FLYWCH1 mRNA

NCBI chr10:13,279,232...13,298,955
Ensembl chr10:13,279,232...13,298,925

G

formin 1

decreases expression

EXP

Propylthiouracil results in decreased expression of FMN1 mRNA

NCBI chr 3:120,555,445...120,939,978
Ensembl chr 3:120,555,431...120,933,124

G

formin-like 1

decreases expression

EXP

Propylthiouracil results in decreased expression of FMNL1 mRNA

NCBI chr10:88,615,290...88,643,411
Ensembl chr10:88,615,869...88,643,411

G

flavin containing dimethylaniline monoxygenase 1

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of FMO1 mRNA
Propylthiouracil results in decreased expression of FMO1 mRNA

PMID:19483382 PMID:30047161

NCBI chr13:77,715,405...77,747,666
Ensembl chr13:77,715,402...77,747,874

G

flavin containing dimethylaniline monoxygenase 2

decreases expression

EXP

Propylthiouracil results in decreased expression of FMO2 mRNA

NCBI chr13:77,755,131...77,777,597
Ensembl chr13:77,757,629...77,777,534

G

fibromodulin

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of FMOD mRNA
Propylthiouracil results in decreased expression of FMOD mRNA

PMID:24780913 PMID:30047161

NCBI chr13:48,045,567...48,056,184
Ensembl chr13:47,990,774...48,056,183

G

fibronectin 1

multiple interactions

ISO

Propylthiouracil inhibits the reaction [Monocrotaline results in increased expression of FN1 protein]

NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137

G

fructosamine 3 kinase

decreases expression

EXP

Propylthiouracil results in decreased expression of FN3K mRNA

NCBI chr10:107,198,566...107,214,176
Ensembl chr10:107,198,892...107,214,175

G

formin binding protein 1

decreases expression

EXP

Propylthiouracil results in decreased expression of FNBP1 mRNA

PMID:24780913 PMID:25825206

NCBI chr 3:34,706,814...34,826,770
Ensembl chr 3:34,706,814...34,822,117

G

formin binding protein 1-like

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of FNBP1L mRNA
Propylthiouracil results in decreased expression of FNBP1L mRNA

PMID:24780913 PMID:30047161

NCBI chr 2:213,331,871...213,432,821
Ensembl chr 2:213,318,662...213,423,051

G

formin binding protein 4

decreases expression

EXP

Propylthiouracil results in decreased expression of FNBP4 mRNA

NCBI chr 3:97,188,852...97,218,916
Ensembl chr 3:97,188,884...97,219,435

G

fibronectin type III domain containing 5

decreases expression

EXP

Propylthiouracil results in decreased expression of FNDC5 mRNA

NCBI chr 5:146,765,951...146,775,611
Ensembl chr 5:146,751,416...146,778,540

G

folliculin interacting protein 2

decreases expression

EXP

Propylthiouracil results in decreased expression of FNIP2 mRNA

NCBI chr 2:166,894,726...167,006,490
Ensembl chr 2:166,897,075...167,006,055

G

focadhesin

increases expression

EXP

Propylthiouracil results in increased expression of FOCAD mRNA

NCBI chr 5:107,610,489...107,932,485
Ensembl chr 5:107,610,416...107,933,109

G

folate hydrolase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of FOLH1 mRNA

NCBI chr 1:149,828,286...149,914,313
Ensembl chr 1:149,840,760...149,914,035

G

folate receptor alpha

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of FOLR1 mRNA

NCBI chr 1:165,631,462...165,650,430
Ensembl chr 1:165,631,462...165,642,669

G

Fos proto-oncogene, AP-1 transcription factor subunit

multiple interactions

EXP

[isoquercitrin analog co-treated with Propylthiouracil] results in decreased expression of FOS mRNA; [Thioctic Acid co-treated with Propylthiouracil] results in decreased expression of FOS mRNA

NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598

G

FOS like 1, AP-1 transcription factor subunit

increases expression

EXP

Propylthiouracil results in increased expression of FOSL1 mRNA

NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:212,183,833...212,192,391

G

FOS like 2, AP-1 transcription factor subunit

decreases expression

EXP

Propylthiouracil results in decreased expression of FOSL2 mRNA

NCBI chr 6:30,017,952...30,039,269
Ensembl chr 6:30,021,916...30,039,406

G

forkhead box A2

decreases expression

EXP

Propylthiouracil results in decreased expression of FOXA2 mRNA

NCBI chr 3:155,923,305...155,927,508
Ensembl chr 3:155,923,307...155,928,757

G

forkhead box B1

decreases expression

EXP

Propylthiouracil results in decreased expression of FOXB1 mRNA

NCBI chr 8:79,288,161...79,290,781
Ensembl chr 8:79,287,616...79,291,490

G

forkhead box C1

decreases expression

EXP

Propylthiouracil results in decreased expression of FOXC1 mRNA

PMID:24780913 PMID:30047161

NCBI chr17:32,840,119...32,844,100
Ensembl chr17:32,805,858...32,844,347

G

forkhead box C2

decreases expression

EXP

Propylthiouracil results in decreased expression of FOXC2 mRNA

NCBI chr19:66,094,718...66,097,420
Ensembl chr19:66,094,700...66,153,977

G

forkhead box D4

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of FOXD4 mRNA
Propylthiouracil results in increased expression of FOXD4 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:231,983,872...231,985,565

G

forkhead box F1

increases expression

EXP

Propylthiouracil results in increased expression of FOXF1 mRNA

NCBI chr19:66,062,635...66,066,427
Ensembl chr19:66,062,369...66,066,428

G

forkhead box I2

increases expression

EXP

Propylthiouracil results in increased expression of FOXI2 mRNA

NCBI chr 1:199,652,703...199,656,503
Ensembl chr 1:199,652,703...199,656,498

G

forkhead box J1

decreases expression

EXP

Propylthiouracil results in decreased expression of FOXJ1 mRNA

NCBI chr10:102,065,163...102,069,945
Ensembl chr10:102,065,170...102,069,241

G

forkhead box J2

decreases expression

EXP

Propylthiouracil results in decreased expression of FOXJ2 mRNA

NCBI chr 4:157,718,990...157,745,468
Ensembl chr 4:157,718,992...157,745,450

G

forkhead box K2

increases expression

EXP

Propylthiouracil results in increased expression of FOXK2 mRNA

NCBI chr10:107,040,933...107,090,860
Ensembl chr10:107,040,933...107,195,823

G

forkhead box M1

increases expression

EXP

Propylthiouracil results in increased expression of FOXM1 mRNA

NCBI chr 4:163,325,628...163,338,100
Ensembl chr 4:163,325,614...163,337,172

G

forkhead box N2

decreases expression

EXP

Propylthiouracil results in decreased expression of FOXN2 mRNA

NCBI chr 6:11,772,180...11,818,751
Ensembl chr 6:11,772,180...11,818,751

G

forkhead box N3

decreases expression

EXP

Propylthiouracil results in decreased expression of FOXN3 mRNA

PMID:24780913 PMID:30047161

NCBI chr 6:124,191,695...124,572,070
Ensembl chr 6:124,195,701...124,572,040

G

forkhead box O6

increases expression

EXP

Propylthiouracil results in increased expression of FOXO6 mRNA

PMID:24780913 PMID:25825206

NCBI chr 5:139,141,329...139,161,629
Ensembl chr 5:139,141,185...139,161,629

G

forkhead box P1

decreases expression

EXP

Propylthiouracil results in decreased expression of FOXP1 mRNA

NCBI chr 4:133,117,346...133,808,647
Ensembl chr 4:133,122,055...133,500,272

G

forkhead box Q1

decreases expression

EXP

Propylthiouracil results in decreased expression of FOXQ1 mRNA

NCBI chr17:33,121,454...33,124,087
Ensembl chr17:33,121,545...33,123,720

G

folylpolyglutamate synthase

increases expression

EXP

Propylthiouracil results in increased expression of FPGS mRNA

NCBI chr 3:36,370,505...36,391,314
Ensembl chr 3:36,370,300...36,391,068

G

formyl peptide receptor 1

decreases expression

EXP

Propylthiouracil results in decreased expression of FPR1 mRNA

NCBI chr 1:67,417,991...67,429,813
Ensembl chr 1:67,421,313...67,422,520

G

Fraser extracellular matrix complex subunit 1

decreases expression

EXP

Propylthiouracil results in decreased expression of FRAS1 mRNA

NCBI chr14:13,095,370...13,506,895
Ensembl chr14:13,095,370...13,504,664

G

FRAS1 related extracellular matrix 2

decreases expression

EXP

Propylthiouracil results in decreased expression of FREM2 mRNA

PMID:30047161 PMID:36843608

NCBI chr 2:139,753,055...139,891,046
Ensembl chr 2:139,753,055...139,891,046

G

FRAS1 related extracellular matrix 3

affects expression

EXP

Propylthiouracil affects the expression of FREM3 mRNA

NCBI chr19:44,212,842...44,271,137
Ensembl chr19:44,212,769...44,271,336

G

Frey regulator of sperm-oocyte fusion 1

increases expression

EXP

Propylthiouracil results in increased expression of FREY1 mRNA

NCBI chr 3:98,809,792...98,810,544
Ensembl chr 3:98,809,792...98,810,544

G

FERM domain containing 1

decreases expression

EXP

Propylthiouracil results in decreased expression of FRMD1 mRNA

NCBI chr 1:63,750,852...63,762,383

G

FERM domain containing 4A

increases expression

EXP

Propylthiouracil results in increased expression of FRMD4A mRNA

PMID:24780913 PMID:30047161

NCBI chr17:78,577,062...79,167,924
Ensembl chr17:78,579,277...79,167,663

G

FERM domain containing 5

decreases expression

EXP

Propylthiouracil results in decreased expression of FRMD5 mRNA

NCBI chr 3:128,945,812...129,217,134
Ensembl chr 3:128,927,671...129,217,074

G

FERM domain containing 6

decreases expression

EXP

Propylthiouracil results in decreased expression of FRMD6 mRNA

PMID:24780913 PMID:30047161

NCBI chr 6:95,081,958...95,155,561
Ensembl chr 6:95,081,985...95,155,560

G

FERM domain containing 7

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of FRMD7 mRNA

NCBI chr X:135,261,272...135,308,178
Ensembl chr X:135,261,029...135,308,786

G

ferric-chelate reductase 1-like

decreases expression

EXP

Propylthiouracil results in decreased expression of FRRS1L mRNA

NCBI chr 5:76,451,101...76,485,319
Ensembl chr 5:76,451,101...76,485,316

G

fibroblast growth factor receptor substrate 2

decreases expression

EXP

Propylthiouracil results in decreased expression of FRS2 mRNA

NCBI chr 7:54,597,182...54,678,656
Ensembl chr 7:54,597,182...54,678,774

G

FRY microtubule binding protein

decreases expression

EXP

Propylthiouracil results in decreased expression of FRY mRNA

NCBI chr12:9,530,360...9,773,391
Ensembl chr12:9,530,360...9,897,603

G

FRY like transcription coactivator

decreases expression

EXP

Propylthiouracil results in decreased expression of FRYL mRNA

NCBI chr14:35,307,225...35,545,199
Ensembl chr14:35,310,656...35,545,147

G

frizzled-related protein

decreases expression

EXP

Propylthiouracil results in decreased expression of FRZB mRNA

NCBI chr 3:85,739,162...85,772,168
Ensembl chr 3:85,739,165...85,772,096

G

fascin actin-bundling protein 2, retinal

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of FSCN2 mRNA
Propylthiouracil results in decreased expression of FSCN2 mRNA

PMID:24780913 PMID:25825206

NCBI chr10:106,121,038...106,139,683
Ensembl chr10:106,133,144...106,139,683

G

fascin actin-bundling protein 3

decreases expression

EXP

Propylthiouracil results in decreased expression of FSCN3 mRNA

NCBI chr 4:58,008,124...58,017,674
Ensembl chr 4:58,008,230...58,017,673

G

follicle stimulating hormone subunit beta

decreases expression

EXP

Propylthiouracil results in decreased expression of FSHB mRNA

NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:114,003,262...114,007,072

G

fibrous sheath interacting protein 1

increases expression

EXP

Propylthiouracil results in increased expression of FSIP1 mRNA

NCBI chr 3:125,528,538...125,671,135
Ensembl chr 3:125,524,528...125,671,135

G

follistatin

decreases expression

EXP

Propylthiouracil results in decreased expression of FST mRNA

NCBI chr 2:47,856,345...47,863,670
Ensembl chr 2:47,856,345...47,863,491

G

follistatin-like 1

increases expression

EXP

Propylthiouracil results in increased expression of FSTL1 mRNA

NCBI chr11:76,400,870...76,454,053
Ensembl chr11:76,391,315...76,455,126

G

follistatin like 3

increases expression

EXP

Propylthiouracil results in increased expression of FSTL3 mRNA

NCBI chr 7:10,574,195...10,579,844
Ensembl chr 7:10,574,186...10,590,509

G

follistatin-like 4

decreases expression

EXP

Propylthiouracil results in decreased expression of FSTL4 mRNA

PMID:24780913 PMID:30047161

NCBI chr10:37,412,288...37,845,405
Ensembl chr10:37,412,288...37,845,393

G

ferritin light chain 1

increases expression

EXP

Propylthiouracil results in increased expression of FTL mRNA

NCBI chr 1:105,072,858...105,074,705
Ensembl chr X:45,399,355...45,399,915
Ensembl chr 2:45,399,355...45,399,915
Ensembl chr 1:45,399,355...45,399,915

G

FtsJ RNA 2'-O-methyltransferase 3

increases expression

EXP

Propylthiouracil results in increased expression of FTSJ3 mRNA

NCBI chr10:91,680,735...91,687,475
Ensembl chr10:91,680,753...91,687,179

G

alpha-L-fucosidase 1

increases expression

EXP

Propylthiouracil results in increased expression of FUCA1 mRNA

NCBI chr 5:153,436,262...153,453,512
Ensembl chr 5:153,436,248...153,453,511

G

alpha-L-fucosidase 2

increases expression

EXP

Propylthiouracil results in increased expression of FUCA2 mRNA

NCBI chr 1:9,706,121...9,720,910
Ensembl chr 1:9,706,094...9,721,706

G

FUN14 domain containing 1

increases expression

EXP

Propylthiouracil results in increased expression of FUNDC1 mRNA

NCBI chr X:7,666,787...7,683,443
Ensembl chr X:7,666,759...7,683,441

G

FUN14 domain containing 2

increases expression

EXP

Propylthiouracil results in increased expression of FUNDC2 mRNA

NCBI chr18:142,829...155,123
Ensembl chr18:142,640...155,674

G

fucose mutarotase

decreases expression

EXP

Propylthiouracil results in decreased expression of FUOM mRNA

NCBI chr 1:204,318,180...204,322,690
Ensembl chr 1:204,316,354...204,322,690

G

furin (paired basic amino acid cleaving enzyme)

increases expression

EXP

Propylthiouracil results in increased expression of FURIN mRNA

NCBI chr 1:143,757,389...143,770,430
Ensembl chr 1:143,757,391...143,773,497

G

fucosyltransferase 1

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of FUT1 mRNA
Propylthiouracil results in increased expression of FUT1 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 1:105,223,399...105,226,817
Ensembl chr 1:105,223,390...105,227,513

G

fuzzy planar cell polarity protein

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of FUZ mRNA
Propylthiouracil results in decreased expression of FUZ mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:104,515,782...104,524,591
Ensembl chr 1:104,516,049...104,521,038

G

Friend virus susceptibility 1

decreases expression

EXP

Propylthiouracil results in decreased expression of FV1 mRNA

NCBI chr 1:103,867,358...103,873,336
Ensembl chr 1:103,867,373...103,873,342

G

FXYD domain-containing ion transport regulator 1

decreases expression

EXP

Propylthiouracil results in decreased expression of FXYD1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:95,414,556...95,418,645
Ensembl chr 1:95,414,557...95,418,591

G

FXYD domain-containing ion transport regulator 2

increases expression

EXP

Propylthiouracil results in increased expression of FXYD2 mRNA

NCBI chr 8:54,609,658...54,616,788
Ensembl chr 8:54,609,658...54,616,957

G

FXYD domain-containing ion transport regulator 3

decreases expression

EXP

Propylthiouracil results in decreased expression of FXYD3 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:95,432,918...95,440,129
Ensembl chr 1:95,432,919...95,439,702

G

FXYD domain-containing ion transport regulator 5

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of FXYD5 mRNA
Propylthiouracil results in increased expression of FXYD5 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:95,395,327...95,404,722
Ensembl chr 1:95,395,146...95,405,364

G

FXYD domain-containing ion transport regulator 6

increases expression

EXP

Propylthiouracil results in increased expression of FXYD6 mRNA

PMID:24780913 PMID:25825206

NCBI chr 8:54,575,578...54,602,715
Ensembl chr 8:54,575,591...54,602,715

G

FXYD domain-containing ion transport regulator 7

decreases expression

EXP

Propylthiouracil results in decreased expression of FXYD7 mRNA

PMID:25825206 PMID:30047161

NCBI chr 1:95,405,071...95,414,407
Ensembl chr 1:95,405,225...95,414,345

G

forty-two-three domain containing 1

decreases expression

EXP

Propylthiouracil results in decreased expression of FYTTD1 mRNA

NCBI chr11:81,383,040...81,412,604
Ensembl chr11:81,383,040...81,412,599

G

frizzled class receptor 1

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of FZD1 mRNA
Propylthiouracil results in increased expression of FZD1 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 4:30,265,074...30,269,472
Ensembl chr 4:30,247,228...30,833,176

G

frizzled class receptor 2

increases expression

EXP

Propylthiouracil results in increased expression of FZD2 mRNA

NCBI chr10:88,061,988...88,063,898
Ensembl chr10:88,061,667...88,065,396

G

frizzled class receptor 9

decreases expression
increases methylation

EXP

Propylthiouracil results in decreased expression of FZD9 mRNA
Propylthiouracil results in increased methylation of FZD9 promoter

NCBI chr12:27,063,640...27,065,954
Ensembl chr12:27,063,415...27,074,485

G

fizzy and cell division cycle 20 related 1

increases expression

EXP

Propylthiouracil results in increased expression of FZR1 mRNA

NCBI chr 7:8,982,765...8,994,689
Ensembl chr 7:8,989,769...8,995,199

G

G0/G1switch 2

decreases expression

EXP

Propylthiouracil results in decreased expression of G0S2 mRNA

NCBI chr13:107,335,036...107,335,948
Ensembl chr13:107,335,036...107,336,293

G

G3BP stress granule assembly factor 1

increases expression

EXP

Propylthiouracil results in increased expression of G3BP1 mRNA

NCBI chr10:40,087,533...40,120,931
Ensembl chr10:40,087,533...40,120,931

G

glucose 6 phosphatase catalytic subunit 3

increases expression

EXP

Propylthiouracil results in increased expression of G6PC3 mRNA

NCBI chr10:87,647,149...87,651,385
Ensembl chr10:87,647,062...87,653,453

G

GRB2-associated binding protein 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of GAB1 mRNA
Propylthiouracil results in decreased expression of GAB1 mRNA

PMID:24780913 PMID:25825206

NCBI chr19:44,035,693...44,143,617
Ensembl chr19:44,035,063...44,143,617

G

GABA type A receptor associated protein like 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GABARAPL1 mRNA

NCBI chr 4:164,666,332...164,675,474
Ensembl chr 4:164,666,246...164,674,578

G

GABA type A receptor associated protein like 2

decreases expression

EXP

Propylthiouracil results in decreased expression of GABARAPL2 mRNA

NCBI chr19:56,819,826...56,830,662
Ensembl chr19:56,819,791...56,830,660

G

gamma-aminobutyric acid type B receptor subunit 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GABBR1 mRNA

NCBI chr20:1,469,779...1,499,352
Ensembl chr20:1,469,779...1,498,607

G

gamma-aminobutyric acid type B receptor subunit 2

decreases expression

EXP

Propylthiouracil results in decreased expression of GABBR2 mRNA

NCBI chr 5:65,743,073...66,083,695
Ensembl chr 5:65,743,073...66,083,695

G

gamma-aminobutyric acid type A receptor subunit alpha 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GABRA1 mRNA

NCBI chr10:27,096,731...27,152,563
Ensembl chr10:27,096,740...27,152,442

G

gamma-aminobutyric acid type A receptor subunit alpha 3

increases expression

EXP

Propylthiouracil results in increased expression of GABRA3 mRNA

NCBI chr X:155,301,979...155,543,870
Ensembl chr X:155,303,928...155,543,863

G

gamma-aminobutyric acid type A receptor subunit alpha 4

decreases expression

EXP

Propylthiouracil results in decreased expression of GABRA4 mRNA

NCBI chr14:36,944,747...37,021,652
Ensembl chr14:36,944,388...37,021,648

G

gamma-aminobutyric acid type A receptor subunit alpha 5

increases expression

EXP

Propylthiouracil results in increased expression of GABRA5 mRNA

NCBI chr 1:117,404,446...117,517,424
Ensembl chr 1:117,404,494...117,516,635

G

gamma-aminobutyric acid type A receptor subunit beta1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of GABRB1 mRNA
Propylthiouracil results in decreased expression of GABRB1 mRNA

PMID:24780913 PMID:30047161

NCBI chr14:36,434,339...36,917,920
Ensembl chr14:36,434,352...36,902,893

G

gamma-aminobutyric acid type A receptor subunit beta 2

decreases expression

EXP

Propylthiouracil results in decreased expression of GABRB2 mRNA

NCBI chr10:27,438,127...27,657,680
Ensembl chr10:27,438,238...27,655,171

G

gamma-aminobutyric acid type A receptor subunit beta 3

increases expression

EXP

Propylthiouracil results in increased expression of GABRB3 mRNA

NCBI chr 1:117,602,772...117,838,230
Ensembl chr 1:117,431,842...117,836,725

G

gamma-aminobutyric acid type A receptor subunit delta

decreases expression

EXP

Propylthiouracil results in decreased expression of GABRD mRNA

NCBI chr 5:171,240,813...171,252,709
Ensembl chr 5:171,240,789...171,253,094

G

gamma-aminobutyric acid type A receptor subunit epsilon

increases expression

EXP

Propylthiouracil results in increased expression of GABRE mRNA

NCBI chr X:155,102,078...155,120,821
Ensembl chr X:155,102,083...155,120,735

G

gamma-aminobutyric acid type A receptor subunit gamma 2

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of GABRG2 mRNA
Propylthiouracil results in increased expression of GABRG2 mRNA

PMID:24780913 PMID:36843608

NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,876,926...26,965,523

G

gamma-aminobutyric acid type A receptor subunit theta

decreases expression

EXP

Propylthiouracil results in decreased expression of GABRQ mRNA

NCBI chr X:155,737,838...155,755,225
Ensembl chr X:155,738,436...155,755,223

G

glutamate decarboxylase 1

increases expression
decreases expression
multiple interactions

EXP

Propylthiouracil results in increased expression of GAD1 mRNA
Propylthiouracil results in decreased expression of GAD1 mRNA
[Thioctic Acid co-treated with Propylthiouracil] results in increased expression of GAD1 mRNA

PMID:24780913 PMID:30047161 PMID:31068541

NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:75,777,534...75,818,759

G

glutamate decarboxylase 2

decreases expression

EXP

Propylthiouracil results in decreased expression of GAD2 mRNA

NCBI chr17:89,671,718...89,734,246
Ensembl chr17:89,671,716...89,941,089

G

growth arrest and DNA-damage-inducible, alpha

decreases expression

EXP

Propylthiouracil results in decreased expression of GADD45A mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807

G

growth arrest and DNA-damage-inducible, beta

decreases expression

EXP

Propylthiouracil results in decreased expression of GADD45B mRNA

NCBI chr 7:9,428,689...9,430,991
Ensembl chr 7:9,428,689...9,430,718

G

growth arrest and DNA-damage-inducible, gamma

decreases expression

EXP

Propylthiouracil results in decreased expression of GADD45G mRNA

NCBI chr17:13,528,606...13,530,351
Ensembl chr17:13,528,610...13,530,369

G

galanin and GMAP prepropeptide

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of GAL mRNA
Propylthiouracil results in increased expression of GAL mRNA

PMID:24780913 PMID:25825206

NCBI chr 1:210,079,709...210,084,572
Ensembl chr 1:210,079,702...210,084,229

G

galactose-3-O-sulfotransferase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GAL3ST1 mRNA

NCBI chr14:83,094,265...83,109,992
Ensembl chr14:83,094,385...83,109,978

G

galactose-3-O-sulfotransferase 4

increases expression

EXP

Propylthiouracil results in increased expression of GAL3ST4 mRNA

NCBI chr12:22,381,576...22,390,566
Ensembl chr12:22,381,576...22,390,824

G

UDP-galactose-4-epimerase

increases expression

EXP

Propylthiouracil results in increased expression of GALE mRNA

NCBI chr 5:153,477,420...153,481,926
Ensembl chr 5:153,478,325...153,481,922

G

galactokinase 1

increases expression

EXP

Propylthiouracil results in increased expression of GALK1 mRNA

NCBI chr10:101,742,067...101,746,244
Ensembl chr10:101,735,061...101,746,258

G

galactokinase 2

increases expression

EXP

Propylthiouracil results in increased expression of GALK2 mRNA

NCBI chr 3:133,563,524...133,696,423
Ensembl chr 3:133,563,538...133,696,528

G

galactose mutarotase

decreases expression

EXP

Propylthiouracil results in decreased expression of GALM mRNA

NCBI chr 6:20,589,775...20,641,516
Ensembl chr 6:20,589,776...20,644,417

G

polypeptide N-acetylgalactosaminyltransferase 1

increases expression

EXP

Propylthiouracil results in increased expression of GALNT1 mRNA

NCBI chr18:15,763,697...15,843,598
Ensembl chr18:15,764,277...15,843,588

G

polypeptide N-acetylgalactosaminyltransferase 13

decreases expression

EXP

Propylthiouracil results in decreased expression of GALNT13 mRNA

NCBI chr 3:59,312,628...59,969,633
Ensembl chr 3:59,383,516...59,965,379

G

polypeptide N-acetylgalactosaminyltransferase 3

increases expression

EXP

Propylthiouracil results in increased expression of GALNT3 mRNA

PMID:22504374 PMID:24780913

NCBI chr 3:71,150,559...71,187,321
Ensembl chr 3:71,150,571...71,174,323

G

polypeptide N-acetylgalactosaminyltransferase 4

increases expression

EXP

Propylthiouracil results in increased expression of GALNT4 mRNA

NCBI chr 7:35,811,904...35,814,445

G

polypeptide N-acetylgalactosaminyltransferase 6

decreases expression

EXP

Propylthiouracil results in decreased expression of GALNT6 mRNA

PMID:24780913 PMID:25825206

NCBI chr 7:133,668,612...133,715,909
Ensembl chr 7:133,668,615...133,698,439

G

polypeptide N-acetylgalactosaminyltransferase 9

decreases expression

EXP

Propylthiouracil results in decreased expression of GALNT9 mRNA

NCBI chr12:51,710,176...51,788,388
Ensembl chr12:51,710,180...51,788,330

G

galanin receptor 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GALR1 mRNA

NCBI chr18:78,046,803...78,062,359
Ensembl chr18:78,046,805...78,062,359

G

galanin receptor 2

decreases expression

EXP

Propylthiouracil results in decreased expression of GALR2 mRNA

NCBI chr10:102,012,086...102,016,057
Ensembl chr10:102,013,370...102,016,055

G

galactose-1-phosphate uridylyltransferase

decreases expression

EXP

Propylthiouracil results in decreased expression of GALT mRNA

NCBI chr 5:61,722,871...61,726,128
Ensembl chr 5:61,722,466...61,726,125

G

guanidinoacetate N-methyltransferase

affects expression
increases expression
decreases expression

EXP

Propylthiouracil affects the expression of GAMT mRNA
Propylthiouracil results in increased expression of GAMT mRNA
Propylthiouracil results in decreased expression of GAMT mRNA

PMID:19483382 PMID:24780913 PMID:30047161

NCBI chr 7:10,099,267...10,102,083
Ensembl chr 7:10,098,571...10,102,083

G

glucosidase, alpha; neutral C

decreases expression

EXP

Propylthiouracil results in decreased expression of GANC mRNA

NCBI chr 3:127,807,132...127,858,995
Ensembl chr 3:127,807,441...127,859,859

G

growth associated protein 43

increases expression

EXP

Propylthiouracil results in increased expression of GAP43 mRNA

NCBI chr11:71,882,131...71,975,799
Ensembl chr11:71,882,131...71,975,797

G

glyceraldehyde-3-phosphate dehydrogenase

affects expression

EXP

Propylthiouracil affects the expression of GAPDH mRNA

NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:159,648,592...159,653,377

G

glyceraldehyde-3-phosphate dehydrogenase, pseudogene 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GAPDH-PS1 mRNA

NCBI chr 3:63,621,152...63,623,050
Ensembl chr 3:63,621,135...63,623,011

G

golgi associated RAB2 interactor 5A

increases expression

EXP

Propylthiouracil results in increased expression of GARIN5A mRNA

NCBI chr 1:104,125,477...104,130,543
Ensembl chr 1:104,125,160...104,135,840

G

glycyl-tRNA synthetase 1

increases expression

EXP

Propylthiouracil results in increased expression of GARS1 mRNA

NCBI chr 4:85,484,939...85,542,876
Ensembl chr 4:85,493,753...85,542,876

G

growth arrest-specific 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GAS1 mRNA

NCBI chr17:4,487,716...4,490,701
Ensembl chr17:4,484,283...4,497,657

G

growth arrest-specific 2

decreases expression

EXP

Propylthiouracil results in decreased expression of GAS2 mRNA

NCBI chr 1:110,587,952...110,721,572
Ensembl chr 1:110,717,312...110,718,541

G

growth arrest specific 7

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of GAS7 mRNA
Propylthiouracil results in increased expression of GAS7 mRNA

PMID:24780913 PMID:30047161

NCBI chr10:52,651,690...52,882,244
Ensembl chr10:52,651,690...52,882,244

G

growth arrest specific 8

decreases expression

EXP

Propylthiouracil results in decreased expression of GAS8 mRNA

NCBI chr19:68,461,280...68,480,810
Ensembl chr19:68,461,304...68,480,806

G

golgi associated kinase 1B

affects expression
increases expression
decreases expression

EXP

Propylthiouracil affects the expression of GASK1B mRNA
Propylthiouracil results in increased expression of FAM198B mRNA
Propylthiouracil results in decreased expression of GASK1B mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 2:167,345,738...167,410,606
Ensembl chr 2:167,345,809...167,410,603

G

gastrin

increases expression

EXP

Propylthiouracil results in increased expression of GAST mRNA

NCBI chr10:85,765,216...85,767,881
Ensembl chr10:85,765,216...85,767,880

G

GATA binding protein 3

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of GATA3 mRNA
Propylthiouracil inhibits the reaction [Monocrotaline results in increased expression of GATA3 protein]

PMID:22504374 PMID:36942326

NCBI chr17:73,544,234...73,575,670
Ensembl chr17:73,553,548...73,575,670

G

GATA binding protein 4

multiple interactions

ISO

Propylthiouracil inhibits the reaction [Monocrotaline results in increased expression of GATA4 protein]

NCBI chr15:41,635,572...41,707,252
Ensembl chr15:41,635,572...41,681,609

G

GATA binding protein 5

increases expression

EXP

Propylthiouracil results in increased expression of GATA5 mRNA

NCBI chr 3:187,796,140...187,804,327
Ensembl chr 3:187,796,142...187,804,327

G

GATA binding protein 6

multiple interactions

ISO

Propylthiouracil inhibits the reaction [Monocrotaline results in increased expression of GATA6 protein]

NCBI chr18:2,460,909...2,492,322
Ensembl chr18:2,458,253...2,492,322

G

GATA zinc finger domain containing 1

increases expression

EXP

Propylthiouracil results in increased expression of GATAD1 mRNA

NCBI chr 4:31,462,251...31,473,827
Ensembl chr 4:31,462,309...31,503,921

G

GATA zinc finger domain containing 2A

increases expression

EXP

Propylthiouracil results in increased expression of GATAD2A mRNA

NCBI chr16:19,463,500...19,553,497
Ensembl chr16:19,463,500...19,553,497

G

glycine amidinotransferase

increases expression

EXP

Propylthiouracil results in increased expression of GATM mRNA

NCBI chr 3:130,112,508...130,137,664
Ensembl chr 3:130,112,509...130,129,355

G

glucosylceramidase beta 1

increases expression

EXP

Propylthiouracil results in increased expression of GBA1 mRNA

NCBI chr 2:176,902,141...176,916,015
Ensembl chr 2:176,907,154...176,916,985

G

1,4-alpha-glucan branching enzyme 1

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of GBE1 mRNA
Propylthiouracil results in decreased expression of GBE1 mRNA

PMID:19483382 PMID:24780913 PMID:30047161

NCBI chr11:22,181,194...22,446,640
Ensembl chr11:22,181,103...22,446,638

G

guanylate binding protein 2

increases expression

EXP

Propylthiouracil results in increased expression of GBP2 mRNA

PMID:24780913 PMID:30047161

NCBI chr 2:234,005,727...234,021,812
Ensembl chr 2:234,008,590...234,021,810

G

guanylate binding protein 4

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of GBP3 mRNA

NCBI chr 2:233,978,163...233,992,124
Ensembl chr 2:233,978,486...233,992,120

G

guanylate binding protein 5

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of GBP5 mRNA
Propylthiouracil results in decreased expression of GBP5 mRNA

PMID:24780913 PMID:25825206

NCBI chr 2:233,910,999...233,930,320
Ensembl chr 2:233,902,113...233,930,826

G

gastrulation brain homeobox 2

increases expression

EXP

Propylthiouracil results in increased expression of GBX2 mRNA

NCBI chr 9:97,957,304...97,959,883
Ensembl chr 9:97,957,304...97,959,883

G

grancalcin

decreases expression

EXP

Propylthiouracil results in decreased expression of GCA mRNA

PMID:24780913 PMID:25825206

NCBI chr 3:67,705,874...67,738,475
Ensembl chr 3:67,705,890...67,737,387

G

glycine C-acetyltransferase

decreases expression

EXP

Propylthiouracil results in decreased expression of GCAT mRNA

NCBI chr 7:112,475,572...112,481,920
Ensembl chr 7:112,475,496...112,482,664

G

GC-rich sequence DNA-binding factor 2

decreases expression

EXP

Propylthiouracil results in decreased expression of GCFC2 mRNA

NCBI chr 4:116,039,432...116,076,330
Ensembl chr 4:116,039,433...116,077,152

G

glucagon receptor

decreases expression

EXP

Propylthiouracil results in decreased expression of GCGR mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr10:106,306,803...106,314,970
Ensembl chr10:106,306,559...106,314,969

G

GTP cyclohydrolase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GCH1 mRNA

NCBI chr15:22,884,006...22,917,412
Ensembl chr15:22,884,006...22,917,412

G

GTP cyclohydrolase I feedback regulator

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of GCHFR mRNA
Propylthiouracil results in decreased expression of GCHFR mRNA

PMID:19483382 PMID:24780913

NCBI chr 3:126,611,892...126,615,926
Ensembl chr 3:126,613,240...126,615,926

G

glucokinase

increases expression

EXP

Propylthiouracil results in increased expression of GCK mRNA

NCBI chr14:84,999,019...85,041,098
Ensembl chr14:84,999,020...85,040,949

G

glucokinase regulator

affects expression

EXP

Propylthiouracil affects the expression of GCKR mRNA

NCBI chr 6:30,765,071...30,795,627
Ensembl chr 6:30,765,075...30,795,627

G

glutamate-cysteine ligase, catalytic subunit

increases expression

EXP

Propylthiouracil results in increased expression of GCLC mRNA

NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893

G

GCN1 activator of EIF2AK4

increases expression

EXP

Propylthiouracil results in increased expression of GCN1L1 mRNA

NCBI chr12:46,652,273...46,715,119
Ensembl chr12:46,652,273...46,713,488

G

glucosaminyl (N-acetyl) transferase 1

increases expression

EXP

Propylthiouracil results in increased expression of GCNT1 mRNA

PMID:24780913 PMID:25825206

NCBI chr 1:224,145,104...224,182,496
Ensembl chr 1:224,141,108...224,185,741

G

glucosaminyl (N-acetyl) transferase 2

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of GCNT2 mRNA
Propylthiouracil results in increased expression of GCNT2 mRNA

PMID:25825206 PMID:30047161

NCBI chr17:24,002,592...24,107,339
Ensembl chr17:24,002,597...24,106,989

G

glucosaminyl (N-acetyl) transferase 3, mucin type

increases expression

EXP

Propylthiouracil results in increased expression of GCNT3 mRNA

NCBI chr 8:79,570,081...79,577,389
Ensembl chr 8:79,566,753...79,581,595

G

glycine cleavage system protein H

increases expression

EXP

Propylthiouracil results in increased expression of GCSH mRNA

NCBI chr19:61,944,850...61,955,607
Ensembl chr19:61,944,850...61,955,607

G

guanine deaminase

increases expression

EXP

Propylthiouracil results in increased expression of GDA mRNA

NCBI chr 1:228,333,401...228,408,901
Ensembl chr 1:228,333,364...228,409,348

G

ganglioside-induced differentiation-associated-protein 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GDAP1 mRNA

NCBI chr 5:6,715,935...6,735,013
Ensembl chr 5:6,715,935...6,735,313

G

ganglioside-induced differentiation-associated protein 1-like 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GDAP1L1 mRNA

NCBI chr 3:172,529,523...172,549,128
Ensembl chr 3:172,509,564...172,549,125

G

growth differentiation factor 10

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of GDF10 mRNA
Propylthiouracil results in decreased expression of GDF10 mRNA

PMID:24780913 PMID:30047161

NCBI chr16:9,243,434...9,256,788
Ensembl chr16:9,243,317...9,256,794

G

growth differentiation factor 11

decreases expression

EXP

Propylthiouracil results in decreased expression of GDF11 mRNA

PMID:24780913 PMID:30047161

NCBI chr 7:1,896,229...1,909,147
Ensembl chr 7:1,896,229...1,905,222

G

growth differentiation factor 5

increases expression

EXP

Propylthiouracil results in increased expression of GDF5 mRNA

PMID:24780913 PMID:30047161

NCBI chr 3:164,914,401...164,918,593
Ensembl chr 3:164,914,401...164,918,593

G

GDP dissociation inhibitor 1

increases expression

EXP

Propylthiouracil results in increased expression of GDI1 mRNA

NCBI chr X:157,238,900...157,245,562
Ensembl chr X:157,238,892...157,245,560

G

glycerophosphodiester phosphodiesterase domain containing 2

increases expression

EXP

Propylthiouracil results in increased expression of GDPD2 mRNA

NCBI chr X:69,866,395...69,875,419
Ensembl chr X:69,866,799...69,875,414

G

gem (nuclear organelle) associated protein 2

decreases expression

EXP

Propylthiouracil results in decreased expression of GEMIN2 mRNA

NCBI chr 6:82,442,419...82,456,050
Ensembl chr 6:82,442,350...82,456,048

G

gem (nuclear organelle) associated protein 4

increases expression

EXP

Propylthiouracil results in increased expression of GEMIN4 mRNA

NCBI chr10:61,560,172...61,571,765
Ensembl chr10:61,564,657...61,596,532

G

gem (nuclear organelle) associated protein 6

increases expression

EXP

Propylthiouracil results in increased expression of GEMIN6 mRNA

NCBI chr 6:20,538,325...20,542,867
Ensembl chr 6:20,538,325...20,542,852

G

gem (nuclear organelle) associated protein 7-like 1

increases expression

EXP

Propylthiouracil results in increased expression of GEMIN7L1 mRNA

NCBI chr 4:79,600,772...79,601,543
Ensembl chr 4:79,600,772...79,601,543

G

gem (nuclear organelle) associated protein 8

decreases expression

EXP

Propylthiouracil results in decreased expression of GEMIN8 mRNA

NCBI chr X:31,891,446...31,910,280
Ensembl chr X:31,891,449...31,910,280

G

GEN1 Holliday junction 5' flap endonuclease

increases expression

EXP

Propylthiouracil results in increased expression of GEN1 mRNA

NCBI chr 6:39,666,675...39,697,480
Ensembl chr 6:39,667,286...39,697,480

G

glial fibrillary acidic protein

increases expression
affects expression

EXP

Propylthiouracil results in increased expression of GFAP mRNA; Propylthiouracil results in increased expression of GFAP protein
Propylthiouracil affects the expression of GFAP mRNA

PMID:22504374 PMID:24780913

NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685

G

G elongation factor, mitochondrial 1

increases expression

EXP

Propylthiouracil results in increased expression of GFM1 mRNA

NCBI chr 2:154,010,601...154,055,523
Ensembl chr 2:154,010,614...154,065,805

G

GTP dependent ribosome recycling factor mitochondrial 2

decreases expression

EXP

Propylthiouracil results in decreased expression of GFM2 mRNA

NCBI chr 2:30,184,063...30,222,811
Ensembl chr 2:30,184,115...30,222,806

G

glutamine-fructose-6-phosphate transaminase 2

decreases expression

EXP

Propylthiouracil results in decreased expression of GFPT2 mRNA

NCBI chr10:34,616,146...34,662,420
Ensembl chr10:34,615,370...34,662,419

G

GDNF family receptor alpha 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GFRA1 mRNA

NCBI chr 1:267,325,297...267,557,037
Ensembl chr 1:267,326,817...267,556,501

G

GDNF family receptor alpha 2

decreases expression

EXP

Propylthiouracil results in decreased expression of GFRA2 mRNA

NCBI chr15:52,351,499...52,443,369
Ensembl chr15:52,351,514...52,477,782

G

GDNF family receptor alpha 3

increases expression

EXP

Propylthiouracil results in increased expression of GFRA3 mRNA

NCBI chr18:26,571,952...26,600,225
Ensembl chr18:26,571,921...26,600,225

G

GDNF family receptor alpha 4

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of GFRA4 mRNA
Propylthiouracil results in decreased expression of GFRA4 mRNA

PMID:24780913 PMID:30047161

NCBI chr 3:138,707,970...138,715,279
Ensembl chr 3:138,703,114...138,711,561

G

GDNF family receptor alpha like

increases expression

EXP

Propylthiouracil results in increased expression of GFRAL mRNA

NCBI chr 8:85,798,337...85,843,705
Ensembl chr 8:85,798,342...85,843,752

G

golgi associated, gamma adaptin ear containing, ARF binding protein 3

decreases expression

EXP

Propylthiouracil results in decreased expression of GGA3 mRNA

NCBI chr10:101,324,378...101,342,373
Ensembl chr10:101,324,378...101,342,373

G

gamma-glutamylamine cyclotransferase

decreases expression

EXP

Propylthiouracil results in decreased expression of GGACT mRNA

NCBI chr15:106,375,924...106,406,649
Ensembl chr15:106,366,120...106,404,004

G

gamma-glutamyl cyclotransferase

decreases expression

EXP

Propylthiouracil results in decreased expression of GGCT mRNA

NCBI chr 4:85,453,387...85,459,597
Ensembl chr 4:85,453,387...85,470,224

G

gamma-glutamyl hydrolase

affects expression

EXP

Propylthiouracil affects the expression of GGH mRNA

NCBI chr 5:38,326,747...38,349,655
Ensembl chr 5:38,326,594...38,349,647

G

gamma-glutamyltransferase 5

increases expression

EXP

Propylthiouracil results in increased expression of GGT5 mRNA

NCBI chr20:13,042,694...13,070,960
Ensembl chr20:13,042,696...13,070,892

G

glycoprotein alpha-galactosyltransferase 1

increases expression

EXP

Propylthiouracil results in increased expression of GGTA1 mRNA

PMID:22504374 PMID:24780913

NCBI chr 3:39,130,466...39,208,652
Ensembl chr 3:39,130,467...39,206,870

G

growth hormone receptor

decreases expression

EXP

Propylthiouracil results in decreased expression of GHR mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 2:54,269,066...54,532,595
Ensembl chr 2:54,270,206...54,532,331

G

growth hormone releasing hormone

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of GHRH mRNA
Propylthiouracil results in decreased expression of GHRH mRNA

PMID:22504374 PMID:30047161

NCBI chr 3:166,412,763...166,432,519
Ensembl chr 3:166,412,764...166,431,880

G

GRB10 interacting GYF protein 1

increases expression

EXP

Propylthiouracil results in increased expression of GIGYF1 mRNA

NCBI chr12:24,800,996...24,819,719
Ensembl chr12:24,802,865...24,811,800

G

GTPase, IMAP family member 7

decreases expression

EXP

Propylthiouracil results in decreased expression of GIMAP7 mRNA

NCBI chr 4:79,001,416...79,005,586
Ensembl chr 4:78,999,384...79,006,756

G

GTPase, IMAP family member 9

decreases expression

EXP

Propylthiouracil results in decreased expression of GIMAP9 mRNA

NCBI chr 4:78,957,451...78,960,284
Ensembl chr 4:78,954,264...78,962,338

G

glycosylated integral membrane protein 1

increases expression

EXP

Propylthiouracil results in increased expression of GINM1 mRNA

NCBI chr 1:4,066,766...4,082,640
Ensembl chr 1:4,066,766...4,082,617

G

GINS complex subunit 1

increases expression

EXP

Propylthiouracil results in increased expression of GINS1 mRNA

NCBI chr 3:160,184,920...160,206,334
Ensembl chr 3:160,180,151...160,206,332

G

GINS complex subunit 2

increases expression

EXP

Propylthiouracil results in increased expression of GINS2 mRNA

PMID:24780913 PMID:30047161

NCBI chr19:65,535,492...65,548,270
Ensembl chr19:65,535,492...65,548,052

G

GINS complex subunit 3

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of GINS3 mRNA
Propylthiouracil results in decreased expression of GINS3 mRNA

PMID:24780913 PMID:25825206

NCBI chr19:9,426,140...9,435,192
Ensembl chr19:9,399,759...9,434,679

G

GINS complex subunit 4

increases expression

EXP

Propylthiouracil results in increased expression of GINS4 mRNA

NCBI chr16:75,489,990...75,502,455
Ensembl chr16:75,490,126...75,505,000

G

gastric inhibitory polypeptide receptor

increases expression

EXP

Propylthiouracil results in increased expression of GIPR mRNA

NCBI chr 1:87,932,316...87,956,084
Ensembl chr 1:87,932,623...87,942,492

G

GIT ArfGAP 1

increases expression

EXP

Propylthiouracil results in increased expression of GIT1 mRNA

NCBI chr10:62,840,165...62,854,508
Ensembl chr10:62,840,394...62,854,508

G

gap junction protein, alpha 3

decreases expression

EXP

Propylthiouracil results in decreased expression of GJA3 mRNA

NCBI chr15:35,296,946...35,322,405
Ensembl chr15:35,295,523...35,322,809

G

gap junction protein, alpha 5

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of GJA5 mRNA
Propylthiouracil results in increased expression of GJA5 mRNA

PMID:22504374 PMID:24780913

NCBI chr 2:187,291,227...187,310,770
Ensembl chr 2:187,234,674...187,318,512

G

gap junction protein, beta 1

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of GJB1 mRNA
Propylthiouracil results in decreased expression of GJB1 mRNA

PMID:19483382 PMID:24780913 PMID:25825206

NCBI chr X:70,541,845...70,549,776
Ensembl chr X:70,541,862...70,549,843

G

gap junction protein, beta 2

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of GJB2 mRNA
Propylthiouracil results in increased expression of GJB2 mRNA

PMID:24780913 PMID:30047161

NCBI chr15:35,375,977...35,393,817
Ensembl chr15:35,375,692...35,393,877

G

gap junction protein, beta 5

increases expression

EXP

Propylthiouracil results in increased expression of GJB5 mRNA

NCBI chr 5:144,965,133...144,968,051
Ensembl chr 5:144,964,751...144,984,021

G

gap junction protein, beta 6

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of GJB6 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of GJB6 mRNA

PMID:24780913 PMID:30085217 PMID:36706583

NCBI chr15:35,400,147...35,410,649
Ensembl chr15:35,398,770...35,410,849

G

gap junction protein, gamma 1

increases expression

EXP

Propylthiouracil results in increased expression of GJA7 mRNA; Propylthiouracil results in increased expression of GJC1 mRNA

PMID:24780913 PMID:30047161

NCBI chr10:88,262,840...88,285,646
Ensembl chr10:88,249,489...88,285,853

G

gap junction protein, gamma 2

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of GJC2 mRNA
Propylthiouracil results in increased expression of GJC2 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr10:44,462,203...44,470,924
Ensembl chr10:44,462,054...44,470,340

G

gap junction protein, gamma 3

decreases expression

EXP

Propylthiouracil results in decreased expression of GJC3 mRNA

PMID:24780913 PMID:25825206

NCBI chr12:22,009,560...22,024,567
Ensembl chr12:22,009,409...22,078,418

G

gap junction protein, delta 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of GJD2 mRNA
Propylthiouracil results in decreased expression of GJD2 mRNA

PMID:24780913 PMID:25825206

NCBI chr 3:121,226,372...121,229,367
Ensembl chr 3:121,226,368...121,230,603

G

glycerol kinase 5

decreases expression

EXP

Propylthiouracil results in decreased expression of GK5 mRNA

NCBI chr 8:105,562,018...105,630,975
Ensembl chr 8:105,562,050...105,631,978

G

gastrokine 2

increases expression

EXP

Propylthiouracil results in increased expression of GKN2 mRNA

NCBI chr 4:121,335,642...121,381,680
Ensembl chr 4:121,375,594...121,381,678

G

gastrokine 3

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of GKN3 mRNA

NCBI chr 4:121,386,319...121,390,719
Ensembl chr 4:121,386,395...121,392,139

G

galactosidase, alpha

increases expression

EXP

Propylthiouracil results in increased expression of GLA mRNA

NCBI chr X:102,062,497...102,073,915
Ensembl chr X:102,056,718...102,073,915

G

galactosidase, beta 1

increases expression

EXP

Propylthiouracil results in increased expression of GLB1 mRNA

NCBI chr 8:122,963,718...123,036,326
Ensembl chr 8:122,963,718...123,036,326

G

galactosidase, beta 1-like

decreases expression

EXP

Propylthiouracil results in decreased expression of GLB1L mRNA

NCBI chr 9:84,141,993...84,154,176
Ensembl chr 9:84,143,841...84,154,176

G

glucuronic acid epimerase

increases expression

EXP

Propylthiouracil results in increased expression of GLCE mRNA

NCBI chr 8:71,441,607...71,507,639
Ensembl chr 8:71,441,616...71,507,587

G

glycine decarboxylase

increases expression

EXP

Propylthiouracil results in increased expression of GLDC mRNA

PMID:24780913 PMID:25825206

NCBI chr 1:237,296,753...237,375,620
Ensembl chr 1:237,296,753...237,375,604

G

gliomedin

decreases expression

EXP

Propylthiouracil results in decreased expression of GLDN mRNA

NCBI chr 8:63,575,270...63,619,346
Ensembl chr 8:63,575,270...63,619,346

G

golgi glycoprotein 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of GLG1 mRNA
Propylthiouracil results in decreased expression of GLG1 mRNA

PMID:30047161 PMID:36843608

NCBI chr19:56,034,248...56,133,538
Ensembl chr19:56,006,459...56,133,528

G

GLI family zinc finger 1

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of GLI1 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of GLI1 mRNA

PMID:24780913 PMID:25825206 PMID:36706583

NCBI chr 7:65,042,237...65,054,888
Ensembl chr 7:65,042,237...65,054,540

G

GLI family zinc finger 2

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of GLI2 mRNA
Propylthiouracil results in increased expression of GLI2 mRNA

PMID:24780913 PMID:25825206 PMID:30047161 PMID:36843608

NCBI chr13:32,499,678...32,716,418
Ensembl chr13:32,499,678...32,716,418

G

GLI family zinc finger 3

decreases expression

EXP

Propylthiouracil results in decreased expression of GLI3 mRNA

NCBI chr17:54,134,064...54,405,198
Ensembl chr17:54,134,064...54,405,198

G

GLI family zinc finger 4

decreases expression

EXP

Propylthiouracil results in decreased expression of GLI4 mRNA

NCBI chr 7:109,205,812...109,211,650
Ensembl chr 7:109,205,953...109,211,648

G

GLIPR1 like 2

decreases expression

EXP

Propylthiouracil results in decreased expression of GLIPR1L2 mRNA

NCBI chr 7:49,401,847...49,432,249
Ensembl chr 7:49,401,860...49,432,267

G

GLIS family zinc finger 1

increases expression

EXP

Propylthiouracil results in increased expression of GLIS1 mRNA

PMID:22504374 PMID:30047161

NCBI chr 5:127,450,934...127,640,929
Ensembl chr 5:127,451,293...127,640,928

G

GLIS family zinc finger 2

increases expression

EXP

Propylthiouracil results in increased expression of GLIS2 mRNA

NCBI chr10:11,457,594...11,484,948
Ensembl chr10:11,457,792...11,477,995

G

GLIS family zinc finger 3

decreases expression

EXP

Propylthiouracil results in decreased expression of GLIS3 mRNA

NCBI chr 1:235,389,567...235,809,416
Ensembl chr 1:235,392,651...235,809,221

G

glomulin, FKBP associated protein

increases expression

EXP

Propylthiouracil results in increased expression of GLMN mRNA

NCBI chr14:2,332,052...2,375,366
Ensembl chr14:2,332,497...2,375,695

G

glyoxalase domain containing 5

increases expression

EXP

Propylthiouracil results in increased expression of GLOD5 mRNA

NCBI chr X:17,145,936...17,160,733
Ensembl chr X:17,145,938...17,160,619

G

glucagon-like peptide 1 receptor

decreases expression

EXP

Propylthiouracil results in decreased expression of GLP1R mRNA

NCBI chr20:8,973,393...9,011,622
Ensembl chr20:8,973,352...9,011,654

G

glycine receptor, alpha 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GLRA1 mRNA

NCBI chr10:40,128,284...40,228,612
Ensembl chr10:40,130,121...40,227,815

G

glycine receptor, alpha 2

affects expression
decreases expression
increases expression

EXP

Propylthiouracil affects the expression of GLRA2 mRNA
Propylthiouracil results in decreased expression of GLRA2 mRNA
Propylthiouracil results in increased expression of GLRA2 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr X:32,651,931...32,873,277
Ensembl chr X:32,652,187...32,873,277

G

glycine receptor, alpha 3

increases expression

EXP

Propylthiouracil results in increased expression of GLRA3 mRNA

NCBI chr16:39,210,534...39,857,332
Ensembl chr16:39,210,536...39,856,764

G

glutaredoxin

increases expression

EXP

Propylthiouracil results in increased expression of GLRX mRNA

PMID:30047161 PMID:36843608

NCBI chr 2:7,073,737...7,083,548
Ensembl chr 2:7,073,759...7,083,543

G

glutaredoxin 2

increases expression

EXP

Propylthiouracil results in increased expression of GLRX2 mRNA

NCBI chr13:58,032,199...58,055,061
Ensembl chr13:58,032,401...58,043,150

G

glutaredoxin 3

increases expression

EXP

Propylthiouracil results in increased expression of GLRX3 mRNA

NCBI chr 1:201,671,410...201,701,722
Ensembl chr 1:201,671,481...201,701,717

G

glutaminase 2

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of GLS2 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of GLS2 mRNA

PMID:24780913 PMID:36706583

NCBI chr 7:1,201,757...1,218,014
Ensembl chr 7:1,201,838...1,218,013

G

glycolipid transfer protein

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of GLTP mRNA
Propylthiouracil results in increased expression of GLTP mRNA

PMID:24780913 PMID:30047161

NCBI chr12:47,567,797...47,587,949
Ensembl chr12:47,567,770...47,587,946

G

glutamate dehydrogenase 1

increases expression

EXP

Propylthiouracil results in increased expression of GLUD1 mRNA

NCBI chr16:9,646,569...9,680,215
Ensembl chr16:9,646,509...9,680,210

G

glutamate-ammonia ligase

decreases expression

EXP

Propylthiouracil results in decreased expression of GLUL mRNA

NCBI chr13:68,519,500...68,585,554
Ensembl chr13:68,576,067...68,585,520

G

glycosylation dependent cell adhesion molecule 1

affects expression

EXP

Propylthiouracil affects the expression of GLYCAM1 mRNA

NCBI chr 7:136,559,039...136,561,299
Ensembl chr 7:136,559,039...136,561,299

G

germ cell-less 1, spermatogenesis associated

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of GMCL1 mRNA
Propylthiouracil results in increased expression of GMCL1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 4:120,697,976...120,737,267
Ensembl chr 4:120,697,976...120,737,257

G

GDP-mannose 4, 6-dehydratase

increases expression

EXP

Propylthiouracil results in increased expression of GMDS mRNA

NCBI chr17:32,304,029...32,830,708
Ensembl chr17:32,304,056...32,830,706

G

glucocorticoid modulatory element binding protein 2

decreases expression

EXP

Propylthiouracil results in decreased expression of GMEB2 mRNA

NCBI chr 3:188,740,210...188,778,377
Ensembl chr 3:188,740,210...188,778,336

G

glia maturation factor, beta

increases expression

EXP

Propylthiouracil results in increased expression of GMFB mRNA

NCBI chr15:22,549,705...22,560,125
Ensembl chr15:22,547,034...22,560,308

G

glia maturation factor, gamma

increases expression

EXP

Propylthiouracil results in increased expression of GMFG mRNA

NCBI chr 1:92,856,154...92,866,722
Ensembl chr 1:92,854,995...92,866,723

G

GDP-mannose pyrophosphorylase A

increases expression

EXP

Propylthiouracil results in increased expression of GMPPA mRNA

NCBI chr 9:84,375,373...84,382,917
Ensembl chr 9:84,375,425...84,382,916

G

GDP-mannose pyrophosphorylase B

increases expression

EXP

Propylthiouracil results in increased expression of GMPPB mRNA

NCBI chr 8:117,616,029...117,622,866

G

G protein subunit alpha 12

decreases expression

EXP

Propylthiouracil results in decreased expression of GNA12 mRNA

PMID:24780913 PMID:25825206

NCBI chr12:18,919,629...19,000,185
Ensembl chr12:18,919,629...19,000,185

G

G protein subunit alpha 14

decreases expression

EXP

Propylthiouracil results in decreased expression of GNA14 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:223,141,802...223,324,210
Ensembl chr 1:223,141,802...223,324,210

G

G protein subunit alpha i1

increases expression

EXP

Propylthiouracil results in increased expression of GNAI1 mRNA

NCBI chr 4:17,706,061...17,790,176
Ensembl chr 4:17,706,025...17,789,198

G

G protein subunit alpha i2

increases expression

EXP

Propylthiouracil results in increased expression of GNAI2 mRNA

PMID:24780913 PMID:30047161

NCBI chr 8:117,167,045...117,187,652
Ensembl chr 8:117,167,045...117,187,622

G

G protein subunit alpha i3

increases expression

EXP

Propylthiouracil results in increased expression of GNAI3 mRNA

NCBI chr 2:198,430,920...198,468,874

G

G protein subunit alpha L

increases expression

EXP

Propylthiouracil results in increased expression of GNAL mRNA

NCBI chr18:62,892,257...63,032,510
Ensembl chr18:62,892,226...63,043,129

G

G protein subunit alpha o1

decreases expression

EXP

Propylthiouracil results in decreased expression of GNAO1 mRNA

NCBI chr19:11,040,788...11,198,437
Ensembl chr19:11,040,788...11,198,437

G

GNAS complex locus

increases expression

EXP

Propylthiouracil results in increased expression of GNAS mRNA

NCBI chr 3:183,489,648...183,554,570
Ensembl chr 3:183,503,243...183,554,536

G

G protein subunit alpha transducin 1

increases expression

EXP

Propylthiouracil results in increased expression of GNAT1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 8:117,229,575...117,234,311
Ensembl chr 8:117,229,575...117,234,311

G

G protein subunit beta 1

increases expression

EXP

Propylthiouracil results in increased expression of GNB1 mRNA

NCBI chr 5:171,357,778...171,424,489
Ensembl chr 5:171,357,797...171,424,488

G

G protein subunit beta 4

increases expression

EXP

Propylthiouracil results in increased expression of GNB4 mRNA

PMID:24780913 PMID:36843608

NCBI chr 2:117,289,112...117,329,050
Ensembl chr 2:117,293,284...117,328,945

G

G protein subunit gamma 10

increases expression

EXP

Propylthiouracil results in increased expression of GNG10 mRNA

PMID:24780913 PMID:30047161

NCBI chr 5:78,651,167...78,658,060
Ensembl chr 5:78,651,167...78,658,059

G

G protein subunit gamma 11

decreases expression

EXP

Propylthiouracil results in decreased expression of GNG11 mRNA

NCBI chr 4:32,977,681...32,983,121
Ensembl chr 4:32,977,664...32,984,438

G

G protein subunit gamma 12

decreases expression

EXP

Propylthiouracil results in decreased expression of GNG12 mRNA

NCBI chr 4:97,340,830...97,464,422
Ensembl chr 4:97,340,472...97,464,476

G

G protein subunit gamma 14

decreases expression

EXP

Propylthiouracil results in decreased expression of GNG14 mRNA

NCBI chr19:39,994,512...39,995,014
Ensembl chr19:39,994,512...39,995,014

G

G protein subunit gamma 2

increases expression

EXP

Propylthiouracil results in increased expression of GNG2 mRNA

NCBI chr15:4,365,222...4,466,060
Ensembl chr15:4,365,135...4,466,059

G

G protein subunit gamma 7

increases expression

EXP

Propylthiouracil results in increased expression of GNG7 mRNA

NCBI chr 7:9,348,148...9,411,924
Ensembl chr 7:9,348,218...9,411,923

G

G protein subunit gamma 8

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of GNG8 mRNA
Propylthiouracil results in increased expression of GNG8 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:86,692,609...86,696,463
Ensembl chr 1:86,692,642...86,696,408

G

G protein nucleolar 3

increases expression

EXP

Propylthiouracil results in increased expression of GNL3 mRNA

NCBI chr16:6,213,844...6,220,029
Ensembl chr16:6,213,871...6,219,845

G

gonadotropin releasing hormone receptor

increases expression

EXP

Propylthiouracil results in increased expression of GNRHR mRNA

NCBI chr14:22,211,666...22,229,654

G

golgin A7 family, member B

decreases expression

EXP

Propylthiouracil results in decreased expression of GOLGA7B mRNA

NCBI chr 1:250,999,268...251,030,169
Ensembl chr 1:251,008,417...251,030,371

G

golgi membrane protein 2

decreases expression

EXP

Propylthiouracil results in decreased expression of CASC4 mRNA

NCBI chr 3:129,280,623...129,349,895
Ensembl chr 3:129,280,701...129,349,895

G

golgi reassembly stacking protein 2

increases expression

EXP

Propylthiouracil results in increased expression of GORASP2 mRNA

NCBI chr 3:75,882,607...75,911,322
Ensembl chr 3:75,882,515...75,911,328

G

glutamic-oxaloacetic transaminase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GOT1 mRNA

NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871

G

glutamic-oxaloacetic transaminase 1-like 1

increases expression

EXP

Propylthiouracil results in increased expression of GOT1L1 mRNA

NCBI chr16:71,563,562...71,576,446
Ensembl chr16:71,563,534...71,570,468

G

glycoprotein Ib platelet subunit beta

increases expression

EXP

Propylthiouracil results in increased expression of GP1BB mRNA

NCBI chr11:95,882,561...95,883,738

G

glycoprotein IX (platelet)

increases expression

EXP

Propylthiouracil results in increased expression of GP9 mRNA

NCBI chr 4:121,792,842...121,794,452
Ensembl chr 4:121,792,653...121,794,475

G

glycoprotein A33

decreases expression

EXP

Propylthiouracil results in decreased expression of GPA33 mRNA

NCBI chr13:80,914,119...80,947,738
Ensembl chr13:80,912,430...80,948,903

G

glycosylphosphatidylinositol anchor attachment 1

increases expression

EXP

Propylthiouracil results in increased expression of GPAA1 mRNA

NCBI chr 7:109,932,556...109,936,139
Ensembl chr 7:109,932,544...109,936,138

G

glycerol-3-phosphate acyltransferase, mitochondrial

decreases expression

EXP

Propylthiouracil results in decreased expression of GPAM mRNA

NCBI chr 1:264,111,599...264,176,112
Ensembl chr 1:264,113,813...264,175,911

G

glycerol-3-phosphate acyltransferase 2, mitochondrial

decreases expression

EXP

Propylthiouracil results in decreased expression of GPAT2 mRNA

NCBI chr 3:135,099,751...135,110,355
Ensembl chr 3:135,096,752...135,110,353

G

G patch domain containing 11

increases expression

EXP

Propylthiouracil results in increased expression of GPATCH11 mRNA

NCBI chr 6:21,982,074...21,995,562
Ensembl chr 6:21,985,202...21,995,381

G

G patch domain containing 4

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of GPATCH4 mRNA
Propylthiouracil results in increased expression of GPATCH4 mRNA

PMID:24780913 PMID:25825206

NCBI chr 2:175,797,503...175,816,547
Ensembl chr 2:175,807,682...175,817,358

G

G patch domain containing 8

decreases expression

EXP

Propylthiouracil results in decreased expression of GPATCH8 mRNA

NCBI chr10:87,932,174...88,012,523
Ensembl chr10:87,932,174...88,012,523

G

GC-rich promoter binding protein 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GPBP1 mRNA

NCBI chr 2:44,756,861...44,824,281
Ensembl chr 2:44,756,861...44,824,315

G

GC-rich promoter binding protein 1-like 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GPBP1L1 mRNA

NCBI chr 5:135,245,188...135,287,299
Ensembl chr 5:135,247,342...135,287,298

G

glypican 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GPC1 mRNA

NCBI chr 9:100,843,645...100,871,458
Ensembl chr 9:100,843,645...100,879,933

G

glypican 2

increases expression

EXP

Propylthiouracil results in increased expression of GPC2 mRNA

NCBI chr12:22,391,489...22,397,822
Ensembl chr12:22,391,489...22,397,822

G

glypican 3

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of GPC3 mRNA
Propylthiouracil results in decreased expression of GPC3 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr X:136,789,770...137,157,598
Ensembl chr X:136,789,770...137,157,639

G

glypican 4

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of GPC4 mRNA
Propylthiouracil results in decreased expression of GPC4 mRNA

PMID:24780913 PMID:36843608

NCBI chr X:136,565,536...136,676,142
Ensembl chr X:136,565,591...136,676,057

G

glypican 6

increases expression

EXP

Propylthiouracil results in increased expression of GPC6 mRNA

NCBI chr15:100,437,415...101,435,038
Ensembl chr15:100,437,943...101,435,027

G

glycerol-3-phosphate dehydrogenase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GPD1 mRNA

PMID:24780913 PMID:25825206

NCBI chr 7:132,722,982...132,730,373
Ensembl chr 7:132,721,915...132,730,368

G

glycerol-3-phosphate dehydrogenase 2

multiple interactions

EXP

Propylthiouracil inhibits the reaction [Thyroxine results in increased activity of GPD2 protein]

NCBI chr 3:62,209,432...62,346,590
Ensembl chr 3:62,210,814...62,346,593

G

G protein-coupled estrogen receptor 1

increases expression

EXP

Propylthiouracil results in increased expression of GPER1 mRNA

NCBI chr12:20,331,073...20,336,527
Ensembl chr12:20,327,679...20,337,144

G

glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of GPIHBP1 mRNA
Propylthiouracil results in increased expression of GPIHBP1 mRNA

PMID:25825206 PMID:30047161

NCBI chr 7:109,166,334...109,169,448
Ensembl chr 7:109,163,160...109,169,448

G

glycosylphosphatidylinositol specific phospholipase D1

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of GPLD1 mRNA
Propylthiouracil results in decreased expression of GPLD1 mRNA

PMID:19483382 PMID:24780913

NCBI chr17:40,512,659...40,560,483
Ensembl chr17:40,512,660...40,554,975

G

glycoprotein m6a

increases expression

EXP

Propylthiouracil results in increased expression of GPM6A mRNA

NCBI chr16:43,374,385...43,706,461
Ensembl chr16:43,374,385...43,706,705

G

GPN-loop GTPase 1

increases expression

EXP

Propylthiouracil results in increased expression of GPN1 mRNA

NCBI chr 6:30,667,337...30,685,011
Ensembl chr 6:30,666,868...30,685,011

G

glycoprotein nmb

increases expression

EXP

Propylthiouracil results in increased expression of GPNMB mRNA

NCBI chr 4:79,341,128...79,362,366
Ensembl chr 4:79,341,021...79,380,240

G

G protein-coupled receptor 12

decreases expression

EXP

Propylthiouracil results in decreased expression of GPR12 mRNA

NCBI chr12:13,636,549...13,640,083
Ensembl chr12:13,627,055...13,643,650

G

G protein-coupled receptor 137

decreases expression

EXP

Propylthiouracil results in decreased expression of GPR137 mRNA

NCBI chr 1:213,558,846...213,562,422
Ensembl chr 1:213,558,846...213,563,966

G

G protein-coupled receptor 137B

decreases expression

EXP

Propylthiouracil results in decreased expression of GPR137B mRNA

NCBI chr17:92,987,792...93,026,003
Ensembl chr17:92,942,559...93,025,911

G

G protein-coupled receptor 143

increases expression

EXP

Propylthiouracil results in increased expression of GPR143 mRNA

NCBI chr X:25,498,601...25,523,408
Ensembl chr X:25,498,601...25,523,400

G

G protein-coupled receptor 146

decreases expression

EXP

Propylthiouracil results in decreased expression of GPR146 mRNA

NCBI chr12:20,365,790...20,381,122
Ensembl chr12:20,364,269...20,381,345

G

G protein-coupled receptor 149

increases expression

EXP

Propylthiouracil results in increased expression of GPR149 mRNA

NCBI chr 2:149,059,333...149,130,798
Ensembl chr 2:149,059,336...149,130,785

G

G protein-coupled receptor 153

decreases expression

EXP

Propylthiouracil results in decreased expression of GPR153 mRNA

NCBI chr 5:168,064,134...168,075,697
Ensembl chr 5:168,064,311...168,074,532

G

G protein-coupled receptor 155

decreases expression

EXP

Propylthiouracil results in decreased expression of GPR155 mRNA

NCBI chr 3:78,623,931...78,677,803
Ensembl chr 3:78,607,976...78,677,803

G

G protein-coupled receptor 158

decreases expression

EXP

Propylthiouracil results in decreased expression of GPR158 mRNA

PMID:24780913 PMID:25825206

NCBI chr17:88,685,879...89,152,659
Ensembl chr17:88,742,823...89,152,658

G

G protein-coupled receptor 160

increases expression

EXP

Propylthiouracil results in increased expression of GPR160 mRNA

NCBI chr 2:114,414,084...114,491,590
Ensembl chr 2:114,410,261...114,474,790

G

G protein-coupled receptor 161

increases expression

EXP

Propylthiouracil results in increased expression of GPR161 mRNA

NCBI chr13:80,111,271...80,156,517
Ensembl chr13:80,117,114...80,152,861

G

G protein-coupled receptor 171

decreases expression

EXP

Propylthiouracil results in decreased expression of GPR171 mRNA

PMID:24780913 PMID:25825206

NCBI chr 2:145,510,305...145,515,392
Ensembl chr 2:145,505,549...145,515,592

G

G protein-coupled receptor 176

increases expression

EXP

Propylthiouracil results in increased expression of GPR176 mRNA

NCBI chr 3:125,690,750...125,791,172
Ensembl chr 3:125,690,751...125,791,172

G

G protein-coupled receptor 182

decreases expression

EXP

Propylthiouracil results in decreased expression of GPR182 mRNA

NCBI chr 7:65,471,254...65,474,110
Ensembl chr 7:65,452,965...65,474,998

G

G protein-coupled receptor 19

decreases expression

EXP

Propylthiouracil results in decreased expression of GPR19 mRNA

NCBI chr 4:169,442,278...169,468,805
Ensembl chr 4:169,436,658...169,471,249

G

G protein-coupled receptor 20

increases expression

EXP

Propylthiouracil results in increased expression of GPR20 mRNA

NCBI chr 7:107,490,419...107,500,993
Ensembl chr 7:107,490,713...107,500,966

G

G protein-coupled receptor 26

decreases expression

EXP

Propylthiouracil results in decreased expression of GPR26 mRNA

PMID:24780913 PMID:25825206

NCBI chr 1:196,196,138...196,235,574
Ensembl chr 1:196,196,767...196,235,559

G

G protein-coupled receptor 27

increases expression

EXP

Propylthiouracil results in increased expression of GPR27 mRNA

NCBI chr 4:133,884,894...133,886,027
Ensembl chr 4:133,883,234...133,904,093

G

G protein-coupled receptor 34

increases expression

EXP

Propylthiouracil results in increased expression of GPR34 mRNA

NCBI chr X:11,777,667...11,786,640
Ensembl chr X:11,776,371...11,843,240

G

G protein-coupled receptor 37

decreases expression

EXP

Propylthiouracil results in decreased expression of GPR37 mRNA

PMID:24780913 PMID:25825206

NCBI chr 4:55,104,355...55,126,420
Ensembl chr 4:55,104,365...55,126,494

G

G protein-coupled receptor 37-like 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GPR37L1 mRNA

PMID:24780913 PMID:25825206

NCBI chr13:49,150,355...49,157,204
Ensembl chr13:49,150,359...49,157,204

G

G protein-coupled receptor 39

increases expression

EXP

Propylthiouracil results in increased expression of GPR39 mRNA

NCBI chr13:39,667,908...39,879,944
Ensembl chr13:39,667,909...39,880,902

G

G protein-coupled receptor 6

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of GPR6 mRNA
Propylthiouracil results in decreased expression of GPR6 mRNA

PMID:24780913 PMID:25825206

NCBI chr20:46,072,480...46,075,251
Ensembl chr20:46,072,453...46,075,875

G

G protein-coupled receptor 61

decreases expression

EXP

Propylthiouracil results in decreased expression of GPR61 mRNA

NCBI chr 2:198,471,430...198,477,827
Ensembl chr 2:198,427,135...198,477,874

G

G protein-coupled receptor 62

decreases expression

EXP

Propylthiouracil results in decreased expression of GPR62 mRNA

NCBI chr 8:115,981,936...115,984,022
Ensembl chr 8:115,966,924...115,984,888

G

G protein-coupled receptor 68

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of GPR68 mRNA
Propylthiouracil results in increased expression of GPR68 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 6:125,865,205...125,895,674
Ensembl chr 6:125,864,942...125,895,674

G

G protein-coupled receptor associated sorting protein 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of GPRASP1 mRNA
Propylthiouracil results in decreased expression of GPRASP1 mRNA

PMID:24780913 PMID:30047161

NCBI chr X:103,556,493...103,564,275
Ensembl chr X:103,501,377...103,565,649

G

G protein-coupled receptor associated sorting protein 2

decreases expression

EXP

Propylthiouracil results in decreased expression of GPRASP2 mRNA

NCBI chr X:103,609,304...103,615,450
Ensembl chr X:103,501,226...103,641,988

G

G protein-coupled receptor associated sorting protein family member 3

increases expression

EXP

Propylthiouracil results in increased expression of GPRASP3 mRNA

NCBI chr X:103,639,366...103,644,561
Ensembl chr X:103,609,243...103,650,463

G

G protein-coupled receptor, class C, group 5, member B

decreases expression

EXP

Propylthiouracil results in decreased expression of GPRC5B mRNA

NCBI chr 1:182,748,247...182,772,711
Ensembl chr 1:182,748,247...182,772,757

G

G protein-coupled receptor, class C, group 5, member C

decreases expression

EXP

Propylthiouracil results in decreased expression of GPRC5C mRNA

NCBI chr10:100,385,682...100,407,953
Ensembl chr10:100,383,631...100,426,962

G

G protein-regulated inducer of neurite outgrowth 1

increases expression

EXP

Propylthiouracil results in increased expression of GPRIN1 mRNA

NCBI chr17:9,869,009...9,881,958
Ensembl chr17:9,868,571...9,894,560

G

GPRIN family member 3

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of GPRIN3 mRNA
Propylthiouracil results in decreased expression of GPRIN3 mRNA

PMID:24780913 PMID:30047161

NCBI chr 4:89,902,198...89,987,496
Ensembl chr 4:89,892,867...89,987,565

G

G-protein signaling modulator 2

increases expression

EXP

Propylthiouracil results in increased expression of GPSM2 mRNA

PMID:24780913 PMID:30047161

NCBI chr 2:199,015,250...199,063,788
Ensembl chr 2:199,015,250...199,063,056

G

glutamic--pyruvic transaminase

multiple interactions
increases expression

EXP

syringic acid inhibits the reaction [Propylthiouracil results in increased expression of GPT protein]; Thyroxine inhibits the reaction [Propylthiouracil results in increased expression of GPT protein]

NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160

G

glutathione peroxidase 1

affects expression
increases expression

EXP

Propylthiouracil affects the expression of GPX1 mRNA
Propylthiouracil results in increased expression of GPX1 mRNA

PMID:19483382 PMID:30047161 PMID:31068541 PMID:36038036

NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581

G

glutathione peroxidase 2

decreases expression

EXP

Propylthiouracil results in decreased expression of GPX2 mRNA

NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:101,226,745...101,230,862

G

glutathione peroxidase 4

affects expression
increases expression

EXP

Propylthiouracil affects the expression of GPX4 mRNA
Propylthiouracil results in increased expression of GPX4 mRNA

PMID:19483382 PMID:31068541

NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629

G

glutathione peroxidase 6

decreases expression

EXP

Propylthiouracil results in decreased expression of GPX6 mRNA

NCBI chr17:48,104,197...48,111,816
Ensembl chr17:48,104,197...48,111,007

G

glutathione peroxidase 7

increases expression

EXP

Propylthiouracil results in increased expression of GPX7 mRNA

NCBI chr 5:128,373,881...128,381,866
Ensembl chr 5:128,372,875...128,381,725

G

GRAM domain containing 1A

decreases expression

EXP

Propylthiouracil results in decreased expression of GRAMD1A mRNA

NCBI chr 1:95,494,378...95,520,730
Ensembl chr 1:95,494,378...95,520,716

G

GRAM domain containing 1B

increases expression

EXP

Propylthiouracil results in increased expression of GRAMD1B mRNA

NCBI chr 8:49,551,642...49,790,965
Ensembl chr 8:49,556,332...49,791,052

G

GRAM domain containing 1C

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of GRAMD1C mRNA
Propylthiouracil results in decreased expression of GRAMD1C mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr11:70,139,076...70,224,478
Ensembl chr11:70,139,184...70,224,478

G

GRAM domain containing 2A

decreases expression

EXP

Propylthiouracil results in decreased expression of GRAMD2A mRNA

NCBI chr 8:68,975,529...69,013,575
Ensembl chr 8:69,003,807...69,013,573

G

GRAM domain containing 4

increases expression

EXP

Propylthiouracil results in increased expression of GRAMD4 mRNA

NCBI chr 7:119,030,225...119,103,875
Ensembl chr 7:119,030,225...119,103,875

G

growth factor receptor bound protein 14

increases expression

EXP

Propylthiouracil results in increased expression of GRB14 mRNA

NCBI chr 3:69,976,331...70,091,921
Ensembl chr 3:69,976,339...70,091,921

G

growth factor receptor bound protein 7

decreases expression

EXP

Propylthiouracil results in decreased expression of GRB7 mRNA

NCBI chr10:83,936,538...83,949,344
Ensembl chr10:83,939,299...83,949,382

G

GREB1 like retinoic acid receptor coactivator

increases expression

EXP

Propylthiouracil results in increased expression of GREB1L mRNA

NCBI chr18:1,665,468...1,902,291
Ensembl chr18:1,766,214...1,900,178

G

gremlin 1, DAN family BMP antagonist

decreases expression

EXP

Propylthiouracil results in decreased expression of GREM1 mRNA

PMID:24780913 PMID:25825206

NCBI chr 3:120,966,639...120,978,319
Ensembl chr 3:120,966,623...120,979,089

G

gremlin 2, DAN family BMP antagonist

decreases expression

EXP

Propylthiouracil results in decreased expression of GREM2 mRNA

NCBI chr13:89,310,897...89,403,856
Ensembl chr13:89,310,662...89,404,312

G

grainyhead-like transcription factor 1

increases expression

EXP

Propylthiouracil results in increased expression of GRHL1 mRNA

NCBI chr 6:46,935,947...46,986,126
Ensembl chr 6:46,935,967...46,980,264

G

glutamate ionotropic receptor AMPA type subunit 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GRIA1 mRNA

NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,711,080...42,030,309

G

glutamate ionotropic receptor AMPA type subunit 2

increases expression

EXP

Propylthiouracil results in increased expression of GRIA2 mRNA

NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:168,247,496...168,367,616

G

glutamate ionotropic receptor AMPA type subunit 3

decreases expression
multiple interactions
increases expression

EXP

Propylthiouracil results in decreased expression of GRIA3 mRNA
isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of GRIA3 mRNA]

PMID:24780913 PMID:31068541

NCBI chr X:125,103,975...125,369,690
Ensembl chr X:125,103,782...125,369,679

G

glutamate ionotropic receptor AMPA type subunit 4

affects expression

EXP

Propylthiouracil affects the expression of GRIA4 mRNA

NCBI chr 8:9,845,421...10,320,021
Ensembl chr 8:9,847,052...10,319,881

G

Grid2 interacting protein

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of GRID2IP mRNA
Propylthiouracil results in decreased expression of GRID2IP mRNA

PMID:24780913 PMID:25825206

NCBI chr12:16,274,809...16,317,319
Ensembl chr12:16,280,168...16,317,278

G

glutamate ionotropic receptor kainate type subunit 1

increases expression

EXP

Propylthiouracil results in increased expression of GRIK1 mRNA

PMID:24780913 PMID:25825206

NCBI chr11:40,655,974...41,056,966
Ensembl chr11:40,655,975...41,056,517

G

glutamate ionotropic receptor kainate type subunit 2

increases expression

EXP

Propylthiouracil results in increased expression of GRIK2 mRNA

NCBI chr20:53,717,564...54,415,283
Ensembl chr20:53,716,090...54,415,202

G

glutamate ionotropic receptor kainate type subunit 3

increases expression

EXP

Propylthiouracil results in increased expression of GRIK3 mRNA

NCBI chr 5:143,052,442...143,268,873
Ensembl chr 5:143,052,442...143,268,873

G

glutamate ionotropic receptor kainate type subunit 4

decreases expression

EXP

Propylthiouracil results in decreased expression of GRIK4 mRNA

NCBI chr 8:51,802,045...52,228,751
Ensembl chr 8:51,802,058...52,102,063

G

glutamate ionotropic receptor NMDA type subunit 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GRIN1 mRNA

NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:28,501,836...28,528,754

G

glutamate ionotropic receptor NMDA type subunit 2A

decreases expression
multiple interactions

EXP

Propylthiouracil results in decreased expression of GRIN2A mRNA
[Thioctic Acid co-treated with Propylthiouracil] results in increased expression of GRIN2A mRNA

PMID:24780913 PMID:31068541

NCBI chr10:6,136,458...6,560,003
Ensembl chr10:6,138,037...6,551,378

G

glutamate ionotropic receptor NMDA type subunit 2B

increases expression

EXP

Propylthiouracil results in increased expression of GRIN2B mRNA

NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:170,322,617...170,773,570

G

glutamate ionotropic receptor NMDA type subunit 3A

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of GRIN3A mRNA
Propylthiouracil results in decreased expression of GRIN3A mRNA

PMID:24780913 PMID:30047161

NCBI chr 5:68,802,333...69,001,880
Ensembl chr 5:68,804,970...69,001,558

G

glutamate ionotropic receptor NMDA type subunit 3B

decreases expression

EXP

Propylthiouracil results in decreased expression of GRIN3B mRNA

NCBI chr 7:10,381,495...10,387,817
Ensembl chr 7:10,381,496...10,387,817

G

glutamate ionotropic receptor NMDA type subunit associated protein 1

affects expression
increases expression

EXP

Propylthiouracil affects the expression of GRINA mRNA
Propylthiouracil results in increased expression of GRINA mRNA

PMID:19483382 PMID:30047161

NCBI chr 7:109,842,870...109,846,048
Ensembl chr 7:109,843,196...109,846,042

G

glutamate receptor interacting protein 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of GRIP1 mRNA
Propylthiouracil results in decreased expression of GRIP1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 7:56,820,501...57,477,877
Ensembl chr 7:56,820,704...57,468,417

G

glutamate receptor interacting protein 2

increases expression

EXP

Propylthiouracil results in increased expression of GRIP2 mRNA

NCBI chr 4:125,828,609...125,913,693
Ensembl chr 4:125,828,609...125,913,750

G

G protein-coupled receptor kinase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GRK1 mRNA

NCBI chr16:82,821,184...82,837,971
Ensembl chr16:82,826,022...82,837,971

G

G protein-coupled receptor kinase 3

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of GRK3 mRNA
Propylthiouracil results in decreased expression of GRK3 mRNA

PMID:22504374 PMID:24780913

NCBI chr12:49,285,228...49,395,803
Ensembl chr12:49,285,263...49,395,802

G

G protein-coupled receptor kinase 4

decreases expression

EXP

Propylthiouracil results in decreased expression of GRK4 mRNA

PMID:18077114 PMID:30047161

NCBI chr14:80,230,699...80,305,292
Ensembl chr14:80,230,816...80,305,292

G

G protein-coupled receptor kinase 5

decreases expression

EXP

Propylthiouracil results in decreased expression of GRK5 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:270,014,314...270,208,294
Ensembl chr 1:270,014,282...270,204,928

G

glutamate metabotropic receptor 1

increases expression
decreases expression
affects expression

EXP

Propylthiouracil results in increased expression of GRM1 mRNA
Propylthiouracil results in decreased expression of GRM1 mRNA
Propylthiouracil affects the expression of GRM1 mRNA

PMID:22504374 PMID:24780913 PMID:25825206

NCBI chr 1:6,878,542...7,273,447
Ensembl chr 1:6,878,545...7,273,443

G

glutamate metabotropic receptor 2

decreases expression

EXP

Propylthiouracil results in decreased expression of GRM2 mRNA

NCBI chr 8:116,158,810...116,171,857
Ensembl chr 8:116,158,810...116,171,857

G

glutamate metabotropic receptor 4

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of GRM4 mRNA
Propylthiouracil results in increased expression of GRM4 mRNA

PMID:24780913 PMID:36843608

NCBI chr20:5,486,024...5,574,668
Ensembl chr20:5,482,977...5,574,668

G

glutamate metabotropic receptor 5

increases expression

EXP

Propylthiouracil results in increased expression of GRM5 mRNA

NCBI chr 1:150,722,711...151,297,585
Ensembl chr 1:150,733,678...151,296,649

G

glutamate metabotropic receptor 6

increases expression

EXP

Propylthiouracil results in increased expression of GRM6 mRNA

NCBI chr10:35,669,003...35,683,729
Ensembl chr10:35,669,003...35,683,729

G

glutamate metabotropic receptor 8

increases expression

EXP

Propylthiouracil results in increased expression of GRM8 mRNA

NCBI chr 4:56,771,247...57,696,951
Ensembl chr 4:56,770,771...57,687,639

G

granulin precursor

increases expression

EXP

Propylthiouracil results in increased expression of GRN mRNA

NCBI chr10:87,887,834...87,893,938
Ensembl chr10:87,886,122...87,893,936

G

gastrin releasing peptide

increases expression

EXP

Propylthiouracil results in increased expression of GRP mRNA

NCBI chr18:61,658,655...61,672,037
Ensembl chr18:61,658,250...61,672,037

G

GrpE-like 1, mitochondrial

affects expression

EXP

Propylthiouracil affects the expression of GRPEL1 mRNA

NCBI chr14:78,517,049...78,522,868
Ensembl chr14:78,517,052...78,522,861

G

GrpE-like 2, mitochondrial

decreases expression

EXP

Propylthiouracil results in decreased expression of GRPEL2 mRNA

NCBI chr18:57,438,168...57,450,408
Ensembl chr18:57,438,168...57,450,717

G

glutaredoxin and cysteine rich domain containing 1

increases expression

EXP

Propylthiouracil results in increased expression of GRXCR1 mRNA

NCBI chr14:40,358,077...40,480,493
Ensembl chr14:40,358,077...40,480,493

G

glutaredoxin and cysteine rich domain containing 2

decreases expression

EXP

Propylthiouracil results in decreased expression of GRXCR2 mRNA

NCBI chr18:34,235,734...34,249,139
Ensembl chr18:34,235,734...34,371,894

G

gasdermin A

increases expression

EXP

Propylthiouracil results in increased expression of GSDMA mRNA

NCBI chr10:84,110,590...84,135,804
Ensembl chr10:84,123,314...84,135,804

G

gasdermin D

increases expression

EXP

Propylthiouracil results in increased expression of GSDMD mRNA; Propylthiouracil results in increased expression of GSDMD protein

NCBI chr 7:109,423,209...109,427,771
Ensembl chr 7:109,422,910...109,430,722

G

gasdermin D like 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GSDMDL1 mRNA

NCBI chr 7:97,509,288...97,519,788
Ensembl chr 7:97,509,319...97,519,777

G

gasdermin E

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of GSDME mRNA
Propylthiouracil results in decreased expression of DFNA5 mRNA

PMID:24780913 PMID:30047161

NCBI chr 4:80,590,344...80,651,943
Ensembl chr 4:80,588,614...80,641,525

G

Gse1 coiled-coil protein

decreases expression

EXP

Propylthiouracil results in decreased expression of GSE1 mRNA

NCBI chr19:65,182,678...65,538,183
Ensembl chr19:65,446,263...65,538,176

G

GSG1-like

increases expression

EXP

Propylthiouracil results in increased expression of GSG1L mRNA

NCBI chr 1:189,871,034...190,084,947
Ensembl chr 1:189,871,034...190,084,947

G

gelsolin

decreases expression

EXP

Propylthiouracil results in decreased expression of GSN mRNA

PMID:24780913 PMID:25825206

NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:38,982,671...39,035,850

G

glutathione synthetase

increases expression

EXP

Propylthiouracil results in increased expression of GSS mRNA

NCBI chr 3:164,508,005...164,538,343
Ensembl chr 3:164,508,005...164,538,306

G

glutathione S-transferase alpha 3

increases expression

EXP

Propylthiouracil results in increased expression of GSTA3 mRNA

PMID:24780913 PMID:30047161

NCBI chr 9:31,154,989...31,180,653
Ensembl chr 9:31,154,989...31,180,654

G

glutathione S-transferase alpha 3 like 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GSTA3L1 mRNA

NCBI chr 9:31,115,727...31,128,997
Ensembl chr 9:31,036,978...31,129,006

G

glutathione S-transferase alpha 4

increases expression

EXP

Propylthiouracil results in increased expression of GSTA4 mRNA

NCBI chr 8:87,947,247...87,964,490
Ensembl chr 8:87,930,566...87,964,488

G

glutathione S-transferase alpha 5

increases expression

EXP

Propylthiouracil results in increased expression of GSTA5 mRNA

NCBI chr 8:87,985,768...87,997,766
Ensembl chr 8:87,985,258...87,997,765

G

glutathione S-transferase mu 2

decreases expression

EXP

Propylthiouracil results in decreased expression of GSTM2 mRNA

NCBI chr 2:198,312,179...198,316,962

G

glutathione S-transferase, mu 5-like

decreases expression

EXP

Propylthiouracil results in decreased expression of GSTM5 mRNA

NCBI chr 2:198,231,285...198,238,122
Ensembl chr 2:198,232,596...198,238,252

G

glutathione S-transferase theta 1

affects expression
increases expression

EXP

Propylthiouracil affects the expression of GSTT1 mRNA
Propylthiouracil results in increased expression of GSTT1 mRNA

PMID:19483382 PMID:22504374 PMID:24780913

NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,083...12,873,019

G

glutathione S-transferase theta 2

decreases expression

EXP

Propylthiouracil results in decreased expression of GSTT2 mRNA

NCBI chr20:12,819,053...12,822,724
Ensembl chr20:12,818,540...12,822,718

G

glutathione S-transferase, theta 3

decreases expression

EXP

Propylthiouracil results in decreased expression of GSTT3 mRNA

NCBI chr20:12,873,618...12,881,974
Ensembl chr20:12,874,374...12,881,973

G

glycosyltransferase-like domain containing 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GTDC1 mRNA

NCBI chr 3:49,176,110...49,571,594
Ensembl chr 3:49,176,110...49,571,843

G

general transcription factor IIB

increases expression

EXP

Propylthiouracil results in increased expression of GTF2B mRNA

NCBI chr 2:234,427,734...234,446,043
Ensembl chr 2:234,427,637...234,446,049

G

general transcription factor IIH subunit 5

affects expression

EXP

Propylthiouracil affects the expression of GTF2H5 mRNA

NCBI chr 1:49,061,904...49,068,612
Ensembl chr 1:49,061,959...49,070,039

G

general transcription factor II I

decreases expression

EXP

Propylthiouracil results in decreased expression of GTF2I mRNA

NCBI chr12:28,037,344...28,112,677
Ensembl chr12:28,037,853...28,112,677

G

GTF2I repeat domain containing 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GTF2IRD1 mRNA

NCBI chr12:27,890,594...27,997,506
Ensembl chr12:27,890,675...27,997,494

G

GTF2I repeat domain containing 2

decreases expression

EXP

Propylthiouracil results in decreased expression of GTF2IRD2 mRNA

NCBI chr12:28,134,199...28,179,089
Ensembl chr12:28,133,792...28,172,876

G

general transcription factor IIIC subunit 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GTF3C1 mRNA

NCBI chr 1:189,634,645...189,700,848
Ensembl chr 1:189,634,645...189,700,995

G

GTP binding protein 6 (putative)

decreases expression

EXP

Propylthiouracil results in decreased expression of GTPBP6 mRNA

PMID:24780913 PMID:30047161

NCBI chr12:52,234,646...52,238,578
Ensembl chr12:52,234,572...52,238,578

G

G-2 and S-phase expressed 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GTSE1 mRNA

NCBI chr 7:118,829,793...118,846,662
Ensembl chr 7:118,829,903...118,846,661

G

gametocyte specific factor 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GTSF1 mRNA

NCBI chr 7:136,417,793...136,436,849
Ensembl chr 7:136,417,793...136,436,094

G

gametocyte specific factor 2

increases expression

EXP

Propylthiouracil results in increased expression of GTSF2 mRNA

NCBI chr 7:136,444,348...136,450,506
Ensembl chr 7:136,444,348...136,450,506

G

guanylate cyclase activator 2B

decreases expression

EXP

Propylthiouracil results in decreased expression of GUCA2B mRNA

NCBI chr 5:138,532,160...138,534,210
Ensembl chr 5:138,532,178...138,534,235

G

guanylate cyclase 1 soluble subunit alpha 1

increases expression

EXP

Propylthiouracil results in increased expression of GUCY1A1 mRNA; Propylthiouracil results in increased expression of GUCY1A3 mRNA

PMID:24780913 PMID:30047161

NCBI chr 2:169,716,684...169,780,360
Ensembl chr 2:169,716,709...169,779,737

G

guanylate cyclase 1 soluble subunit alpha 2

decreases expression

EXP

Propylthiouracil results in decreased expression of GUCY1A2 mRNA

NCBI chr 8:8,785,212...9,174,322
Ensembl chr 8:8,785,121...9,174,272

G

guanylate cyclase 1 soluble subunit beta 1

increases expression

EXP

Propylthiouracil results in increased expression of GUCY1B1 mRNA

NCBI chr 2:169,646,897...169,697,060
Ensembl chr 2:169,646,898...169,696,987

G

guanylate cyclase 1 soluble subunit beta 2

increases expression

EXP

Propylthiouracil results in increased expression of GUCY1B2 mRNA

NCBI chr15:40,774,907...40,845,463
Ensembl chr15:40,774,906...40,845,463

G

guanylate cyclase 2E

decreases expression

EXP

Propylthiouracil results in decreased expression of GUCY2E mRNA

NCBI chr10:54,453,753...54,478,639
Ensembl chr10:54,457,844...54,472,898

G

gulonolactone (L-) oxidase

affects expression

EXP

Propylthiouracil affects the expression of GULO mRNA

NCBI chr15:44,381,226...44,403,314
Ensembl chr15:44,381,214...44,403,422

G

GULP PTB domain containing engulfment adaptor 1

decreases expression

EXP

Propylthiouracil results in decreased expression of GULP1 mRNA

PMID:24780913 PMID:25825206

NCBI chr 9:54,114,823...54,391,058
Ensembl chr 9:54,114,731...54,397,452

G

glucuronidase, beta

increases expression

EXP

Propylthiouracil results in increased expression of GUSB mRNA

NCBI chr12:32,337,281...32,350,838
Ensembl chr12:32,334,075...32,363,024

G

glycophorin A

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of GYPA mRNA

NCBI chr19:44,354,669...44,370,304
Ensembl chr19:44,354,706...44,370,291

G

glycophorin C

decreases expression

EXP

Propylthiouracil results in decreased expression of GYPC mRNA

NCBI chr18:24,434,921...24,467,592
Ensembl chr18:24,434,922...24,440,053

G

glycogen synthase 2

increases expression

EXP

Propylthiouracil results in increased expression of GYS2 mRNA

NCBI chr 4:177,096,063...177,137,236
Ensembl chr 4:177,096,063...177,137,236

G

granzyme A

affects expression
increases expression

EXP

Propylthiouracil affects the expression of GZMA mRNA
Propylthiouracil results in increased expression of GZMA mRNA

PMID:19483382 PMID:30047161

NCBI chr 2:46,473,763...46,485,696
Ensembl chr 2:46,473,763...46,485,696

G

granzyme M

increases expression

EXP

Propylthiouracil results in increased expression of GZMM mRNA

NCBI chr 7:10,661,683...10,667,448
Ensembl chr 7:10,661,684...10,667,504

G

H19 imprinted maternally expressed transcript

affects expression

EXP

Propylthiouracil affects the expression of H19 mRNA

NCBI chr 1:207,160,175...207,162,851

G

H1.0 linker histone

decreases expression

EXP

Propylthiouracil results in decreased expression of H1F0 mRNA

NCBI chr 7:112,473,280...112,475,140
Ensembl chr 7:112,473,222...112,475,006

G

H1.1 linker histone, cluster member

affects expression

EXP

Propylthiouracil affects the expression of H1F1 mRNA

NCBI chr17:41,762,278...41,794,876

G

H1.10 linker histone

increases expression

EXP

Propylthiouracil results in increased expression of H1F10 mRNA

NCBI chr 4:121,997,834...121,998,897
Ensembl chr 4:121,997,831...121,998,966

G

H1.2 linker histone, cluster member

decreases expression

EXP

Propylthiouracil results in decreased expression of H1F2 mRNA

NCBI chr17:41,818,962...41,820,453
Ensembl chr17:41,779,051...41,822,317

G

H1.4 linker histone, cluster member

decreases expression

EXP

Propylthiouracil results in decreased expression of H1F4 mRNA

NCBI chr17:41,914,425...41,915,206
Ensembl chr17:41,914,431...41,916,129

G

H1.5 linker histone, cluster member

affects expression

EXP

Propylthiouracil affects the expression of H1F5 mRNA

NCBI chr17:47,421,875...47,422,905
Ensembl chr17:47,421,843...47,477,387

G

H2A clustered histone 13

increases expression

EXP

Propylthiouracil results in increased expression of HIST1H2AF mRNA

NCBI chr17:41,807,261...41,807,653

G

H2A clustered histone 20

increases expression

EXP

Propylthiouracil results in increased expression of H2AC20 mRNA

NCBI chr 2:186,468,748...186,469,226

G

H2A clustered histone 21

decreases expression

EXP

Propylthiouracil results in decreased expression of H2AC21 mRNA

NCBI chr 2:186,468,224...186,468,657

G

H2A clustered histone 25

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of H2AC25 mRNA
Propylthiouracil results in decreased expression of H2AC25 mRNA

PMID:24780913 PMID:30047161

NCBI chr10:44,233,283...44,234,835
Ensembl chr10:44,233,181...44,241,197

G

H2A clustered histone 4

increases expression

EXP

Propylthiouracil results in increased expression of H2AC4 mRNA

NCBI chr17:47,495,624...47,496,127
Ensembl chr17:47,495,546...47,496,173

G

H2A.J histone

increases expression

EXP

Propylthiouracil results in increased expression of H2AJ mRNA

NCBI chr 4:171,406,922...171,407,406
Ensembl chr 4:171,406,177...171,408,845

G

H2A.X variant histone

increases expression

EXP

Propylthiouracil results in increased expression of H2AX mRNA

NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079

G

H2A.Z variant histone 1

increases expression

EXP

Propylthiouracil results in increased expression of H2AZ1 mRNA

NCBI chr 2:229,026,464...229,031,411
Ensembl chr 2:229,028,843...229,031,411

G

H2B clustered histone 14

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of H2BC14 mRNA
Propylthiouracil results in decreased expression of H2BC14 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr17:47,488,627...47,489,008

G

H2B clustered histone 21

increases expression

EXP

Propylthiouracil results in increased expression of H2BC21 mRNA

NCBI chr 2:186,469,452...186,471,899

G

H2B clustered histone 27

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of H2BC27 mRNA
Propylthiouracil results in increased expression of H2BC27 mRNA

PMID:24780913 PMID:30047161

NCBI chr10:44,232,318...44,233,065
Ensembl chr10:44,232,318...44,233,065

G

H2B clustered histone 3

decreases expression

EXP

Propylthiouracil results in decreased expression of H2BC3 mRNA

NCBI chr17:41,807,913...41,808,543

G

H2B clustered histone like 1

decreases expression

EXP

Propylthiouracil results in decreased expression of H2BC4 mRNA

NCBI chr17:47,448,213...47,448,683
Ensembl chr17:41,859,441...41,869,168
Ensembl chr17:41,859,441...41,869,168

G

H3 clustered histone 1

increases expression

EXP

Propylthiouracil results in increased expression of H3C1 mRNA

NCBI chr17:41,796,236...41,796,759
Ensembl chr17:41,795,396...41,797,281
Ensembl chr17:41,795,396...41,797,281

G

H3.3 histone B

affects expression

EXP

Propylthiouracil affects the expression of H3F3B mRNA

NCBI chr10:101,755,404...101,764,616
Ensembl chr10:101,755,404...101,757,636

G

H3 histone, family 3C

increases expression

EXP

Propylthiouracil results in increased expression of H3F3C mRNA

NCBI chr 7:88,390,848...88,391,887
Ensembl chr 7:88,378,607...88,392,406

G

H3.3 histone like 1

affects expression

EXP

Propylthiouracil affects the expression of H3C15 mRNA

NCBI chr 6:63,827,248...63,828,885
Ensembl chr 7:88,378,607...88,392,406

G

H4 clustered histone 1

increases expression

EXP

Propylthiouracil results in increased expression of H4C1 mRNA

NCBI chr17:47,393,764...47,394,168
Ensembl chr17:47,393,603...47,453,972
Ensembl chr17:47,393,603...47,453,972
Ensembl chr 4:47,393,603...47,453,972
Ensembl chr17:47,393,603...47,453,972
Ensembl chr17:47,393,603...47,453,972

G

hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)

decreases expression

EXP

Propylthiouracil results in decreased expression of H6PD mRNA

NCBI chr 5:165,717,456...165,753,158
Ensembl chr 5:165,721,654...165,753,125

G

hyaluronan binding protein 4

decreases expression

EXP

Propylthiouracil results in decreased expression of HABP4 mRNA

NCBI chr17:940,672...963,358
Ensembl chr17:941,389...963,300

G

3-hydroxyacyl-CoA dehydratase 4

decreases expression

EXP

Propylthiouracil results in decreased expression of HACD4 mRNA

PMID:24780913 PMID:25825206

NCBI chr 5:107,935,514...107,961,271
Ensembl chr 5:107,934,937...107,962,836

G

hydroxyacyl-CoA dehydrogenase

decreases expression

EXP

Propylthiouracil results in decreased expression of HADH mRNA

PMID:24780913 PMID:30047161

NCBI chr 2:222,462,049...222,504,446
Ensembl chr 2:222,462,049...222,504,446

G

histidine ammonia lyase

affects expression

EXP

Propylthiouracil affects the expression of HAL mRNA

NCBI chr 7:29,894,495...29,924,744
Ensembl chr 7:29,893,855...29,924,744

G

hydroxyacid oxidase 1

increases expression

EXP

Propylthiouracil results in increased expression of HAO1 mRNA

NCBI chr 3:142,102,873...142,281,527
Ensembl chr 3:142,224,612...142,281,494

G

hydroxyacid oxidase 2

affects expression

EXP

Propylthiouracil affects the expression of HAO2 mRNA

NCBI chr 2:188,888,848...188,921,567
Ensembl chr 2:188,889,212...188,913,133

G

huntingtin-associated protein 1

increases expression

EXP

Propylthiouracil results in increased expression of HAP1 mRNA

PMID:24780913 PMID:25825206

NCBI chr10:85,778,267...85,786,553
Ensembl chr10:85,778,267...85,786,503

G

hyaluronan and proteoglycan link protein 1

increases expression

EXP

Propylthiouracil results in increased expression of HAPLN1 mRNA

NCBI chr 2:22,366,967...22,431,709
Ensembl chr 2:22,366,967...22,429,098

G

hyaluronan and proteoglycan link protein 2

decreases expression

EXP

Propylthiouracil results in decreased expression of HAPLN2 mRNA

PMID:24780913 PMID:25825206

NCBI chr 2:175,786,767...175,794,515
Ensembl chr 2:175,789,009...175,794,438

G

hyaluronan and proteoglycan link protein 3

decreases expression

EXP

Propylthiouracil results in decreased expression of HAPLN3 mRNA

NCBI chr 1:142,455,828...142,473,877
Ensembl chr 1:142,454,629...142,471,832

G

hyaluronan and proteoglycan link protein 4

decreases expression

EXP

Propylthiouracil results in decreased expression of HAPLN4 mRNA

PMID:24780913 PMID:30047161

NCBI chr16:19,367,041...19,375,173
Ensembl chr16:19,367,041...19,375,442

G

harbinger transposase derived 1

decreases expression

EXP

Propylthiouracil results in decreased expression of HARBI1 mRNA

NCBI chr 3:98,137,087...98,145,992
Ensembl chr 3:98,137,123...98,146,315

G

hyaluronan synthase 2

increases expression

EXP

Propylthiouracil results in increased expression of HAS2 mRNA

NCBI chr 7:90,002,929...90,028,933
Ensembl chr 7:90,002,929...90,018,535

G

histone H3 associated protein kinase

increases expression

EXP

Propylthiouracil results in increased expression of GSG2 mRNA; Propylthiouracil results in increased expression of HASPIN mRNA

PMID:24780913 PMID:30047161

NCBI chr10:58,246,244...58,249,031
Ensembl chr10:58,240,447...58,249,249

G

histone acetyltransferase 1

increases expression

EXP

Propylthiouracil results in increased expression of HAT1 mRNA

NCBI chr 3:76,624,442...76,672,701
Ensembl chr 3:76,624,869...76,672,696

G

HAUS augmin-like complex, subunit 1

increases expression

EXP

Propylthiouracil results in increased expression of HAUS1 mRNA

NCBI chr18:73,550,549...73,561,757
Ensembl chr18:73,548,669...73,565,761

G

HAUS augmin-like complex, subunit 4

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of HAUS4 mRNA
Propylthiouracil results in increased expression of HAUS4 mRNA

PMID:25825206 PMID:30047161

NCBI chr15:31,964,555...31,976,853
Ensembl chr15:31,964,556...31,975,941

G

HAUS augmin-like complex, subunit 7

increases expression

EXP

Propylthiouracil results in increased expression of HAUS7 mRNA

NCBI chr X:156,306,320...156,331,940
Ensembl chr X:156,306,320...156,352,158

G

HAUS augmin-like complex, subunit 8

decreases expression

EXP

Propylthiouracil results in decreased expression of HAUS8 mRNA

NCBI chr16:17,964,813...17,979,313
Ensembl chr16:17,964,814...17,979,192

G

hemoglobin alpha, adult chain 1

decreases expression

EXP

Propylthiouracil results in decreased expression of HBA-A1 mRNA

NCBI chr10:15,841,724...15,842,580
Ensembl chr10:15,841,763...15,842,603

G

hemoglobin alpha, adult chain 2

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of HBA-A2 mRNA
Propylthiouracil results in decreased expression of HBA-A2 mRNA; Propylthiouracil results in decreased expression of HBA1 mRNA

PMID:19483382 PMID:24780913 PMID:25825206

NCBI chr10:15,828,291...15,829,138
Ensembl chr10:15,828,377...15,829,141

G

hemoglobin subunit beta

decreases expression
affects expression

EXP

Propylthiouracil results in decreased expression of HBB mRNA; Propylthiouracil results in decreased expression of HBB-B1 mRNA
Propylthiouracil affects the expression of HBB mRNA

PMID:19483382 PMID:24780913 PMID:25825206

NCBI chr 1:167,662,310...167,663,721
Ensembl chr 1:167,630,245...167,663,873

G

hemoglobin, epsilon 2

decreases expression

EXP

Propylthiouracil results in decreased expression of HBE2 mRNA

PMID:24780913 PMID:25825206

NCBI chr 1:167,691,174...167,692,802
Ensembl chr 1:167,683,760...167,706,139

G

heparin-binding EGF-like growth factor

increases expression

EXP

Propylthiouracil results in increased expression of HBEGF mRNA

NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,380,337...28,390,220

G

hemoglobin subunit gamma 1

decreases expression

EXP

Propylthiouracil results in decreased expression of HBG1 mRNA

NCBI chr 1:167,683,760...167,685,315
Ensembl chr 1:167,683,760...167,706,139

G

hemoglobin subunit zeta

increases expression

EXP

Propylthiouracil results in increased expression of HBZ mRNA

NCBI chr10:15,848,279...15,849,757
Ensembl chr10:15,848,289...15,849,768

G

holocytochrome c synthase

increases expression

EXP

Propylthiouracil results in increased expression of HCCS mRNA

NCBI chr X:28,505,370...28,514,812
Ensembl chr X:28,505,417...28,514,812

G

hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2

decreases expression

EXP

Propylthiouracil results in decreased expression of HCN2 mRNA

NCBI chr 7:10,620,422...10,639,457
Ensembl chr 7:10,620,422...10,639,457

G

hyperpolarization activated cyclic nucleotide-gated potassium channel 4

increases expression

EXP

Propylthiouracil results in increased expression of HCN4 mRNA

NCBI chr 8:68,118,062...68,155,482
Ensembl chr 8:68,118,062...68,155,495

G

hypocretin neuropeptide precursor

decreases expression

EXP

Propylthiouracil results in decreased expression of HCRT mRNA

NCBI chr10:86,190,289...86,191,524
Ensembl chr10:86,189,775...86,191,524

G

hypocretin receptor 1

increases expression

EXP

Propylthiouracil results in increased expression of HCRTR1 mRNA

NCBI chr 5:147,761,392...147,771,846
Ensembl chr 5:147,760,145...147,770,850

G

hypocretin receptor 2

increases expression

EXP

Propylthiouracil results in increased expression of HCRTR2 mRNA

NCBI chr 8:85,870,279...85,986,405
Ensembl chr 8:85,870,279...85,986,405

G

hematopoietic cell signal transducer

increases expression

EXP

Propylthiouracil results in increased expression of HCST mRNA

NCBI chr 1:94,804,429...94,806,661
Ensembl chr 1:94,804,430...94,806,641

G

histone deacetylase 1

increases expression

EXP

Propylthiouracil results in increased expression of HDAC1 mRNA

NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:147,138,156...147,165,387

G

histone deacetylase 10

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of HDAC10 mRNA
Propylthiouracil results in decreased expression of HDAC10 mRNA

PMID:22504374 PMID:24780913 PMID:30047161

NCBI chr 7:122,078,768...122,084,457
Ensembl chr 7:122,078,768...122,083,870

G

histone deacetylase 11

decreases expression

EXP

Propylthiouracil results in decreased expression of HDAC11 mRNA

PMID:24780913 PMID:30047161

NCBI chr 4:125,203,044...125,224,584
Ensembl chr 4:125,202,299...125,224,582

G

histone deacetylase 3

increases expression

EXP

Propylthiouracil results in increased expression of HDAC3 mRNA

NCBI chr18:30,021,847...30,041,061
Ensembl chr18:30,021,941...30,041,025

G

histone deacetylase 6

increases expression

EXP

Propylthiouracil results in increased expression of HDAC6 mRNA

NCBI chr X:17,222,538...17,244,373
Ensembl chr X:17,222,856...17,244,370

G

histone deacetylase 9

increases expression

EXP

Propylthiouracil results in increased expression of HDAC9 mRNA

NCBI chr 6:56,489,472...57,351,654
Ensembl chr 6:56,490,988...57,351,835

G

histidine decarboxylase

affects expression
multiple interactions
decreases expression
increases expression

EXP
ISO

Propylthiouracil affects the expression of HDC mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of HDC mRNA
Propylthiouracil results in decreased expression of HDC mRNA
Propylthiouracil results in increased expression of HDC mRNA

PMID:19483382 PMID:22504374 PMID:24780913 PMID:36706583

NCBI chr 3:134,300,628...134,318,704
Ensembl chr 3:134,300,632...134,318,711

G

HDGF like 2

increases expression

EXP

Propylthiouracil results in increased expression of HDGFRP2 mRNA

NCBI chr 9:996,687...1,016,352
Ensembl chr 9:996,758...1,016,735

G

HDGF like 3

increases expression

EXP

Propylthiouracil results in increased expression of HDGFRP3 mRNA

NCBI chr 1:145,233,996...145,287,115
Ensembl chr 1:145,236,758...145,286,001

G

haloacid dehalogenase-like hydrolase domain containing 3

decreases expression

EXP

Propylthiouracil results in decreased expression of HDHD3 mRNA

NCBI chr 5:80,966,878...80,970,345
Ensembl chr 5:80,954,610...80,970,854

G

heme binding protein 1

increases expression

EXP

Propylthiouracil results in increased expression of HEBP1 mRNA

NCBI chr 4:169,705,665...169,735,199
Ensembl chr 4:169,705,668...169,735,199

G

hdc homolog, cell cycle regulator

increases expression

EXP

Propylthiouracil results in increased expression of HECA mRNA

NCBI chr 1:14,345,306...14,395,226
Ensembl chr 1:14,345,306...14,395,191

G

HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of HECW1 mRNA

NCBI chr17:55,366,904...55,780,028
Ensembl chr17:55,366,657...55,776,212

G

helicase, lymphoid specific

increases expression

EXP

Propylthiouracil results in increased expression of HELLS mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:246,113,580...246,159,230
Ensembl chr 1:246,114,096...246,159,228

G

HEN methyltransferase 1

increases expression

EXP

Propylthiouracil results in increased expression of HENMT1 mRNA

NCBI chr 2:199,258,107...199,291,739
Ensembl chr 2:199,274,480...199,287,822

G

hepatic and glial cell adhesion molecule

decreases expression

EXP

Propylthiouracil results in decreased expression of HEPACAM mRNA

NCBI chr 8:45,276,594...45,294,006
Ensembl chr 8:45,276,683...45,295,548

G

hephaestin

increases expression

EXP

Propylthiouracil results in increased expression of HEPH mRNA

PMID:24780913 PMID:30047161

NCBI chr X:65,160,628...65,412,457
Ensembl chr X:65,305,773...65,412,453

G

HECT and RLD domain containing E3 ubiquitin protein ligase family member 1

decreases expression

EXP

Propylthiouracil results in decreased expression of HERC1 mRNA

NCBI chr 8:75,796,347...75,965,347
Ensembl chr 8:75,796,357...75,965,347

G

HECT and RLD domain containing E3 ubiquitin protein ligase 4

decreases expression

EXP

Propylthiouracil results in decreased expression of HERC4 mRNA

NCBI chr20:25,329,005...25,403,443
Ensembl chr20:25,328,822...25,403,372

G

hes family bHLH transcription factor 1

increases expression
decreases expression
multiple interactions

EXP

Propylthiouracil results in increased expression of HES1 mRNA
Propylthiouracil results in decreased expression of HES1 mRNA
[Propylthiouracil results in increased abundance of Thyroxine] which results in increased expression of HES1 mRNA

PMID:15862623 PMID:24780913 PMID:25825206 PMID:36843608

NCBI chr11:84,210,632...84,213,045
Ensembl chr11:84,210,633...84,213,061

G

hes family bHLH transcription factor 2

increases expression

EXP

Propylthiouracil results in increased expression of HES2 mRNA

NCBI chr 5:167,947,948...167,964,660
Ensembl chr 5:167,949,918...167,955,601

G

hes family bHLH transcription factor 3

decreases expression

EXP

Propylthiouracil results in decreased expression of HES3 mRNA

NCBI chr 5:168,076,337...168,082,270
Ensembl chr 5:168,077,093...168,078,987

G

hes family bHLH transcription factor 5

increases expression
decreases expression
increases methylation
multiple interactions

EXP

Propylthiouracil results in increased expression of HES5 mRNA
Propylthiouracil results in decreased expression of HES5 mRNA
Propylthiouracil results in increased methylation of HES5 promoter
[Propylthiouracil results in increased abundance of Thyroxine] which results in increased expression of HES5 mRNA

PMID:15862623 PMID:24780913 PMID:25825206 PMID:33150595

NCBI chr 5:170,804,511...170,807,988
Ensembl chr 5:170,803,940...170,806,021

G

hes family bHLH transcription factor 6

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of HES6 mRNA
Propylthiouracil results in decreased expression of HES6 mRNA

PMID:24780913 PMID:30047161

NCBI chr 9:99,449,375...99,451,343
Ensembl chr 9:99,449,371...99,451,096

G

hes family bHLH transcription factor 7

increases expression

EXP

Propylthiouracil results in increased expression of HES7 mRNA

NCBI chr10:54,322,971...54,327,776
Ensembl chr10:54,322,971...54,327,776

G

hexosaminidase subunit alpha

increases expression

EXP

Propylthiouracil results in increased expression of HEXA mRNA

NCBI chr 8:68,832,524...68,857,462
Ensembl chr 8:68,809,615...68,859,560

G

hexosaminidase D

increases expression

EXP

Propylthiouracil results in increased expression of HEXD mRNA

NCBI chr10:106,978,426...107,002,252
Ensembl chr10:106,978,165...106,997,083

G

hes-related family bHLH transcription factor with YRPW motif 2

increases expression

EXP

Propylthiouracil results in increased expression of HEY2 mRNA

NCBI chr 1:28,641,100...28,651,187
Ensembl chr 1:28,641,057...28,651,187

G

hes-related family bHLH transcription factor with YRPW motif-like

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of HEYL mRNA
Propylthiouracil results in increased expression of HEYL mRNA

PMID:24780913 PMID:30047161

NCBI chr 5:140,793,271...140,810,262
Ensembl chr 5:140,793,271...140,810,262

G

homeostatic iron regulator

decreases expression

EXP

Propylthiouracil results in decreased expression of HFE mRNA

NCBI chr17:41,841,302...41,849,359
Ensembl chr17:41,841,252...41,851,208

G

helicase for meiosis 1

increases expression

EXP

Propylthiouracil results in increased expression of HFM1 mRNA

PMID:24780913 PMID:25825206

NCBI chr14:3,002,103...3,108,567
Ensembl chr14:3,001,906...3,084,401

G

homogentisate 1, 2-dioxygenase

affects expression

EXP

Propylthiouracil affects the expression of HGD mRNA

PMID:19483382 PMID:24780913

NCBI chr11:76,592,202...76,643,776
Ensembl chr11:76,592,204...76,643,767

G

hepatocyte growth factor

decreases expression

EXP

Propylthiouracil results in decreased expression of HGF mRNA

PMID:24780913 PMID:25825206

NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851

G

HGF activator

decreases expression

EXP

Propylthiouracil results in decreased expression of HGFAC mRNA

NCBI chr14:79,932,219...79,938,773
Ensembl chr14:79,932,222...79,939,029

G

heparan-alpha-glucosaminide N-acetyltransferase

decreases expression

EXP

Propylthiouracil results in decreased expression of HGSNAT mRNA

NCBI chr16:72,807,967...72,840,180
Ensembl chr16:72,807,849...72,840,176

G

hedgehog acyltransferase-like

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of HHATL mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of HHATL mRNA

PMID:24780913 PMID:36706583

NCBI chr 8:130,324,510...130,331,580
Ensembl chr 8:130,324,510...130,331,509

G

Hedgehog-interacting protein

decreases expression

EXP

Propylthiouracil results in decreased expression of HHIP mRNA

PMID:24780913 PMID:25825206

NCBI chr19:44,768,038...44,856,878
Ensembl chr19:44,767,536...44,862,795

G

HIC ZBTB transcriptional repressor 1

increases expression

EXP

Propylthiouracil results in increased expression of HIC1 mRNA

NCBI chr10:60,512,855...60,517,812
Ensembl chr10:60,500,565...60,523,448

G

HIC ZBTB transcriptional repressor 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of HIC2 mRNA
Propylthiouracil results in decreased expression of HIC2 mRNA

PMID:24780913 PMID:30047161

NCBI chr11:97,241,308...97,294,429
Ensembl chr11:97,240,704...97,271,713

G

hypoxia inducible factor 1 subunit alpha

increases expression

EXP

Propylthiouracil results in increased expression of HIF1A mRNA; Propylthiouracil results in increased expression of HIF1A protein

NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323

G

hypoxia inducible factor 3 subunit alpha

decreases expression

EXP

Propylthiouracil results in decreased expression of HIF3A mRNA

NCBI chr 1:86,846,196...86,878,527
Ensembl chr 1:86,850,554...86,877,838

G

HIG1 hypoxia inducible domain family, member 1B

increases expression

EXP

Propylthiouracil results in increased expression of HIGD1B mRNA

NCBI chr10:88,302,284...88,304,558
Ensembl chr10:88,302,790...88,304,558

G

histone H4 transcription factor

decreases expression

EXP

Propylthiouracil results in decreased expression of HINFP mRNA

NCBI chr 8:53,525,576...53,541,101
Ensembl chr 8:53,527,236...53,540,555

G

histidine triad nucleotide binding protein 1

increases expression

EXP

Propylthiouracil results in increased expression of HINT1 mRNA

NCBI chr10:39,490,225...39,493,970
Ensembl chr 4:93,430,926...93,431,642
Ensembl chr10:93,430,926...93,431,642

G

huntingtin interacting protein 1

increases expression

EXP

Propylthiouracil results in increased expression of HIP1 mRNA

NCBI chr12:26,769,868...26,904,367
Ensembl chr12:26,769,961...26,904,296

G

huntingtin interacting protein 1 related

decreases expression

EXP

Propylthiouracil results in decreased expression of HIP1R mRNA

NCBI chr12:38,251,085...38,279,756
Ensembl chr12:38,251,086...38,279,654

G

homeodomain interacting protein kinase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of HIPK1 mRNA

NCBI chr 2:193,937,261...193,988,247
Ensembl chr 2:193,937,261...193,975,164

G

homeodomain interacting protein kinase 4

decreases expression

EXP

Propylthiouracil results in decreased expression of HIPK4 mRNA

NCBI chr 1:91,938,308...91,948,680
Ensembl chr 1:91,938,278...91,948,683

G

histone cluster 1, H2ai like 2

increases expression

EXP

Propylthiouracil results in increased expression of HIST1H2AIL2 mRNA

NCBI chr17:47,448,902...47,449,362
Ensembl chr17:47,239,742...47,456,381

G

histone cluster 1, H2an

increases expression

EXP

Propylthiouracil results in increased expression of HIST1H2AN mRNA

NCBI chr17:41,961,533...41,963,297
Ensembl chr17:41,961,379...41,968,019

G

histone cluster 1, H2ao

decreases expression

EXP

Propylthiouracil results in decreased expression of HIST1H2AO mRNA

NCBI chr17:47,400,488...47,400,878
Ensembl chr17:47,400,471...47,470,855

G

histone cluster 1 H2B family member Q

decreases expression

EXP

Propylthiouracil results in decreased expression of HIST1H2BQ mRNA

PMID:24780913 PMID:25825206

NCBI chr17:41,859,955...41,869,889
Ensembl chr17:41,857,231...41,870,107
Ensembl chr17:41,857,231...41,870,107

G

histone cluster 3, H2ba

increases expression

EXP

Propylthiouracil results in increased expression of HIST3H2BA mRNA

NCBI chr10:44,225,421...44,226,050
Ensembl chr10:44,224,629...44,226,832

G

HIVEP zinc finger 1

increases expression

EXP

Propylthiouracil results in increased expression of HIVEP1 mRNA

PMID:24780913 PMID:25825206

NCBI chr17:22,790,855...22,920,359
Ensembl chr17:22,790,855...22,917,196

G

HIVEP zinc finger 3

increases expression

EXP

Propylthiouracil results in increased expression of HIVEP3 mRNA

NCBI chr 5:138,610,592...139,013,058
Ensembl chr 5:138,943,312...139,010,430

G

hexokinase 1

increases expression

EXP

Propylthiouracil results in increased expression of HK1 mRNA

PMID:22504374 PMID:30047161

NCBI chr20:30,773,222...30,874,814
Ensembl chr20:30,773,220...30,874,814

G

hexokinase domain containing 1

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of HKDC1 mRNA

NCBI chr20:30,878,037...30,917,044
Ensembl chr20:30,878,319...30,916,704

G

holocarboxylase synthetase

decreases expression

EXP

Propylthiouracil results in decreased expression of HLCS mRNA

PMID:24780913 PMID:25825206

NCBI chr11:46,925,491...47,123,111
Ensembl chr11:46,925,491...47,105,082

G

HLF transcription factor, PAR bZIP family member

decreases expression

EXP

Propylthiouracil results in decreased expression of HLF mRNA

NCBI chr10:75,651,320...75,708,979
Ensembl chr10:75,654,534...75,708,619

G

high mobility group 20A

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of HMG20A mRNA
Propylthiouracil results in increased expression of HMG20A mRNA

PMID:30047161 PMID:36843608

NCBI chr 8:65,715,688...65,791,663
Ensembl chr 8:65,715,219...65,791,608

G

high mobility group AT-hook 1

decreases expression

EXP

Propylthiouracil results in decreased expression of HMGA1 mRNA

NCBI chr20:5,612,902...5,620,596
Ensembl chr20:5,613,471...5,620,593

G

high mobility group box 1

affects expression
increases expression

EXP

Propylthiouracil affects the expression of HMGB1 mRNA
Propylthiouracil results in increased expression of HMGB1 mRNA

PMID:24780913 PMID:30047161

NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327
Ensembl chr12:39,039,050...39,041,327

G

high-mobility group box 1, pseudogene 33

decreases expression

EXP

Propylthiouracil results in decreased expression of HMGB1P1 mRNA

NCBI chr19:71,943,091...71,944,367
Ensembl chr19:71,943,082...71,944,278

G

high mobility group box 2

increases expression

EXP

Propylthiouracil results in increased expression of HMGB2 mRNA

NCBI chr16:37,721,374...37,723,950
Ensembl chr16:37,721,379...37,723,860

G

high mobility group box 3

increases expression

EXP

Propylthiouracil results in increased expression of HMGB3 mRNA

NCBI chr X:154,341,106...154,346,087
Ensembl chr X:154,340,935...154,346,097

G

3-hydroxy-3-methylglutaryl-CoA lyase

increases expression

EXP

Propylthiouracil results in increased expression of HMGCL mRNA

NCBI chr 5:153,461,738...153,475,552
Ensembl chr 5:153,461,769...153,475,604

G

3-hydroxy-3-methylglutaryl-CoA lyase like 1

increases expression

EXP

Propylthiouracil results in increased expression of HMGCLL1 mRNA

NCBI chr 8:85,637,708...85,799,759
Ensembl chr 8:85,637,958...85,767,740

G

3-hydroxy-3-methylglutaryl-CoA reductase

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of HMGCR mRNA
Propylthiouracil results in increased expression of HMGCR mRNA

PMID:24780913 PMID:30047161

NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533

G

3-hydroxy-3-methylglutaryl-CoA synthase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of HMGCS1 mRNA

PMID:24780913 PMID:25825206

NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:53,382,643...53,399,802

G

3-hydroxy-3-methylglutaryl-CoA synthase 2

increases expression

EXP

Propylthiouracil results in increased expression of HMGCS2 mRNA

PMID:22504374 PMID:24780913

NCBI chr 2:188,564,348...188,590,872
Ensembl chr 2:188,547,767...188,592,242

G

high mobility group nucleosome binding domain 1

affects expression
increases expression

EXP

Propylthiouracil affects the expression of HMGN1 mRNA
Propylthiouracil results in increased expression of HMGN1 mRNA

PMID:19483382 PMID:24780913

NCBI chr11:48,891,813...48,897,732
Ensembl chr11:48,891,814...48,897,771

G

high mobility group nucleosomal binding domain 2

increases expression

EXP

Propylthiouracil results in increased expression of HMGN2 mRNA

NCBI chr 5:151,475,907...151,479,361
Ensembl chr 5:151,475,909...151,479,397

G

high mobility group nucleosome binding domain 5B

increases expression

EXP

Propylthiouracil results in increased expression of HMGN5B mRNA

NCBI chr 1:126,634,026...126,635,981
Ensembl chr 1:126,633,922...126,636,136

G

heme oxygenase 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of HMOX1 mRNA
Propylthiouracil results in decreased expression of HMOX1 mRNA

PMID:30047161 PMID:36038036

NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818

G

H6 family homeobox 1

increases expression

EXP

Propylthiouracil results in increased expression of HMX1 mRNA

PMID:25825206 PMID:30047161

NCBI chr14:79,585,840...79,589,626
Ensembl chr14:79,585,840...79,589,626

G

heterogeneous nuclear ribonucleoprotein A1

increases expression

EXP

Propylthiouracil results in increased expression of HNRNPA1 mRNA

NCBI chr 7:136,253,633...136,260,085
Ensembl chr 7:136,253,278...136,260,085

G

heterogeneous nuclear ribonucleoprotein A/B

increases expression

EXP

Propylthiouracil results in increased expression of HNRNPAB mRNA

PMID:24780913 PMID:30047161

NCBI chr10:36,358,004...36,363,898
Ensembl chr10:36,358,006...36,364,307

G

heterogeneous nuclear ribonucleoprotein F

increases expression

EXP

Propylthiouracil results in increased expression of HNRNPF mRNA

NCBI chr 4:152,755,668...152,776,867
Ensembl chr 4:152,722,617...152,815,769

G

heterogeneous nuclear ribonucleoprotein H1

increases expression

EXP

Propylthiouracil results in increased expression of HNRNPH1 mRNA

NCBI chr10:35,187,412...35,203,909
Ensembl chr10:35,193,890...35,203,906

G

heterogeneous nuclear ribonucleoprotein R

increases expression

EXP

Propylthiouracil results in increased expression of HNRNPR mRNA

NCBI chr 5:153,826,482...153,872,272
Ensembl chr 5:153,826,692...153,858,344

G

homer scaffold protein 1

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of HOMER1 mRNA
Propylthiouracil results in increased expression of HOMER1 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 2:26,279,012...26,388,279
Ensembl chr 2:26,278,105...26,381,657

G

hook microtubule-tethering protein 2

increases expression

EXP

Propylthiouracil results in increased expression of HOOK2 mRNA

NCBI chr19:40,056,732...40,075,027
Ensembl chr19:40,056,732...40,081,270

G

HOP homeobox

decreases expression

EXP

Propylthiouracil results in decreased expression of HOPX mRNA

PMID:24780913 PMID:25825206 PMID:30085217 PMID:36843608

NCBI chr14:31,410,235...31,437,189
Ensembl chr14:31,410,221...31,437,188

G

homeobox A9

decreases expression

EXP

Propylthiouracil results in decreased expression of HOXA9 mRNA

NCBI chr 4:82,653,847...82,659,958
Ensembl chr 4:82,653,825...82,662,093

G

homeo box B7

decreases expression

EXP

Propylthiouracil results in decreased expression of HOXB7 mRNA

NCBI chr10:81,749,159...81,752,577
Ensembl chr10:81,749,097...81,752,550

G

haptoglobin

increases expression

EXP

Propylthiouracil results in increased expression of HP mRNA

NCBI chr19:54,449,151...54,453,701
Ensembl chr19:54,446,217...54,467,518

G

hippocalcin-like 1

affects expression
decreases expression

EXP

Propylthiouracil affects the expression of HPCAL1 mRNA
Propylthiouracil results in decreased expression of HPCAL1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 6:46,206,809...46,313,364
Ensembl chr 6:46,260,494...46,313,353

G

hippocalcin-like 4

increases expression

EXP

Propylthiouracil results in increased expression of HPCAL4 mRNA

NCBI chr 5:140,739,577...140,751,529
Ensembl chr 5:140,739,635...140,751,530

G

4-hydroxyphenylpyruvate dioxygenase-like

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of HPDL mRNA
Propylthiouracil results in increased expression of HPDL mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 5:135,523,258...135,524,864
Ensembl chr 5:135,523,262...135,535,704

G

15-hydroxyprostaglandin dehydrogenase

increases expression

EXP

Propylthiouracil results in increased expression of HPGD mRNA

NCBI chr16:38,996,876...39,034,831
Ensembl chr16:38,996,876...39,034,831

G

hematopoietic prostaglandin D synthase

increases expression

EXP

Propylthiouracil results in increased expression of HPGDS mRNA

NCBI chr 4:95,698,265...95,727,733
Ensembl chr 4:95,702,392...95,938,501

G

hepsin

decreases expression

EXP

Propylthiouracil results in decreased expression of HPN mRNA

NCBI chr 1:95,464,468...95,480,169
Ensembl chr 1:95,464,470...95,480,199

G

hypoxanthine phosphoribosyltransferase 1

affects expression
increases expression

EXP

Propylthiouracil affects the expression of HPRT1 mRNA
Propylthiouracil results in increased expression of HPRT1 mRNA

PMID:19483382 PMID:30047161

NCBI chr X:137,655,744...137,687,718
Ensembl chr X:137,655,680...137,687,712

G

HPS1, biogenesis of lysosomal organelles complex 3 subunit 1

increases expression

EXP

Propylthiouracil results in increased expression of HPS1 mRNA

NCBI chr 1:251,500,427...251,526,529
Ensembl chr 1:251,500,427...251,526,739

G

HPS4, biogenesis of lysosomal organelles complex 3 subunit 2

decreases expression

EXP

Propylthiouracil results in decreased expression of HPS4 mRNA

NCBI chr12:49,924,444...49,955,201
Ensembl chr12:49,924,444...49,953,613

G

HPS5, biogenesis of lysosomal organelles complex 2 subunit 2

affects expression

EXP

Propylthiouracil affects the expression of HPS5 mRNA

NCBI chr 1:106,417,902...106,457,220
Ensembl chr 1:106,417,902...106,452,859

G

HR, lysine demethylase and nuclear receptor corepressor

decreases expression

EXP

Propylthiouracil results in decreased expression of HR mRNA

PMID:24780913 PMID:25825206 PMID:30047161 PMID:30085217

NCBI chr15:52,036,540...52,056,019
Ensembl chr15:52,036,540...52,056,015

G

HRas proto-oncogene, GTPase

increases expression
multiple interactions

EXP

Propylthiouracil results in increased expression of HRAS mRNA; Propylthiouracil results in increased expression of HRAS protein
Thyroxine inhibits the reaction [Propylthiouracil results in increased expression of HRAS protein]; xiaoluowan inhibits the reaction [Propylthiouracil results in increased expression of HRAS protein]

PMID:30047161 PMID:35101570

NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:205,725,975...205,729,590

G

histidine rich calcium binding protein

decreases expression

EXP

Propylthiouracil results in decreased expression of HRC mRNA

NCBI chr 1:104,949,750...104,953,475
Ensembl chr 1:104,949,741...104,954,193

G

histamine receptor H 1

decreases expression

EXP

Propylthiouracil results in decreased expression of HRH1 mRNA

PMID:24780913 PMID:25825206

NCBI chr 4:149,120,511...149,204,267
Ensembl chr 4:149,120,039...149,208,248

G

histamine receptor H 2

decreases expression

EXP

Propylthiouracil results in decreased expression of HRH2 mRNA

NCBI chr17:10,371,083...10,412,979
Ensembl chr17:10,371,083...10,391,041

G

harakiri, BCL2 interacting protein

increases expression

EXP

Propylthiouracil results in increased expression of HRK mRNA

PMID:24780913 PMID:25825206

NCBI chr12:44,048,402...44,070,561
Ensembl chr12:44,048,402...44,070,561

G

HCLS1 binding protein 3

decreases expression

EXP

Propylthiouracil results in decreased expression of HS1BP3 mRNA

NCBI chr 6:36,911,864...36,942,126
Ensembl chr 6:36,911,864...36,942,126

G

heparan sulfate-glucosamine 3-sulfotransferase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of HS3ST1 mRNA

NCBI chr14:75,398,101...75,429,628
Ensembl chr14:75,398,026...75,436,848

G

heparan sulfate-glucosamine 3-sulfotransferase 3A1

decreases expression

EXP

Propylthiouracil results in decreased expression of HS3ST3A1 mRNA

PMID:24780913 PMID:30047161

NCBI chr10:49,593,208...49,679,854
Ensembl chr10:49,593,009...49,679,854

G

heparan sulfate-glucosamine 3-sulfotransferase 5

increases expression

EXP

Propylthiouracil results in increased expression of HS3ST5 mRNA

NCBI chr20:41,661,785...41,972,550
Ensembl chr20:41,773,601...41,972,542

G

heparan sulfate-glucosamine 3-sulfotransferase 6

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of HS3ST6 mRNA
Propylthiouracil results in decreased expression of HS3ST6 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr10:14,286,555...14,292,660
Ensembl chr10:14,286,507...14,292,660

G

heparan sulfate 6-O-sulfotransferase 2

increases expression

EXP

Propylthiouracil results in increased expression of HS6ST2 mRNA

NCBI chr X:135,887,224...136,182,388
Ensembl chr X:135,888,472...136,182,353

G

heparan sulfate 6-O-sulfotransferase 3

decreases expression

EXP

Propylthiouracil results in decreased expression of HS6ST3 mRNA

NCBI chr15:102,688,420...103,407,725
Ensembl chr15:102,688,365...103,408,384

G

heat shock factor binding protein 1-like 1

decreases expression

EXP

Propylthiouracil results in decreased expression of HSBP1L1 mRNA

NCBI chr18:75,957,266...75,963,024
Ensembl chr18:75,957,266...75,963,024

G

hydroxysteroid 11-beta dehydrogenase 1

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of HSD11B1 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of HSD11B1 mRNA

PMID:24780913 PMID:36706583

NCBI chr13:107,277,526...107,327,462
Ensembl chr13:107,257,239...107,327,432

G

hydroxysteroid 11-beta dehydrogenase 2

increases expression

EXP

Propylthiouracil results in increased expression of HSD11B2 mRNA

PMID:24780913 PMID:30047161

NCBI chr19:50,307,569...50,312,812
Ensembl chr19:50,307,569...50,312,812

G

hydroxysteroid (17-beta) dehydrogenase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of HSD17B1 mRNA

NCBI chr10:86,510,011...86,512,211
Ensembl chr10:86,510,011...86,512,210

G

hydroxysteroid (17-beta) dehydrogenase 11

decreases expression

EXP

Propylthiouracil results in decreased expression of HSD17B11 mRNA

NCBI chr14:5,997,893...6,047,816
Ensembl chr14:5,997,906...6,047,811

G

hydroxysteroid (17-beta) dehydrogenase 13

decreases expression

EXP

Propylthiouracil results in decreased expression of HSD17B13 mRNA

NCBI chr14:6,056,708...6,071,463
Ensembl chr14:6,056,774...6,072,823

G

hydroxysteroid (17-beta) dehydrogenase 3

decreases expression

EXP

Propylthiouracil results in decreased expression of HSD17B3 mRNA

NCBI chr17:1,032,958...1,064,283
Ensembl chr17:1,032,958...1,064,283

G

hydroxysteroid (17-beta) dehydrogenase 4

affects expression

EXP

Propylthiouracil affects the expression of HSD17B4 mRNA

NCBI chr18:45,515,427...45,604,467
Ensembl chr18:45,515,373...45,604,467

G

hydroxysteroid (17-beta) dehydrogenase 7

decreases expression

EXP

Propylthiouracil results in decreased expression of HSD17B7 mRNA

NCBI chr13:84,702,875...84,722,810
Ensembl chr13:84,705,631...84,722,754

G

hydroxysteroid dehydrogenase like 2

affects expression

EXP

Propylthiouracil affects the expression of HSDL2 mRNA

NCBI chr 5:79,238,881...79,274,051
Ensembl chr 5:79,212,525...79,274,798

G

heat shock transcription factor 1

increases activity

ISO

Propylthiouracil results in increased activity of HSF1 protein

NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:110,076,710...110,103,665

G

heat shock protein 90 alpha family class A member 1

decreases expression

EXP

Propylthiouracil results in decreased expression of HSP90AA1 mRNA

NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:135,523,616...135,528,499

G

heat shock protein 90 beta family member 1

decreases expression

EXP

Propylthiouracil results in decreased expression of HSP90B1 mRNA

NCBI chr 7:22,997,962...23,012,293
Ensembl chr 7:22,997,962...23,012,293

G

heat shock protein family A (Hsp70) member 12A

decreases expression

EXP

Propylthiouracil results in decreased expression of HSPA12A mRNA

NCBI chr 1:267,921,780...268,083,171
Ensembl chr 1:267,921,782...268,082,794

G

heat shock protein family A (Hsp70) member 12B

increases expression

EXP

Propylthiouracil results in increased expression of HSPA12B mRNA

PMID:22504374 PMID:25825206

NCBI chr 3:138,799,396...138,817,396
Ensembl chr 3:138,799,398...138,818,935

G

heat shock protein family A (Hsp70) member 2

increases expression

EXP

Propylthiouracil results in increased expression of HSPA2 mRNA

NCBI chr 6:100,864,172...100,866,946
Ensembl chr 6:100,864,553...100,867,133

G

heat shock protein family A (Hsp70) member 4

increases expression

EXP

Propylthiouracil results in increased expression of HSPA4 mRNA

NCBI chr10:37,908,866...37,951,994
Ensembl chr10:37,908,866...37,949,835

G

heat shock protein family A (Hsp70) member 4 like

decreases expression

EXP

Propylthiouracil results in decreased expression of HSPA4L mRNA

NCBI chr 2:125,668,346...125,726,404
Ensembl chr 2:125,668,236...125,720,986

G

heat shock protein family A (Hsp70) member 5

affects expression

EXP

Propylthiouracil affects the expression of HSPA5 mRNA; Propylthiouracil affects the expression of HSPA5 protein

NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790

G

heat shock protein family A (Hsp70) member 8

increases expression

EXP

Propylthiouracil results in increased expression of HSPA8 mRNA

NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372

G

heat shock protein family A (Hsp70) member 9

increases expression

EXP

Propylthiouracil results in increased expression of HSPA9 mRNA

PMID:22504374 PMID:30047161

NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,804,774...26,828,398

G

heat shock protein family B (small) member 1

increases expression

EXP

Propylthiouracil results in increased expression of HSPB1 mRNA

NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301

G

heat shock protein family B (small) member 2

decreases expression

EXP

Propylthiouracil results in decreased expression of HSPB2 mRNA

NCBI chr 8:59,989,640...59,991,215
Ensembl chr 8:59,976,623...59,990,901

G

heat shock protein family B (small) member 3

increases expression

EXP

Propylthiouracil results in increased expression of HSPB3 mRNA

NCBI chr 2:47,028,451...47,029,165
Ensembl chr 2:47,024,757...47,029,373

G

heat shock protein family B (small) member 6

decreases expression

EXP

Propylthiouracil results in decreased expression of HSPB6 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:94,934,372...94,936,516
Ensembl chr 1:94,933,543...94,936,512

G

HSPA (Hsp70) binding protein 1

increases expression

EXP

Propylthiouracil results in increased expression of HSPBP1 mRNA

NCBI chr 1:78,194,067...78,217,836
Ensembl chr 1:78,189,305...78,217,835

G

heat shock protein family D (Hsp60) member 1

increases expression

EXP

Propylthiouracil results in increased expression of HSPD1 mRNA; Propylthiouracil results in increased expression of HSPD1 protein

PMID:19059321 PMID:30047161

NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037

G

heat shock protein family E (Hsp10) member 1

increases expression

EXP

Propylthiouracil results in increased expression of HSPE1 mRNA

NCBI chr 9:64,084,327...64,087,415
Ensembl chr 9:64,085,068...64,087,502

G

heat shock protein family H (Hsp110) member 1

decreases expression

EXP

Propylthiouracil results in decreased expression of HSPH1 mRNA

NCBI chr12:10,427,368...10,446,602
Ensembl chr12:10,427,297...10,446,891

G

HIV-1 Tat interactive protein 2

decreases expression

EXP

Propylthiouracil results in decreased expression of HTATIP2 mRNA

PMID:24780913 PMID:25825206

NCBI chr 1:108,609,424...108,624,810
Ensembl chr 1:108,605,811...108,624,815

G

HIV-1 Tat specific factor 1

decreases expression

EXP

Propylthiouracil results in decreased expression of HTATSF1 mRNA

NCBI chr X:139,972,742...139,986,923
Ensembl chr X:139,972,742...139,986,923

G

5-hydroxytryptamine receptor 1B

decreases expression

EXP

Propylthiouracil results in decreased expression of HTR1B mRNA

NCBI chr 8:91,395,405...91,414,815
Ensembl chr 8:91,052,432...91,418,583

G

5-hydroxytryptamine receptor 1D

decreases expression

EXP

Propylthiouracil results in decreased expression of HTR1D mRNA

NCBI chr 5:153,939,735...153,960,012
Ensembl chr 5:153,939,516...153,960,012

G

5-hydroxytryptamine receptor 1F

decreases expression

EXP

Propylthiouracil results in decreased expression of HTR1F mRNA

NCBI chr11:16,089,266...16,090,665
Ensembl chr11:16,081,053...16,274,580

G

5-hydroxytryptamine receptor 2A

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of HTR2A mRNA
Propylthiouracil results in decreased expression of HTR2A mRNA

PMID:24780913 PMID:25825206

NCBI chr15:56,360,647...56,428,703
Ensembl chr15:56,359,596...56,431,619

G

5-hydroxytryptamine receptor 2B

decreases expression

EXP

Propylthiouracil results in decreased expression of HTR2B mRNA

NCBI chr 9:94,184,442...94,206,851
Ensembl chr 9:94,190,109...94,204,087

G

5-hydroxytryptamine receptor 2C

increases expression

EXP

Propylthiouracil results in increased expression of HTR2C mRNA

PMID:24780913 PMID:25825206

NCBI chr X:115,453,190...115,682,325
Ensembl chr X:115,452,842...115,682,324

G

5-hydroxytryptamine receptor 3A

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of HTR3A mRNA
Propylthiouracil results in decreased expression of HTR3A mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 8:58,138,514...58,150,960
Ensembl chr 8:58,138,226...58,150,884

G

5-hydroxytryptamine receptor 4

increases expression

EXP

Propylthiouracil results in increased expression of HTR4 mRNA

NCBI chr18:58,036,277...58,221,327
Ensembl chr18:58,036,277...58,219,622

G

5-hydroxytryptamine (serotonin) receptor 5B

decreases expression

EXP

Propylthiouracil results in decreased expression of HTR5B mRNA

PMID:24780913 PMID:30047161

NCBI chr13:35,239,662...35,252,586
Ensembl chr13:35,239,662...35,252,586

G

5-hydroxytryptamine receptor 6

decreases expression

EXP

Propylthiouracil results in decreased expression of HTR6 mRNA

NCBI chr 5:156,579,901...156,595,147
Ensembl chr 5:156,579,901...156,595,147

G

5-hydroxytryptamine receptor 7

increases expression

EXP

Propylthiouracil results in increased expression of HTR7 mRNA

NCBI chr 1:243,049,064...243,173,636
Ensembl chr 1:243,049,081...243,173,230

G

HtrA serine peptidase 1

affects expression
increases expression
decreases expression

EXP

Propylthiouracil affects the expression of HTRA1 mRNA
Propylthiouracil results in increased expression of HTRA1 mRNA
Propylthiouracil results in decreased expression of HTRA1 mRNA

PMID:19483382 PMID:24780913 PMID:30047161

NCBI chr 1:194,928,069...194,977,619
Ensembl chr 1:194,927,687...194,977,620

G

HtrA serine peptidase 4

increases expression

EXP

Propylthiouracil results in increased expression of HTRA4 mRNA

NCBI chr16:73,704,255...73,717,722
Ensembl chr16:73,704,184...73,717,722

G

hormonally upregulated Neu-associated kinase

decreases expression

EXP

Propylthiouracil results in decreased expression of HUNK mRNA

NCBI chr11:43,127,244...43,244,502
Ensembl chr11:43,127,244...43,244,502

G

hyaluronidase 1

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of HYAL1 mRNA
Propylthiouracil results in increased expression of HYAL1 mRNA

PMID:25825206 PMID:30047161

NCBI chr 8:117,129,311...117,133,162
Ensembl chr 8:117,129,277...117,133,146

G

hyaluronidase 2

increases expression

EXP

Propylthiouracil results in increased expression of HYAL2 mRNA

NCBI chr 8:117,121,802...117,125,494
Ensembl chr 8:117,121,787...117,125,493

G

Hydin, axonemal central pair apparatus protein

decreases expression

EXP

Propylthiouracil results in decreased expression of HYDIN mRNA

NCBI chr19:55,146,382...55,492,660
Ensembl chr19:55,146,466...55,492,660

G

hydroxypyruvate isomerase

increases expression

EXP

Propylthiouracil results in increased expression of HYI mRNA

NCBI chr 5:137,179,975...137,182,654
Ensembl chr 5:137,179,976...137,182,654

G

hydroxylysine kinase

decreases expression

EXP

Propylthiouracil results in decreased expression of HYKK mRNA

NCBI chr 8:64,212,043...64,235,809
Ensembl chr 8:64,212,071...64,235,818

G

HYLS1, centriolar and ciliogenesis associated

increases expression

EXP

Propylthiouracil results in increased expression of HYLS1 mRNA

NCBI chr 8:42,170,505...42,179,573
Ensembl chr 8:42,168,546...42,179,725

G

isoamyl acetate hydrolyzing esterase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of IAH1 mRNA

NCBI chr 6:46,594,177...46,601,394
Ensembl chr 6:46,594,080...46,601,392

G

integrin-binding sialoprotein

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of IBSP mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of IBSP mRNA

PMID:24780913 PMID:36706583

NCBI chr14:5,744,497...5,757,242
Ensembl chr14:5,744,501...5,775,299

G

intercellular adhesion molecule 2

increases expression

EXP

Propylthiouracil results in increased expression of ICAM2 mRNA

NCBI chr10:91,808,449...91,819,319
Ensembl chr10:91,808,316...91,815,072

G

intercellular adhesion molecule 5

increases expression

EXP

Propylthiouracil results in increased expression of ICAM5 mRNA

NCBI chr 8:27,843,563...27,851,767
Ensembl chr 8:27,844,780...27,857,104

G

isoprenylcysteine carboxyl methyltransferase

decreases expression

EXP

Propylthiouracil results in decreased expression of ICMT mRNA

NCBI chr 5:168,084,487...168,097,519
Ensembl chr 5:168,086,057...168,093,094

G

inhibitor of DNA binding 1

increases expression

EXP

Propylthiouracil results in increased expression of ID1 mRNA

PMID:25825206 PMID:30047161

NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:161,671,538...161,672,685

G

inhibitor of DNA binding 2

increases expression
decreases expression
increases methylation

ISO
EXP

Propylthiouracil results in increased expression of ID2 mRNA
Propylthiouracil results in decreased expression of ID2 mRNA
Propylthiouracil results in increased methylation of ID2 promoter

PMID:23397585 PMID:33150595

NCBI chr 6:47,469,162...47,470,995
Ensembl chr 6:47,457,554...47,472,961

G

inhibitor of DNA binding 3

increases expression

ISO
EXP

Propylthiouracil results in increased expression of ID3 mRNA

PMID:23397585 PMID:24780913

NCBI chr 5:153,656,253...153,657,860
Ensembl chr 5:153,630,498...153,657,856

G

isocitrate dehydrogenase (NADP(+)) 1

increases expression

EXP

Propylthiouracil results in increased expression of IDH1 mRNA

NCBI chr 9:74,027,887...74,057,442
Ensembl chr 9:74,027,892...74,049,555

G

isocitrate dehydrogenase (NADP(+)) 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of IDH2 mRNA
Propylthiouracil results in decreased expression of IDH2 mRNA

PMID:30047161 PMID:36843608

NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:143,439,323...143,467,248

G

isopentenyl-diphosphate delta isomerase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of IDI1 mRNA

PMID:24780913 PMID:25825206

NCBI chr17:66,539,761...66,547,524
Ensembl chr17:66,539,763...66,547,524

G

alpha-L-iduronidase

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of IDUA mRNA
Propylthiouracil results in decreased expression of IDUA mRNA

PMID:24780913 PMID:36843608

NCBI chr14:1,175,994...1,203,913
Ensembl chr14:1,176,577...1,204,066

G

immediate early response 2

increases expression

EXP

Propylthiouracil results in increased expression of IER2 mRNA

NCBI chr19:40,399,373...40,400,897
Ensembl chr19:40,398,160...40,402,708

G

immediate early response 3

increases expression

EXP

Propylthiouracil results in increased expression of IER3 mRNA

NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,933,174...2,934,377

G

immediate early response 5

decreases expression

EXP

Propylthiouracil results in decreased expression of IER5 mRNA

NCBI chr13:69,820,450...69,822,542
Ensembl chr13:69,820,451...69,822,543

G

immediate early response 5-like

increases expression

EXP

Propylthiouracil results in increased expression of IER5L mRNA

NCBI chr 3:34,141,866...34,143,457
Ensembl chr 3:34,139,672...34,144,452

G

intermediate filament family orphan 1

decreases expression

EXP

Propylthiouracil results in decreased expression of IFFO1 mRNA

NCBI chr 4:159,631,309...159,648,531
Ensembl chr 4:159,630,763...159,648,527

G

interferon, alpha-inducible protein 27 like 2A

decreases expression

EXP

Propylthiouracil results in decreased expression of IFI27L2B mRNA

NCBI chr 6:128,363,658...128,365,144
Ensembl chr 6:128,363,658...128,365,146

G

IFI30, lysosomal thiol reductase

increases expression

EXP

Propylthiouracil results in increased expression of IFI30 mRNA

NCBI chr16:18,709,570...18,713,635
Ensembl chr16:18,709,563...18,715,711

G

interferon-induced protein 44

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of IFI44 mRNA
Propylthiouracil results in decreased expression of IFI44 mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 2:243,286,050...243,303,869
Ensembl chr 2:243,286,052...243,306,877

G

interferon induced with helicase C domain 1

increases expression

EXP

Propylthiouracil results in increased expression of IFIH1 mRNA

NCBI chr 3:67,635,924...67,683,968
Ensembl chr 3:67,637,545...67,683,968

G

interferon-induced protein with tetratricopeptide repeats 2

increases expression

EXP

Propylthiouracil results in increased expression of IFIT2 mRNA

NCBI chr 1:241,515,735...241,521,799
Ensembl chr 1:241,515,709...241,521,798

G

interferon induced transmembrane protein 1

decreases expression

EXP

Propylthiouracil results in decreased expression of IFITM1 mRNA

NCBI chr 1:205,496,757...205,498,796
Ensembl chr 1:205,496,807...205,498,776

G

interferon induced transmembrane protein 2

decreases expression

EXP

Propylthiouracil results in decreased expression of IFITM2 mRNA

NCBI chr 1:205,481,168...205,482,348

G

interferon induced transmembrane protein 2, pseudogene 2

decreases expression

EXP

Propylthiouracil results in decreased expression of IFITM2-PS2 mRNA

NCBI chr13:70,737,384...70,738,072

G

interferon induced transmembrane protein 3

increases expression

EXP

Propylthiouracil results in increased expression of IFITM3 mRNA

NCBI chr 1:205,540,649...205,541,758
Ensembl chr 1:205,481,168...205,547,920

G

interferon induced transmembrane protein 3, pseudogene 2

increases expression

EXP

Propylthiouracil results in increased expression of IFITM7 mRNA

NCBI chr11:46,606,814...46,607,230
Ensembl chr11:46,606,814...46,607,230

G

interferon induced transmembrane protein 6

decreases expression

EXP

Propylthiouracil results in decreased expression of IFITM6 mRNA

NCBI chr 1:205,546,648...205,547,920

G

interferon alpha and beta receptor subunit 2

decreases expression

EXP

Propylthiouracil results in decreased expression of IFNAR2 mRNA

NCBI chr11:44,099,574...44,131,941
Ensembl chr11:44,099,753...44,131,937

G

interferon gamma

decreases expression

EXP

Propylthiouracil results in decreased expression of IFNG mRNA; Propylthiouracil results in decreased expression of IFNG protein

NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216

G

interferon-related developmental regulator 1

decreases expression

EXP

Propylthiouracil results in decreased expression of IFRD1 mRNA

NCBI chr 6:62,996,560...63,044,996
Ensembl chr 6:62,996,562...63,016,131

G

intraflagellar transport 122

increases expression

EXP

Propylthiouracil results in increased expression of IFT122 mRNA

PMID:24780913 PMID:30047161

NCBI chr 4:150,577,525...150,648,052
Ensembl chr 4:150,539,786...150,648,052

G

intraflagellar transport 27

decreases expression

EXP

Propylthiouracil results in decreased expression of IFT27 mRNA

NCBI chr 7:111,619,145...111,635,129
Ensembl chr 7:111,619,077...111,634,936

G

intraflagellar transport 43

increases expression

EXP

Propylthiouracil results in increased expression of IFT43 mRNA

NCBI chr 6:111,460,689...111,537,224
Ensembl chr 6:111,456,476...111,537,224

G

intraflagellar transport 46

decreases expression

EXP

Propylthiouracil results in decreased expression of IFT46 mRNA

NCBI chr 8:53,975,085...54,000,837
Ensembl chr 8:53,984,242...54,000,836

G

intraflagellar transport 70B

decreases expression

EXP

Propylthiouracil results in decreased expression of IFT70B mRNA

NCBI chr 3:81,263,074...81,265,645

G

immunoglobulin (CD79A) binding protein 1b

increases expression

EXP

Propylthiouracil results in increased expression of IGBP1B mRNA

NCBI chr 4:173,260,206...173,261,556
Ensembl chr 4:173,260,297...173,261,755

G

insulin-like growth factor 1

affects expression
increases methylation
decreases expression
increases expression

EXP

Propylthiouracil affects the expression of IGF1 mRNA
Propylthiouracil results in increased methylation of IGF1 promoter
Propylthiouracil results in decreased expression of IGF1 mRNA
Propylthiouracil results in increased expression of IGF1 mRNA

PMID:19483382 PMID:24780913 PMID:33150595

NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764

G

insulin-like growth factor 1 receptor

decreases expression

EXP

Propylthiouracil results in decreased expression of IGF1R mRNA

NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:130,959,997...131,248,664

G

insulin-like growth factor 2

decreases expression

EXP

Propylthiouracil results in decreased expression of IGF2 mRNA

NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:207,243,873...207,260,667

G

insulin-like growth factor 2 receptor

increases expression

EXP

Propylthiouracil results in increased expression of IGF2R mRNA

NCBI chr 1:50,526,878...50,615,265
Ensembl chr 1:50,526,878...50,615,265

G

insulin-like growth factor binding protein, acid labile subunit

affects expression

EXP

Propylthiouracil affects the expression of IGFALS mRNA

NCBI chr10:14,397,076...14,408,439
Ensembl chr10:14,403,399...14,407,138

G

insulin-like growth factor binding protein 2

affects expression
increases expression

EXP

Propylthiouracil affects the expression of IGFBP2 mRNA
Propylthiouracil results in increased expression of IGFBP2 mRNA

PMID:19483382 PMID:24780913

NCBI chr 9:81,864,811...81,892,179
Ensembl chr 9:81,864,783...81,892,171

G

insulin-like growth factor binding protein 3

increases expression

EXP

Propylthiouracil results in increased expression of IGFBP3 mRNA

PMID:22504374 PMID:24780913

NCBI chr14:86,270,208...86,277,944
Ensembl chr14:86,270,208...86,277,944

G

insulin-like growth factor binding protein 4

affects expression

EXP

Propylthiouracil affects the expression of IGFBP4 mRNA

NCBI chr10:84,491,471...84,503,487
Ensembl chr10:84,485,775...84,503,473

G

insulin-like growth factor binding protein 5

increases expression

EXP

Propylthiouracil results in increased expression of IGFBP5 mRNA

NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:81,897,616...81,914,390

G

insulin-like growth factor binding protein 6

decreases expression
multiple interactions
increases expression

EXP
ISO

Propylthiouracil results in decreased expression of IGFBP6 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of IGFBP6 mRNA
Propylthiouracil results in increased expression of IGFBP6 mRNA

PMID:24780913 PMID:25825206 PMID:36706583

NCBI chr 7:135,154,919...135,159,550
Ensembl chr 7:135,154,685...135,159,795

G

insulin-like growth factor binding protein 7

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of IGFBP7 mRNA
Propylthiouracil results in increased expression of IGFBP7 mRNA

PMID:24780913 PMID:25825206

NCBI chr14:31,091,681...31,151,623
Ensembl chr14:31,091,347...31,151,620

G

insulin-like growth factor binding protein-like 1

increases expression

EXP

Propylthiouracil results in increased expression of IGFBPL1 mRNA

NCBI chr 5:64,872,056...64,887,461
Ensembl chr 5:64,872,057...64,887,461

G

IGF-like family receptor 1

decreases expression

EXP

Propylthiouracil results in decreased expression of IGFLR1 mRNA

NCBI chr 1:94,945,866...94,948,476
Ensembl chr 1:94,945,967...94,948,473

G

immunoglobulin heavy chain 6 like 1

decreases expression

EXP

Propylthiouracil results in decreased expression of IGH-6L1 mRNA

NCBI chr 5:153,799,522...153,801,010

G

IgLON family member 5

decreases expression

EXP

Propylthiouracil results in decreased expression of IGLON5 mRNA

NCBI chr 1:103,017,985...103,035,512
Ensembl chr 1:103,018,518...103,035,870

G

immunoglobulin superfamily, member 1

affects expression
increases expression

EXP

Propylthiouracil affects the expression of IGSF1 mRNA
Propylthiouracil results in increased expression of IGSF1 mRNA

PMID:24780913 PMID:25825206

NCBI chr X:133,947,717...133,963,154
Ensembl chr X:133,947,429...133,962,962

G

immunoglobulin superfamily, member 10

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of IGSF10 mRNA
Propylthiouracil results in decreased expression of IGSF10 mRNA

PMID:24780913 PMID:30047161

NCBI chr 2:145,725,868...145,754,850
Ensembl chr 2:145,725,878...145,754,579

G

immunoglobin superfamily, member 21

decreases expression

EXP

Propylthiouracil results in decreased expression of IGSF21 mRNA

NCBI chr 5:157,570,964...157,795,290
Ensembl chr 5:157,570,964...157,795,290

G

immunoglobulin superfamily, member 3

increases expression

EXP

Propylthiouracil results in increased expression of IGSF3 mRNA

NCBI chr 2:191,499,972...191,588,249
Ensembl chr 2:191,500,045...191,588,249

G

immunoglobulin superfamily, member 9

increases expression

EXP

Propylthiouracil results in increased expression of IGSF9 mRNA

NCBI chr13:87,480,979...87,497,974
Ensembl chr13:87,481,279...87,497,974

G

Indian hedgehog signaling molecule

decreases expression

EXP

Propylthiouracil results in decreased expression of IHH mRNA

NCBI chr 9:83,952,986...83,959,203
Ensembl chr 9:83,952,986...83,959,203

G

IKAROS family zinc finger 4

increases expression

EXP

Propylthiouracil results in increased expression of IKZF4 mRNA

NCBI chr 7:1,643,379...1,687,524
Ensembl chr 7:1,644,799...1,687,094

G

interleukin 10

multiple interactions
decreases expression

EXP

thymoquinone inhibits the reaction [Propylthiouracil results in decreased expression of IL10 mRNA]

PMID:24534949 PMID:34234489

NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580

G

interleukin 11

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of IL11 mRNA
Propylthiouracil results in increased expression of IL11 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:78,098,622...78,104,915
Ensembl chr 1:78,096,930...78,104,915

G

interleukin 11 receptor subunit alpha 1

decreases expression

EXP

Propylthiouracil results in decreased expression of IL11RA1 mRNA

NCBI chr 5:61,727,650...61,737,265
Ensembl chr 5:61,727,931...61,737,264

G

interleukin 13 receptor subunit alpha 1

decreases expression

EXP

Propylthiouracil results in decreased expression of IL13RA1 mRNA

NCBI chr X:120,213,670...120,294,777
Ensembl chr X:120,214,075...120,274,461

G

interleukin 15

decreases expression

EXP

Propylthiouracil results in decreased expression of IL15 mRNA

NCBI chr19:42,536,160...42,611,349
Ensembl chr19:42,545,346...42,611,348

G

interleukin 16

increases expression

EXP

Propylthiouracil results in increased expression of IL16 mRNA

NCBI chr 1:147,026,852...147,127,177
Ensembl chr 1:147,027,097...147,127,023

G

interleukin 17B

decreases expression

EXP

Propylthiouracil results in decreased expression of IL17B mRNA

NCBI chr18:57,411,532...57,415,903
Ensembl chr18:57,411,532...57,415,903

G

interleukin 17 receptor E

increases expression

EXP

Propylthiouracil results in increased expression of IL17RE mRNA

NCBI chr 4:148,160,384...148,173,830
Ensembl chr 4:148,159,475...148,173,827

G

interleukin 18

increases expression

EXP

Propylthiouracil results in increased expression of IL18 mRNA

NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286

G

interleukin 18 binding protein

increases expression

EXP

Propylthiouracil results in increased expression of IL18BP mRNA

NCBI chr 1:165,784,916...165,787,990
Ensembl chr 1:165,784,069...165,786,955

G

interleukin 18 receptor 1

decreases expression

EXP

Propylthiouracil results in decreased expression of IL18R1 mRNA

NCBI chr 9:50,223,274...50,257,370
Ensembl chr 9:50,223,200...50,257,367

G

interleukin 1 alpha

multiple interactions

EXP

[isoquercitrin analog co-treated with Propylthiouracil] results in increased expression of IL1A mRNA; [Thioctic Acid co-treated with Propylthiouracil] results in increased expression of IL1A mRNA

NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013

G

interleukin 1 beta

increases expression
multiple interactions

EXP

Propylthiouracil results in increased expression of IL1B mRNA; Propylthiouracil results in increased expression of IL1B protein
Triiodothyronine inhibits the reaction [Propylthiouracil results in increased expression of IL1B protein]

PMID:24780913 PMID:29796989 PMID:37047793

NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601

G

interleukin 1 receptor type 1

increases expression

EXP

Propylthiouracil results in increased expression of IL1R1 mRNA

NCBI chr 9:50,000,558...50,076,579
Ensembl chr 9:50,000,566...50,076,579

G

interleukin 1 receptor type 2

decreases expression

EXP

Propylthiouracil results in decreased expression of IL1R2 mRNA

NCBI chr 9:49,879,928...49,920,374
Ensembl chr 9:49,877,266...49,920,374

G

interleukin 1 receptor accessory protein

decreases expression

EXP

Propylthiouracil results in decreased expression of IL1RAP mRNA

NCBI chr11:87,567,813...87,704,346
Ensembl chr11:87,575,116...87,704,342

G

interleukin 2 receptor subunit beta

increases expression

EXP

Propylthiouracil results in increased expression of IL2RB mRNA

NCBI chr 7:111,913,828...111,928,537
Ensembl chr 7:111,913,828...111,928,537

G

interleukin 2 receptor subunit gamma

increases expression

EXP

Propylthiouracil results in increased expression of IL2RG mRNA

NCBI chr X:70,435,340...70,439,052
Ensembl chr X:70,435,343...70,439,161

G

interleukin 33

increases expression

EXP

Propylthiouracil results in increased expression of IL33 mRNA

NCBI chr 1:237,115,478...237,149,897
Ensembl chr 1:237,115,572...237,150,901

G

interleukin 34

increases expression

EXP

Propylthiouracil results in increased expression of IL34 mRNA

NCBI chr19:55,624,368...55,690,576
Ensembl chr19:55,624,369...55,673,376

G

interleukin 4 receptor

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of IL4R mRNA; Propylthiouracil results in increased expression of IL4RA mRNA
Propylthiouracil results in decreased expression of IL4R mRNA

PMID:24780913 PMID:25825206 PMID:30047161

NCBI chr 1:189,545,739...189,570,639
Ensembl chr 1:189,544,988...189,570,636

G

interleukin 5

decreases expression

EXP

Propylthiouracil results in decreased expression of IL5 mRNA

NCBI chr10:38,375,132...38,378,003
Ensembl chr10:38,375,132...38,378,003

G

interleukin 6

multiple interactions
increases expression

EXP

syringic acid inhibits the reaction [Propylthiouracil results in increased expression of IL6 protein]; Thyroxine inhibits the reaction [Propylthiouracil results in increased expression of IL6 protein]; Triiodothyronine inhibits the reaction [Propylthiouracil results in increased expression of IL6 mRNA]
Propylthiouracil results in increased expression of IL6 mRNA; Propylthiouracil results in increased expression of IL6 protein

PMID:29796989 PMID:34047416

NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610

G

interleukin 6 receptor

increases expression

EXP

Propylthiouracil results in increased expression of IL6R mRNA

NCBI chr 2:177,582,020...177,646,705
Ensembl chr 2:177,582,164...177,645,221

G

interleukin 7 receptor

decreases expression

EXP

Propylthiouracil results in decreased expression of IL7R mRNA

NCBI chr 2:60,179,561...60,204,937
Ensembl chr 2:60,181,382...60,211,027

G

immunoglobulin-like domain containing receptor 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ILDR1 mRNA

NCBI chr11:77,591,146...77,624,268
Ensembl chr11:77,569,621...77,624,140

G

interleukin enhancer binding factor 3

increases expression

EXP

Propylthiouracil results in increased expression of ILF3 mRNA

NCBI chr 8:28,198,454...28,236,634
Ensembl chr 8:28,198,543...28,236,612

G

integrin-linked kinase

increases expression

EXP

Propylthiouracil results in increased expression of ILK mRNA

NCBI chr 1:169,500,716...169,506,972
Ensembl chr 1:169,498,681...169,506,964

G

inner membrane mitochondrial protein

increases expression

EXP

Propylthiouracil results in increased expression of IMMT mRNA

NCBI chr 4:105,438,657...105,477,370
Ensembl chr 4:105,438,712...105,477,368

G

inositol monophosphatase 1

affects expression
increases expression

EXP

Propylthiouracil affects the expression of IMPA1 mRNA
Propylthiouracil results in increased expression of IMPA1 mRNA

PMID:19483382 PMID:30047161

NCBI chr 2:93,370,200...93,391,474
Ensembl chr 2:93,370,299...93,391,468

G

inositol monophosphatase 2

increases expression

EXP

Propylthiouracil results in increased expression of IMPA2 mRNA

NCBI chr18:63,104,113...63,135,232
Ensembl chr18:63,104,083...63,137,543

G

impact RWD domain protein

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of IMPACT mRNA
Propylthiouracil results in decreased expression of IMPACT mRNA

PMID:24780913 PMID:30047161

NCBI chr18:4,383,546...4,422,280
Ensembl chr18:4,383,575...4,422,278

G

interphotoreceptor matrix proteoglycan 1

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of IMPG1 mRNA

NCBI chr 8:90,123,821...90,269,903
Ensembl chr 8:90,123,821...90,269,903

G

internexin neuronal intermediate filament protein, alpha

decreases expression

EXP

Propylthiouracil results in decreased expression of INA mRNA

NCBI chr 1:255,838,129...255,849,680
Ensembl chr 1:255,838,129...255,849,680

G

innate immunity activator

increases expression

EXP

Propylthiouracil results in increased expression of INAVA mRNA

NCBI chr13:50,218,149...50,238,430
Ensembl chr13:50,218,150...50,238,454

G

inner centromere protein

increases expression

EXP

Propylthiouracil results in increased expression of INCENP mRNA

PMID:22504374 PMID:30047161

NCBI chr 1:215,945,558...216,017,247
Ensembl chr 1:215,948,283...215,977,084

G

inhibitor of growth family, member 4

decreases expression

EXP

Propylthiouracil results in decreased expression of ING4 mRNA

NCBI chr 4:159,528,183...159,536,762
Ensembl chr 4:159,528,189...159,536,761

G

inhibin subunit alpha

decreases expression

EXP

Propylthiouracil results in decreased expression of INHA mRNA

NCBI chr 9:84,443,109...84,446,010
Ensembl chr 9:84,443,109...84,446,009

G

inhibin subunit beta A

decreases expression

EXP

Propylthiouracil results in decreased expression of INHBA mRNA

NCBI chr17:53,787,159...53,810,942
Ensembl chr17:53,791,444...53,804,508

G

inhibin subunit beta B

multiple interactions
decreases expression
affects expression
increases expression

ISO
EXP

AKT1 protein mutant form promotes the reaction [Propylthiouracil results in increased expression of INHBB mRNA]
Propylthiouracil results in decreased expression of INHBB mRNA
Propylthiouracil affects the expression of INHBB mRNA

PMID:7819453 PMID:20951798 PMID:24780913 PMID:36843608

NCBI chr13:33,083,671...33,089,373
Ensembl chr13:33,083,671...33,089,609

G

inhibin subunit beta C

increases expression

EXP

Propylthiouracil results in increased expression of INHBC mRNA

NCBI chr 7:65,069,450...65,082,919
Ensembl chr 7:65,069,451...65,082,919

G

inhibin subunit beta E

affects expression

EXP

Propylthiouracil affects the expression of INHBE mRNA

NCBI chr 7:65,061,531...65,064,519
Ensembl chr 7:65,061,531...65,064,519

G

inka box actin regulator 2

decreases expression

EXP

Propylthiouracil results in decreased expression of INKA2 mRNA

NCBI chr 2:195,873,617...195,888,983
Ensembl chr 2:195,873,497...195,893,605

G

INO80 complex subunit B

decreases expression

EXP

Propylthiouracil results in decreased expression of INO80B mRNA

NCBI chr 4:117,185,427...117,188,930
Ensembl chr 4:117,185,620...117,189,168

G

inositol polyphosphate-4-phosphatase type I A

increases expression

EXP

Propylthiouracil results in increased expression of INPP4A mRNA

NCBI chr 9:47,024,064...47,142,391
Ensembl chr 9:47,087,471...47,135,968

G

inositol polyphosphate-4-phosphatase type II B

affects expression
increases expression

EXP

Propylthiouracil affects the expression of INPP4B mRNA
Propylthiouracil results in increased expression of INPP4B mRNA

PMID:24780913 PMID:30047161

NCBI chr19:42,824,710...43,575,039
Ensembl chr19:42,829,871...43,185,091

G

inositol polyphosphate-5-phosphatase D

increases expression

EXP

Propylthiouracil results in increased expression of INPP5D mRNA

NCBI chr 9:95,735,533...95,840,584
Ensembl chr 9:95,735,530...95,840,589

G

inositol polyphosphate-5-phosphatase F

decreases expression

EXP

Propylthiouracil results in decreased expression of INPP5F mRNA

NCBI chr 1:192,620,891...192,700,681
Ensembl chr 1:192,620,891...192,700,681

G

inositol polyphosphate-5-phosphatase J

decreases expression

EXP

Propylthiouracil results in decreased expression of INPP5J mRNA

NCBI chr14:82,597,789...82,608,930
Ensembl chr14:82,597,790...82,609,678

G

inositol polyphosphate-5-phosphatase K

decreases expression

EXP

Propylthiouracil results in decreased expression of INPP5K mRNA

NCBI chr10:60,974,183...60,995,047
Ensembl chr10:60,973,950...60,995,046

G

insulin 1

multiple interactions
decreases expression

EXP

[Fructose co-treated with Propylthiouracil] results in increased expression of INS1 protein
Propylthiouracil results in decreased expression of INS1 mRNA

PMID:25882089 PMID:30047161

NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682

G

INSC, spindle orientation adaptor protein

decreases expression

EXP

Propylthiouracil results in decreased expression of INSC mRNA

PMID:24780913 PMID:25825206

NCBI chr 1:178,427,360...178,534,827
Ensembl chr 1:178,427,423...178,535,047

G

insulin induced gene 1

decreases expression

EXP

Propylthiouracil results in decreased expression of INSIG1 mRNA

PMID:24780913 PMID:25825206

NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778

G

INSM transcriptional repressor 1

increases expression

EXP

Propylthiouracil results in increased expression of INSM1 mRNA

NCBI chr 3:154,093,310...154,096,243
Ensembl chr 3:154,092,734...154,096,047

G

INSM transcriptional repressor 2

decreases expression

EXP

Propylthiouracil results in decreased expression of INSM2 mRNA

NCBI chr 6:78,708,983...78,711,575
Ensembl chr 6:78,705,641...78,717,027

G

insulin receptor

increases methylation
decreases expression

EXP

Propylthiouracil results in increased methylation of INSR promoter
Propylthiouracil results in decreased expression of INSR mRNA

NCBI chr12:5,991,135...6,129,275
Ensembl chr12:5,981,835...6,128,803

G

integrator complex subunit 10

increases expression

EXP

Propylthiouracil results in increased expression of INTS10 mRNA

NCBI chr16:25,682,818...25,735,840
Ensembl chr16:25,682,050...25,734,528

G

integrator complex subunit 14

increases expression

EXP

Propylthiouracil results in increased expression of VWA9 mRNA

NCBI chr 8:74,370,687...74,398,153
Ensembl chr 8:74,371,015...74,396,209

G

integrator complex subunit 2

increases expression

EXP

Propylthiouracil results in increased expression of INTS2 mRNA

NCBI chr10:71,529,021...71,576,529
Ensembl chr10:71,401,151...71,575,206

G

integrator complex subunit 7

increases expression

EXP

Propylthiouracil results in increased expression of INTS7 mRNA

PMID:24780913 PMID:30047161

NCBI chr13:105,686,208...105,739,609
Ensembl chr13:105,686,128...105,739,608

G

inversin

decreases expression

EXP

Propylthiouracil results in decreased expression of INVS mRNA

NCBI chr 5:67,406,511...67,559,355
Ensembl chr 5:67,406,485...67,559,350

G

inositol hexakisphosphate kinase 1

decreases expression

EXP

Propylthiouracil results in decreased expression of IP6K1 mRNA

NCBI chr 8:117,594,177...117,613,266
Ensembl chr 8:117,594,317...117,613,274

G

inositol hexakisphosphate kinase 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of IP6K2 mRNA
Propylthiouracil results in decreased expression of IP6K2 mRNA

PMID:25825206 PMID:30047161

NCBI chr 8:118,362,154...118,388,668
Ensembl chr 8:118,362,795...118,388,667

G

importin 11

increases expression

EXP

Propylthiouracil results in increased expression of IPO11 mRNA

NCBI chr 2:39,903,316...40,076,485
Ensembl chr 6:128,852,646...128,855,832

G

importin 13

decreases expression

EXP

Propylthiouracil results in decreased expression of IPO13 mRNA

NCBI chr 5:136,719,204...136,740,118
Ensembl chr 5:136,719,204...136,741,847

G

importin 7

increases expression

EXP

Propylthiouracil results in increased expression of IPO7 mRNA

NCBI chr 1:173,497,472...173,537,707
Ensembl chr 1:173,497,503...173,536,778

G

IQ motif and ankyrin repeat containing 1

increases expression

EXP

Propylthiouracil results in increased expression of IQANK1 mRNA

NCBI chr 7:109,605,642...109,639,854
Ensembl chr 7:109,605,703...109,639,853

G

IQ motif containing B1

decreases expression

EXP

Propylthiouracil results in decreased expression of IQCB1 mRNA

NCBI chr11:77,410,986...77,465,540
Ensembl chr11:77,410,314...77,465,478

G

IQ motif containing F2

decreases expression

EXP

Propylthiouracil results in decreased expression of IQCF2 mRNA

G

IQ motif containing G

decreases expression

EXP

Propylthiouracil results in decreased expression of IQCG mRNA

NCBI chr11:81,235,204...81,276,249
Ensembl chr11:81,235,090...81,276,249

G

IQ motif containing GTPase activating protein 1

increases expression

EXP

Propylthiouracil results in increased expression of IQGAP1 mRNA

NCBI chr 1:144,088,788...144,178,989
Ensembl chr 1:144,088,793...144,179,043

G

IQ motif containing GTPase activating protein 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of IQGAP2 mRNA
Propylthiouracil results in decreased expression of IQGAP2 mRNA

PMID:30047161 PMID:36843608

NCBI chr 2:28,629,558...28,904,649
Ensembl chr 2:28,629,558...28,904,649

G

IQ motif containing GTPase activating protein 3

increases expression

EXP

Propylthiouracil results in increased expression of IQGAP3 mRNA

NCBI chr 2:175,840,001...175,881,799
Ensembl chr 2:175,839,949...175,881,797

G

IQ motif and Sec7 domain ArfGEF 2

decreases expression

EXP

Propylthiouracil results in decreased expression of IQSEC2 mRNA

NCBI chr X:24,734,202...24,816,566
Ensembl chr X:24,734,246...24,816,566

G

IQ motif and Sec7 domain ArfGEF 3

increases expression

EXP

Propylthiouracil results in increased expression of IQSEC3 mRNA

NCBI chr 4:156,283,040...156,379,396
Ensembl chr 4:156,283,043...156,379,396

G

IQ motif and ubiquitin domain containing

increases expression
affects expression

EXP

Propylthiouracil results in increased expression of IQUB mRNA
Propylthiouracil affects the expression of IQUB mRNA

PMID:22504374 PMID:24780913

NCBI chr 4:53,897,336...53,962,279
Ensembl chr 4:53,897,332...53,954,925

G

inositol 1,4,5-triphosphate receptor associated 1

decreases expression

EXP

Propylthiouracil results in decreased expression of IRAG1 mRNA

NCBI chr 1:174,416,383...174,528,913
Ensembl chr 1:174,416,385...174,528,851

G

interleukin-1 receptor-associated kinase 2

decreases expression

EXP

Propylthiouracil results in decreased expression of IRAK2 mRNA

PMID:24780913 PMID:30047161

NCBI chr 4:148,341,704...148,398,211
Ensembl chr 4:148,341,719...148,398,210

G

interleukin-1 receptor-associated kinase 3

decreases expression

EXP

Propylthiouracil results in decreased expression of IRAK3 mRNA

PMID:24780913 PMID:30047161

NCBI chr 7:57,538,522...57,600,166
Ensembl chr 7:57,539,557...57,598,706

G

interferon regulatory factor 3

decreases expression

EXP

Propylthiouracil results in decreased expression of IRF3 mRNA

NCBI chr 1:104,616,608...104,621,402
Ensembl chr 1:104,616,469...104,621,401

G

interferon regulatory factor 5

decreases expression
increases expression

EXP

Propylthiouracil results in decreased expression of IRF5 mRNA
Propylthiouracil results in increased expression of IRF5 mRNA

PMID:24780913 PMID:30047161

NCBI chr 4:59,092,914...59,104,596
Ensembl chr 4:59,081,357...59,112,552

G

interferon regulatory factor 6

decreases expression

EXP

Propylthiouracil results in decreased expression of IRF6 mRNA

NCBI chr13:107,200,876...107,220,083
Ensembl chr13:107,200,731...107,220,049

G

interferon regulatory factor 7

increases expression

EXP

Propylthiouracil results in increased expression of IRF7 mRNA

NCBI chr 1:205,796,956...205,800,543
Ensembl chr 1:205,796,959...205,800,023

G

interferon regulatory factor 9

increases expression

EXP

Propylthiouracil results in increased expression of IRF9 mRNA

NCBI chr15:33,065,422...33,071,881
Ensembl chr15:33,065,659...33,071,879

G

immunity-related GTPase M

increases expression

EXP

Propylthiouracil results in increased expression of IRGM mRNA

NCBI chr10:33,734,640...33,742,720
Ensembl chr10:33,732,961...33,743,228

G

immunity-related GTPase Q

increases expression

EXP

Propylthiouracil results in increased expression of IRGQ mRNA

NCBI chr 1:89,251,846...89,259,799
Ensembl chr 1:89,239,205...89,259,799

G

insulin receptor substrate 1

decreases expression

EXP

Propylthiouracil results in decreased expression of IRS1 mRNA

NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:90,993,519...91,054,538

G

insulin receptor substrate 4

decreases expression

EXP

Propylthiouracil results in decreased expression of IRS4 mRNA

NCBI chr X:110,132,490...110,148,473
Ensembl chr X:110,132,405...110,149,088

G

iroquois homeobox 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of IRX1 mRNA
Propylthiouracil results in decreased expression of IRX1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:33,123,122...33,128,951
Ensembl chr 1:33,123,122...33,128,951

G

iroquois homeobox 2

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of IRX2 mRNA
Propylthiouracil results in decreased expression of IRX2 mRNA

PMID:24780913 PMID:30047161

NCBI chr 1:32,489,512...32,494,930
Ensembl chr 1:32,489,512...32,494,930

G

iroquois homeobox 4

decreases expression

EXP

Propylthiouracil results in decreased expression of IRX4 mRNA

NCBI chr 1:31,859,101...31,868,089
Ensembl chr 1:31,859,101...31,868,089

G

iroquois homeobox 5

decreases expression
multiple interactions

EXP
ISO

Propylthiouracil results in decreased expression of IRX5 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of IRX5 mRNA

PMID:24780913 PMID:30047161 PMID:36706583

NCBI chr19:30,812,033...30,816,885
Ensembl chr19:30,797,202...30,815,029

G

iron-sulfur cluster assembly 1

increases expression

EXP

Propylthiouracil results in increased expression of ISCA1 mRNA

NCBI chr17:4,910,816...4,923,478
Ensembl chr17:4,910,795...4,923,476

G

iron-sulfur cluster assembly 2

increases expression

EXP

Propylthiouracil results in increased expression of ISCA2 mRNA

NCBI chr 6:110,149,593...110,151,103
Ensembl chr14:71,931,399...71,934,660
Ensembl chr 6:71,931,399...71,934,660

G

ISG15 ubiquitin-like modifier

increases expression

EXP

Propylthiouracil results in increased expression of ISG15 mRNA

NCBI chr 5:172,066,369...172,067,656
Ensembl chr 5:172,066,369...172,067,656

G

interferon stimulated exonuclease gene 20

multiple interactions

ISO

[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of ISG20 mRNA

NCBI chr 1:142,234,729...142,246,403
Ensembl chr 1:142,236,137...142,246,401

G

ISL LIM homeobox 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ISL1 mRNA

NCBI chr 2:49,813,618...49,823,442
Ensembl chr 2:49,813,618...49,823,442

G

ISL LIM homeobox 2

increases expression

EXP

Propylthiouracil results in increased expression of ISL2 mRNA

NCBI chr 8:64,819,879...64,824,864
Ensembl chr 8:64,819,879...64,824,864

G

isthmin 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ISM1 mRNA

NCBI chr 3:147,476,983...147,555,900
Ensembl chr 3:147,475,533...147,555,908

G

isochorismatase domain containing 1

increases expression

EXP

Propylthiouracil results in increased expression of ISOC1 mRNA

PMID:24780913 PMID:30047161

NCBI chr18:54,356,757...54,377,170
Ensembl chr18:54,356,734...54,377,170

G

ISY1 splicing factor homolog

increases expression

EXP

Propylthiouracil results in increased expression of ISY1 mRNA

PMID:22504374 PMID:24780913

NCBI chr 4:121,833,870...121,854,561
Ensembl chr 4:121,806,992...121,854,561

G

inositol-3-phosphate synthase 1

affects expression

EXP

Propylthiouracil affects the expression of ISYNA1 mRNA

NCBI chr16:18,873,119...18,876,116
Ensembl chr16:18,873,121...18,875,955

G

integrin subunit alpha 1

increases expression

EXP

Propylthiouracil results in increased expression of ITGA1 mRNA

NCBI chr 2:48,379,181...48,545,336
Ensembl chr 2:48,386,249...48,545,284

G

integrin subunit alpha 10

affects expression

EXP

Propylthiouracil affects the expression of ITGA10 mRNA

NCBI chr 2:186,871,711...186,891,012
Ensembl chr 2:186,871,711...186,891,012

G

integrin subunit alpha 2b

decreases expression

EXP

Propylthiouracil results in decreased expression of ITGA2B mRNA

NCBI chr10:87,908,697...87,926,225
Ensembl chr10:87,908,697...87,925,833

G

integrin subunit alpha 4

increases expression

EXP

Propylthiouracil results in increased expression of ITGA4 mRNA

NCBI chr 3:84,569,487...84,646,276
Ensembl chr 3:84,560,369...84,641,039

G

integrin subunit alpha 7

decreases expression

EXP

Propylthiouracil results in decreased expression of ITGA7 mRNA

NCBI chr 7:1,944,447...1,973,347
Ensembl chr 7:1,944,460...1,973,339

G

integrin subunit alpha 8

increases expression

EXP

Propylthiouracil results in increased expression of ITGA8 mRNA

NCBI chr17:80,213,139...80,410,633
Ensembl chr17:80,213,143...80,410,633

G

integrin subunit alpha 9

increases expression

EXP

Propylthiouracil results in increased expression of ITGA9 mRNA

NCBI chr 8:127,185,244...127,493,296
Ensembl chr 8:127,169,226...127,493,296

G

integrin subunit beta 1

increases expression

EXP

Propylthiouracil results in increased expression of ITGB1 mRNA

NCBI chr19:73,602,277...73,650,271
Ensembl chr19:73,602,126...73,650,269

G

integrin subunit beta 4

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of ITGB4 mRNA
Propylthiouracil results in decreased expression of ITGB4 mRNA

PMID:24780913 PMID:30047161

NCBI chr10:101,705,592...101,741,933
Ensembl chr10:101,705,587...101,741,932

G

integrin subunit beta 5

decreases expression

ISO
EXP

Propylthiouracil results in decreased expression of ITGB5 mRNA

PMID:23397585 PMID:24780913 PMID:30047161

NCBI chr11:80,333,588...80,449,373
Ensembl chr11:80,333,590...80,449,373

G

integrin subunit beta 6

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of ITGB6 mRNA
Propylthiouracil results in decreased expression of ITGB6 mRNA

PMID:22504374 PMID:30047161

NCBI chr 3:65,454,964...65,579,179
Ensembl chr 3:65,456,713...65,530,333

G

integrin subunit beta 7

affects expression

EXP

Propylthiouracil affects the expression of ITGB7 mRNA

NCBI chr 7:135,225,962...135,243,522
Ensembl chr 7:135,226,555...135,243,597

G

integrin subunit beta 8

decreases expression

EXP

Propylthiouracil results in decreased expression of ITGB8 mRNA

PMID:24780913 PMID:30047161

NCBI chr 6:146,267,982...146,351,245
Ensembl chr 6:146,165,484...146,351,245

G

inter-alpha trypsin inhibitor, heavy chain 3

decreases expression
multiple interactions
increases expression

EXP
ISO

Propylthiouracil results in decreased expression of ITIH3 mRNA
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of ITIH3 mRNA
Propylthiouracil results in increased expression of ITIH3 mRNA

PMID:24780913 PMID:30047161 PMID:30085217 PMID:36706583

NCBI chr16:6,108,378...6,123,609
Ensembl chr16:6,108,382...6,123,374

G

inter-alpha-trypsin inhibitor heavy chain 4

affects expression

EXP

Propylthiouracil affects the expression of ITIH4 mRNA

NCBI chr16:6,086,985...6,102,162
Ensembl chr16:6,086,973...6,102,160

G

IL2-inducible T-cell kinase

decreases expression

EXP

Propylthiouracil results in decreased expression of ITK mRNA

NCBI chr10:31,254,667...31,316,004
Ensembl chr10:31,254,667...31,316,004

G

intelectin 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ITLN1 mRNA

NCBI chr13:86,464,641...86,490,655
Ensembl chr13:86,464,669...86,490,651

G

integral membrane protein 2A

decreases expression

EXP

Propylthiouracil results in decreased expression of ITM2A mRNA

NCBI chr X:76,559,183...76,565,144
Ensembl chr X:76,559,181...76,565,437

G

integral membrane protein 2B

increases expression

EXP

Propylthiouracil results in increased expression of ITM2B mRNA

NCBI chr15:54,955,549...54,978,455
Ensembl chr15:54,955,552...54,978,455

G

inosine triphosphatase

increases expression

EXP

Propylthiouracil results in increased expression of ITPA mRNA

NCBI chr 3:138,338,549...138,350,329
Ensembl chr 3:138,338,349...138,350,329

G

inositol 1,4,5-trisphosphate receptor, type 1

decreases expression

EXP

Propylthiouracil results in decreased expression of ITPR1 mRNA

NCBI chr 4:142,743,401...143,066,505
Ensembl chr 4:142,743,334...143,066,504

G

inositol 1,4,5-trisphosphate receptor, type 2

increases expression

EXP

Propylthiouracil results in increased expression of ITPR2 mRNA

NCBI chr 4:180,759,325...181,165,361
Ensembl chr 4:180,760,442...181,164,763

G

inositol 1,4,5-trisphosphate receptor interacting protein

decreases expression

EXP

Propylthiouracil results in decreased expression of ITPRIP mRNA

NCBI chr 1:256,704,087...256,727,661
Ensembl chr 1:256,699,832...256,727,644

G

ITPRIP like 2

increases expression

EXP

Propylthiouracil results in increased expression of ITPRIPL2 mRNA

NCBI chr 1:182,235,361...182,237,256
Ensembl chr 1:182,231,093...182,245,858

G

iodotyrosine deiodinase

multiple interactions
decreases expression

EXP

Propylthiouracil inhibits the reaction [TG protein affects the localization of IYD protein]; Propylthiouracil inhibits the reaction [TSHB protein results in increased expression of IYD mRNA]
Propylthiouracil results in decreased expression of IYD mRNA

NCBI chr 1:42,410,099...42,425,414
Ensembl chr 1:42,410,130...42,426,386

G

izumo sperm-oocyte fusion 1

increases expression

EXP

Propylthiouracil results in increased expression of IZUMO1 mRNA

NCBI chr 1:105,227,603...105,233,357

G

IZUMO1 receptor, JUNO

decreases expression

EXP

Propylthiouracil results in decreased expression of IZUMO1R mRNA

NCBI chr 8:20,025,830...20,030,829
Ensembl chr 8:20,025,831...20,029,578

G

jade family PHD finger 1

increases expression
decreases expression

EXP

Propylthiouracil results in increased expression of JADE1 mRNA
Propylthiouracil results in decreased expression of JADE1 mRNA

PMID:24780913 PMID:30047161

NCBI chr 2:126,471,124...126,524,252
Ensembl chr 2:126,471,124...126,524,252

G

jade family PHD finger 2

decreases expression

EXP

Propylthiouracil results in decreased expression of JADE2 mRNA

NCBI chr10:36,576,187...36,625,129
Ensembl chr10:36,576,187...36,623,532

G

jade family PHD finger 3

increases expression

EXP

Propylthiouracil results in increased expression of JADE3 mRNA

NCBI chr X:4,222,369...4,424,164
Ensembl chr X:4,223,425...4,398,627

G

jagged canonical Notch ligand 1

increases expression
multiple interactions
decreases expression

EXP
ISO

Propylthiouracil results in increased expression of JAG1 mRNA
Propylthiouracil inhibits the reaction [Monocrotaline results in increased expression of JAG1 protein]
Propylthiouracil results in decreased expression of JAG1 mRNA

PMID:25825206 PMID:30047161 PMID:36942326

NCBI chr 3:144,859,453...144,894,883
Ensembl chr 3:144,859,453...144,894,872

G

jagged canonical Notch ligand 2

increases expression
multiple interactions

EXP
ISO

Propylthiouracil results in increased expression of JAG2 mRNA
Propylthioura